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Abstract 
By catalysing the transfer of mannose from guanosine 5'-diphosphate mannose 
(GDP-Man) to dolichyl-pyrophosphoryl-cz-NN'-diacetylchitobioside (Dol-PP-
G1cNAc2), -1,4-Mannosyltransferase plays an essential role in the biosynthesis of 
N-glycans, the oligosaccharides linked to asparagine residues of glycoproteins. In 
vitro, a chemo-enzymatic approach to the ManGlcNAc2 trisaccharide has been 
sought as its chemical synthesis has proved particularly challenging, the introduction 
of a mannose residue in a cis-1,2-13-D-mannosidic linkage being highly kinetically 
disfavoured. The application of the enzyme for biocatalysis is however hampered by 
poor expression levels of the corresponding Saccharomyces cerevisiae gene, ALG1 
and by its very high specificity for phospholipid substrates. This glycosyltransferase 
has thus become a major target for development into an efficient biocatalyst for 
glycopeptide and glycoprotein synthesis. The aim of the current project has been to 
investigate ways in which production of the enzyme can be improved and new 
substrate specificities can be studied. For these purposes, a series of forms of 3-1,4-
mannosyltransferases fused to either the C-terminus of the green fluorescent protein 
(GFP) or the C- or N- terminus of the SNAP-tag were produced in Escherichia coli. 
It was also sought to achieve improved expression levels of the gene fusions and 
stability of the chimeric proteins by switching to a Pichia pastoris expression system. 
However, an N-terminal GFP fusion produced from a bacterial expression vector was 
considered to be the most promising and the corresponding gene fusion was used in 
directed evolution studies for improved expression levels. Key to these studies was 
the development of a new assay for the enzyme that could be used in a 'high-
throughput' fashion. Screening for active enzyme was achieved using hierarchical 
methods: firstly, identification of colonies exhibiting good fluorescence indicated 
production of folded protein. Secondly, an affinity assay using GDP-sepharose was 
developed to isolate fluorescent mutants binding to GDP. A library of ALG1 mutants 
fused to GFP was generated by error-prone PCR and after screening, a number of 
promising candidates was isolated and characterised. Upon closer analysis, none of 
these mutants gave reliably higher expression levels than the wild-type gene. It is 
hypothesised that the levels of expression of the genes were not stable enough to 
identify any useful high-expression mutants. The studies yielded a few mutants with 
multiple amino-acid changes but similar activity to the native enzyme and provided 




ADP adenosine 5'-diphosphate 
ALGI asparagine-linked glycosylation gene 1 
Algip yeast 13-1 ,4-mannosyltransferase 
AOX alcohol oxidase 
AOX alcohol oxidase gene 
APS ammonium persulphate 
ATP adenosine 5'-triphosphate 
BG 06-benzylguanine 
BLAST Basic Linear Alignment Search Tool 
bp base pairs 
BSA bovine serum albumin 
C cytidine 
CAT catalase 
CDG congenital disorder of glycosylation 
cDNA complementary deoxyribonucleic acid 
CDP cytidine 5'-diphosphate 
CHO Chinese hamster ovary 
CIP calf intestinal phosphatase 
CMP cytidine 5'-monophosphate 
DAB 3,3 '-diaminobenzidine 
dATP 2' -deoxyadenosine 5' -triphosphate 
dCTP 2' -deoxycytidine 5' -triphosphate 
DEPC diethylpyrocarbonate 
dGTP 2'-deoxyguanosine 5 '-triphosphate 
DHA dihydroxyacetone 
DHAS dihydroxyacetone synthase 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
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dNTP 2' -deoxyribonucleoside 5' -triphosphate 
Dol dolichyl 
DPGn2 dolichylpyrophosphoryl-a-N, N'-diacetylchitobioside 
D'lT dithiothreitol 
dflP 2'-deoxythymidine 5' -triphosphate 
dUTP 2' -deoxyuridine 5' -triphosphate 
EDTA ethylenediamine tetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
epPCR error-prone PCR 
ER endoplasmic reticulum 
ER Man endoplasmic reticulum inannosidase 
FACS fluorescence-activated cell sorting 
FLD formaldehyde dehydrogenase 
FMDH formate dehydrogenase 
FPLC fast protein liquid chromatography 
Fuc fucose 




GAT gal actosyltransferase 
GAP glyceraldehyde-3-phosphate 
GDP guanosine 5'-diphosphate 
GFP green fluorescent protein 
Glc glucose 








hAGT human 06-alkylguanine-DNA alkyltransferase 
HEPES 4-(2-hydroxyethyl)piperazine- I -ethanesulfonic acid 
HPLC high performance liquid chromatography 
HRP horseradish peroxidase 
IgG inmrnnoglobulin G 
IMAC immobilised metal-affinity chromatography 
IPTG isopropyl- 1 -thio-3-D-galactoside 
kb kilo base pairs 
kDa kilo Daltons 
K44 dissociation constant 
Km Michaelis constant 
LB Lysogeny Broth 
LDH lactate dehydrogenase 
Man mannose 
MES 2-(N-morpholino)ethanesulfonic acid 
MGYC Minimal Glycerol Yeast extract Casamino acid 
MMYC Minimal Methanol Yeast extract Casamino acid 
mRNA messenger RNA 
MTB mannosyltransferase buffer 
NAD nicotinamide adenine dinucleotide 
N-CAM neural cell adhesion molecule 
NDP nucleotide diphosphate 
NeuNAc N-acetylneuraminic acid 
ORF open reading frame 
P phosphate 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PDB protein data bank 
PDRS potential dolichol recognition sequence 
PEG polyethylene glycol 




PPGn2 phytanylpyrophosphoryl-cx-N, N'-diacetylchitobioside 
PVDF polyvinylidene difluoride 
QY quantum yield 
RNA ribonucleic acid 
RNAse ribonuclease 
rpm revolutions per minute 
SAP shrimp alkaline phosphatase 





lBS Tris-buffered saline 
TE Tris-EDTA 
TEMED 	N,N,N',N'-[tetramethyl]ethylenediarnine 
TLC thin-layer chromatography 
'VFBS Tween-Tris-buffered saline 
Tris tris[hydroxymethyl]aminomethane 
tRNA transfer RNA 
U uridine 
UDP uridine 5'-diphosphate 
UTP uridine 5'-triphosphate 
UV ultraviolet 
wpPCR whole plasmid PCR 
YNB Yeast Nitrogen Base 
YPD Yeast extract! Peptone/ Dextrose 
YPDS Yeast extract! Peptone/ Dextrose/ Sorbitol 
YPP Yeast extract! Peptone/ Peptone from casein digest 
X 
Definitions 
- Units of enzyme: for glycosyltransferases, 1 unit (U) is equivalent to the 
amount of enzyme required to transfer 1 imol of monosaccharide per minute under 
standard conditions. 
- Specific activity: amount of product formed by an enzyme in a given amount 
of time under given conditions per milligram of enzyme. 
- Quantum yield: ratio of the amount of light emitted from a sample to the 
amount of light absorbed by the sample. 
xi 
I General introduction 
I-i Biosynthesis of glycoproteins 
The addition of oligosaccharide chains to proteins is a wide spread phenomenon in 
both prokaryotes and eukaryotes, as emphasised by the fact that half the known 
eukaryotic proteins are considered to be glycoproteins (Taniguchi et al., 2004). The 
chemical diversity of oligosaccharide structures that can be added to proteins allows 
glycoproteins to fulfil a wide range of functions (Upreti et al., 2003; Helenius & 
Aebi, 2004). In other words, by modifying the characteristics of the parent protein, 
the oligosaccharide chains play a crucial role in diversifying the functions that can be 
displayed by a given protein sequence (Flitsch et al., 1992). The glycosylation of a 
protein is therefore an essential process in defining its function. Glycosylation can 
occur either via O-glycosylation pathways or an N-glycosylation pathway, depending 
on the nature of the glycosidic linkage formed between the mono-/oligosaccharide 
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Scheme 1-1: General structure of 0-linked glycans 1 and Winked glycans 2 
glycoproteins. Hi and R2 represent the remaining of the peptide chain. 
I-i-i O-glycosylation 
O-glycans 1 (Scheme 1-1) refer to glycoproteins, in which the glycosidic bond is 
often formed between the anomeric carbon of a saccharide and the side-chain 
hydroxyl of serine and/or threonine residues (Gemmill & Trimble, 1999). 0-
glycosylation is a species dependent process, where monosaccharide residues are 
added directly and in a stepwise fashion to a serine and/or threonine residue. In yeast, 
0-glycosylation is initiated by the addition, in the endoplasmic reticulum (ER), of an 
I 
initial mannose (Man) to the nascent polypeptide chain, while in mammals 0-
glycosylation takes place in the Golgi apparatus by initial addition of N-
acetylgalactosamine (GalNAc), fucose (Fuc) or Man residues (Gemmill & Trimble, 
1999). Although the sequence of events is very similar from one species to another, 
no general pathway can be proposed for the formation of 0-glycans 1, as the 
extension of the oligosaccharide side chain in the Golgi involves different sugars in 
mammals (galactose (Gal), N-acetylglucosamine (GlcNAc), N-acetylneuraminic acid 
(NeuNAc), Fuc) and yeasts (Man and/or Gal) (Gemmill & Trimble, 1999). However, 
0-glycans are generally biantennary structures, which are mainly found either 
clustered on cell surfaces or on excreted glycoproteins known as mucins (Freire et 
al., 2003). The most studied O-GalNAc structure is mainly present on cell surface 
and extracellular proteins, while O-GIcNAc structures undergo further glycosylation 
and phosphorylation during the cell cycle and cell growth. Although less studied, 0-
fucosylation, 0-mannosylation and O-glucosylation are essential in the early stages 
of development and for the physiological functions of the associated proteins (Peter-
Katalinic, 2005). 
1-1-2 N-glycosylation 
N-glycosylation is one of the most important post-translational modifications of 
proteins. The importance of N-glycosylation is emphasised by the fact that the 
proportion of glycosylation sites on cell surface proteins is two-fold higher than what 
would be expected by chance, underlying possible evolutionary pressures to enrich 
for glycosylation sites (Gahmberg & Tolvanen, 1996). 
In N-glycans 2 (Scheme 1-1), the glycosidic linkage is formed between the anomeric 
carbon of the first sugar residue and the side-chain amido group of an asparagine 
residue (Asn), contained in the consensus sequence or sequon: asparagine-X-
threonine/serine, where X can be any amino acid except proline (Robbins, 1999). 
The addition of the oligosaccharide to the asparagine residue requires the formation 
of a loop to enhance the nucleophilicity of the asparagine amide by creating a contact 
between the hydroxyl groups of the serine or threonine residue and the asparagine 
amide (Helenius & Aebi, 2004). This loop enables the transfer of the glycan to the 
2 
otherwise chemically rather inert side chain of the asparagine residue (Helenius & 
Aebi, 2004). If proline is present in the middle of the sequon, the loop can not be 
formed and therefore transfer of the oligosaccharide core 3 can not take place 
(Helenius & Aebi, 2004). 
Contrary to O-glycans 1, the vast majority of N-glycans 2 have in common the initial 
steps of their biosynthetic pathways and glycosylation occurs by transfer of a core 
oligosaccharide made of 14 sugar residues, i.e. Glc3Man9GlcNAc2 3 (Gic standing 












Scheme 1-2: The Glc 3Man9GlcNAc2 oligosacoharide core 3 transferred to most N-linked 
gycoproteins 2. The oigosaccharide s represented after the transfer to asparagine (3b). 
Gic stands for glucose. 
Newly synthesised proteins are co-translationally glycosylated in the ER then sent to 
the Golgi apparatus for further, species-specific modifications and finally they are 
targeted to their final destination, i.e. different organelles, the plasma membrane or 
the periplasm, amongst others (Gemmill & Trimble, 1999). 
1-1-3 First steps of the biosynthesis of N-glycans 2 in the ER 
In all eukaryotes, the N-glycan precursor Glc3Man9GlcNAc2 3 is synthesised in the 
endoplasmic reticulum as a lipid-linked intermediate, anchored to the endoplasmic 




Scheme 1-3: General structure of dolichol 4, which belongs to a family of polyisoprenoids 
and contains a variable number of isoprene units, between 15-16 for yeast species and 
unto 20 for hiaher eukarvotes. 
The synthesis of the oligosaccharide core 3 (Scheme 1-2) involves 
glycosyltransferases, which transfer a single monosaccharide from a donor, either a 
nucleotide sugar or dolichyl-phosphate-mannose S (Dol-P-Man) and dolichyl-
phosphate-glucose 6 (Dol-P-Glc) to the acceptor substrate, i.e. the growing 
oligosaccharide linked to dolichol pyrophosphate (Scheme 1-4) (Upreti et at, 2003). 
The initial step involves the transfer of an N-acetylglucosamine (GlcNAc) residue to 
dolichol phosphate (Dol-P), which is catalysed by the enzyme N-acetylglucosamine-
1-phosphate transferase, Alg7p in Saccharotnyces cerevisiac (Scheme 1-4). The 
following step requires the formation of a complex between Algl3p and Algl4p for 
the 13-1,4-addition of a second N-acetylglucosamine residue (Bickel et al., 2005; Gao 
et al., 2005). The formed dolichylpyrophosphoryl-a-N, N'-diacetylchitobioside 7a 
(DPGn2) is then extended by five mannoses on the cytosolic face of the ER, using 
different mannosyltransferases, requiring guanosine 5'-diphosphate-mannose 8 
(GDP-Man) (Scheme 1-10) as the sugar donor. After flipping of the acceptor 
substrate towards the luminal face of the ER, four mannoses and three glucoses are 
transferred from Dol-P-Man S and Dol-P-Glc 6 respectively. During this process, 
Alg9p was recently found to act twice on the growing oligosaccharide chain to add 
two a-1,24inked mannoses (Frank & Aebi, 2005) (Scheme 1-4). 
The Glc3Man9GlcNAc2 3 oligosaccharide is finally transferred to the nascent 
polypeptide chain (Burda & Aebi, 1999). This transfer requires the recognition of the 
oligosaccharide side chain of the protein, especially of the terminal (X-1,2-linked 
glucose, by the oligosaccharyltransferase (Helenius & Aebi, 2004). 
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Scheme 1-4: Schematic representation of the first steps of N-glycosylation in the ER in the yeast Saccharomyces cerevisiae, the common model 
for eukaryotic organisms. The S. cerevisiac gene encoding the corresponding glycosyltransferase involved in each step is indicated, when known. 
1-1-4 Glycosylation in the ER: Importance of glycosylation for the 
folding and quality control of proteins 
As soon as the glycan 3 is transferred to the nascent protein, it plays an essential role 
for the subsequent stabilisation of the protein (Helenius & Aebi, 2004). The 
oligosaccharyltransferase indeed accepts substrates that are still unfolded and the 
glycan 3 is subsequently required for the protein folding and quality control 
(Helenius & Aebi, 2001; Gahmberg & Tolvanen, 1996). The oligosaccharide chain is 
important for the entry of the newly synthesised glycoprotein into the calnexin-
calreticulin cycle (Scheme 1-5), i.e. the cycle involved in the control of correct 
protein folding in higher eukaryotes (Parodi, 1999; Butters, 2002). 
The process requires the initial trimming of the two terminal glucoses by glucosidase 
I and glucosidase II respectively, to enable the binding of the resulting 
oligosaccharide 9 to either the soluble caireticulin or the membrane-bound calnexin, 
both fulfilling similar functions. 
a- 4ER57 
	
9a 	 Glucosidase II 
C3 
 r GIucosI\j iOa 
translerase 
3b 	Glucosidase II / 	 &ucosidase Folded protein 
Glucosidase I 
Scheme 1-5: Representation of the calnexin-caireticulin cycle. CRX stands for calnexin 
and CRN stands for its soluble equivalent, calreticulin. Both act as folding sensors for the 
newly synthesised glycoproteins. Reproduced from Helenius & Aebi, 2001. 
These two lectins also act as molecular chaperones as they prevent aggregation and 
degradation of proteins and expose them to ERp57, a thiol-disulfide oxidoreductase, 
a cofactor which promotes disulfide bond formation (Helenius & Aebi, 2001). Once 
proper folding is obtained, the glycoprotein is released from calnexinlcalreticulin by 
removal of the last glucose residue of GlcMan9G1cNAc2 9 by glucosidase R. 
However, if the protein is not properly folded it will be recognised by uridine 5'-
diphosphate glucose: •glycoprotein glucosyltransferase which will reglucosylate the 
glycoprotein and enable the protein to re-enter the cycle until proper folding is 
achieved (Parodi, 1999). If, however, the protein fails to fold, it is directed to ER-
associated degradation process (Helenius & Aebi, 2004). Finally, in both yeast and 
vertebrates, an cc-1,2-mannosidase, either ER mannosidase I or ER mannosidase II, 
removes a mannose residue to yield one of the isomers ba or lOb of the 
MangGlcNAc2 structure (Scheme 1-7). 
Alternative processing of the GlcMan9G1cNAc2 9 structure involves an a-
endomannosidase, which removes the a-1,3-Glc-a-1,2-Man disaccharide to yield the 
Man8GlcNAc2 isomer lOc (Scheme 17) (Moremen, 2002). The formed 
Man8G1cNAc2 isomers 10a, IN and lOc are all transported to the Golgi, this 
transport being mediated by two lectins that serve as cargo capture and transport 
receptor for ER to Golgi traffic of glycoproteins (Helenius & Aebi, 2001). 
1-1-5 Glycosylation in the Golgi 
The first Golgi modifications of the oligosaccharide moieties Man8G1cNAc2 bOa, lOb 
or lOc include the trimming of certain monosaccharides by glycosidases and the 
addition of various carbohydrate side-chains by glycosyltransferases, in a species-
specific manner (Dean, 1999). In yeast, the oligosaccharide chain is never trimmed 
further than Man8GlcNAc2 10 and usually high-mannose type N-linked glycans 11 
(Scheme 1-6) are formed by addition of mannoses by mannosyltransferases 
(Macauley-Patrick et al., 2005). In vertebrates, further diversification is introduced 
on the N-glycans 2 leading to the formation of high-mannose 11, hybrid 12 or 
complex type 13 oligosaccharide chains (Scheme 1-6) (Elbein, 1991). The process 
starts with the trimming of the oligosaccharide core MangGlcNAc2 10 by ct-1,2-
mannosidases potentially leading to the Man5GlcNAc2 oligosaccharide 15, although 
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Scheme 1-6: General structures of N-linked glycans: high-mannose 11, hybrid 12 and 
complex type 13. The pentasaccharide core 14 common to all N-linked glycans 2 is shown - -- - 
within the boxes. 
Complex N-glycan glycoproteins 13 first require the action of a N-
acetyiglucosaminyltransferase, GIcNAcT-I (or GuT I), which adds GIcNAc in a 
1,2-linkage to Man5GlcNAc2 15. This oligosaccharide 12 is an example of the hybrid 
type glycan and it is the substrate for a a-mannosidase II, which acts on 
GIcNAcMan5G1cNAc2-Asn 12 to remove both the cz-1,3-mannose and ct-1,6-
mannose (Scheme 1-7). The resulting structure, i.e. GlcNAcMan3GlcNAc2-Asn 16, 
can remain as such or serve as a substrate for a GIcNAcT-11 (or GnT II) initiating the 
formation of the complex type glycoproteins 13 (Varki et al., 1999). Further 
modifications of N-glycans of the hybrid 12 and complex 13 type commonly involve 
the addition of two or more G1cNAc-bearing branches and fucosylation of the 
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Scheme 1-7: Further modifications in the ER and the Golgi apparatus of the Winked glycans 2 of mammalian glycoproteins after transfer of the core 
Glc3Man9GIcNAc2  3 oligosaccharide to asparagine. These modifications lead to the high-mannose 11, hybrid 12 and complex type 13 N-linked 
glycans of glycoproteins. GIc: glucosidase; Man: mannosidase; GnT: GIcNAc transferase. Reproduced from Moremen, 2002. 
A number of factors influence whether a glycosylation site is to be further modified 
or not. Steric factors and the tertiary structure of the folded glycoprotein substrate are 
known to direct the action of glycosidases and glycosyltransferases (Paulson, 1989). 
Also, the presence of certain monosaccharides can act as a signal to stop further 
glycosylation. For example, in Saccharomyces cerevisiae (S. cerevisiae), after the 
addition of the initial ct-i ,6-linked mannose to Man8OlcNAc2 10, the addition of a a-
1,2-linked mannose to this later determines whether the oligosaccharide is to be 
further elongated or is to remain a core size oligosaccharide (Dean, 1999). The 
polypeptide sequence can also affect its own glycosylation directly as illustrated by 
lysosomal enzymes for which the transfer of a GIcNAc-phosphate to certain 
mannoses necessitates the recognition of a specific lysosomal protein domain by the 
transferring enzyme (Paulson, 1989). Finally, the ultimate glycosylation of 
glycoproteins depends on the differential expression of the many 
glycosyltransferases genes varying between species, tissues, cell types within each 
tissue and the time of the development that is being considered (Paulson, 1989). 
In conclusion, while the diversity of glycoforms in the ER remains limited, allowing 
processing enzymes to differentiate the maturing glycoproteins, further 
diversification is introduced in the Golgi to give rise to the tremendous diversity of 
glycoconjugates that reach the cell surface (ilelenius & Aebi, 2004). This switch 
from structural uniformity in the ER to diversification in the Golgi coincides with a 
marked change in glycan function from quality control to targeting and biological 
activity. Despite the diversity of glycan structures displayed by the cells, all N-linked 
glycans 2 carry the mark of their conserved biosynthetic pathway, as they have all 
been shown to have retained the same pentasaccharide core, Man3GlcNAc2 14 
(Scheme 1-6). 
1-1-6 Transport from the Golgi apparatus 
Once terminal glycosylation is achieved, the glycoprotein is transported to its final 
localisation where it can potentially fulfil a biological role. The intracellular transport 
and targeting of glycoproteins are influenced by the modifications introduced to the 
N-linked glycans 2 in the Golgi (Helenius & Aebi, 2004; Gahmberg & Tolvanen, 
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1996). The best example is the selective targeting of lysosomal hydrolases from the 
Golgi apparatus to endosomes and lysosomes (Helenius & Aebi, 2001). The presence 
of a mannose-6-phosphate on the high mannose structure of the glycan attached to 
lysosomal enzymes serves as the targeting signal for localisation of these enzymes to 
the lysosome (Paulson, 1989). This process starts with the transfer of a GIcNAc-
phosphate to terminal and subterminal mannoses, which is catalysed by an enzyme 
that recognises a protein domain shared only by lysosomal enzymes (Paulson, 1989; 
Helenius & Aebi, 2001). After removal of the GicNAc, the remaining mannose-6-
phosphate group is recognised by mannose-6-phophate receptors in the trans-Golgi 
network (Helenius & Aebi, 2001). The ligand receptor complex then exits the Golgi 
via a coated vesicle and is delivered first to a pre-lysosomal and then to a lysosomal 
compartment (lElbein, 1991). In this manner, lysosomal enzymes are physically 
separated from other proteins that are also synthesised and glycosylated in the ER but 
destined for membrane insertion or secretion (Elbein, 1991; Helenius & Aebi, 2001). 
The mannose-6-phosphate receptor is also known as the insulin-like growth factor-11 
receptor as when it is present on cell surfaces, it enables the degradation of non-
glycosylated insuline-like growth factor II as well as the degradation / activation of 
extracellular mannose-6-phosphate bearing l.igands (Hawkes & Kar, 2004). Loss of 
the mannose-6-phosphate / insulin-like growth factor 11 receptor results in an 
increase of cell proliferation, a decrease in apoptosis and an enhancement in tumour 
invasion and metastasis and this receptor has therefore been proposed to act as a 
tumour suppressor (Huang et al., 2006). 
More generally, when the oligosaccharide chain has reached its final constitution, the 
glycoprotein is targeted to the extracellular space, the lysosome, or the plasma 
membrane where it will display its own specific function (Helenius & Aebi, 2004). 
1-2 Functions of the carbohydrate moiety of glycoproteins 
1-2-1 Direct effect of the glycan on the protein 
One of the most important functions of carbohydrate chains is to stabilise the protein 
structure and facilitate its folding (Paulson, 1989). When protein glycosylation is 
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inhibited, proteins are much less stable and tend to misfold and aggregate in the cell, 
thus failing to reach a proper conformation and functional state (Helenius & Aebi, 
2001; Elbein, 1991). Glycoproteins are then much more sensitive to adverse effects 
and show reduced stability to the heat, various detergents or proteases (Elbein, 1991). 
The oligosaccharide moieties of glycoproteins thus confer resistance of the 
polypeptide chains to denaturation and proteolysis (Helenius & Aebi, 2004). For 
example, O-glycans 1 at 13-turns of proteins have been shown to protect proteins 
from Ihe action of proteases as the O-glycans 1 mask this turn from the proteases 
(Gahmberg & Tolvanen, 1996; Upreti et al., 2003). Finally, the introduction of N-
linked glycans 2 restricts the conformational space available to the polypeptide 
chain, leading to structural rigidity and increased stability in a segment proximal to 
the glycosylation site (Helenius & Aebi, 2004). This increased stability directs the 
protein-folding pathway and is likely to stem from a decrease in the disorder of 
unfolded proteins upon glycosylation, thus destabilising the unfolded state of the 
glycosylated variants compared to the non-glycosylated ones (Imperiali & O'Connor, 
1999). Once the folded structure is achieved, the glycan moiety does not take part in 
the maintenance of the structure and monosaccharides can usually be removed or/and 
modified with little impact on the overall secondary structure (Helenius & Aebi, 
2004). However, the importance of the sugar chain on the properties of a protein 
depends on the extent of its glycosylation. The addition of large, hydrophilic residues 
of substantial molecular weight does indeed affect the biophysical properties of the 
protein, leading to an increase in solubility and a fine-tuning of the charge and the 
isoelectric point of the protein (Imperiali & O'Connor, 1999; Paulson, 1989). 
1-2-2 Biological functions of the glycan moiety of glycoproteins 
Once a glycoprotein has gained its final structure and reached its final localisation, 
its biophysical properties allow it to play essential roles in a wide variety of 
biological functions important not only for the cell but also for the whole organism. 
Of particular importance to the functions of glycoproteins is the presence of either 
sialic acid or fucose residues on the glycan moiety. Sialic acids are often found as 
non-reducing end sugars on mammalian glycolipids and glycoproteins as the 
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negative charge that they possess alters the biological properties of surface 
glycoproteins, thus involving them in a number of biological processes including 
cell-cell interactions, T-cell interactions and cellular fate (Tribulatti et al., 2005). 
Fucose (6-deoxy-L-galactose) is also a common terminal modification of glycan 
structures and its addition is regulated during cellular differentiation. The addition of 
fucose confers unique functional properties to oligosaccharide moieties allowing 
them to play novel biological functions compared to their non-fucosylated 
counterpart (Becker & Lowe, 2003). These functions include the antigenic properties 
of the ABO blood group, the interactions between microbe and host, the selectin-
mediated leukocytes adhesion, roles in development and in human diseases, amongst 
others (Becker & Lowe, 2003). 
1-2-2-1 Glycoproteins as receptors 
One of the main functions of the oligosaccharides present on a protein is to serve as 
recognition units for carbohydrate-binding proteins such as lectins, glycosidases and 
glycosyltransferases (Helenius & Aebi, 2004). On the surface of cells such 
recognition events mediate interaction with a large number of external ligands such 
as hormones, bacterial toxins, viruses and circulating proteins (Gahmberg & 
Tolvanen, 1996; Hu & Walker, 2002). For example, some bacteria and Trypanosoma 
cruzi avoid being the target of an immune response from their host by presenting 
sialic acids on their pili (Atayde et al., 2004). Sialic acids are normal surface 
components of host erythrocytes and this therefore protects the bacteria from attack 
(Upreti et al., 2003). Cellular adhesions mediated by cell-surface carbohydrates are 
also critical in intracellular interactions in processes such as fertilisation, 
differentiation during development and oncogenesis (Elbein, 1991). 
1-2-2-2 Structural role of glycoproteins 
Additionally, N-glycans 2 play a role in the maintenance of tissue structure, porosity 
and integrity (Varki et al., 1999). The cell surface glycoproteins are important 
structural elements in bacteria as they help maintaining the form and shape of these 
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organisms (Upreti et al., 2003). Interestingly, the bacterial and fungal cell walls have 
a carbohydrate composition different from that of mammals and this makes them 
ideal targets for cell-wall-specific based drugs (Williams & Davies, 2001). 
1-2-2-3 Glycosylation in immune responses 
Another important role is the involvement of the sugar chains on proteins in immune 
responses. The glycosylation pattern of some glycoproteins serves to modulate the 
immune response as specific mannose oligosaccharide can activate as well as inhibit 
cellular immune response at several different levels (Elbein, 1991; Helenius & Aebi, 
2004). Additionally, immunoglobulins and other serum proteins as well as tumour 
antigens actually are N-linked glycoproteins (Elbein, 1991). Moreover, N-linked 
glycans 2 as well as 0-linked glycans 1 and lipid-linked glycans are involved in 
leukocyte adhesion and recruitment in inflammation (Lowe, 2003). N-glycans 2 also 
provide signals for protein targeting as exemplified by the clearance from the blood 
of glycoproteins that have lost their terminal sialic acids. These asialo- and 
asialogalacto-glycoproteins are recognised by the asialo- and asialogaiacto-
glycoprotein receptor proteins on the blood cells and targeted to liver hepatocytes 
and macrophages, respectively (Paulson, 1989; Elbein, 1991). 
1-2-2-4 Roles of glycans in development and cancer invasion 
Finally, glycosylation has a role to play during development. Some polypeptide-
specific glycosylations are developmentally regulated. The best known example is 
the polypeptide-specific polysialic acid substitutions on the neural cell adhesion 
molecule, N-CAM (Paulson, 1989). The large polysialic moiety is present on 
embryonic N-CAM to reduce the affinity of the homotypic N-CAM binding 
interactions that mediate cell-cell adhesion and thus prevent tight adhesions during 
periods of active cell migration (Paulson, 1989). The polysialic motif is no longer 
present on adult N-CAM as it is then no longer required. More generally, the 
terminal saccharides of glycoproteins differ at different stages of the early 
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development and depend on the differential expression of the glycosyltransferases 
genes that synthesise them (Paulson, 1989; Kemmner et al., 2003). 
The understanding of the expression pattern of glycosyltransferases at a given time in 
a given cell is also important for the study of metastasis and carcinogenesis. Certain 
monosaccharides present on the N-glycans 2 of cell surface glycoproteins are indeed 
involved in cancer invasion and metastasis (Taniguchi et al., 2004). The presence of 
these specific monosaccharides result from different expression levels of the 
glycosyltransferases genes in carcinoma cells compared to that of healthy cells, as 
illustrated by the altered expression of sialyltransferases genes in carcinoma cells 
(Kemmner et al., 2003). The alterations in the expression of the glycosyltransferases 
genes are responsible for the aberrant biosynthesis of membrane-bound 
carbohydrates during carcinogenesis and metastasis (Kemmner et al., 2003; 
Taniguchi et al., 2004). 
1-2-2-5 Congenital disorders of glycosylation 
The fundamental role of N-linked glycans 2 in development is probably best 
illustrated by the congenital disorders of glycosylation (CDG) that have been the 
focus of many studies over the past 10 years (Grubenmann et al., 2004). Up to now, 
18 inherited human CDGs resulting from altered protein N-glycosylation have been 
identified but this number is likely to increase in the future (Freeze & Aebi, 2005). 
The first CDGs were identified from the abnormal sialylation of a proportion of 
serum transferrin molecules, which results in various clinical features including 
psychomotor retardation, low muscle tone, incomplete brain development, visual 
problems, coagulation disorders and endocrines abnormalities (Freeze & Aebi, 
2005). This group of human diseases is usually caused by defective glycosylation of 
glycoproteins due to mutations in the genes required for the biosynthesis of N-
glycans 2 (Schwarz et al., 2004). The congenital disorders of glycosylation have 
been separated into two types depending on whether the defect occurs before or after 
the transfer of 3 to the nascent glycoproteins (Schwarz et al., 2004). Thus, type I 
encompasses the deficiencies of enzymes involved in the biosynthesis in the ER and 
the transfer of the glycan chain 3 to the nascent protein while type II refers to defects 
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affecting the trimming and the elongation of the N-linked glycans 2 in the ER and the 
Golgi (Schwarz et al., 2004). From a clinical point of view, CDG group I patients are 
identified by the absence of the entire oligosaccharide moieties normally present on 
the sequons of transferrin, while CDG group II patients present incomplete 
oligosaccharide at the glycosylated sites of transferrin (Freeze & Aebi, 2005). This 
difference results from the biosynthetic pathway of N-glycans: the assembly of the 
complete oligosaccharide chain on the lipid carrier is essential for the transfer of the 
oligosaccharide to the sequon by the oligosaccharyltransferase complex, which only 
recognises the complete sugar chains. Therefore, a mutation affecting the activity of 
any enzyme involved in the assembly of the G1c3Man9G1cNAc2 3 structure would 
result in an absence of glycosylation. By contrast, glycosylation in the Golgi is not a 
stepwise process as glycosyltransferases compete for the same substrate at branching 
points in the pathway and the resulting structure is depending on the localisation, the 
expression level of the various genes encoding the different glycosyltransferases, the 
availability of the substrates and other factors (Freeze & Aebi, 2005). This explains 
that CDG group I patients display glycoproteins that either lack whole 
oligosaccharide chains or present the normal structure whereas CDG group ii 
patients possess oligosaccharides of incomplete composition. Congenital disorders of 
glycosylation are not only caused by defect in N-glycosylation but also in 0-
glycosylation. CDG lIc was found to be caused by a deficiency in the GDP-fucose 
transporter, which provides fii cose to both N- and 0-glycans. The absence of fucose 
on the N-linked glycans of 1gM and on the 0-linked glycans of leukocyte surface 
proteins results in an increased number of circulating leukocytes and leads to 
frequent infections (Freeze & Aebi, 2005). Similarly, CDG hf is due to a defect in 
the CMP-sialic acid transporter, which leads to normal sialylation of the serum 
glycoproteins, including transferrin but absence of the sialyl-Lewis' on leukocytes. 
In those two cases, the transferrin is normally glycosylated and new means to detect 
the origins of the disorders had to be developed. Also, defect in one of the protein 
involved in trafficking of components of the glycosylation machinery resulted in 
aberrant glycosylation but whether this should be classified as a CDG is open 
discussion (Freeze & Aebi, 2005). 
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The defect in mannosyltransferase I, the human enzyme involved in the addition of 
the first mannose to DPGn2 7a, corresponding to CDG-Ik, results in particularly 
severe phenotypes with death in early infancy (Kranz et al., 2004). 
These molecular causes for inherited deficiencies emphasise the importance of 
glycosylation for viability and normal development, requiring over 100 intact 
glycosyltransferases, glycosidases and transport proteins for sugar nucleotides 
(Schwarz et al., 2004). The viability of biological systems is thus highly dependent 
on the proper functioning of glycosidases and glycosyltransferases, the architects of 
the glycan structures. 
1-3 Glycoforms and synthetic utility of glycosyltransferases 
The study of glycoproteins functions has long been hampered by the diversity of 
glycoforms and glycotypes that might exist for a given glycoprotein (Rademacher et 
al., 1988). This is referred to as the microheterogeneity of glycoproteins and reflects 
the fact that an identical sequon can bear different glycan structures depending on the 
cell where it has been produced in and the expression pattern of the glycosidases and 
glycosyltransferases genes at the time the N-glycan 2 was synthesised (Varki et al., 
1999). This heterogeneity has been a barrier to determining the functions of specific 
glycoforms as their often almost identical structures do not allow for their separation. 
Only heterologous pools of glycoproteins could be obtained from natural sources. 
Each modification is important for the biological function of the final glycoprotein, 
as the change of a single monosaccharide may completely modify the activity of the 
resulting protein. One of the best examples of glycoproteins possessing different 
functions according to its glycosylation is glycodelin, a glycoprotein present in 
reproductive tissues (Scheme 1-8) (Koistinen et al., 2003; Morris et al., 1996). 
Although glycodelin always possesses the same polypeptide sequence, glycosylation 
of this protein was shown to be gender-specific, i.e. glycodelin-A is found in amiotic 
fluid (Dell et al., 1995) while glycodelin-S is present in seminal plasma (Scheme 1-
8). The different N-glycans 2 found on the two glycodelins impart different functions 
to the protein: glycodelin-A inhibits sperm-egg binding and possesses 
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immunosuppressive properties while glycodelin-S is proposed to be responsible for 
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Scheme 1-8: Different N-glycans 17-24 present at asparagine residues 28 and 63 of 
glycodelin-S. Reproduced from Morris at al., 1996. 
Despite the difficulties generated by the microheterogeneity of glycoproteins, their 
functions have become more and more accessible to our understanding with the 
cloning of more and more genes encoding glycosidases and glycosyltransferases 
(Varki et al., 1999). But, despite impressive advances in recent times, some 
biological imperatives for glycosylation still remain unclear (Williams & Davies, 
2001). The ability to manipulate the glycosidases and glycosyltransferases genes and 
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to synthesise N-glycans 2 of precise structure by controlled removal or addition of 
specific saccharide units will allow further deciphering of the functions of 
glycoproteins. 
1-4 Glycosyltransf erases 
1-4-1 Definition and specificity 
Glycosyltransferases catalyse the transfer of a monosaccharide from an activated 
donor substrate 25 to an acceptor molecule 26 (Scheme 1-9). 
GT 	 0 Ii 
o 	+ HO7 	 + Ho-P-Al 
0-P-Al 	 OH 
25 	
OH 
26 	 27 	 28 
Scheme 1-9: General reaction catalysed by a glycosyltransferase (GT). For facilitated 
representation, the hydroxyl groups of the sugars have not been drawn. 
Each enzyme has its own donor, acceptor and linkage specificity (Unligil & Rini,- 
2000). The typical donor 25 for Leloir pathway enzymes is a nucleotide 5'-
diphosphate sugar (NDP-sugar) 25a (Scheme 1-10) but non-Leloir enzymes accept 
other types of substrates, for example dolichyl-phosphate-mannose S and dolichyl-
phosphate-glucose 6. 
Scheme 1-10: Guanosine 5-diphosphate mannose 8 as an example of nucleotide 5'-
diphosphate sugar (NDP-sugar) 25a, the typical sugar donors for the Leloir pathway 
enzymes. 
The possible nature of the acceptor substrate 26 is much broader including proteins, 
growing oligosaccharide-chains, lipids, steroids and carotenoids, amongst others 
(Saxena et al., 1995). Glycosyltransferases are generally highly specific for one 
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particular type of acceptor substrate 26. This very narrow acceptor substrate 
specificity explains the step-wise addition of carbohydrate units to the growing 
oligosaccharide chain during the biosynthesis of N-glycans 2 as the product of one 
glycosyl -transferis usually the substrate for the next glycosyltransferase (Scheme 1-
4) (Varki et al., 1999). The binding of a glycosyltransferase to its acceptor substrate 
26 indeed necessitates the recognition of a few monosaccharide units on the acceptor 
26 but the protein sequence can also influence the action of the enzyme (1-1-5) 
(Varki et al., 1999). 
1-4-2 Primary sequence and secondary structure 
Glycosyltransferases have commonly been classified according to their donor 25 and 
acceptor 26 substrates, linkage specificities and homologies in their primary 
sequences (Hu et al., 2003). This classification now counts 78 families (Breton etal., 
2005) but this number is constantly increasing due to the identification of more and 
more of these sugar-transferring enzymes (http://afmb.cnrs-mrs.fr/CAZY/) . Members 
of the same family can be of very different sources, suggesting a common ancestor 
and an evolutionary pressure to maintain these sequence similarities (Varki et al., 
1999). 
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Scheme 1-11: Schematic representation of a sialyltransferase as an example of 
glycosyltransferase possessing a type II membrane protein topology. The conserved large 
(L), small (S) and very small (VS) sialylmotifs of the catalytic motif are represented. TMB 
stands for transmembrane domain. 
For example, members of the sialyltransferase family are characterised by three 
sialyl motifs: sialyl motif large L (50 amino acids), small S (23 amino acids) and 
very small VS (6 amino acids) (Scheme 1-11) (Breton & Imberty, 1999). 
More interestingly, glycosyltransferases from different families have been shown to 
contain a similar DXD motif and this motif is presumed to be important in the 
coordination of the metal cation in binding of the nucleotide sugar (Breton & 
Imberty, 1999). However, there is little homology between glycosyltransferases of 
different families and even between two glycosyltransferases that accept the same 
acceptor but catalyse a different transfer (Breton & Imberty, 1999) or even 
sometimes between two members of the same family (Ha et al., 2000). Despite little 
primary sequence homology, Golgi-localised glycosyltransferases have been shown 
to have the same overall secondary structure characterised by a short N-terminal 
cytoplasmic domain, a trans-membrane domain, a stem region and a large luminal C-
terminal catalytic domain (Breton & Imberty, 1999). These glycosyltransferases have 
been classified as type II membrane proteins as they display the corresponding 
topology (Scheme 1-11) (Breton & Imberty, 1999). 
1-4-3 Reaction conditions and mechanism 
Primary observation concluded that most glycosyl-transfers require the presence of a 
metal cation, generally Mg 2 or Mn2 and a pH between 5.0 and 7.0, compatible with 
the pH values observed in the ER and the Golgi apparatus (Varki et al., 1999). The 
reactions were found to be regio- and stereo-selective and to occur with either 
retention or inversion of configuration at the anomeric carbon, depending on the 
enzyme (Scheme 1-12) (Saxena et al., 1995). On this basis, glycosyltransferases have 
been classified in two groups, i.e. inverting glycosyltransferases and retaining 
glycosyltransferases as a single glycosyltransferase can produce only one type of 
linkage (Varki et al., 1999). 
The mechanism of action of glycosyltransferases is unknown although it is 
commonly thought that the reaction proceeds via an SN2 mechanism whereby a 
nucleophile of the acceptor 26 would attack the anomeric position of the donor 25 
(Scheme 1-12). As such a mechanism results in an inversion of configuration, 
retaining glycosyltransferases are assumed to proceed through a glycosyl-enzyme 
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Scheme 1-12: Mechanisms for glycosyl-transfer with inversion (upper part) or retention 
(lower part) of configuration at the anomeric position. Adapted from Rye & Withers, 2000. 
Ri represents the remaining of the acceptor substrate 26. The hydroxyl groups on the sugar 
moiety of the NDP-sugar 25a are not represented. 
Moreover, an acidic residue is thought to act as a base to help the deprotonation of 
the nucleophile hydroxyl, a mechanism derived from the oxocarbenium-ion-like 
character of the glycosyltransferase transition state (Unligil & Rini, 2000). 
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In more detail: for retaining enzymes, the carboxylate of the side chain of an amino 
acid residue attacks the anomeric position of the sugar donor 25 (Scheme 1-12). A 
second carboxylate then acts as a nucleophile to displace the nucleotide diphosphate 
(NDP) from the NDP-sugar 25a. The transfer of the sugar from the formed glycosyl-
enzyme intermediate involves displacement of the enzyme from the intermediate by 
the hydroxyl group of the acceptor 26 (Thomson etal., 2000). 
1-4-4 Glycosyltransf erases structural superfamiues 
1,' 	
\ /0 - 
Scheme 1-13: Schematic representation of the phage T4 p-galactosyltransferase putative 
active site as a model for the catalytic active site of members of the glycosyltransferases A 
superfamily. Reproduced from Breton & Imberty, 1999. 
In the past few years, crystal structures of different types of glycosyltransferases 
have been obtained shedding new light on the structures and mechanisms of 
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glycosyltransferases. The glycosyltransferases have indeed been classified in only 
three structural super-families, according to the crystal structures obtained to date. 
The glycosyltransferase A superfamily is characterised by a ciJI3/a sandwich that 
resembles a Rossmann fold (i.e. a (x/13  open sheet motif) (Breton et al., 2005). The 
active site is created by the association of a central P sheet with a smaller one 
(Breton et al., 2005). Members of this family possess a DXD motif involved in the 
binding of divalent cation that is essential to enzymatic activity (Scheme 1-13). 
They all use a NDP-sugar 25a as a donor substrate 25 and a catalytic base in the 
active site (Hu & Walker, 2002). The metal cation anchors the pyrophosphoryl group 
of the NDP-sugar donor 25a in the catalytic active site of the enzyme, through 
interaction with the DXD motif (Hu & Walker, 2002). Interestingly, both retaining 
and inverting glycosyltransferases belong to this family (Scheme 1-14), showing that 
the structural elements required for glycosyl-transfer are retained, independently of 
the strereochemistry of the reaction (Breton et al., 2005). Retention or inversion of 
conformation at the anomeric position depends on whether there are interactions with 
both or only one of the aspartate residues of the DXD motif (Breton et al., 2005). 
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Scheme 1-14: Ribbon diagram of the crystal structure of mouse c-1,4-N-
acetylhexoaminyltransferase complexed with UDP-GaINAc as an example of structure of the 
glycosyltransf erase A superfamily. The bound NDP-sugar 25a is represented with a stick 
model and the manganese ion is represented by a ball. From Breton et al., 2005. UDP stands 
for uridine 5'-diphosphate. 
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The glycosyltransferase B superfamily is characterised by two Rossrnann folds 
separated by a linker region where the active site is located (Scheme 1-15). 
Glycosyltransferases from this family do not require a divalent cation for activity, 
although the rate of catalysis can be enhanced when such a ligand is present (Hu & 
Walker, 2002). In contrast to the glycosyltransferase A superfamily, the a/13/ct 
folding unit is used to bind the NDP-sugar donors 25a as it stabilises the a phosphate 
and anchors both the ribose and hexose sugar, explaining the lack of requirement for 
a divalent metal cation (Hu et al., 2003). The binding occurs at the highly conserved 
C-domain through interactions via a glutamate residue and glycine-rich loops 
(Breton et al., 2005). The N-domain is structurally more diverse, reflecting the wide 
variety of possible acceptor substrates (Breton etal., 2005). 
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Scheme 1-15: Ribbon diagram of the crystal structure of E. co/i MurG complexed with UDP-
GIcNAc as an example of the g lycosyltran sfe rase B superfamily. From Breton et al., 2005. 
The glycosyltransferase C superfamily (Scheme 1-16) is characterised by a aII3Ia 
sandwich that differs from that of the GT-A superfamily. Moreover, members of this 
family do not require a metal cation for activity (Breton et al., 2005). 
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Scheme 1-16: Ribbon diagram of the crystal structure of Campylobacter jejuni 
sialyltransf erase CstIl complexed with CMP-3FNeuAc, member of the glycosy!transferase C 
superfamily. CMP stands for cytidine 5'-monophosphate. From Breton et al., 2005. 
More generally, most crystal structures of glycosyltransferases present flexible loops 
in the vicinity of the donor/acceptor binding, probably involved in the protection of 
the bound NDP-sugar 25a from hydrolysis and in product 27 release (Unligil & Rini, 
2000). It is suggested that the product might be bound tightly to the donor/acceptor 
binding site and that cleavage of the linkage would send the signal that the reaction is 
complete and distortion of the loop would then allow for product 27 release, thus 
avoiding product 27 inhibition (Unligil & Rini, 2000). For some 
glycosyltransferases, the free enzyme has no affinity for the acceptor substrate 26 
and binding of the donor substrate 25a is required to induce a change in the 
conformation of the enzyme that is leading to the creation of the acceptor 26 binding 
site (Breton et al., 2005). Moreover, the change of conformation creates a lid over 
the donor substrate 25a that is thought to protect the NDP-sugar 25a against 
hydrolysis by water molecules (Breton et al., 2005). However, such a conformational 
change upon donor substrate 25a binding was not observed for the yeast ct-1,2-
mannosyltransferase where the active site seems to be preformed, suggesting that this 
is not a general rule for all glycosyltransferases (Lobsanov et at., 2004). 
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1-5 Need to broaden the substrate specificity of glycosyltransf erases 
Glycosyltransferases are the ideal tools for the synthesis of N-glycans 2 of known 
composition, as they enable the controlled introduction of a monosaccharide unit on 
an oligosaccharide chain. However, their synthetic utility is currently limited by their 
narrow substrate specificities, which enables only structurally related acceptor 
substrates 26 to be accepted. Moreover the mechanistic basis for NDP-sugar 25a 
binding has been unravelled by the crystal structures recently obtained but 
generalisation of the mechanisms of binding of the acceptor substrates 26 has not yet 
been made, probably owing to the greater structural diversity exhibited by these 
substrates. Therefore, rational design can not yet be applied to modify the substrate 
specificity of these enzymes as was achieved for glycosidases (Kim et al., 2004). Of 
primary interest would be to utilize glycosyltransferases to synthesise the 
pentasaccharide core 14 common to all N-glycans 2, which is difficult to obtain by 
chemical means in large quantities. Moreover, further glycosylation of this core is 
thought to be less critical by an enzymatic approach as the subsequent enzymes are 
thought to only recognise the terminal sugars of the oligosaccharide chains. 
Additionally, as far as in vitro studies are concerned, the requirement for the 
synthesis of the oligosaccharide chain 3 on a lipid-carrier followed by its transfer to a 
protein is a time-consuming process and the ability to synthesise glycans directly 
onto proteins would be of high interest. This would require altering the acceptor 
substrate specificities of the initial glycosyltransferases involved in the N-
glycosylation pathway. As chitobiose can be chemically synthesised, the first target 
for such evolution studies is the i- 1 ,4-mannosyltransferase that catalyses the addition 
of the first mannose of the pentasaccharide core 14. 
1-6 13-1 ,4-mannosyltransferase 
The 131 ,4-mannosyltransferase naturally catalyses the transfer of mannose from 
GDP-Man 8 to dolichylpyrophosphoryl-a-NN'-diacetylchitobioside 7a, Dol-PP-
GIcNAc2 or DPGn2 (Scheme 1-17) (Albright & Robbins, 1990). 
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The uniqueness of the 13-1 ,4-mannosyltransferase compared to the other 
mannosyltransferases of the N-glycosylation pathway is due to its ability to form a 
1,4-mannosidic linkage between a GlcNAc residue and a Man residue (Scheme 1-
17). 
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Scheme 1-17: Transfer of mannose from GOP-Man 8 to either the natural dolichyl-linked 
acceptor substrate 7a or the synthetic phytanyl-linked acceptor substrate 29a catalysed by the 
3-1 ,4-mannosyltransterase. A protein linked substrate 30a is being considered as an 
alternative substrate for the mannosyltransferase. 
Chemical syntheses of this linkage have been challenging as it is highly kinetically 
disfavoured and the strategies therefore require many protection and activation steps, 
leading to overall low yields (Dudkin & Crich, 2003). In the aim of synthesising the 
pentasaccharide core 14 of N-glycans, the use of an enzymatic strategy for the 
formation of this particular linkage has therefore been considered (Flitsch et al., 
1991). 
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1-6-1 First characterisations of the -1 ,4-mannosyltransferase 
Before cloning of glycosyltransferase genes became wide-spread, 13-1,4-
mannosyltransferases had been isolated and partially purified from a variety of 
sources including the yeast S. cerevisiae (1980), pig aorta (1986) and suspension 
cultured soybean cells (Kaushal & Elbein, 1987). These studies on the purified 13-1,4-
mannosyltransferases established the conditions for the maximal activity of the 
enzyme, i.e. detergent requirement, optimum pH of 6.9-7.0, requirement for a 
divalent cation such as Mg 2 (Kaushal & Elbein, 1987). The inhibitory effect of 
various NDP-sugars 25a was also studied and the use of GDP-Man 8 as the sugar 
donor was confirmed by unsuccessful attempts to replace it with Dol-P-Man 5. 
Finally, the membrane-bound character of the enzyme was proved by its activation in 
the presence of phospholipids in the reaction media (Albright & Robbins, 1990). 
Although the purification processes were relatively successful, the direct use of 13-
1,4-mannosyltransferase was still limited by its low natural abundance (Kaushal et 
al., 1987) and its low stability (Albright & Robbins, 1990), which created problems 
of isolation and purification (Revers et al., 1999). Therefore, the isolation of the 
genes encoding this enzyme has proven crucial to the use of the 3-1,4-
mannosyltransferase for chemical purposes. The first eukaryotic gene encoding a 
1,4-mannosyltransferase was isolated from the yeast S. cerevisiae in the early 1990s. 
1-6-2 Previous work on the yeast gene AWl 
Work on the yeast gene ALGJ (asparagine-linked glycosylation gene 1) started with 
the study of S. cerevisiae mutants defective in N-glycosylation (Albright & Robbins, 
1990). This study led to the isolation of the algi-] mutant, which had a temperature-
sensitive growth and accumulated Doi-PP-GIcNAc2 7a. This was the first evidence 
of the importance of ALGI in the formation of Dol-PP-G1cNAc2 7a. Later the S. 
cerevisiae gene ALGI was cloned and found to correct the defect in growth at high 
temperature and to lead to normal assembly of Glc 3Man9GlcNAc2-PP-Dol 3a (Couto 
et al., 1984). Further insights into the role of ALG1 were provided by its sequencing 
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and the analysis of its transcript (Albright & Robbins, 1990). The search for the 
genomic DNA region complementing the aig]-] mutation led to the characterisation 
of an open reading frame of 1347 bases corresponding to ALGI. This gene was 
shown to encode a J3-1,4-mannosyltransferase of 449 amino acids with a molecular 
weight of 51.9 kDa, possessing a region of 27 hydrophobic residues near the N-
terminus (residues 8-34) and an 13 amino acid sequence, possibly involved in 
dolichol recognition (Albright & Robbins, 1990). The potential dolichol recognition 
sequence was identified by homology to amino acid sequences from the Dpml and 
Alg7 proteins, which also use dolichyl-linked substrates and for which this sequence 
had already been characterised. This sequence is included in the larger hydrophobic 
region of 27 amino acids at the N-terminus, which has been characterised as a trans-
membrane region, acting as an anchor of the enzyme in the ER membrane (Albright 
& Robbins, 1990). In conclusion, the 3-1,4-mannosyltransferase possesses an overall 
topology comparable to that of Golgi glycosyltransferases (Scheme 1-11) with an N-
terminal tail, a trans-membrane domain and a large C-domain but with the difference 
that the C-catalytic domain is facing the cytosol and not the lumen of the ER. 
1-6-3 Recombinant expression of the yeast ALGI gene 
With the isolation of the ALGI gene encoding the yeast 3-1 ,4-mannosyltransferase, 
recombinant expression became possible (Revers et al., 1994). However, another 
problem needed to be solved for the use of this enzyme in chemo-enzymatic 
synthesis, which was the limited availability of dolichol 4 (Scheme 1-3). Dolichol 4 
had so far been isolated from natural sources in only low quantities, e.g. 5 kg of pig 
liver would yield 100-200 mg of dolichol 4 as a mixture of homologues (Flitsch et 
al., 1991; Flitsch et al., 1992). However, a shorter and easier to synthesise lipid-
linked chitobiose, phytanylpyrophosphoryl-u.-NN'-diacetylchitobioside 29a, was 
found to be a substrate for yeast mannosyltransferases with similar Km as the one for 
the natural substrate 7a, thus paving the way to the chemo-enzymatic synthesis of the 
N-glycans pentasaccharide 14 (Flitsch et al., 1991; Flitsch et al., 1992) (Scheme 1-
17). 
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Once a new substrate for the enzyme had been obtained, work focused on the 
recombinant expression of the gene and a bacterial expression system was chosen for 
the production of the enzyme. This system offers higher expression levels and 
facilitated purification compared to eukaryotic expression systems. As the yeast 3-
1 ,4-mannosyltransferase faces the ER cytosol, it is also probably not glycosylated 
and therefore eukaryotic glycosylation is not necessary to obtain the enzyme in an 
active form (Revers, 1996). Additionally, as the hydrophobic region was thought to 
only anchor the f3-1 ,4-mannosyltransferase in the membrane and have no role in 
catalytic activity, it was considered that its deletion would have no adverse effects on 
catalysis (Wilson et al., 1995). Moreover, this deletion was envisaged to facilitate the 
production of a soluble protein and was deemed possible as the potential dolichol 
















Scheme 1-18: The pLR36 plasmid containing the ,4LG1L\TM isoform of the yeast 3-1,4-
mannosyltransferase gene fused to a myc tag. The gene fusion was incorporated into the 
pET1 6b vector for over-expression using the T7Iac promoter (from Waft et al., 1998). 
Hence, two isoforms of the gene, ALGJA2 and ALGJATM, were cloned into vectors 
suitable for expression in a bacterial host using either the Trc promoter or the 77lac 
promoter (Scheme 1-18) to allow comparison between the full-length enzyme and 
the trans-membrane deleted version (Revers et al., 1994; Wilson et al., 1995). The 
first isoform, ALGJA2, whose second codon was mutated from phenylalanine to 
valine, led to the production of the full-length enzyme in an active form in both 
systems but in both cases it was found that expression of the gene was deleterious to 
the cells (Revers, 1996). The second isoform, ALGI ATM, contained a deletion of the 
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entire transmembrane domain, i.e. residues 2-35 inclusive. Expression of this gene 
also produced the desired protein in both systems but yielded higher 
mannosyltransferase activities due to the unaltered growth of the cells harbouring the 
plasmids containing this particular isoform (Revers, 1996). Moreover, the apparent 
Km  values for the phytanyl-linked substrate 29a were found to be comparable for the 
truncated and the untruncated version of the enzyme, i.e. 1.7 IiM and 25 jiM, 
respectively (Revers et al., 1994) (Table 1-19). 
Km (in jiM) DPGn2 7a PPCn2 29a GDP-Man 8 
Non- 
truncated 17 25 1.7 
enzyme  
Truncated 
/ 17 2.1 
enzyme  
Immobilised 
truncated / 14 4.8 
enzyme  
Table 1-19: Michaelis constant (Km) values for the donor and acceptor substrates of 
different forms of the -1 4-mannosyltransferase.  
These values were also in good agreements with those reported for the wild-type 3-
I ,4-mannosyitransferase incubated with the natural doiichyl-linked substrate 7a (Km 
= 17 jiM). 
Finally, the decahistidine sequence introduced by the pET vector (Scheme 1-18) 
facilitated the immobilisation of the protein from the crude cell extract for 
application in preparative synthesis. Immobilisation of the enzyme was deemed 
necessary to remove bacterial protein contaminants that would render the purification 
of the jrisaccharide ManGlcNAc2 7 difficult and cause a loss of transferase activity 
through the action of bacterial proteases (Watt et al., 1998). The enzyme was tested 
for activity in its immobilised form and it was found to be active towards its 
substrates with similar Km values to those reported for the non-immobilised version 
of this enzyme, i.e. 14 jiM for PPGn2 29a and 4.8 jiM for GDP-Man 8 (Revers etal., 
1999). 
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Recently, the human gene encoding this enzyme was isolated and expressed in the 
yeast S .cerevisiae where it was shown to complement the algi-] mutation, 
indicating that the gene does encode a -1,4-mannosy1transferase (Takahashi et al., 
2000). The human enzyme is predicted to have a topology similar to that of the S. 
cerevisiae f-1,4-mannosy1transferase, thus ressembling the type II membrane protein 
topology (Scheme 1-11) but interestingly, it does not present any potential dolichol 
recognition sequence, emphasising further that this motif is not necessary for the 3-
1,4-mannosyltransferase catalytic activity (Takahashi et al., 2000). 
1-7 Aim of the project 
Although the production of the 13-I ,4-mannosyltransferase in a bacterial system and 
its immobilisation on solid support facilitated the synthesis of the trisaccharide 29b, 
the requirement for a lipid carrier is still a hurdle for the wide spread application of 
this enzyme in chemo-enzymatic syntheses. The PPGn2 substrate 29a, although 
easier to synthesise than the natural substrate DPGn2 7a, is still rather difficult to 
obtain. Moreover, with the aim of synthesising a glycoprotein, reproducing the 
natural pathway, i.e. synthesising the oligosaccharide chain on a lipid-carrier and 
then transferring it to the protein, is an unnecessary and tedious process. Direct 
synthesis of the trisaccharide ManGcNAc2 b onto the protein would therefore be 
highly advantageous. However, this is currently limited by the inability to synthesise 
the trisaccharide b, due to the substrate specificity of the 3-1,4-mannosyltransferase. 
Although the yeast mannosyltransferase accepts the phytanyl-linked substrate 29a in 
place of the dolichyl-linked one 7a, the shorter straight lauryl-linked substrate was 
not accepted as substrate by the enzyme (Flitsch et al., 1992). Direct attempts to 
mannosylate a protein-linked substrate also did not work, emphasising the need to 
modify the enzyme for the transfer to become possible (Ines Sprung, personal 
communication). Due to the lack of structural information on this enzyme, random 
mutagenesis and directed evolution towards a protein linked substrate 30a is being 
considered (Scheme 1-17). 
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The search for such mutants would first require the development of a new assay for 
detecting the enzymatic activity as the one currently in use involves the transfer of 
radioactivity from a water-soluble donor, i.e. GDPManIMan* 8 to a hydrophobic 
acceptor, i.e. PPGn2 29a, to form a hydrophobic product, i.e. ManGlcNAc2-PF-
phytanol 29b (Scheme 1-17). Therefore, the reaction is monitored by the difference 
of radioactivity between the organic layer and the aqueous layer. This method is not 
applicable to a glycan linked to a polypeptide 39a as the sugar-donor 8 and the 
product 30b would be found in the same phase (aqueous phase). Moreover, this 
method cannot be used for the high-throughput screening of a library of mutants, as it 
involves tedious steps of product extraction and the hazardous handling of 
radioactive materials. No other general assays for glycosyltransferase activities exist 
owing to the great diversity of possible acceptor substrates and the lack of 
fluorescence/UV changes associated with glycosyl-transfers. Additionally, the 
availability of both mannosyltransferase substrates is limited and the screening of a 
library by a method that would use a minimal amount of both substrates needs to be 
considered (Scheme 1-20). 
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Scheme 1-20: Proposed competitive binding assay for -1 ,4-mannosyltransferase 
mutants. This assay would allow the isolation of mutants possessing higher affinity for the 
new substrate 30a or for GDP-mannose 8 than for GDP 31 immobilised on solid support. 
The immobilisation of the man nosyltransferase on the column and its subsequent release 
would be followed by fluorescence measurements, due to the introduction of a 
fluorophore on the 0-1 ,4-mannosyltransferase. 
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For these reasons, a binding assay for the 3- I ,4-mannosyltransferase activity was 
proposed, whereby the binding of the 3-1,4-mannosyltransferase on GDP 31 
immobilised on solid-support, would be followed by fluorescence (Scheme 1-20). 
The aim of the first part of this work (Chapter 2) was therefore to study the 
possibility of fluorescently labelling the 3-1,4-mannosyltransferase. Given the 
success obtained using the bacterial system for the expression of the ALG]L'TM gene 
and the ability to easily produce libraries in this system, initial studies focussed on 
producing a fluorescently-labelled 3-I ,4-mannosyltransferase in Escherichia coli (F. 
coli). 
In the second part (Chapter 3), the ability to express the ALG1TM gene in a Pichia 
pastoris expression system was studied with the hope of obtaining a more stable and 
soluble protein. The cloning of putative glycosyltransferase genes was also 
considered as homologues constitute an alternative source of f3-1,4- 
mannosyltransferase  that might be better expressed or more soluble. 
The binding of the fluorescently labelled enzyme to GDP 31 immobilised on a solid-
support was examined in the last chapter (Chapter 4). Moreover, the adaptation of 
such a column to a 96-well plate format was attempted. Finally a library was 
generated by random mutagenesis and mutants were screened using the screening 
method developed. 
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II Fluorescent labelling of the -1,4-mannosyltransferase 
Il-i Introduction: fluorescent labelling of proteins 
The development of a new assay for the mannosyltransferase required the attachment 
of a fluorescent tag to the mannosyltransferase to follow the binding and the 
subsequent release of the enzyme to immobilised GDP 31 (Scheme 1-20). The 
introduction of a fluorescent label can be achieved in three ways, as will be detailed 
below. 
Il-i-i Chemical methods for fluorescent detection of proteins 
Traditionally, fluorescent detection of proteins has exploited the fluorescence 
properties of the amino acid tryptophan 32 (Scheme 2-I). However, this approach is 
limited when multiple tryptophan residues 32 are present in the protein, as the 
resulting fluorescent spectra can become extremely complicated (Steward et al., 
1997). This problem can be solved by introducing phenylalanine or tyrosine in place 
of all but one tryptophan 32 in the protein sequence but this can alter the protein 
structure or function and is therefore not desirable (Steward et al., 1997). 
Alternatively, the post-translational introduction of dansyl groups, for example on 
asparagine 33 or lysine 34 (Scheme 2-1), or other chemical fluorophores is used to 
fluorescently label proteins and increase the detection range of proteins (Bartzatt, 
2001). 
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Scheme 2-1: Tryptophan 32, dansylated asparagine 33 and dansylated lysine 34. 
Although reactions of most fluorophores occur at the N-terminal a amino group, 
other amino groups might react leading to an extensive modification of the protein, 
which can be deleterious to the protein structure and function (Chersi et al., 1997). 
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This conventional chemical approach is unsuitable when batch to batch reproducible 
fluorescent measurements are required as they yield a heterologous population of 
conjugates depending on the number of sites that have been effectively labelled 
(Lewis et at, 1999). 
11-1-2 Incorporation of fluorescent unnatural amino acid into proteins 
A more recent strategy is the introduction of a fluorescent non-natural amino acid in 
the protein sequence (Scheme 2-2) (Steward et at, 1997). This has been mostly 
achieved by the use of an amber suppressor tRNA, which is aminoacylated with the 
unnatural amino acid and will replace the amber (UAG) stop codon (Kohrer et al., 
2004). Alternatively, non-natural amino acids have been targeted to a specific 
position in the amino acid sequence by use of a four base codon / anticodon pair 
(Taki et al., 2001). However, until recently, the method was only applied in 
combination with in vitro synthesis systems, yielding only low amounts of proteins 
(Steward et al., 1997). 
Scheme 2-2: Dinucleotide 5-phospho-2'-deoxyribocytidylriboadenosine aminoacylated 
with a natural amino acid 35 or an unnatural amino acid 36 (Taki et al., 2001) leading to 
the formation of the aminoacylated suppressor tANA by subsequent ligation to a 
truncated suppressor tRNAcUA (-CA) or tRNAc0 (-CA) using T4 RNA ligase. 
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The transfer to an in viva system requires: I) a suppressor tRNA that will not be a 
substrate for any of the host aminoacyl-tRNA synthetases 2) an aminoacyl-tRNA 
synthetase that accepts the suppressor tRNA but no tRNA of the cell 3) a mutant of 
the aminoacyl-tRNA synthetase that will only react with the unnatural amino acid 
(Kohrer et al., 2004). 
Alternatively, a suppressor tRNA already aminoacylated with the unnatural amino 
acid can be introduced in the cell by injection, transfection or electroporation (Kohrer 
et al., 2004). Lately, a method has been developed to genetically encode up to 30 
unnatural amino acids in E. coli, yeast and mammalian cells, using translational 
components that are orthogonal to their endogenous host counterparts (Xie & 
Schultz, 2005). 
11-1-3 Gene fusion approaches 
A gene fusion produces a hybrid gene from two previously separate genes by 
bringing together the coding region of two open reading frames either in vivo by 
transposon derivatives or in vitro by recombinant DNA techniques. The expression 
of a gene fusion results in the production of a chimeric protein, which possesses the 
properties of the two proteins encoded by the fused genes. 
The use of a gene fusion strategy is highly advantageous over chemical methods as 
the fluorescent partner can be introduced in a perfectly controlled manner at either 
the N- or the C-terminus of the enzyme (Lewis et al., 1999). The gene fusion 
therefore enables the production of homogeneously labelled proteins, in a 
reproducible manner. Moreover, the gene fusion strategy usually reduces the 
susceptibility of the foreign gene product to degradation by host proteases because 
the resulting fusion may benefit from the inherent resistance of the native fusion 
partner (Revers, 1996). Currently different fusion partners are commonly used to 
introduce fluorescence on a protein: 
- fusion to the green fluorescent protein (GFP) (11-1-3-1) 
- fusion to the SNAP-tag and reaction with BG-fluorescein 37(11-1-3-2) 
- fusion to a small peptide sequence subsequently recognised by a fluorescent 
partner (11-1-3-3) 
E3 
11-1 -3-1 The green fluorescent protein (GFP) 
In Nature, the green fluorescent protein (GFP) is responsible for the green glow of 
the jellyfish Aequorea victoria by conversion of the blue light emitted by aequorin to 
green light (Inouye & Tsuji, 1994). The process starts with the binding of calcium 
ions by the apoaequorin, which results in an intramolecular reaction that converts 
apoaequorin into an oxygenase (Niwa et al., 1996). This oxygenase then catalyses 
the oxidation by molecular oxygen of an imidazole compound present in the 
jellyfish, coelenterazine 38, to coelenteramide 39 and the reaction produces CO2, 
light (2trnax = 470 nm) and a blue fluorescent protein (Scheme 2-3). This blue 
fluorescent protein is made up of coelenteramide 39 bound to apoaequorin and the 
emission of light results from the excited state of the coelenteramide 39. 
38 	 39 
Scheme 2-3: The imidazole compound, coelenterazine 38, which is associated with the 
proaequorin in the jellyfish and its excited state coelenteramide 39, formed by oxidation of 
coelenterazine 38 by molecular oxygen, reaction catalysed by the aequorin after binding 
of calcium ions. 
However, in the presence of GFP, the produced energy is transferred by resonance to 
a chromophore in GFP, leading to the greenish bioluminescence of the jellyfish 
(Niwa et al., 1996). 
GFP is now one of the most widely exploited proteins in biochemistry and cell 
biology (Tsien, 1998). This stems from the ability of this protein to form its 
chromophore under a wide range of conditions, without any requirement for 
jellyfish-specific cofactor or enzyme, enabling successful production of the 
fluorescent protein in a wide range of organisms (Kahana & Silver, 1996). The 
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Escherichia coli (Inouye & Tsuji, 1994) and Caenorhabditis elegans (Kahana & 
Silver, 1996). Excitation by UV light resulted in a green glow from these organisms. 
Since then, GFP has been produced in a large number of organisms, eukaryotes as 
well as prokaryotes, both on its own and as an N- or C-terminal fusion to another 
protein (Barondeau et al., 2003). GFP has been targeted to almost every major 
organelles of the cell, suggesting that there is no limitation to the use of GFP due to 
its size or shape or to the different pH and redox conditions found in various 
organelle (Tsien, 1998). GFP therefore found applications as reporter of gene 
expression (Heim et al., 1995) and as fluorescent marker for subcellular localisation 
(Huh et al., 2003), amongst others. 
GFP is composed of 238 amino acids, weighing 27 kDa and its chromophore results 
from the post-translational modification of the tripeptide Ser 65 -Tyr 66-0ly67 40. The 
mechanism for the formation of the chromophore 44 is thought to require three steps: 
cyclisation (42), dehydration (43) and oxidation (44) (Tsien, 1998; Barondeau et al., 
2003) (Scheme 2-4). 
Tyr" 
Scheme 2-4: Formation of the GFP fluorophore 44. After folding of the protein into a j3-
barrel, the amide of G1y 67 proceeds to nucleophilic attack of the carbonyl of Ser 65 (42), 
followed by dehydration of the 5er 65 carbonyl oxygen (43). Finally, the cz-j3 bond of Tyr 66 
is dehydrogenated by molecular oxygen and its aromatic ring is then conjugated with the 
imidazolidinone, yielding the extended system of conjugated double bonds 44 required 
for fluorescence properties (Tsien, 1998; Barondeau et aL, 2003). 
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This mechanism is supported by the requirement for molecular oxygen. Moreover, 
the protein architecture contains an 80° bend in the central helix, which promotes 
distortion at G1y 67 , leading to the formation of the thermodynamically disfavoured 
ring 42 through coupling to an electronic conjugation trapping step (Barondeau et al., 
2003). The resulting GFP chromophore 44 has an excitation coefficient maximum at 
395 nm of 24,000 M'cm' () and a quantum yield (QY) of 0.77 (Kahana & Silver, 
1996). The wild-type GFP shows two excitation peaks, the major one at 396 nm and 
a secondary one at 475 nm and one emission peak at 507 nm (Heim et at, 1995). 
Although these characteristics are of high interest, the wild-type GFP has several 
deficiencies for some particular applications such as fluorescence-activated cell 
sorting (FACS) for which higher fluorescence signal at the sole excitation 
wavelength of 475 nm is required for use with the standard fluorescein 
isothiocyanate excitation-emission filters (Cormack et al., 1996). More generally a 
higher fluorescence signal was needed for the observation of whole cell fluorescence 
(Crameri et al., 1996). For each particular application, GFP mutants have therefore 
been generated and screened for the desired improvements (Cormack et al., 1996; 
Crameri et al., 1996; Heim et al., 1995). New fluorescent proteins have also been 
engineered to emit light at new wavelengths within the visible spectrum by 
replacement of the residues forming or surrounding the fluorophore. These include 
the yellow fluorescent protein (S65G, S72A, T203F, Xemjssjon = 522 nm), the cyan 
fluorescent protein (Y66W, = 485 nm) and the blue fluorescent protein 
(Y6611, Aemission = 448 nm), which find applications in combination with one another 
for the study of proteins interactions in vivo (Tsien, 1998). 
Of particular interest to our study is the Cycle 3 GFP mutant, which contains 3 
substitutions, 17 100S, M154T and V164A compared to the wild-type GFP (Crameri et 
al., 1996). The GFP gene was first improved for codon usage and then submitted to 
random mutagenesis (IV-1-2-1). The resulting mutants were screened for improved 
whole cell fluorescence of E. coli cells containing the mutants compared to cells 
containing the wild-type GFP. The Cycle 3 GFP mutant was isolated on this ground 
and its higher fluorescence level was interpreted by replacement of hydrophobic 
residues by more soluble ones, which resulted in the production of a mostly soluble, 
fluorescent protein. The wild-type GFP is normally essentially contained in inclusion 
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bodies as a non-soluble, non-fluorescent protein when produced in E. coli cells. 
Moreover K coli colonies expressing the Cycle 3 GFP mutant grew 3-fold faster than 
those expressing the wild-type GFP, probably owing to a reduction in toxicity of the 
over-expressed gene due to the introduced mutations (Crameri et al., 1996). 
This mutant should therefore be of high interest when E. coli expression is the goal. 
For all these properties the Cycle 3 GFP was chosen as a fusion partner for the 
AIgIATM]p in order to visualise the mannosyltransferase and follow its 
immobilisation on GDP-matrices (Scheme 1-20). 
Il-i -3-2 SNAP-tag 
A more recent gene fusion approach uses the SNAP-tag, a 21 kDa protein, which 
was developed from the human DNA repair enzyme, 0 6-alkylguanine-DNA 
alkyltransferase 45 (hAGT), which naturally transfers the alkyl group of 0 6-alkylated 
guanine-DNA 46 to one of its cysteine residues to form compound 47 (Keppler et al., 
2003). This repair mechanism is untypical as the reaction is irreversible, i.e. the 
enzyme is covalently linked to the alkyl group and therefore itTeversibly inactivated 
(Scheme 2-5). 
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Scheme 2-5: Mechanism of action of the human DNA repair enzyme, 0 6-alkylguanine-
DNA alkyltransferase 45 (hAGI). A cysteine residue of the enzyme reacts with the methyl 
group of 0 6-alkylguanine 46 and the enzyme 47 is irreversibly inactivated. 
Another interesting feature of this enzyme 45 is that it shows little substrate 
specificity and was shown to accept 0 6-benzylguanine (BG) as its substrate. The 
range of accepted substrates was further extended to encompass a broad range of 
derivatised 06-benzylguanines, for example fluorescein derivatised 06 
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benzylguanine (BG-fluorescein 37), enabling introduction of properties that can not 
be genetically encoded onto the hAUT (Juillerat et at, 2003) (Scheme 2-6). 
In vivo labelling of the wild-type hAGT, either alone or fused to another protein, 
with derivatives of 0 6-benzylguanines 37, 49 and SO was achieved in E. coli, S. 
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Scheme 2-6: Reaction of a hAGT fusion protein 45a with 0 6-benzylguanines (BG) 
derivatives: BG-biotin 49, BG-PEG-biotin 50 and BG-fluorescein 37. 
The activity of the enzyme for the BO-fluorescein 37 and BG-biotin 49 substrates 
was enhanced by directed evolution (IV-1-2-1) (Juillerat et al., 2003). One of the 
isolated mutants is the SNAP-tag which, compared to the wild-type, presents the 
following differences: C62A, Q1I5S, Q116H, K125A, A127T, R128A, C150N, 
51511, S152N, N157G, S159E mutations, additional silent mutations and truncation 
after G182. In the present study, the BG-fluorescein substrate 37 was of particular 
interest as it has excellent fluorescent properties (e. = 76,000 1vF'cm 1 , QY = 0.77) 
and could therefore be used to fluorescently label a SNAP-tag-mannosyltransferase 
fusion. 
11-1 -3-3 Strep-tag II 
The Strep tag is a nine amino acid peptide (AWRHPQFGG) that can be fused to the 
C-terminal of proteins and mediates binding to streptavidin with high affinity 
(Schmidt et al., 1996). More recently, the tag has been modified to the Strep tag II 
(NWSHPQFEK) in order to allow fusions to the N-terminus of proteins, while 
retaining the binding capacity to streptavidin (Maier et al., 1998). A streptavidin 
variant was engineered for improved affinity of the Strep tag II, the Kd value being of 
1 .tM compared to 13 RM for streptavidin (KorndOrfer & Skerra, 2002). As it is 
possible to synthesis fluorescent streptavidin, it is theoretically possible to attach a 
fluorescent molecule to a protein through this tag. However, no literature reports the 
use of the Strep tag for this particular application. 
11-1 -3-4 Biarsenical ligands and tetracysteine motifs 
The sequence Cys-Cys-Xaa-Xaa-Cys-Cys (where Xaa is any amino acid except 
cysteine) forms stable complexes with biarsenical compounds, a property that ;V-
exploited to fluorescently label a fusion partner (Juillerat et al., 2003). A fluorescein 
derivative with two As(HI) substituents 52 binds this peptide motif and fluoresces 
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Scheme 2-7: Reaction between the tetracysteine motif of the LumioiM  tag and the 




Of all the methods presented above, the gene fusion approach appeared to be the 
most feasible for the controlled introduction of a fluorescent label on the 
mannosyltransferase and the envisaged mannosyltransferase mutants. The 
dansylation method (11-1-1) has indeed been reported to label batches of homologous 
protein differently depending on the reaction conditions (Lewis et al., 1999). The 
difficulty to reproducibly label the mannosyltransferase would be further increased 
with the generation of mutants of the .mannosyltransferase as the number of sites that 
can possibly be labelled would vary from one mutant to the other. The suppressor 
tRNA methodology (11-1-2) might become highly advantageous in the future but 
further improvements are currently still needed for the production of proteins in 
engineered F. ccli strains. 
Different fusion partners were envisaged for the mannosyltransferase but only the 
GFP (11-1-3-1) and SNAP tag (11-1-3-2) were selected as only those two systems 
introduce a fluorescent label through a covalent linkage. A stable system was deemed 
advantageous over systems involving non-covalent interactions with a fluorescent 
label to ensure that no release of the fluorescent label would occur during the 
downstream applications of the fluorescently labelled mannosyltransferase. 
Interestingly, fusion of GFP to an octapeptide has already been reported for the study 
of the binding of this octapeptide to its corresponding antibody immobilised on 
agarose beads (Lewis et al., 1999). The binding was monitored by measuring the 
GFP fluorescence signal of the washing and elution fractions, as was envisaged for 
detecting the binding of mannosyltransferase mutants to GDP 31 immobilised on 
solid support. Moreover, the GFP could be used as a folding reporter (Waldo et al., 
1999) a property that was potentially useful to improve the solubility of the 
mannosyltransferase and study its tolerance to mutations (Chapter 4). A variety of 
constructs were therefore made displaying different fusions between the GFP gene or 
SNAP tag coding sequence and the ALGI ATM] gene fragment so as to find the 
system which would provide the fusion protein in the most stable form for 
application in the proposed binding assay (Scheme 1-20). 
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11-2 Materials 
11-2-1 Polymerase chain reactions 
Custom oligonucleotide primers were synthesised by Thermo Electron GmbH (Ulm, 
Germany). 2'deoxyribonucleoside 5'-triphosphate (dNTPs) mixes were purchased 
either from Sigma-Aldrich (Poole, UK) or Roche (Lewes, UK), at a concentration of 
10 mM of each dNTP. Turbo Pfu and YieldAce®  polymerases were from Stratagene 
(Cambridge, UK) and Taq polymerase was from Promega (Southampton, UK). 
Polymerase chain reactions were performed on a Robocycler gradient 96 (Stratagene, 
Cambridge, UK) or on Eppendorf thermal cyclers: Mastercycler®  either personal or 
gradient (Eppendorf, Hamburg, Germany). 
11-2-2 DNA gels 
The agarose for DNA gels was from Fisher Scientific (Fisher Biotech, molecular 
biology grade, Pittsburgh, USA) and the gels were visualised using either a 
transilluminator (Anachem, Luton, UK) or an Image Master VDS-CL 
(Amershanibiosciences, Little Chalfont, UK). The I kb and 100 bp deoxyribonucleic 
acid (DNA) ladders were from New England Biolabs (Hertfordshire, UK). 
11-2-3 Restriction digests and ligations 
Restriction endonucleases and T4 DNA ligase were from New England Biolabs 
(Hertfordshire, UK). Alternatively, the rapid ligation kit from Roche (Lewes, UK) 
was used. 
11-2-4 Cloning and expression vectors 
The GFP fusion TOPO® TA expression kit, the TOPO TA Cloning® kit and the 
TOPO blunt end Cloning® kit were from Invitrogen (Paisley, UK). The pET 
expression vectors were from Novagen (CN Biosciences, UK). 
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11-2-5 DNA purification 
The QlAprep®miniprep kit for plasmid purification and the QlAquick ® spin gel 
extraction kit and PCR purification kit were from Qiagen (Crawley, UK). 
11-2-6 Sequencing 
Sequencing reactions were carried out using the BigDye®Terminator  v3.1 Cycle 
sequencing kit (Applied Biosciences, Foster City, USA) and automated sequencing 
was performed as a service by the ICAPB sequencing service (University of 
Edinburgh). Alternatively, sequencing was performed as a service by DNASHEF 
Technologies (Department of Haematology, Edinburgh Royal Infirmary). 
11-2-7 Bacterial strains 
E. coli strains BL21(DE3) and BL21(DE3)pLysS and the chemically competent TOP 
10 E. co/i cells were purchased from Invitrogen (Paisley, UK). E. coli ORIGATv1I 
(DE3) pLysS competent cells were from Novagen (Madison, USA). 
11-2-8 Culture media, antibiotics and induction of expression 
Lysogeny broth (LB) growth medium (or LB Miller: 10 g.E' tryptone, 5 g.E' yeast 
extract, 10 g.E' NaCl) and LB agar (10 g.E' tryptone, 5 g.E 1 yeast extract, 10 g.E' 
NaCl, 15 g.E' agar) were purchased either from Sigma-Aldrich (Poole, UK) or 
Fisher Scientific (Pittsburgh, USA). SOC medium was either prepared or obtained 
from Invitrogen (Paisley, UK). BACTO media components (Yeast nitrogen base, 
yeast extract and tryptone) were from Difco (Detroit, USA). Sodium chloride was 
from Fisher Scientific. Ampicillin, kanamycin sulphate, chloramphenicol, 
tetracycline and carbenicillin were obtained from Sigma-Aldrich (Poole, UK). 
Incubations were performed either in orbital incubators S150 (Stuart Scientific, 
Surrey, UK) or in New Brunswick Scientific incubator shakers (models 025 or 
innoval'M 4300 or 4330) (New Brunswick Scientific, Ayrshire, Scotland). Isopropyl- 
47 
1-thio--D-galactoside (WIG) was purchased from Promega (Southampton, UK). 
Absorbance measurements of cell cultures were carried out on a Biophotometer 
Eppendorf (Hamburg, Germany), at 600 nm. 
11-2-9 SIDS PAGE and Western blot 
Precast gels for polyacrylamide gel electrophoresis (PAGE) (4-20% or 10-20% Tris-
HC1) and 10 xTGS running buffer were from BioRad (York, UK). The protein 
molecular weight marker, Precision plus proteinTM  Standards All Blue, was obtained 
from BioRad (York, UK) as well as the electrophoresis tanks and power supplies, 
either 200 or 1000. sodium dodecyl sulphate (SDS)-PAGE gels were routinely 
stained with EZ Blue TM  gel staining reagent from Sigma-Aldrich (Poole, UK). 
Irnmunoblotting was performed on HybondTM ECLTM nitrocellulose membrane 
(Amersham Pharmacia Biotech, Little Chalfont, UK) using a monoclonal poly anti-
His peroxidase conjugate serum (Sigma-Aldrich) and revealed with DAB peroxidase 
substrate (Sigma fastTM  3, 3'-diaminobenzidine tablet sets). Alternatively Western 
blots were performed on PVDF Western blotting membrane from Roche Lewes, 
UK). Blotting papers PROTEAN XL and thick blotting papers were from BioRad 
(York, UK). Liquid blots were performed using the BioRad Mini Trans-Blot ®cell. 
Semi-dry blots were performed using the BioRad trans-blot semi dry apparatus. The 
primary anti-GFP antiserum was from Invitrogen (Paisley, UK) and the secondary 
antibody was an anti-rabbit IgG horse radish peroxidase (HRP) conjugated from 
Sigma-Aldrich (Poole, UK). 
11-2-10 Fluorescence and absorbance measurements 
Fluorescence measurements were performed on a spectra MAX gemini XS 
spectrofluorimeter (Molecular Device, Sunnyvale, USA) and the results were 
analysed using the software Soft Max Pro. Solutions to be analysed were loaded into 
the wells of either black well microplates (96 well, FluoroNunc TM, Nunc, Roskilde, 
Denmark) or the Sero-Wel, polystyrene microtiter microplates, 96-well from Sterilin 
(Barloworid Scientific, Staffordshire, UK). Fluorescence was observed under 
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Anachem transilluminator (Luton, UK). The absorbance of the samples were 
measured on microtiter plate reader VersaMax from Molecular Devices, (Sunnyvale, 
USA) from solutions loaded into Sero-Wel, polystyrene microtiter microplates, 96-
well from Sterilin (Barloworid Scientific, Staffordshire, UK). 
11-2-11 Purification on Nickel column, protein concentration and 
thrombin cleavage 
Microsart® disposable filters were obtained from Sartorius (Gottingen, Germany). 
The Akta fast protein liquid chromatography (FPLC) system and HiTrapChelating 
HP lnTh columns were from Amershambiosciences (Little Chalfont, UK). PD10 
desalting columns were purchased from Amershambiosciences (Little Chalfont, UK). 
The Thrombin Cleavage Capture Kit was from Novagen (Madison, USA). Protein 
concentrators were all from Vivapsin (Vivascience, Hannover, Germany). 
11-2-12 Radioactive assay 
Ultima Gold scintillation fluid was from Packard Bioscience (Groningen, The 
Netherlands). The ammonium salt of guanosine diphospho-D-[U-' 4C]mannose 
(GDPMan*) was from Amersham Pharmacia Biotech (Little Chalfont, UK). 
Scintillation counting was performed on a liquid scintillation analyzer TRI-CARB 
2100TR (Packard, The Netherlands). 
11-2-13 SNAP reagents 
All SNAP reagents were from the SNAP-tag Substrate Protein Labelling Test 
Material from Covalys (Witterswil, Switzerland). 
11-2-14 General 
All other chemicals were laboratory grade reagents. 
11-3 Methods 
11-3-1 Agarose gel electrophoresis 
Deoxyribonucleic acid (DNA) fragments were analysed on 0.5 Tris-Borate-EDTA 
(TBE: 44 mmol.L' Tris-HC1, 44 mmol.L' boric acid, 1 mmolJ) EDTA, pH = 8.0) 
1% agarose gel containing ethidium bromide (0.5 g.niU'). The DNA fragments 
were visualised under an ultraviolet (UV) transilluminator at 312 nm. When required, 
the DNA fragment was excised from the gel using a sterile blade and the DNA was 
isolated using the Qiagen Qiaquick Gel Extraction Kit following the provided 
protocol. 
11-3-2 Polymerase chain reactions (PCR) 
The PCR mixtures were set as follows in a SO jtL volume with (PCR1) or without 
(PCR2) the addition of MgCl2: 
- 5 Pt of 10 x Cloned Pfu DNA polymerase reaction buffer ( 200 mM Tris-HCI, 
pH = 8.8; 20 MM  MgSO4; 100 mlvi KC1; 100 mlvi (NH4)2SO4; 1 % Triton-X-100; 
1 mg. niL' nuclease-free bovine serum albumin (BSA)) 
- 1 RL of dNTP mix (10mM each; C1 = 0.2 mlvi each) 
- 1 RL of DNA template (10-50 ng of plasmid DNA; Cf = 0.2-1 ng.L') 
- 3 j.tL of sense primer (10 pmol.pU'; Cf = 0.6 pmol.j.tL) 
- 3 jiL of antisense primer (10 pmol.pJJ'; Cf = 0.6 pmo1.L) 
- 36.5 / 34 jiL of sterile water 
- 0 / 2.5 jiL of MgCl2 (25 mlvi; C1 = 1.25 mlvi) or dimethyl sulfoxide (DMSO) 
- 0.5 pt of Turbo Pfu polymerase  (2.5 U.j.tL) 
Different thermal cycles were used to amplify the targeted DNA sequences. 
> Thermal cycle 1 
- cycle]: 72 °C for 10 mm, 95 °C for 1 mm 
- cycles 2-32: 95 °C for 1 mm, 50 °C for 1 mm, 72 °C for 2 min 30s 
- cycle 33: 72 °C for 10 mm 
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> Thermal cycle 2 
- cycle ]:72°Cforl0min,95°Cforlmin 
- cycles 2-32: 95 °C for 1 mm, 58 or 50 or 47 °C for 1 mm, 72 °C for 2 min 30 s 
- cycle 33: 72°C for 10 mm 
The PCR products were analysed on a 1% agarose 0.5 TBE electrophoresis gel. 
11-3-3 Analytical PCR 
The reaction conditions were the same as above except that YieldAce®  polyrnerase 
(5 U.p.xL') and its corresponding buffer were used in place of Turbo Pfu polymerase 
and its reaction buffer. The thermal cycle I described above was for this application. 
11-3-4 Overlap PCR 
The fusion of two overlapping DNA fragments was achieved by overlap PCR using 
the following method: 
- 5 piL of 10 x Cloned Pfu DNA polymerase reaction buffer 
- 0.5 }.LL of dNTP mix (10mM each; C1 = 0.2 mM each) 
- 1 itL of DNA fragment I 
- 1 iLL of DNA fragment 2 
- 40 j.tL of sterile water 
- 0.5 iLL of Turbo Pfu pdlymerase (2.5 U.pL') 
The reaction was carried out under the following conditions: 
> Thermal cycle 3 
- cycle]: 72 °C for 10 mm, 95 °C for 1 mm 
- cycles 2-3: 95 °C for I mm, 47 °C for 1 mm, 72 °C for 2 min 30 s 
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The cycle was then stopped and 1 p.tL of sense and antisense oligonucleotide primers 
(10 pmol.pL'; CF = 0.6 pmol.pL') were added to the reaction mixture. The thermal 
cycle was continued as follows: 
- cycles 3-30: 95 °C for 1 mm, 47 °C for I mm, 72 °C for 2 min 30 s 
- cycle 31:72°C for 10 mm 
The PCR product was analysed on a I % agarose 0.5 TBE electrophoresis gel. 
11-3-5 TOPO® cloning reactions 
11-3-5-1 Addition of A-overhangs to the amplified PCR products 
A-overhangs were added to the obtained PCR products either by repeating the 
thermal cycle used for the amplification of the gene or by heating at 70 °C for 20 
mm, using the following reaction mixture: 
- 5 IlL of thermophilic DNAPoIy. lOx buffer (50mM KCI; 10 m Tris-HCI, pH = 
9.0; 1% v/v Triton" -X-100) 
- 5 j.tLofMgCl2(25 mM; Cf=2.5 MM) 
- 1 pL of 2'-deoxyadenosine 5'-triphosphate (dATP) (10 mM; Cf= 0.2 mM) 
- 30 ML of DNA template 
- 8.5 jiL of sterile distilled water 
- 0.5 ML of Taq polymerase (5 U.1iL 1 ) 
The PCR product was them cleaned using the Qiagen gel purification kit. 
11-3-5-2 TOPO® TA cloning into pCR®2.1-TOPO® or pcDNA3.1/NT-GFP-
TOPO® 
The TOPO® cloning reactions were carried out as follows: 
- 4 j.tL of PCR product with A-overhangs 
- I j.tL of salt solution (1.2 M NaCl, 0.06 M MgCl2) 
- 1 ML of sterile water 
- 1 ML of TOPO ® vector (Invitrogen) 
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The reaction was incubated on ice for 30 min and 2 jiL were used to transform 50 j.LL 
of E. coli chemically competent TOP10 cells. The cells were incubated on ice for 30 
min and then heat-shocked at 42 °C for 30 s and immediately after transferred to ice. 
250 j.tL of room temperature Soc medium were then added to the cells and the cells 
were incubated for lh, at 37 °c, in the horizontally shaking incubator. The whole 
volumes were finally spread on a LB agar plate supplemented with 100 g.mL' 
ampicillin and the colonies were grown at 37 °c, overnight. 
11-3-5-3 TOPO® cloning reaction into pUB/Bsd-TOPO 
The TOPO®  cloning reactions were carried out as follows: 
- 4 ML of blunt end PCR product 
- 1 ML of salt solution (1.2M NaCl, 0.06M M902) 
- 1 gL of pUBIBsd-TOPO ® vector (Invitrogen) 
The procedure was then identical to that described in 11-3-5-2. 
11-3-6 Restriction digest of the PCR products and the vectors 
The reactions were routinely carried out as follows: 
NEB Buffer + BSA 	 21sL 
PR product or vector 	 14 ML 
Restriction endonuclease 1 	0.4 pL 
Restriction endonuclease 2 	0.4 ML 
H20 	 3.2 ML 
The reaction buffer was chosen to maximise the efficiency of both endonucleases 
following the New England Biolabs recommendations. All reaction components 
were mixed and the reaction was carried out at 37 °c for 3 h or overnight. The 
restriction endonucleases were then deactivated at the temperature recommended by 
the manufacturer, for 20 mm. The obtained DNA fragments were purified using the 
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appropriate Qiagen DNA purification kit. When possible, the restriction digest 
products were analysed on a 1% agarose 0.5 TBE electrophoresis gel to ensure that 
the reaction had been carried to completion. 
11-3-7 Analytical restriction digests 
Constructs were analysed by dual restriction digests as follows: 
NEB Buffer + BSA 2pL 
PCR product or vector 2 utL 
Restriction endonuclease 1 0.4 jsL 
Restriction endonuclease 2 0.4 pL 
1120 15.2 
The reaction was left at 37 °C for 3 h and the restriction digest products were 
analysed on a 1% agarose 0.5 TBE electrophoresis gel. The reactions products were 
then purified using the appropriate Qiagen purification kit. 
11-3-8 Partial restriction digests of PCR products 
The partial restriction digests were carried out with the appropriate endonucleases as 
follows: 
NEB Buffer + BSA 
Plasmid 
Restriction endonuclease I 
Restriction endonuclease 2 
1120 












Solution B was split in 6x10 p.tL and solution A was introduced in the first tube, from 
which 10 KL were subsequently taken, introduced in the following tube and carefully 
mixed with the content of this later. This process was repeated until the last tube was 
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reached to create solutions of decreasing concentration of the two restriction 
endonucleases. The reactions were then carried out for different time-span ranging 
from 20 min to 50 mm, at 37 °C. The enzymes were finally deactivated at 70 °C for 
20 min and the products of the restriction digest were analysed by agarose gel 
electrophoresis. The products were purified from the gel and concentrated to dryness 
under vacuum, in a Speed Vac Plus SC1IOA, Savant (GMI, Minesota, USA). The 
dried product was re-suspended in 10 ML of Qiagen EB buffer (10 mM Tris-HCI, pH 
= 8.5). 
11-3-9 Ligation reactions 
11-3-9-1 Standard ligation 
The ligation reactions were routinely set as follows: 
- 4 ML of T4 DNA ligase buffer (500 mM Tris-HCI, 100 MM M902, 100  MM 
dithiothreitol (Dfl), 10 m ATP, 250 g.mL 4 BSA, pH = 7.5) 
- 2 ML of vector 
-10 ML of DNA insert 
- 5 p1. of T4 DNA ligase (400,000 U.mL 4 ) 
- 19FtLofH20 
The DNA insert was first added the vector and the sterile water. This mixture was 
heated at 45°C for 5 min and then placed on ice for 5 mm. The remaining 
components of the mixture were then added and the reaction was left at room 
temperature overnight. 5 11L of ligation reaction was transformed into 50 p1. of 
chemically competent TOPIO E. coli. The cells were incubated on ice for 30 mm, 
heat-shocked at 42 °C for 30 s and immediately after, placed on ice for 2 mm. 250 
ML of room temperature SOC medium were added to the cells and the cells were 
grown for 1 h, at 37 °C, in the horizontally shaking incubator. The whole volumes 
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were finally spread on a LB agar plate supplemented with the appropriate antibiotics 
and the colonies were grown at 37 °C, overnight. 
11-3-9-2 Rapid ligation 
The rapid ligation kit from Roche was used alternatively under the following 
conditions: 
- 5 gL of 2x T4 DNA ligase buffer (composition not available) 
- 1 }IL of vector 
-1.5 RL of DNA insert 
- 1 RL of lOx DNA dilution buffer (composition not available) 
- 0.5 tiL of T4 DNA ligase 
- 1.5jsLofH20 
The reaction was carried out at room temperature for 5 to 15 min and 10 jiL of 
ligation reaction was transformed into 50 jiL of chemically competent TOP1O E. coli. 
The cells were then treated as described for the standard ligations (11-3-9-1). 
11-3-10 Isolation of the constructed plasmids 
The constructs were routinely isolated using the Qiagen mini prep kit, following the 
manufacturer's instructions. 
11-3-11 Sequencing of the constructs 
To 300 j.tL of DNA were added 30 RL of 3 M sodium acetate, pH = 5.2 and 750 jiL 
(x 2.5V) of 100 % ethanol. The solution was mixed vigorously using a vortex and 
incubated at -20 °C for 2 h. The precipitated DNA was isolated by centrifugation at 
13 000 x g, 4 °C, for 30 mm. The pellet was washed with 400 RL 70 % ethanol and 
re-isolated by centrifugation in the same conditions, for 10 mm. The ethanol was 
removed and the DNA pellet was air-dried before being re-suspended in 18 jiL of TE 
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buffer. The DNA concentration of the sample was determined on a Biophotometer 
(Eppendorfl. 






0.7 jxL (250-300 ng) 




The sequencing PCR were run under the following conditions: 
> Thermal cycle 4 
- cycle 1:95 °C for 1 mm 
- cycles 2-30: 96 °C for 30 s, 50 °C for 30 s, 60 °C for 4 mm 
The reaction mixture was then given to the ICAPB sequencing service. 
11-3-12 Transformation of the plasmids into E. coil expression strains 
and growth of bacterial cells 
Typically, 1 ILL (around 10-50 ng) of construct was transformed into One Shot ® 
chemically competent E. coii (50 piL). The transformation was carried out following 
the manufacturer's instructions and the cells harbouring the construct were selected 
by plating the transformation on LB agar (1 % w/v tryptone, 1 % w/v NaCl, 0.5 % 
wlv yeast extract, I % agar) supplemented with the appropriate antibiotic(s). 
The pETI 6b and pET20b vectors carry the ampicillin resistance gene and therefore 
cells harbouring plasmids derived from these vectors were selected by addition of 
100 isg.mU' of ampicillin to the culture medium. Selection of cells harbouring 
constructs derived from either pET24a or pET28a were selected by addition of 50 
gnilJ' kanamycin to the culture medium. E. coli BL21(DE3)pLysS cells 
necessitated the extra addition of 34 j.tg.mL' of chloramphenicol. E. coil ORIGAMI 
(DE3)pLyss cells harbouring pET16b-GFPALGIATMI were selected with 
ampicillin (50 tg.mL'), kanamycin (50 .tg.mL'), tetracycline (12.5 jsg.mL') and 
chloramphenicol (34 ptg.mL'). 
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Single colonies were subsequently grown, overnight, at 37 °C, with continuous 
shaking (250 rpm), in 10 mL of selective LB medium (1 % w/v tryptone, 1 % w/v 
NaCl, 0.5 % w/v yeast extract). 5 mL of these starting cultures were used to inoculate 
100 mL of LB medium supplemented with fresh antibiotic(s) and the cultures were 
grown at 37 °C, under continuous shaking (250 rpm). When an absorbance at 600 nm 
of 0.6 was reached, expression was induced with 100 tL of a 1 M solution of IPTG, 
to a final concentration of 1 mM. Growth was then continued at different 
temperatures for 1 to 3 h. 1 mL samples were routinely taken for analysis and the 
remaining cells were finally harvested by centrifugation for 30 mm, at 10 000 rpm, 4 
C C. 
11-3-13 Sodium dodecyl-sulphate polyacrylamide gel electrophoresis 
(SDS PAGE) 
11-3-13-1 Preparation of the samples 
11-3-13-1-1 Whole cell samples 
To 1 mL cell pellet was added variable volumes of SIDS PAGE loading buffer ( 62.5 
mM Tris-HCI, 10 % v/v glycerol, 2 % w/v SIDS, 1 % v/v 13-mercaptoethanol, 0.05 °° 
w/v bromophenol blue, pH = 6.8). The sample was incubated at 95 °C for 5 min and 
5-30 iii. of the sample was loaded on the gel. 
11-3-13-1-2 Cell-free extract and insoluble fraction samples 
To 1 mL cell pellet was added 500 piL of enzyme buffer. The cells were lysed by 
sonication for 2 min and centrifuged at maximum speed in a microcentrifuge. The 
soluble fraction was removed by aspiration, introduced in a clean microcentrifuge 
tube and added an equal volume of 2 xSDS PAGE loading buffer. The insoluble 
fraction was also added SDS PAGE loading buffer in quantities depending on the 
size of the obtained pellet. 
11-3-13-2 SDS-PAGE analysis 
Protein analysis was carried out by gel electrophoresis under denaturing conditions, 
i.e. in the presence of SDS and 3-mercaptoethano1, at a constant voltage of 200 V, in 
the BioRad Mini-PROTEAN ® II vertical gel electrophoresis apparatus, for 45 min to 
90 mm. Pre-cast gels for polyacrylamide electrophoresis (4-20% or 10-20% Tris-
HC1) and TGS running buffer (25mM Tris-HCI, 192 mM glycine, 0.1% SDS, pH = 
8.3) were used. The gels were routinely stained overnight in the EZ Blue gel staining 
solution after 30 min equilibration in water. 
11-3-14 Western blot 
Following an SDS PAGE gel, blotting was performed using a BioRad Mini Trans-
Blot apparatus®  cell by perpendicular electrophoresis onto a nitrocellulose membrane 
at a constant current of 150 mA for 2 h, in Towbin buffer (25 mM Tris-HC1; 192 m 
glycine; 10 % methanol). After washing with phosphate-buffered saline (PBS, 0.01 
M phosphate buffer, 2.7 mlvi KC, 137 mM NaCl, pH = 7.4 ), the membrane was 
blocked in 200 mL PBS supplemented with 10 g non-fat dried milk (Marvel) for a 
minimum of 1 h and up to 20 h. Reaction with the monoclonal peroxidase-
conjugated anti-His antibody was performed by incubation of the membrane in 25 
ml. PBS, 5 % non-fat dried milk and 25 j.tL (dilution: 1: 1 000) of antibody for at 
least two hours. The membrane was finally washed 3 times with PBS, 0.05 % Tween 
20 and 2 times with PBS and added the DAB peroxidase reaction mixture containing 
600 p.tg.mU' 3,3'-diaminobenzidine (DAB), 0.03 % w/v NiC12 and 0.03 % H202 in 
Iris-buffered saline (TBS: 20 mM Tris-HC1; 500 mM NaCl; pH = 7.5). After 10-15 
mm, the reaction was quenched by extensive washings with water. 
For the reaction with anti-GFP antiserum, the membrane was blocked in 200 ML 
TBS, 5 % non-fat dried milk, for at least 2 h. The membrane was incubated in 10 mL 
TBS, 5 % non-fat dried milk containing 2 iL (dilution: 1: 5 000) of anti-GFP 
antiserum, at room temperature for 2 h 30 mm. The membrane was washed with 
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TBS, 0.05 % Tween 20 and subsequently incubated in 25 niL TBS, 5 % non-fat dried 
milk and 2.5 ML (dilution: 1/10000) monoclonal anti-rabbit immunoglobulin 
peroxidase conjugate, for 1 h 30 mm. The membrane was washed extensively with 
TBS, 0.05 % Tween 20 and finally TBS, prior to the addition of the DAB reagent 
mixture. 
11-3-15 Mannosyltransferase assay (Flitsch etal., 1991) 
To approximately 100 mg of frozen cell pellet (roughly equivalent to a 25 mL cell 
pellet) were added 1 mL of mannosyltransferase buffer I (MTBI: 50 mM Tris, 10 
mM 3-mercaptoethanol, 5 mM MgCl2, 0.25 % v/v Triton-X- 100, pH = 7.5) and lysis 
was promoted by sonication over a period of 10 mm. A spatula tip of 
deoxyribonuclease I (DNase I) was then added and the crude cell extracts were 
cleared by centrifugation for 5 mm, at 13 000 x g, at room temperature. This cell 
preparation was added to the reaction vial, which already contained PPGn2 29a (10 
MM) and the reaction buffer (MTBI). Finally, GDPManIMan*  8 (20 PM) was added 
and time was monitored. The reactions were carried out in reaction vials, for 40 mm, - 
at 37 °C, with continuous stirring. Blanks were made where no acceptor substrate 
were introduced in the reaction vial. 100 .xL aliquots were taken every 10 min and 
the reaction was quenched with 100 ML chloroform/methanol (CFICIilMeOH) (1/1). 
The organic and aqueous layers were separated by centrifugation at 13 000 x g, for 5 
mm. The organic layer and the interface were then washed 2 times with 100 ML 
sterile water and 50 ML CHCI3IMeOFI (1/1) and the interface was isolated and re-
suspended in 100 ML CHCI3IMeOH/H20 (10/10/3). The organic, interface and 
aqueous fractions were finally transferred to scintillation tubes containing 4 inL of 
scintillation counting fluid. The level of radioactivity in each fraction was 
determined using the scintillation counter. Measurements were taken in duplicate. 
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11-3-16 Immobilisation of the -1,4-mannosyltransferase on NI-NTA resin 
under gravity flow 
To approximately 200 mg of frozen bacterial cell pellets were added 1 ml. of binding 
buffer (5 mlvi imidazole, 0.5 M NaCl, 20 mlvi Tris, 0.25 % v/v Triton-X-100, pH = 
7.5) and a point spatula of DNase I. The solution was then split in 4 x 250 piL, which 
were completed to 1 mL with binding buffer. Clear cell extracts were obtained by 
centrifugation at 13 000 x g, for 20 mm, at 4 °C and then by filtration through a 0.45 
gm filter. The filtered sample was finally loaded on 1 mL of resin and the solution 
was left to elute under gravity flow, at 4 °C. The flow-through was re-loaded on the 
column to maximise the binding of the enzyme and the column was then washed 
with 10 column volume of binding buffer and 3 column volumes of MTB buffer (50 
mlvi Tris, 5 mlvi M902, 0.25 % v/v Triton-X-100, pH = 7.5), prior to re-suspension 
of the resin in an equal amount of MTB. This 50 % v/v slurry was stored at 4 °C until 
required. 
11-3-17 Partial purification of the -1,4-mannosyltransferase on Ni-NTA 
resin using an FPLC system 
To 2.2 g of bacterial cell pellet was added 6 mL of FPLC buffer A (0.5 M NaCl, 20 
mlvi Tris-FIC1, 0.25 % v/v Triton-X-100, 1 mlvi phenylmethylsulphonylfluoride 
(PMSF) pH = 7.5). The cells were thawed on ice and added 60 piL of 1 M M902 and 
a point spatula of DNase I. The sample was incubated on ice for 45-60 mm, with 
regular shaking. The solution was split in 6 x 1 ml- in microcentrifuge tubes and the 
soluble portion was decanted following centrifugation at 13 000 x g, 6 °C, for 30 
mm. The supernatants were pooled and filtered through a 0.45 pim filter. 
Prior to immobilisation of the histidine-tagged proteins, the pumps of the Akta FPLC 
system were washed with 70 % ethanol and water and equilibrated with either FPLC 
buffer A or FPLC buffer B (0.5 M NaCl, 20 mM Tris-HCI, 0.25 % Triton-X-100, 1 
mM PMSF, 1 M imidazole, pH = 7.5). The system was operated using the 
UNICORN 3.21 software after the manual loading of the sample in the injection 
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loop. The immobilisation was carried out at 4 °C, on a HiTrapChelating HP lmL 
column, which had been manually charged with 1 mL of 0.1 M filtered NiSO4 and 
washed with 4 mL filtered sterile water and equilibrated with FPLC buffer A. A flow 
rate of 1 mL.min 1 was set and 1 mL elution fractions were collected with a gradient 
of increasing imidazole concentration as follows: 
10 x I mL of a 30 mM imidazole solution 
10 x 1 mL of a 60 MM imidazole solution 
10 x 1 mL of a 250 mM imidazole solution 
10 x 1 ml. of a 500 mM imidazole solution 
10 x I mL of a 1 M imidazole solution 
The fractions were collected automatically by a fraction collector and the collected 
fractions for each gradient step were gathered and concentrated by centrifugation in 
Vivaspin 6 mL concentrators (cut off: 10 kDa) at 4 °C, 4 000 rpm, for 35 mm. The 
concentrated fractions were added 2 niL of MTBI buffer and re-centrifuged at 4 000 
rpm, for 20 mm. This washing step was repeated twice to remove traces of 
imidazole. The samples were finally added an equal volume of SDS-PAGE loading 
buffer and analysed by SDS-PAGE (11-3-13) and Western blot (11-3-14). 
11-3-18 Fluorescence measurements 
The fluorescence of cell pellets from 1 mL of culture was observed by direct 
exposure to UV light using the Anachem transilluminator as the UV source. 
200 RL of the sample to be analysed were routinely introduced in the well of a dark 
well plate or a Sero-Wel plate and the emission spectrum of the GFP chromophore 
between 500 nm and 600 nm was recorded on a MAX gemini XS spectrofluorimeter 
(Molecular Devices, Sunnyvale, USA). The excitation wavelength was fixed at 395 
nm and a cut off was set at 475 nm. In the case of the SNAP tag, the excitation 
wavelength was set at 488 nm and the emission spectrum was recorded between 513 
nm and 543 nm, with a cut off at 495 nm. 
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11-3-19 Fermentation 
Fermentations were carried out in New Brunswick Scientific BIOFLO 4500 
Fermentor/Bioreactor (New Brunswick Scientific, Hertfordshire, UK), by Doctor 
John White in a 10 L scale starting from a 100 mL culture of E. coli BL21(DE3) 
cells freshly transformed with pET16b-GFPALGJATMI grown at an absorbance at 
600 nm of 1. The antibiotic used for the fermentations was carbenicillin at a 
concentration of 100 gg.mL' and cells were grown for 4 h after IPTG induction of 
expression at either 37 °C or 20°C. 
11-3-20 Bradford assay 
To a 1 mL cell pellet (between 26 mg to 31 mg of wet cell pellet) was added 200 pL 
of MTBI buffer. The cells were opened by sonication and the soluble fraction was 
isolated by centrifugation at 4 °C, 4 000 rpm, for 10 mm. To 4 pL of the supernatant 
was added 196 tL of Bradford reagent (0.1 mg.mL' Coomassie Blue G, 5 % 
methanol, 8.5 % H3PO4). The protein concentration was determined compared to 
BSA standards, which were prepared as follows, starting from a BSA solution at I 
mg.mL 1 : 
Protein concentration (in 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 
mg.mL') 
BSA (in jiL) 5 10 15 20 25 30 35 40 45 50 
H20 (in RL) 45 40 35 30 25 20 15 10 5 0 
The absorbance of 200 jiL samples loaded into Sero-Wel, polystyrene microtiter 
microplates (Sterilin) was measured at 595 nm on the LTV-visible microtiter plate 
reader. 
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11-3-21 Immobilisations on nickel column and thrombin cleavage 
To the cell pellet of a 100 mL culture of E. coli BL2I (DE3) cells harbouring 
pET28a-GFPALGIaTM1 was added 6 mL of FPLC buffer A (0.5 M NaCl, 20 mM 
Tris-HCI, 0.25 % v/v Triton-X-100, 1 mM PMSF, pH = 7.5). The immobilisation 
was then carried out on a HiTrapChelating HP 1 mL column using the Akta FPLC 
system as already described (11-3-17). 
The gradient of imidazole was set as follows: 
3 x 1 mL of a 250 mM imidazole solution 
3 x I mL of a 500 mM imidazole solution 
3 x 1 mL of a IM imidazole solution 
For every fraction, a 20 RL aliquot was taken and added an equal volume of SDS-
PAGE loading buffer to be analysed by SDS-PAGE (11-3-13) and Western blot (11-3-
14). The third elution fraction was found to contain the fusion protein and it was 
concentrated to a 1.5 mL volume by centrifugation in Vivaspin 6 ml- concentrators 
(cut off: 10 kDa) at 4°C, 4 000 rpm, for 35 mm. The concentrated sample was loaded 
onto a PDIO desalting column to remove traces of imidazole and eluted with 3.5 rnL 
of MTBI. The amount of protein was determined to be 2.60 .tgj.tL' using the 
Bradford assay described in 11-3-20. The small scale optimisation of the thrombin 
cleavage was carried out following the manufacturer's instructions and indicated that 
a dilution of 1 / 50 of the commercial thrombin was optimal for the removal of the N-
terminal His tag from proteins. The reaction was set as follows: 
- 100 p.L of 10 x thrombin cleavage buffer (200 mM Tris-HCI, pH = 8.4; 1.5 M 
NaCl; 25 mM CaD2) 
- 80 j.tL of protein solution 
- 20 RL of biotinylated thrombin (0.02 U4tL' in 50 mM sodium citrate, pH = 6.5, 
200 mM NaCl, 0.1 % polyethylene glycol (PEG-8000), 50 % glycerol) 
- 800 pL of H20 
The reaction was left at room temperature for seven hours, 20 IlL aliquots being 
taken after 2, 5 and 7 h for SDS-PAGE analysis of the cleavage. The reaction 
mixture was desalted using a PD1O column and re-loaded on a HiTrapChelating HP 
1 mL and submitted to the same conditions as described above. The 9 mL of the 
elution fraction were concentrated down to 200 IlL by centrifugation in Vivaspin 6 
mL concentrators (cut off: 30 kDa) at 4 °C, 4 000 rpm, for 35 min and the GFP 
fluorescence of this sample was measured as described in 11-3-18. 
11-3-22 SNAP reaction with BC-fluorescein 37 
To a 50 mL cell pellet was added 3 mL of SNAP buffer (50 mM 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid sodium salt buffer solution (HEPES), 
pH = 7.5; 1 mM Un'; 1 mM PMSF; 0.25 % v/v Triton-X-100) and the cells were 
lysed by sonication for 2 mm. The supernatants were isolated by centrifugation at 13 
000 x g, at 4 °C, for 10 mm. 7 mL of SNAP buffer containing 5 .tL of BG-
fluorescein 37 in DMSO were added to the supernatant and the reaction was carried 
at 4 °C for I h. The excess of substrate 37 was removed by molecular weight based 
separation using a Vivaspin concentrator with a cut off at 30 kDa. 200 1sL of the 
concentrated sample was introduced in the well of a microtiter plate and the 
fluorescence signal of the BG-fluorescein 37 was recorded. 
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11-4 Results and discussion 
Due to the superiority of the pET system for the expression of the ALG] gene over 
other bacterial expression systems (Revers, 1996) (1-6-3), all genetic manipulations 
aimed at introducing the gene fusions into a pET expression vector (11-4-2). Of all 
the systems tested (Revers, 1996), expression of ALGJ A2 and ALGJATM genes (1-6-
2) had indeed been found to be successful from both pTrc expression vectors and 
pET expression vectors but the pET system yielded higher amounts of proteins, 
allowing protein isolation (Revers, 1996). Moreover, work was continued with the 
ALGIL'STM isoform as expression of the ALGILI2 was found to be toxic for the cells 
while catalysis was not affected by the truncation of the enzyme (1-6-2). The 
ALGIATM1 gene was thus fused at the 5'end of the GFP gene (11-1-3-1) or the 3' or 
5' ends of the SNAP tag coding sequence (11-1-3-2). Fusions at the N-terminus of the 
rnannosyltransferase were favoured since glycosyltiansferases are known to possess 
their catalytic domain at their C-terminus and fusions to this end is often considered 
to yield catalytically inactive chimera (Abe et al., 2003; Abe et al., 2004). The 
cloning therefore aimed at fusing the GFP gene or the SNAP tag coding sequence to 
the ALG]ATM1 gene truncation and inserting the gene fusions into a pET expression 
vector. More details will be given below concerning the cloning strategy and the pET 
expression system. 
11-4-1 General cloning strategies 
Most of the cloning strategies used a TOPO ® TA cloning reaction (11-3-5), which 
enables cloning of genes without the requirement for restriction digest and ligation 
steps (Scheme 2-8) (Shuman, 1991; Shuman, 1994). This reaction uses a linear 
vector with single 3' thymidine (T) overhangs, to which a viral topoisomerase I is 
covalently linked. This enzyme normally binds to double-stranded DNA at specific 
sites and cleaves the phosphodiester backbone after 5'-CCC'TT sequences in one 
strand. The energy released by this cleavage was used to create a covalent link 
between the 3' phosphate of the cleaved strand of the cloning vector and a tyrosyl 
residue of the topoisomerase (Shuman, 1994). If a DNA fragment carries adenosine 
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(A) overhangs at the 3 end of one of its strands, the free hydroxyl group on the other 
strand can attack the phospho-tyrosyl bond between the DNA and the enzyme 
(Scheme 2-8) (Tian et al., 2004). This results in the formation of a phosphodiester 
linkage between the vector and the DNA insert and the release of the enzyme. The 
introduction of A-overhangs on a PCR product is possible using the terminal 
transferase activity of the Taq polymerase enzyme, which adds a single 2'-
deoxyadenosine to the 3' end of PCR products. Hence, the TOPO ® TA cloning 
reaction uses the properties of both the Taq polymerase and the viral topoisomerase I 
to rapidly introduce a DNA fragment in a vector. Alternatively, a TOPO ® reaction 
can be carried out with a blunt end PCR product, in which case the TOPO vector 
does not possess the T overhangs. 
Topoisomerase I 
Topoisomerase i (IIIIIIIIIII) 
Recognition site 
	
\ 	AGGG TTCCC 
,/" 	TOPO vector 
CCCTF 	P 
GGGA Topoisomerase I 















Release of the topoisomerase I 
upon ligation 
Scheme 2-8: TOPO TA cloning uses the A-overhangs introduced by the Taq DNA 
polymerase onto a PCR product to insert it into a TOPO vector, thanks to the action of the 
topoisomerase I that is covalently bound to this vector. Reproduced from the TOPO 
Cloning Kits, Invitrogen. 
This step was deemed necessary for the subsequent isolation of a high quantity of 
DNA from TOP1O E. coli cultures harbouring the TOPO construct. Production of 
substantial amounts of DNA was needed when the next step was a partial digestion, 
which should produce sufficient amounts of the full-length DNA coding sequence 
displaying cohesive termini for the final ligation step. Alternatively, insertion of a 
DNA fragment into a TOPO vector was used when direct attempts to ligate the cut 
PCR product had failed, as the dual restriction digest can then be monitored on 
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agarose polyacrylamide gel. The DNA thus generated presented the cohesive termini 
required for the ligation in a pET expression vector. 
11-4-2 Overview of the pET system 
In the pET vector series, transcription of the target gene depends on the exogenous 
T7 RNA polymerase, which binds highly specifically to a 23-base-pair sequence 
rarely found in prokaryotes and eukaryotes (Tabor & Richardson, 1985; Chen & 
Schneider, 2005). This polymerase presents the extra advantage of elongating 
nucleotide chains five times faster than the endogenous E. coli polymerases, enabling 
over-expression of the gene of interest compared to genes expressed solely by 
endogenous E. coli polymerases (Tunitskaya & Kochetkov, 2002). The T7 DNA 
polymerase is provided by the host, which is a lysogen of bacteriophage DE3, i.e. a 
bacterial strain where the DE3 bacteriophage was integrated into the chromosome 
(Scheme 2-9). Additionally, the host carries a DNA fragment comprising the lad 
gene, which produces the lac repressor and the lacUV5 promoter upstream of the 
gene for the T7 RNA polymerase. 
IPTO induction 
E. coli RNA polymerase 
	 T7 RNA 	IPTG induction 
poyrnerase 
1-11 
la c repressor ( 
lad gene 





Scheme 2-9: Schematic representation of the pET system, exploiting the T7/ac promoter 
for expression of the gene of interest. This system requires the use of a DE3 lysogen as 
the host. Reproduced from Novagen. lac o: lac operator. 
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Uiidei non-induced conditions, the be repressor binds the bu operator uid inhibits 
the transcription of the T7 RNA polymerase by E. coli polymerases. Once the 
appropriate lysogen has been transformed, the production of T7 RNA polyrnerase 
and the subsequent transcription of the target gene therefore require the addition of a 
lac repressor inhibitor, e.g. IPTG. The pET16b, pET24a and pET28a vectors present 
an extra level of control as they possess a T71ac promoter, i.e. a lac operator 
downstream of the sequence coding for the T7 promoter of transcription (Scheme 2- 
This feature stabilises toxic genes under non-induced conditions as transcription by 
any T7 RNA polymerase that might be produced is blocked by binding of the lac 
repressor to the lac operator of the vector. Initial work focused on constructing GFP 
gene or SNAP tag coding sequence fusions to ALGMTMI into pET vectors and 
expressing the fusion genes in the appropriate host cells to produce a fluorescently 
I abel led man novltransferac 
11-4-3 pET16b-GFP 
The pET 1 6b-GFP construct was created to provide a reference for the expression of 
the GFP gene in the pET system. 
11-4-3-1 Construction of pET16b-GFP 
The GFP gene was amplified by PCR (11-3-2: PCR2, thermal cycle 1) from the 
commercially available pcDNA3. 1INT-GFP-TOPO ®  vector, using oligonucleotide 
primers designed to introduce a Nde I restriction site at the 5' end (GFP-For) and a 
BarnH I restriction site as well as a stop codon at the 3' end (GFP-Rev). 
5-CCCAAGCTGGCTAGACCATATGGCCAGCAAAGG-3' 
GFP-For 	Sense 	
Nde I restriction site 
5-CGCTAGCACCGOGGATCCTTAGC1TII GTAGAGCTC-3 
GFP-Rev 	Antisense 	
BamH I restriction site and stop codon 
The strategy then involved cloning the amplified GFP gene into the pCR2.1 0-
TOPO® vector using a TOPO TA cloning reaction (11-3-5-I and 11-3-5-2). This was 
deemed necessary to produce sufficient amounts of DNA to enable its partial 
digestion with Nde I and BamH I restriction endonucleases as the OFF gene contains 
internal restriction sites (1 BamH I and 1 Nde I). After control of the gene insertion 
into the pCR2.1 0-TOPO® vector by EcoR I restriction digest (11-3-7), the plasmid 
was partially digested with BamH I and Nde I (11-3-8). The resulting 716 base pairs 
(bp) DNA fragment was isolated by agarose gel electrophoresis (11-3-1), purified 
using the Quiaquick protocol and ligated directionally into the unique 
complementary sites of the T71ac expression vector pET16b (11-3-9-1). The insertion 
of the GFP gene into pET16b was checked by PCR (11-3-3) using GFP-For and GFP-
Rev as oligonucleotide primers. Sequencing (11-3-11) of the final construct proved 
that the OFF gene was inserted in frame with the ten histidine tag (His tag) coding 
sequence of the pETl 6b vector and without mutation. 
11-4-3-2 Expression of GFP from pET16b-GFP transformed into E. coil 
BL21(DE3) cells 
The PET] 6b-GFP construct was transformed into either F. coli BL2I (DE3) or F. coli 
BL21(DE3)pLysS cells (11-3-12). Growth of the transformed cells was carried out as 
described in methods (11-3-12). 
Expression of the GFP gene was revealed by the green fluorescence of the cell pellet 
of F. coli BL2I (DE3) cells harbouring the construct when observed under UV light 
(11-3-18) and the presence of a band of 31.6 kilo Daltons (kDa) on SDS-PAGE gel 
(11-3-13) (Figure 2-10). 
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Figure 2-10: SDS-PAGE gel of the whole cell content of E. co/i BL21 (DE3) cells harbouring 
either pET16b-GFP (Lane 2) or pET16b (Lane 3). Lane 1: BioRad Precision Plus protein 
Standards. 
The fluorescence spectra (Figure 2-11) of the soluble fraction were recorded (11-3-
18) and found to be identical in shape to those reported in the literature (Inouye & 
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Figure 2-11: Fluorescence spectra of the GFP chromophore present in the soluble fraction of 
E. co/i BL21(DE3) cell extracts harbouring pET16b-GFP. The emission spectrum was 
recorded at a fixed excitation wavelength of 395 nm. The excitation spectrum was recorded 
at a fixed emission wavelength of 507 nm. 
As the GFP was produced in an active form and in substantial quantities using the 
pET system, work subsequently focused on producing the N-terminal fusion of GFP 
to the f- 1 ,4-mannosyltransferase. 
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11-4-4 pET1 6b-GFPALG1ATM1 
The pET16b-GFPALGMTM1 construct was designed for over-expression of the 5' 
end GFP gene fusion toALGI ATM 1 placed under the 771ac promoter, to produce the 
N-terminal GFP fusion to A1g1ATM1p. The pET16b vector was initially chosen as it 
introduces an N-terminal 10 histidine tag, which facilitates protein detection by 
Western blot and purification by immobilised-metal affinity chromatography 
(IMAC). Moreover, it enabled direct comparison of expression between the 
ALGI ATM gene from the pLR36 construct (pETl6b-ALGJATM) (Scheme 1-18) and 
the GFPALGIATM1 gene fusion cloned in the same expression vector (Revers, 
1996). 
11-4-4-1 Construction of pET16b-GFPALG1ATM1 
The ALGJ gene was amplified from the yeast Saccharomyces cerevisiae (S. 
cerevisiae) genomic DNA by PCR (11-3-2: PCR1, thermal cycle I) with 
oligonucleotide primers designed to eliminate the hydrophobic N-terminus, i.e. 







BarnH I restriction site and stop codon 
5-CCCAAGCTGGCTAGACCATATGGCCAGCAAAGG-3 
GFP- For 	Sense  
Nde I restriction site 
The amplified 1 245 bp DNA fragment was inserted into the pcDNA3. 1/NT-GFP-
TOPO® vector using the TOPO® TA cloning reaction (11-3-5-1 and 11-3-5-2). As this 
cloning strategy is non-directional, the obtained constructs were analysed for the 
correct insertion of the PCR product, i.e. correct orientation and reading frame, by 
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restriction analysis using BamH I and Nc/c I (11-3-7). Correct constructs yielded 
bands at 4983, 1111, 653, 290, 230 and 167 bp on DNA agarose gel electrophoresis. 
Since the pcDNA3. 1INT-GFP-TOPO ® vector is designed for mammalian expression, 
further genetic manipulations were required to introduce GFPALGJATM1 into a 
bacterial expression vector. Ligation into the pETlôb vector necessitated the 
introduction of an Nde I restriction site at the 5' end and of a BanzH I site at the 3' 
end. The obtained gene fusion was therefore amplified by PCR (11-3-2: PCR1, 
thermal cycle 1) using the GFP-For oligonucleotide primer to introduce a Nc/c I 
restriction site at the 3 end of GFPALGIESTM1 and the ALG1-Rev oligonucleotide 
primer, including a 5' end BaniH I restriction site and a stop codon. As the amplified 
gene fusion contained 3 Nde I and 4 BamH I restriction sites, it was deemed 
necessary to clone the gene into pCR2.10TOPO®  to produce sufficient amount of 
the correctly cut product. The insert was introduced in the pCR2 . 1 0 TOPO® vector 
using the TOPO® cloning reaction (11-3-5-1 and 11-3-5-2) and the resulting construct 
was subjected to partial restriction digest with BamH I and Nde I (11-3-8). The 
resulting partial digestion product was purified by agarose gel electrophoresis (11-3-
1) and ligated into the unique complementary sites of the pET16b vector (11-3-9-1). 
The obtained plasmids were verified by analytical PCR (11-3-3) using the GFP-For 
and ALGI-Rev primers to check for insertion and successful constructs were 
sequenced. The sequencing (11-3-11) revealed the introduction of the 
GFPALGJ ATM 1 gene fusion in frame with the coding sequence of the N-terminal 10 
histidine tag coding sequence and the presence of 7 base pair mutations 
corresponding to 3 amino acid substitutions: 11216Y, N254D and D4440. None of 
the amino acids substitutions were found in conserved regions (Appendix 1). As the 
sequencing results were delayed, the construct was used in further experiments prior 
to analysis of the sequencing results and it was found to produce an active enzyme. It 
was therefore decided to continue work with this construct, especially as an identical 
construct containing only one mutation (V298A) had not yielded detectable protein 
as no protein band (79.3 kDa) was observed on a Western blot using a monoclonal 
anti-His antibody and no mannosyltransferase activity was detected when the cell 
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extract was assayed for transfer of mannose from radiolabelled GDP-Man 8 to 
PPGn2 29a. 
11-4-4-2 Expression of GFPALG1ATM1 from pET1 6b-GFPALG1ATM1 
transformed into E. coil BL21(DE3) cells 
The pET16b-GFPALGJATM1 construct was transformed into E. coli BL21(DE3) 
cells, which were subsequently grown as described in methods (11-3-12). Expression 
analysis of the GFPALG]L\TM 1 gene fusion by Western blot using a monoclonal 
anti-His antibody (11-3-14) revealed the presence of a band at 79.3 kDa, indicating 
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Figure 2-12: Western blot of the whole cell content of E. coil BL21 (DE3) cells harbouring 
pET16b-GFP (Lane 2) or pET16b-GFPALG1LTM1 after 10, 30, 20 min and 2 h of IPTG 
induction of expression (Lanes 3-6). Lane 1: BioRad Precision Plus protein Standards. 
Production of the fusion protein over time was detected by the increase in intensity of the 
79.3 kDa band. 
Although the His 1 0GFPA1g1ATM1 protein was produced, it was found to be 
degraded by proteases, essentially into a product slightly bigger than GFP (31.6 
kDa), as was observed by the presence of a band between 25 and 37 kDa on the 
Western blot (Figure 2-12). Attempts to reduce the proteolysis were made by using a 
non-induced strategy for production of the protein as this strategy was found highly 
successful to improve the production of a galactose oxidase (Dr. Franck Escalettes, 
personal communication). In a non-induced strategy, the cells are grown at 26 °C for 
24 h without addition of IPTG and the protein production results solely from the 
basal expression of the gene in E. coli BL21(DE3) cells. However, in the case of the 
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mannosyltransferase gene, no improvement resulted from these growth conditions. 
The cells were therefore cultured as described in methods (11-3-12) and the produced 
fusion protein was further characterised. The cell extract of E. coli BL21(DE3) cells 
harbouring pET I 6b-GFPALGJ LVI'M 1 displayed significant levels of 
mannosyltransferase activity (11-3-15) (Figure 2-13) and green fluorescence of the 
cell pellet was observed under UV light (11-3-18). 
Figure 2-13: Mannosyl-transfer catalysed by HisGFPAlg1TM1p from E. co/i BL21(DE3) 
cell extracts harbouring pET16b-GFPALG1TM1. The radioactivity levels of the organic 
and aqueous phases after mannosyltransferase reaction with radiolabelled GDP-Man 8 in 
the presence of PPGn 2 29a (1) or without (2) were measured. 
Despite the detected activity, the degradation products were considered problematic 
for downstream applications. Reducing the proteolysis of the fusion protein was 
deemed necessary, as it was thought that the presence of degradation products of size 
slightly higher than GFP would interfere with fluorescence measurement of the 
fusion protein, as they probably contained an active chromophore 44. It was 
considered that non-detected (because not bearing a His tag) degradation products 
could also be responsible for the mannosyltransferase activity of the whole cell 
extract. Attempts were therefore made to produce a more robust GFPA1g I ATM 1 p 
fusion protein by expressing the GFPALGJATM 1 gene fusion in different K co/i 
strains. 
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11-4-4-3 Expression of GFPALGIATM1 from pET16b-GFPALG1ATM1 
transformed into E. coil ORIGAMI(DE3)pLysS cells 
E. coli ORIGAMI(DE3)pLyss is a modified strain containing mutations in both the 
thioredoxin reductase and the glutathione reductase genes, leading to improved 
folding of proteins by facilitating disulfide bond formation. Proteolysis is generally 
considered to arise from improper folding of the produced protein, leading to its 
degradation by the host proteases. Moreover, the pLysS plasmid carried by the E. 
coli ORIGAMI(DE3)pLysS cells provides T7 lysozyme, which inhibits the T7 RNA 
polymerase, eliminating basal expression of the gehe of interest. The pLysS system 
thus gives a higher control on the production of the protein of interest, a property of 
high interest when the gene expression may be toxic to the cells. However, 
transformation into E. coli ORIGAMI(DE3)pLysS cells proved difficult (11-3-12) 
and only a few colonies were obtained after selection on LB agar plates, irrespective 
of the construct: pET16b-GFP (1 colony obtained) and pET16b-GFPALGJATM1 (8 
to 15 colonies). The cells were also found difficult to cultivate (11-3-12) as was 
observed from the growth profile (Figure 2-14). 
Oo,Mh bcluviwr of Ecoli Dill (1t3) a brnbou,tg pErith- 	 O,yah behaviour of Ecoli (3)JGAM( 	TysS cells limboming 
OP/IL/SI DIMI 	 pEIIth-GPALDIDTh4I 
Figure 2-14: Comparison of the growth behaviour of E. co/i BL21(DE3) cells and E. co/i 
ORIGAMI(DE3)pLysS cells harbouring the same construct, i.e. pET16b-GFPALGIATM1. 
The BL21 cells showed a typical growth behaviour with an exponential growth followed by 
a plateau but the ORIGAMI cells appeared particularly slow and presented an untypical 
linear growth profile. 
Although GFP was produced from pET16b-GFP as observed by the fluorescence of 
the cell pellet when exposed to UV light (11-3-18), the cells failed to produce the 
His10GFPA1g1ATM1 protein fusion as no band of the correct size (79.3 kDa) was 
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observed on either a SDS-PAGE gel (11-3-13) or a Western blot using the anti His tag 
antibody (11-3-14). Further analyses of the DNA content of the cultured cells showed 
that the pET16b-GFPALGJATM1 construct had been lost during the growth. In 
conclusion, the expression of the GFPALGIATMI gene fusion from the pET16b 
vector was found not to be possible in E. co/i ORIGAMI(DE3)pLysS cells, as it 
greatly hampered the growth of the cells. Moreover, the high antibiotic selection 
required for the growth of those cells led to only a few colonies after transformation, 
limiting the use of this strain for the transformation of a library, where a high number 
of colonies after transformation is required. Due to the difficulties associated with the 
use of these cells, expression of GFPALGIATM1 was not tried again in this 
particular E. coli strain. E. coli BL21(DE3)pLysS cells, which retains the pLysS 
system for controlled expression of the gene of interest, were subsequently tried to 
reduce the degradation by the host proteases. 
11-4-4-4 Expression of GFPALG1ATM1 from pET16b-GFPALG1ATM1 
transformed into E. coil BL21 (DE3)pLysS 
Expression of GFPALGIz\TMI from the pET16b-GFPALGIz\TMI construct 
transformed into E. coli BL21(DE3)pLysS cells produced the expected protein as 
was observed on the Western blot using the anti His tag antibody (11-3-14) by the 
presence of a 79.3 kDa protein band of increasing intensity over time (Figure 2-15). 
Figure 2-15: Western blot of the whole cell content of E. co/i BL21(DE3)pLysS cells 
harbouring pET16b-GFPALG1TM1, 0, 10,20,30 mm, 1,2 and 3 h after IPTG induction 
of expression (Lanes 2-8). Lane 1: BioRad Precision Plus protein Standards. 
Degradation was already observed after 30 min of growth in the presence of IPTG (bands 
between 30 and 45 kDa. 
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Despite the tighter control of the pLysS system, degradation was observed as soon as 
the production of the fusion protein was detected and further work with the pETl6b-
GFPALG] ATM 1 construct was therefore carried out in E. co/i BL21(DE3) cells. 
11-4-4-5 Fermentation of E. co/i BL21(DE3) cells harbouring pET16b-
GFPALG1ATM1 
Fermentation of E. co/i BL21(DE3) cells harbouring pET16b-GFPALG]ATM1 was 
tried for the production of GFPA1g1ATM1p (11-3-19). When cells are grown by 
fermentation, the culture conditions are monitored and can be more easily optimised 
and reproduced to maximise production of the protein of interest and minimise 
degradation by proteases. 









Figure 2-16: Western blot of the whole cell content of E. co/i BL21 (DE3) cells harbouring 
pET16b-GFPALG11TM1 during the fermentation at 37 °C, 0, 30 mm, 1 h, 1 h 30 mm, 2 h, 
2 h 30 mm, 3 h and 3 h 30 min after IPTG addition (Lanes 2-9). Lane 1: BioRad Precision 
Plus protein Standards. 
A first fermentation was carried out at 37 °C throughout the growth and a detectable 
amount of fusion protein was produced as detected by the presence of a band at 79.3 
kDa on the Western blot using the anti His tag antibody (11-3-14) but substantial 
amounts of degradation products were also detected (Figure 2-16). Attempts to 
reduce the degradation were made by lowering the temperature down to 20 °C after 
IPTG induction of expression but only a degradation band, at around 30 kDa, was 
observed on the Western blot using the anti-GFP antibody (H-3-14) (Figure 2-17). 
Further work was pursued using the product of the fermentation at 37 °C and the 
amount of produced soluble proteins was measured using the Bradford assay (11-3-
20) and determined to be 2 mg.mL'. 









Figure 2-17: Western blot using an anti-GFP antiserum of the whole cell content of E. co/i 
BL21(DE3) cells harbouring pET16b-GFPALG1tTM1 during the fermentation at 20 °C, 0, 
1 h, 2 h, 3 h and 4 h after IPTG addition (Lanes 2-6). Lane 1; BioRad Precision Plus 
protein Standards. 
11-4-4-6 Immobilisation of the His 10GFPAIg1ATM1p fusion protein on Ni-
column 
As the fermentation of E. co/i BL2I(DE3) cells harbouring pET16b-
GFPALGJATM1 showed that it would be difficult to reduce the proteolysis by 
altering the culture conditions, attempts to separate the degradation protein fragments 
and the full-length His 1 0GFPA1g1ATM1p fusion protein using an immobilized-metal 





,~—NH HN '_(O N  
R1 
Scheme 2-18: Nickel ion chelated to sepharose High Performance present in the 
HiTrapchelating column and to a histidine residue of a protein (from 
Amershambiosciences). 
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Affinity chromatography using nickel ions relies on the affinity of these ions for 
nitrogen-rich heterocyclic ligands, such as the imidazolyl side-chain of histidine. By 
immobilising the nickel ions on a chelating adsorbent, immobilisation of histidine-
rich proteins can be achieved. The affinity is further increased when strings of 
consecutive histidines are present in the protein sequence, enabling the highly 
selective isolation of proteins carrying a 6 or 10 histidine tag. After mild washing of 
the column to remove unbound proteins, the proteins bearing a tag are displaced by a 
competitive binder, imidazole, or by lowering the pH or by stripping of the nickel 
ions from the resin. Binding to nickel ions had already been used to immobilise the 
truncated -1,4-mannosyltransferase, A1g1ATM1p (Revers, 1996) and to purify a 
variety of glycosyltransferases (Chen et al., 2001; Kurkela et al., 2003; Kanipes et 
al., 2003). 










Figure 2-19: Western blot showing HisGFPAlg1TM1p at different stages of purification 
by IMAC. Lane 1: BioRad Precision Plus protein Standards. Lanes 2-7: soluble fraction 
from E. co/i BL21(DE3) cells harbouring pET16b-GFPALG1TM1 in FPLC buffer at 
different steps of the purification process: loaded sample (1.5 mg of cell pellet in 6.5 mL 
FPLC buffer A), column flow-through (30 mM imidazole) and collected fractions 
corresponding to elution with, respectively, 60 mM, 250 mM, 500 mM and 1 M imidazole. 
This purification technique was therefore applied to the product of the expression of 
GFPALGIATM1 from the pET16b-GFPALGJATM1 transformed into E. coli 
BL21(DE3) cells using the presence of the 10 histidine tag introduced at the N-
terminus of the produced fusion protein (11-3-17). However, as the 
His 10GFPA1g1ATM1 protein was highly degraded, some degradation products also 
carried a His tag and were co-purified with the labelled enzyme as was seen on the 
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Western blot (11-3-14) by the presence of a band at around 30 kDa (Figure 2-19). 
Although the buffer conditions were varied in different experiments, it proved 
impossible to elute separately the His10GFPAIg1ATM1p from the tagged degradation 
products in a reproducible manner. Interestingly, the fluorescence signal of the 
sample enabled the visualisation of the binding of the fluorescent proteins bearing a 
tag and their subsequent release from the column by measuring the emission 
spectrum of the GFP chromophore at a fixed excitation wavelength of 395 nm on the 
fluorescent plate reader (11-3-18) (Figure 2-20). 
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Figure 2-20: IMAC of the fermentation product followed by measurement of the GFP 
fluorescence. For each fraction, the emission spectrum was recorded at a fixed excitation 
wavelength of 395 nm. CS: crude sample; FW: flow-through; F: eluted fractions; FS: 
filtered concentrated sample loaded onto the column. 
In conclusion, the immobilisation of His 1 0GFPAIg1ATMIp on nickel column 
through chelation of its His tag was achieved successfully and followed by 
measurement of the GFP fluorescence signal. However, as some of the degradation 
products also possessed the His tag, hence the same affinity for nickel ions, they 
were co-immobilised with the full-length fusion protein. Attempts were made to vary 
the imidazole concentration and elute the tagged proteins in a stepwise fashion, but 
no conditions to separate the His30GFPAlgl ATM i p from other proteins were found 
that could be reproduced. Moreover, the elution with imidazole had been shown to 
yield an inactive mannosyltransferase and elution from the column should thus be 
avoided if use of the enzyme as an active catalyst is required (Revers, 1996). 
Mannosyltransferases are commonly known to be instable in preparations as well as 
sensitive to high ionic strength (Revers, 1996). For example, the S. cerevisiae 13-i,4- 
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mannosyltransferase was found to be inactive after elution with 0.5 M NaCl and 1 M 
imidazole-HCI from a nickel (H) chelation chromatography column. The bioassay of 
the resulting cell extracts displayed a 98 % loss of activity compared to the control 
and the removal of the solutes did not allow for the recovery of the bioactivity 
(Revers, 1996). 
11-4-5 pET20b-GFPALG1ATM1 
GFP 	 ALGIATM I 	NEIIII 
New constructs were made to facilitate the isolation of the full-length protein fusion 
and to demonstrate that the protein fusion was active as a mannosyltransferase and a 
GFP chromophore. With this aim, the GFPALG 1 ATM 1 gene fusion was inserted into 
the pET20b vector, which contains a pel B signal sequence for potential periplasmic 
localisation and the possibility to introduce a His6 tag at the C-terminus of the 
mannosyltransferase. The signal peptide for periplasmic export of the produced 
protein is cleaved during the translocation mechanism and thus does not affect the 
protein function. Periplasmic export of the produced protein can greatly reduce the 
degradation as the periplasm is known to contain far fewer proteases than the 
cytoplasm (Makrides, 1996). The presence of the tag at the C-terminus in this 
expression vector was also of interest as it enabled determination of the tolerance of 
the A1g1ATM1p to C-terminal fusions. Some glycosyltransferases have been found 
to be inactivated by C-terminal fusions (Benciirová, 2003). Also, a C-terminal His 
tag would allow for facilitated isolation of the fluorescent full-length fusion protein 
from the fluorescent degradation products by IMAC. The N-terminal degradation 
products would indeed not possess the C-terminal His tag and hence, they should not 
be retained onto the nickel column. The fluorescence of the elution fraction could 
then be solely attributed to GFPA1g1ATM1His6p as the degradation products that 
might be retained would not contain an intact GFP. 
11-4-5-1 Construction of pET20b-GFPALG1ATM1 
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The GFPALG]ATM1 gene fusion was amplified from the pET16b-GFPALG]ATM1 
construct by PCR (11-3-2: PCR1, thermal cycle 2). The oligonucleotide primers, 
GFP-pET20bis-For and ALG1pET20bis-Rev, were designed to introduce an EcoR I 
and a Not I restriction site, respectively. The antisense oligonucleotide primer was 
also designed to introduce the GFPALGIATM1 gene fusion in frame with the C-
terminal 6 histidine tag encoded by the pET20b vector. 
GFP-pET20bis- 	 5-CCATATGAATFCCCGTCATATGGCGAGGAAAGOAGAA-3 
Sense 
For 	 EcoR I restriction site 
ALGI pET2Obis- 	 5-GCFI1TGflAGCAGCCGGCGGCCGCATGAATFAGC-3' 
Antisense 
Rev 	 Not I restriction site 
The obtained PCR product was cut with EcoR I and Not I restriction enzymes as 
described in methods (11-3-6) and ligated into the unique complementary site of the 
pET20b vector, using the standard ligation protocol (11-3-9-1). The successful 
insertion of the gene was verified by screening PCR, using the above oligonucleotide 
primers (11-3-3). The correct introduction of the gene in the expression vector was 
verified by sequencing (11-3-11) before any expression work was carried out. The 
construct was found to contain the same mutations as the pET16b-GFPALGJATM1 
construct, i.e. the template used for the initial amplification of the GFPALGJLTM1 
gene fusion (11-4-4-1) (Appendix 1). 
11-4-5-2 Attempted expression of GFPALGIATM1 from pET20b-
GFPALGIATM1 transformed into different E. coil BL21 (DE3) strains 
The pET20b-GFPALGIATMI construct was transformed into either E. coli 
BL21(DE3) or E. co/i BL21(DE3)pLysS cells and the transformed cells were grown 
as described in methods (11-3-12). Expression of GFPALGIATM1 from pET2Ob-
GFPALGJ ATM 1 was tried in both cell strains but in neither case was a protein band 
of the correct size (79 kDa) observed on a protein electrophoresis gel (11-3-13). 
Further analyses of the growth behaviour showed that the E. coli BL21(IDE3) cells 
failed to grow whereas the E. coli BL2I (DE3)pLysS cells growth was altered after 
RE 
IPTG induction of expression. Attempts to grow E. co/i BL21(DE3)pLysS cells for 
only 1 hour after induction failed to yield detectable amounts of protein so work on 
this construct was not carried any further. It was concluded that expression of 
GFPALG1ATM1 from the pET20b-GFPALGh\TMI construct was lethal to the cells 




As attempts to reduce the proteolysis by periplasmic export of the produced protein 
proved unsuccessful, a new strategy involving the modification of the linkage 
between the proteins to be fused was considered. The length of the linkage between 
the GFP and the ALG1ATM1 could have an influence on the stability of the fusion 
protein (Waldo et al., 1999). Most of the linkages reported in the literature were 
considerably shorter than the one introduced by the TOPO vector, that is, between 16 
and 6 amino acids in length compared to 22 amino acids for the TOPO vector (Table 
2-21). Moreover, the linkers were glycine-rich as these residues are thought to impart 
flexibility to the linker and this should facilitate folding of both fusion partners. 
linker 	 reference 
GSGPVLAVPSSDPLVQCGGIAL pcDNA-3. 1-NT-GFP- TOPO 
GSAGSAAGSGEF 	 Waldo et al., 1999 
GGGSGGGSGGGSGGGS 	Waldo et al., 1999 
GGGGSGGGGT 	 Kratz et al., 1999 
GGTGEL Baird etal., 1999 
GGTGGS 
Table 2-21: Examples of linkers between the GFP and proteins reported in the literature. 
The linker present in the TOPO vector is clearly longer and less glycine-rich than the other 
linkers. 
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The pET24a-RisGFP-link-ALGJ ATM 1 construct was therefore made, introducing a 
glycine-rich four amino acids linker between the two proteins, i.e.GGGT. 
11-4-6-1 Construction of pET24a-HisGFP-link-ALGIATM1 
The HisGFP gene fusion was amplified from the pET16b-GFPALGJATM1 construct 
with the HisGFP-For and the His-GFP-link-Rev oligonucleotide primers, introducing 
respectively an EcoR I restriction site at the 5' end and a nucleotide sequence 
encoding a 4 amino acid linker at the 3' end. The ALGIeXTM1 gene was amplified 
from S. cerevisiae genomic DNA using the ALG1-link-GFP-For and link-ALG1-bis-
Rev primers containing respectively a 5' end nucleotide sequence encoding a 4 amino 
acid linker and an Eag I restriction site as well as a stop codon. Both PCR were run 
under identical conditions (11-3-2: PCRI, thermal cycle 2). 
5'-ACTITFAAGAAGGAGAGAATFCATGGGCCATCATCATCAT-3' 
HisGFP-For Sense 
EcoR I restriction site 
His-GFP- = .--5'-ACCACCACCACCGCiTiTGTAOAGCTCATC-3--_-,, 
Antisense 
link-Rev 4 amino acid linker 
ALO1-link- 5'-GGTGGTGGTACATCGACCAAAAAAAGGATC-3' 
Sense 
GFP-For 4 amino acid linker 
link-ALG1- 5'-AAAAAGAAAGCJCTGAGflACGGCCGGCTCAATGAAflAGC-3 
Antisense 
bis-Rev Eag I restriction site and stop codon 
The gene fusion was achieved by annealing the complementary DNA fragments 
encoding the 4 amino acids linker and by amplifying the resulting DNA sequence by 
PCR using the oligonucleotide primers HisGFP-For and link-ALG1-bis-Rev (11-3-4). 
The resulting HIsGFP-link-ALGMTM1 gene fusion with added A-overhangs was 
ligated into pCR2.1 ®-TOPO® (11-3-5-1 and 11-3-5-2) and re-amplified from this 
construct (11-3-2: PCRI, thermal cycle 2). The gene fragment was then inserted into 
the pUBIBsd-TOPO vector using the TOPO cloning reaction (11-3-5-3). This 
construct was cut with EcoR I and Eag I (11-3-6) and the resulting restriction digest 
product was ligated into the corresponding sites of the pET24a expression vector, 
using the rapid ligation method (11-3-9-2). The correct insertion of the gene was 
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verified by analytical restriction digest of the final construct using EcoR I and Eag I 
restriction endonucleases (11-3-7). The sequencing (11-3-11) of the pET24a-HisGFP-
link-ALGJATM1 construct revealed the presence of 3 base pair mutations leading to 
one amino acid substitution (F! 15C), introducing an extra cysteine residue in the 
protein sequence (Appendix 1). 
11-4-6-2 Expression of HIsGFP-link-ALG1ATM1 from pET24a-HisGFP-
link-ALG1ATM1 transformed into E. coil BL21 (DE3) cells 
Expression of the HisGFP-link-ALGIATM1 gene fusion from the pET24a-HisGFP-
link-ALG] ATM! construct during the growth of E. coli BL2 1 (DE3) cells (11-3-12) 
produced a protein of the expected size (77.7 kDa) as was detected by the presence 
of a band of increasing intensity over time on a SDS-PAGE gel (11-3-13) (Figure 2-
22). 













Figure 2-22: SDS-PAGE gel of the whole cell content of E. ccli BL21 (DE3) cells 
harbouring pET24a-HisGFP-link-ALG1TM1. Samples of two identical cultures were 
taken at 0 h (Lanes 1 and 5), 1 h (Lanes 2 and 6); 2 h (Lanes 3 and 7), 3 h (Lanes 4 and 
8) after IPTG addition. Lane 9: BioRad Precision Plus protein Standards. 
The cell extract was tested for mannosyltransferase activity (Figure2-23). Transfer of 
mannose from radiolabelled GDP-mannose 8 to PPGn2 29a (11-3-15) had occurred as 
substantial levels of radioactivity were found in the organic phase, showing that the 
enzyme was produced in an active form (Figure 2-23). 
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Figure 2-23: Mannosyl-transfer catalysed by HisGFP-link-Alg1TM1p from E. co/i 
BL21 (DE3) cell extracts harbouring pET24a-HisGFP-link-ALG1TM1. The radioactivity 
evels of the organic and aqueous phases after mannosyltransferase reaction with 
radiolabelled GDP-Man 8 in the presence of PPGn 2 29a (1) or without (2) were measured. 
11-4-6-3 Expression of HisGFP-link-ALG1TM1 from pET24a-HisGFP-
Iink-ALG1TM1 transformed into E. co/i BL21 (DE3)pLysS cells 
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pLysS system was tried in an attempt to reduce the degradation of the HisGFP-link-
AIg1ATM1 protein. After transformation, cells were cultured as described in 
methods (11-3-12). Production of the protein resulting from the growth, under IPTG 
induction of expression, of E. coli BL21(DE3) and E. coli BL2I(DE3)pLysS cells 
harbouring pET24a-HisGFP-link-ALGJATMI, was compared (Figure 2-24). 





Figure 2-24: Western blot from E. co/i BL21(DE3) (Lanes 2 to 4) or E. co/i 
BL21(DE3)pLysS (Lanes 5 to 7) cells harbouring pET24a-HisGFP-link-ALG1TM1, 
grown at 37°C. Lane 1: BioRad Precision Plus protein Standards. Lanes 2 and 5: whole 
cell content; Lanes 3 and 6: soluble fractions; Lanes 4 and 7: insoluble fractions. 
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The pLysS system did result in lesser degradation but it was also observed that no 
protein was found in the soluble fraction when produced from those cells whereas 
some proteins were found to be soluble when produced from E. coli BL21(DE3) 
cells. Further work was therefore carried out with E. coli BL2I(DE3) cells. As a 
general conclusion, although the pET24a-Hi sGFP-link-ALGJ ATM 1 construct 
yielded the fusion protein in an active form, the expected improvements in 
expression and stability were not observed, probably due to the presence of an extra 
cysteine residue resulting from the mutation introduced during the PCR amplification 
of the gene encoding the mannosyltransferase (11-4-6-1). 
11-4-7 pET28a-GFPALG1ATM1 
MTV (ilP 	 ALGh\TMI 
A final construct containing the GFPALG1ATM1 gene fusion was made in the 
pET28a vector, which encodes a cleavable N-terminal His6 tag and a non-cleavable 
C-terminal His6 tag. This construct was used to demonstrate that the fusion protein 
was active and that the activity was not only due to the degradation products. The 
presence of the two His tags introduced by the pET28a was exploited to separate the 
full-length fusion protein from the fluorescent degradation products, as explained in 
more detail below. 
11-4-7-1 Construction of pET28a-GFPALG1ATM1 
The GFPALGJATM1 gene fusion was amplified from pET16b-GFPALGJATM1 
with the oligonucleotide primers GFP-pET20b-For and pET28a-GFPALG I His-Rev 
designed to introduce a read-through at the 3' end of the ALGIATMI gene, placing 
the C-terminal His tag coding sequence in the same reading frame as the gene fusion 





For 	 EcoR I restriction site 
pET28a- 	
5'-GClTI'GTFAGCAGCCGGACGGCCGGATGAATI'AGCYFCAA -3' 
GFPALG I His- Antisense 	
Eag I restriction site 
Rev 
The amplified DNA fragment was cut with EcoR I and Eag I as described in methods 
(11-3-6) and ligated into the corresponding sites of the pET28a vector, using the rapid 
ligation method (11-3-9-2). The construct was analysed by restriction digest with 
Hind III (11-3-7). The correct insertion of the gene in the final vector was verified by 
sequencing (11-3-11) of the construct prior to transformation of the construct into 
expression strains (11-3-12). The pET28a-GFPALG 1 ATM I construct contained the 
same mutations as the pET16b-GFPALGIATMI construct (11-4-4-1) (Appendix 1). 
11-4-7-2 Expression of GFPALG1ATM1 from pET28a-GFPALG1ATM1 
transformed into E. coil BL21(DE3) cells 
E. co/i BL21(DE3) cells harbouring the pET28a-GFPALGJATMI construct were 
grown as described in methods (11-3-12). The production of the GFPAIg1ATM1 
protein bearing both a N- and a C-terminal His6 tag from the pET28a-
GFPALG]ATM1 construct was observed on Western blot using the anti-His tag 
antibody (11-3-14) by the presence of a band at 82.4 kDa (Figure 2-25). 






Figure 2-25: Western blot of the whole cell content of two cultures of E. co/i BL21 (DE3) 
cells harbouring pET28a-GFPALG1TM1. Both cultures were grown under identical 
conditions to establish the reproducibility of the protein production (Lanes 2 and 4: culture 
1; Lanes 4 and 5: culture 2). Lane 1: BioRad Precision Plus protein Standards. 
11-4-7-3 Purification of the protein fusion produced from pET28a-
GFPALG1TM1 
The proteins produced by culture of E. co/i BL2I(DE3) cells harbouring pET28a-
GFPALGMTM1 under IPTG induction of expression were loaded on a 
HiTrapChelating HP lmL column to isolate the proteins carrying Histidine tags (H-
3-2 1) (Figure 2-26). 










Figure 2-26: Western blot monitoring the immobilisation of HisGFPAlg1TM1Hisp on 
sepharose column through chelation to nickel ions. Lane 1: BioRad Precision Plus protein 
Standards. Lane 2: loaded sample; Lane 3: flow-through; Lanes 4-8: elution fractions; 
Lane 9: elution fraction three concentrated. The protein fusion was detected by the 
presence of an 82.4 kDa band. 
This step allowed the removal of the contaminant bacterial proteins and the isolation 
of all proteins presenting a His tag at either the C- or the N-terminus, after elution 
from the column. 











Figure 2-27: Western blot monitoring the thrombin cleavage of the N-terminal His tag of 
the protein mixture. Lane 1: BioRad Precision Plus protein Standards Lane 2: Blank; 
Lanes 3-5: thrombin cleavage after 2 h, 3 h and 7 h. After 7 hours, the smear 
correspondinq to the deqradation products was no lonqer visible. 
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The tagged proteins were then submitted to thrombin digestion (11-3-21), which was 
monitored by SDS-PAGE gel (11-3-13) (Figure 2-27). 
During this procedure, the thrombin cleavable N-terminal His tags were removed and 
any degradation protein containing the His 6GFP protein fragment but not the full-
length His6GFPA1g1ATM1His6p lost their only His tag and hence, their ability to 
form a chelate with nickel ions. When the cleavage was deemed complete by SDS-
PAGE analysis of the reaction (Figure 2-27), the resulting protein mixture was 
loaded on a HiTrapChelating HP lmL column to only retain the C-terminally tagged 
proteins, thus removing degradation material that might contribute to the total 
fluorescence of the cell pellets (11-3-21). 
It was considered that any resulting protein displaying fluorescence found in the 
elution fraction, and therefore binding to immobilised nickel ions through its C-
terminal His tag, should be the full-length fusion protein. The presence of a GFP 
fluorescence signal (11-3-18) (Figure 2-28) in the elution fraction could therefore be 
considered as a proof that the full-length fusion protein was at least fluorescently 
active and that the fluorescence was not only produced by the degraded material. An 
SDS-PAGE analysis (fl-3-13) also revealed the presence of a band at the correct size 
(82.4 kDa) in the elution fraction (Figure 2-28). 
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Figure 2-28: Fluorescence emission spectrum of GFP recorded from the elution fraction 
after the second affinity chromatography. As the N-terminal degradation products, 
carrying the full-length GFP have been removed, the fluorescence observed was 
attributed to the fusion protein. The SDS-PAGE gel of the samples loaded on the column 
(Lane 1) and eluted from the column (Lane 2) showed a band at 82.4 kDa. 
The cell extract was also tested for mannosyltransferase activity (11-3-15), but the 
radioactivity level of the organic fraction was found to be equivalent to that of the 
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blank, suggesting that no transfer of radiolabelled mannose 8 to PPGn2 29a had 
occurred (Figure 2-29). A potential explanation for the lack of mannosyltransferase 
activity was that the presence of a C-terminal His tag was detrimental to the 
Alg 1 ATM ip activity, as was found for other glycosyltransferases (Abe et al., 2004). 
Another explanation is that the three amino acid substitutions introduced during the 
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Figure 2-29: Mannosyl-transfer catalysed by H1sGFPAIgIaTM1 Hisp horn E. coli 	- 
BL21 (DE3) cell extracts harbouring pET28a-GFPALGIaTM1. The radioactivity levels of 
the organic and aqueous phases after mannosyltransferase reaction with radiolabelled 
GDP-Man Bin the presence of PPGn 2 29a (1) or without (2)  were measured. 
11-4-8 Fusions of ALG1ATM1 to the SNAP tag 
Finally, fusions of ALGJATM1 to the SNAP tag coding sequence were made to 
enable the introduction of a chemical fluorophore onto the -1,4-
mannosyltransferase. This was hoped to help the stability of the fluorescently 
labelled mannosyltransferase as the fluorescence level of the chemical compound 
does not depend on the proper folding of the fusion protein, as was the case with 
GFP. Fusion of the SNAP tag to the N-terminus or the C-terminus of A1g1ATMIp 
was achieved by introducing the corresponding gene fusions into the pET28a vector, 
which presented the advantages outlined above (11-4-7). 
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11-4-8-1 Construction of pET28a-SNAPALG1ATM1 
' 	
_SNAP 
The cloning steps were carried out by Claudia Witzig (project student), as far as the 
pET28a-SNAP construct. This intermediate construct was useful to study the 
expression behaviour of the SNAP gene when expressed alone from the pET28a 
vector. The SNAP tag was amplified from the pSNAP2I vector by PCR with 
oligonucleotide primers designed to contain a Nhe I restriction site at the 5' end 
(pCWl-SNAP-For) and a BarnH I restriction site at the 3' end (pCW1-SNAP-Rev) 
(11-3-2: PCR1, thermal cycle 1). 
	
pCW 1- 	 5-GGTGAAAACCTGTACTI'CGCTAGCATGGACAAGGAT -3 
Sense 
SNAP-For 	 Nhe I restriction site 
pCW 1- 	 5- AGGCGCGCCGGATCCTCCTCCCAAGCCTGGCTF-3 
Antisense 
SNAP-Rev 	 BamH I restriction site 
The amplified PCR product was ligated into pCR2.1 0-TOPO® vector using the 
TOPO TA cloning reaction (11-3-5-1 and 11-3-5-2). The resulting construct was 
submitted to restriction digest with Nhe I and BamH I (11-3-6) and inserted in the 
corresponding sites of the similarly pre-cut pET28a vector (H-3-9-2). The 
ALGILVI'Ml gene was amplified from S. cerevisiae genomic DNA by PCR (11-3-2: 
PCR1, thermal cycle 1) with oligonucleotide primers designed to include a Sac I 
restriction site at the 5' end and an Xho I restriction site at the 3' end. 
pCW1 - 	 5'-CTCTACAAAAGCGGTGGTGAGCTCTCGACCAAA -3 
Sense 
ALG 1-For 	 Sac I restriction site 
pCWl - 	 5'-GGTGGTGCCCGAGTGCTCGAGCAATCAATGAATFAGCTF -3 
Antisense 
ALG 1-Rev 	 Xho I restriction site and stop codon 
Cohesive termini between the PCR product and the pET28a-SNAP construct were 
subsequently produced by dual restriction digest with Sac I and Xho I (11-3-6) and the 
ALGJATM1 gene was finally inserted into the unique Sac I and Xho I restriction sites 
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of the pET28a-SNAP construct by the rapid ligation method (11-3-9-2). The correct 
insertion of the gene was verified by analytical restriction digest using Sac I and Xho 
I restriction endonucleases (H-3-7). The pET28a-SNAPALG1 ATM 1 construct 
contained a 6 amino acid linker between the two genes and was verified by 
sequencing (11-3-11) before any work was carried out. No mutation was found in the 
gene fusion. 




All the cloning on this construct was carried out by Claudia Witzig (project student). 
The ALGIATM1 gene was amplified from S. cerevisiae genomic DNA by PCR with 
oligonucleotide primers designed to include a Nhe I restriction site at the 5' end and a 
BamH I restriction site at the 3' end (11-3-2: PCR1, thermal cycle 1). 
pCW2- 	 5'-CTCTACAAAAGCGGTGGTGCTAGCTCGACCAAA -3 
Sense 
ALG 1-For 	 Nhe I restriction site 
pCW2- 	 5'-GGTGCTAGAGTGCGGCCGGGATCCATGAAUAGCTI' -3' 
Antisense 
ALG1-Rev 	 BamH I restriction site 
Cohesive termini were then produced by introducing both the obtained DNA 
fragment and the expression vector pET28a in parallel restriction digests with Nhe I 
and BarnH I restriction endonucleases (11-3-6). The ALGJATM1 gene was 
subsequently ligated into the unique complementary sites of the pET28a vector (11-3-
9-2). The next step was the amplification of the SNAP tag from the pSNAP2 1 
construct by PCR (11-3-2: PCR1, thermal cycle 1) using oligonucleotide primers 






SNAP-For 	 Sac I restriction site 
pCW2- 	 5-GGAACCAGGCGCGCCCTCGAGTTATCCCAAGCC -3' 
Antisense 
SNAP-Rev 	 Xho I restriction site and stop codon 
The obtained PCR product and the pET28a-ALG1ATM1 construct were then subject, 
in parallel, to dual restriction digest with Sac I and Xho I (11-3-6). The cut SNAP 
DNA fragment was finally ligated into the corresponding restriction sites of the 
pET28a-ALGJATM1 construct using the rapid ligation method (11-3-9-2). The 
pET28a-ALGI ATM 1 SNAP construct was finally verified by analytical restriction 
digest using Sac I and Xho I restriction endonucleases (11-3-7) and sequenced (11-3-
11) prior to any other work. No mutations were found in the gene fusion coding 
sequence. 
11-4-8-3 Expression of SNAP fusions to ALG1ATM1 from the pET28a 
constructs transformed into E. coil BL21 (DE3)pLysS cells 
Both the pET28a-SNAPALG]ATM1 and pET28a-ALGJ ATM 1SNAP constructs 
were transformed (11-3-12) into K coli BL21(DE3)pLysS and the cells were grown 
as described in methods (11-3-12). Expression of the SNAPALGIATM1 and 
ALG]ATM1SNAP genes yielded the production of the desired fusion proteins as was 
visualised by the presence of bands at 73.3 kDa on the Western blot using the 
monoclonal anti-His tag antibody (11-3-14) (Figure 2-30). 











Figure 2-30: Western blot from different fractions of E. coil BL21(DE3)pLysS cells 
harbouring pET28a-SNAPALGIATM1 (Lanes 1-4) or pET28a-ALGIATM1SNAP (Lanes 6 
and 7): soluble fractions (Lanes 1, 2 and 7), concentrated soluble fractions (Lane 3), 
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The cell extracts were also assayed for mannosyltransferase activity (11-3-15) and the 
SNAPAIg1àTM1p showed a transfer of radioactive mannose from the aqueous 
phase to the organic phase, which AIgIATMISNAPp did not show (Figure 2-31). 
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Figure 2-31: Mannosyl-transfer catalysed by HisAIg1ATM1SNAPp from E. coil 
BL21(DE3)pLysS cell extracts harbouring pET28a-ALG1ATM1SNAP (1 and 2) or 
Hi5SNAPAIg1ATM1p from E. coil BL21(DE3)pLysS cell extracts harbouring pET28a-
SNAPALG1aTM1. The radioactivity levels of the organic and aqueous phases after 
mannosyltransferase reaction with radiolabelled GDP-Man 8 in the presence of PPGn 2 
29a (1 and 3) or without (2 and 4) were measured. 
The labelling reaction was also tried for all three proteins: SNAPp, 
SNAPAIgMTM1p and AIgIATM1SNAPp (11-3-22). In all three cases, the 
concentrate showed a high level of fluorescence after removal of most of the 
unreacted BO-fluorescein 37 by concentration of the sample using a protein 
concentrator with a cut off at 30 kDa (Figure 2-32). 
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Figure 2-32: Fluorescent emission spectrum of the SNAPp after reaction with BG-
fluorescein 37 recorded at a fixed excitation of 488 nm. The SNAPAIg1ATM1p and 
AIg1aTM1 SNAPp gave exactly the same curves. 
M. 
In conclusion, expression of SNAPALGJATM1 from the pET28a-SNAPALGJATM1 
construct was found to yield an active fusion protein contrary to expression of 
ALG1ATM1SNAP from the pET28a-ALGJ ATM 1SNAP. This result further suggests 
that the mannosyltransferase does not tolerate fusion to its C-terminus. However, in 
both cases, the labelling by reaction of the SNAP tag with BG-fluorescein 37 was 
obtained successfully, as most of the fluorescence was retained in the concentrate 
after elimination of the excess BG-fluorescein 37 using a protein concentrator. As 
expected this system allowed the measurement of a greater fluorescent value 
compared to the GFP system, in which fluorescence is depending on the proper 
folding of its protein sequence. However, no labelling of the protein occurred when 
the substrate 37 was added directly into the culture medium, suggesting that the E. 
coli cells were not permeable to the substrate 37. This strategy therefore required 
opening the cells by sonication prior to the labelling reaction, which complicated the 
removal of the excess BG-fluorescein 37. 
11-4-9 Summary 
A series of fusions between GFP or SNAP tag and ALG.ILTM1 have been 
constructed in the pET vector series and expression of the fusion genes was detected 
in most cases. In more detail, the expression of the GFPALG]ATM1 gene fusion 
from the pETI6b-GFPALGIATM1 construct produced the fusion protein in an active 
form despite the presence of three amino acid substitutions (H216Y, N254D and 
D444G)(11-4-4-2) (Appendix 1). However, degradation products were also identified 
(11-4-4-2) and they were considered problematic for downstream applications as they 
would interfere with the measurements of the GFP fluorescence of the fusion protein. 
Expression of the gene fusion was subsequently tried in different E. coli strains and 
at different temperatures to reduce the degradation by host proteases but in neither 
case were improvements obtained (11-4-4-3 to 11-4-4-5). Also, affinity 
chromatography failed to isolate the full-length fusion protein from fluorescent 
degradation materials since these latter also possessed the N-terminal His tag and 
therefore similar affinity for nickel ions. 
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Periplasmic export was then attempted but the expression of GFPALGJATM1 from 
the pET20b-GFPALGJATM1 was found to be lethal to E. coli cells (11-4-5). 
Further attempts to stabilise the chimeric protein were made by constructing pET24a-
Hi sGFP-link-ALGI ATM 1, where the linker between the two proteins was shortened 
and more flexible compared to the initial pET16b-GFPALGJATM1 (11-4-6). 
Although the chimeric protein possessed both GFP fluorescence and 
mannosyltransferase activity, no significant changes relative to the degradation were 
observed, possibly due to the Fl 15C amino acid substitution that introduces an extra 
cysteine in the protein sequence (11-4-6-1) (Appendix 1). 
Finally, the N- and C-terminally His tagged GFPA1g1ATM1p produced from the 
pET28a-GFPALG1ATM1 vector was shown to possess fluorescent properties as after 
the removal of the N-terminal His tag from the degradation materials, resulted in an 
elution fraction displaying GFP fluorescence (11-4-7-3). However, this particular 
fusion was found not to catalyse the transfer of mannose from radiolabelled GDP-
Man 8 to the acceptor substrate 29a, probably due to intolerance of A1g1ATM1p to 
the C-terminal His tag fusion (11-4-7-3). 
Similarly, the presence of a C-terminal SNAP tag yielded an inactive protein 
emphasising the possibility that AIg1ATM1p does not tolerate C-terminal fusions (II-
4-8-3). In contrast, the SNAPAIg1ATM1p was found to be active (11-4-8-3) and its 
use was therefore considered for downstream applications. 
Finally the mannosyltransferase activity of the proteins produced by all constructs 
was compared (Figure 2-33). The quantity of radioactive GDP-mannose 8 was the 
same, i.e. 2775 dpm, in all the assays and therefore all radioactive measurements 
were normalised compared to this value to allow for comparison between the 
different experiments. Direct comparison of the presented resulted is however 
hampered by the fact that the assay conditions had to be modified between the first 
experiments (Figure 2-33, samples 1-3) and the others (Figure 2-33, samples 4-8), in 
order to limit the use of the acceptor substrate PPGn2 29a, which availiblity was 
limited. The assay conditions of the first samples (samples 1-3) were therefore 
different than those of the other samples ( samples 4-8) but are given as an example 
of the yield that can be achieved with various truncated forms of the 
mannosyltransferase produced from the pLR36 construct (Revers, 1996). 
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Figure 2-33: Mannosyl-transfer catalysed by different forms of the 3-11-4 
mannosyltransferase produced from the different constructs. 
1 cell extract of E. cob BL21 (DE3)pLyss harbouring pLR36. 
2 soluble fraction of E. col/ BL21 (DE3)pLysS harbouring pLR36 
3 immobilised AIg1ATMp produced by E. col/ BL21 (DE3)pLysS harbouring pLR36 (11-3- 
16) 
4 cell extract of E. co/iBL21(DE3) harbouring pET16b-GFPALGIATM1 
5 cell extract of E. coil BL21 (DE3) harboudng pET24a-HisGFP-l1nk-ALG1ATM1 
6 cell extract of E. co/iBL21(DE3)pLysS harbouring pET28a-SNAPALGIATM1 
7 cell extract of E. co/iBL21(DE3)pLysS harbouring pET28a-ALGIATM1SNAP 
8 cell extract of E. co/iBL21(DE3) harbouring pET28a-GFPALGIATM1 
Sample 1 2 3 4 5 6 7 8 
Yield of GDPMan*  transfer  60** 23.8* 24.8* 5.8 10 4.3 0.6 0.4 
Yield of PPGn2M 15 23 24.9 11 19.9 8.6 1.2 0.8 
In the assay of the cellular extract of E. coil BL21(DE3)pLysS harbouring pLR36 
(sample 1), the reaction was carried out in a volume of lmL and the concentration of 
PPGn2 29a was 40 RM while that of GDPManfMan* 8 was 20 jsM. For samples 2 
and 3, the assay was also carried out in a 1 mL volume but the concentration of 
GDPmannose/mannose* 8 was 20 jiM while that of PPGn2 29a was 20 jiM. For all 
the other assays (samples 4-8), the reaction volume was 500 RL and the 
concentration of PPGn2 29a was 10 jiM while that of GDPManJMan*  8 was 20 RM. 
The difference in assay conditions accounts for the higher yields of transfer observed 
in the first three reactions (samples 1-3) compared to the other assays (samples 4-8). 
The table therefore mainly enables the comparison of the activity of the enzymes 
resulting from the constructs made during this work (samples 4 to 8), as they were all 
tested under identical conditions. 
Overall, the fusion of the 3-1,4-mannosyltransferase to another protein was found to 
reduce the activity, probably due to the greater instability of the large fusion proteins 
generated. Of the proteins produced in this work, the protein fusion produced by 
expression of HisGFP-link-ALGJATM1 from K coli BL21(DE3) cells harbouring 
the pET24a-HisGFP-link-ALGI ATM 1 construct was found to be the most active. 
However, degradation of the HisGFP-link-A1g1ATM1 protein was observed when 
expression of HisGFP-link-ALG]ATM1 was carried out. It was therefore decided to 
attempt expression of the ALG]ATM1 gene and its fusions in a Pichia pastoris 
expression system as this organism allows for the export of the produced protein to 
the culture medium, thus isolating it from the action of intracellular proteases. 
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Ill Production of f3-1,4-mannosyltransferases in Pichia pastoris 
Ill-i General features of recombinant protein production in yeasts 
Yeast expression systems are generally considered to offer advantages over both 
prokaryotic and mamalian expression systems. On the one hand, they retain the ease 
of manipulation of prokaryotic systems while, on the other hand, they offer the post-
translational machinery characteristic of eukaryotes (Cha et at., 2005). Yeasts indeed 
offer a set of post-translational modifications not available in bacterial systems, such 
as disulfide bond formation, proper protein folding, glycosylation and proteolytic 
processing (Macauley-Patrick et at., 2005). But, contrary to mammalian expression 
systems, yeast cells do not require special culture conditions for growth and 
fermentations can be easily carried out to high cell densities in minimal media with 
facile control of the parameters influencing protein productivity and activity 
(Macauley-Patrick et al., 2005). Due to these diverse characteristics, yeast expression 
systems have been widely employed as a cost-effective alternative to mammalian 
systems for large-scale production of recombinant proteins. When industrial and - - 
pharmaceutical applications are targeted, yeasts offer the extra advantage of not 
harbouring pyrogens, pathogens or viral inclusions (Shao et at., 2003). Moreover, as 
the vectors used for transformation are stably integrated into the genome, genetic 
stability of recombinant elements is ensured even in continuous and large-scale 
fermentation processes (Goodrick et al., 2001). Thus, the industrial productions of 
insulin-growth factor, hepatitis B vaccines, human serum albumin and phytase rely 
on a yeast expression system (Gellisen, 2000). 
Ill-i-i Methylotrophic yeasts 
The methylotrophic yeasts, i.e. Hansenula, Candida, Torulopsis and Pichia, are 
capable of growing on medium where methanol is the sole source of carbon (Houard 
et al., 2002). These yeasts are as easy to manipulate as the well-characterised 
Saccharomyces cerevisiae but present an extra advantage since they do not over-
mannosylate proteins (Houard et at., 2002). In most applications, hyper- 
101 
mannosylation of recombinant proteins is not desirable as this modification is 
characteristic of yeast proteins and might affect the function of the recombinant 
protein. The proteins are indeed likely to display a different glycosylation pattern 
when produced in their parent organism and the improper glycosylation introduced 
by the yeast might be damaging to their biological roles (Gellisen, 2000). Finally, the 
methylotrophic yeast Pichia pastoris adds terminal ct-1,2-mannoses instead of the 
suspected allergens a-I. ,3-mannoses added by S. cerevisiae (Daly & Hearn, 2005). 
Methylotrophs have therefore become the preferred hosts for yeast heterologous gene 
expression as they offer a safe and convenient system for the production of 
compounds intended for applications in human therapeutics (Gellisen, 2000). 
111-1 -2 Methanol metabolism 
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Scheme 3-1: Methanol metabolism pathway of the methylotrophic yeast Pichia pastor/s. 
AOX: alcohol oxidase; CAT: catalase; ELD: formaldehyde dehydrogenase; FMDH: 
formate dehydrogenase; DHAS: dihydroxyacetone synthase; GAP: glyceraldehyde-3-
phosphate; DHA: dihydroxyacetone. Adapted from Gellisen, 2000. 
The metabolism of methanol by methylotrophic yeasts involves a set of enzymes that 
are not produced when cells are grown on medium containing other sources of 
carbon such as glucose or glycerol, as another metabolic pathway is then taken. The 
methanol metabolism is initiated in a special organelle, the peroxisome, where 
methanol is oxidised to formaldehyde by an alcohol oxidase, the reaction releasing 
hydrogen peroxide which is decomposed into water and molecular oxygen by the 
peroxisomal catalases (CAT) thereby limiting the toxic effects of this by-product 
(Scheme 3-1) (Gellisen, 2000). Peroxisomes can take up to 80 % of the cell volume 
under methanol induced production of these enzymes. As the alcohol oxidases have 
low affinity for 02, the yeasts compensate by producing large amounts of the 
enzyme, accounting for up to 30 % of total cell protein (Cereghino & Gregg, 2000). 
After the production of formaldehyde, this is either converted to dihydroxyacetone 
(DHA) and glyceraldehyde-3-phosphate (GAP) by the peroxisomal assimilatory 
pathway enzyme dihydroxyacetone synthase (DHAS) or to formate by the cytosolic 
assimilatory pathway enzyme formaldehyde dehydrogenase (ELD), which is then 
oxidised to carbon dioxide by •a formate dehydrogenase (FMDH) (Gellisen, 2000). 
Large amounts of DITIAS and FMDFI are also produced, and these two enzymes can 
constitute up to 20 % of the total cell protein (Gellisen, 2000). As the expression of 
the genes encoding these enzymes is strongly regulated at the transcription level, the 
use of these genes promoters is a powerful means to control the expression of 
heterologous genes (flouard et al., 2002). 
111-1 -3 Methylotrophic yeasts for recombinant protein production 
As the alcohol oxidase is the most highly produced of all the methanol-metabolism 
pathway enzymes, the isolation of its promoters in the various yeasts has been 
essential for the applicability of these organisms for the high-level production of 
recombinant proteins (Daly & Hearn, 2005). Alternatively, the glyceradehyde-3-
phosphate dehydrogenase gene is constitutively highly expressed in these organisms 
and its promoter has also been isolated for high level heterologous gene expression. 
Finally, the possibility to secrete the produced protein into the medium by 
introduction of a secretion signal sequence upstream of the gene of interest greatly 
facilitates the purification of the produced protein. Lysis of the cell is no longer 
required and the foreign secreted protein can be easily separated from the whole cells 
by filtration or centrifugation (Macauley-Patrick et al., 2005). Moreover, there is a 
very low level of native secreted proteins and the recombinant protein is thus likely 
to account for most of the protein content in the culture supernatant (Macauley-
Patrick et at., 2005). 
The commercial availability of the yeast Pichia pastoris (P. pastoris) expression 
system has been particularly useful for laboratory research allowing production of 
milligram-to-gram quantities of recombinant proteins (Cereghino & Gregg, 2000; 
Macauley-Patrick et al., 2005). In this yeast, the alcohol oxidase is encoded by two 
genes AOXI and AOX2, the former being responsible for most of the alcohol oxidase 
activity and the glyceradehyde-3-phosphate dehydrogenase is encoded by the GAP 
gene. Both the AOXJ and GAP genes have been isolated and introduced into 
commercial vectors for the yeast over-expression of heterologous genes. 
111-1 -4 Expression of glycosyltransferase genes in the yeast P. pastoris 
The P. pastoris expression system has been widely applied to the production of 
known and putative glycosyltransferases as the system was found productive enough 
to enable their structural characterisation and their exploitation as biocatalysts in the 
synthesis of oligosaccharides (Gallet et al., 1998). For example, the S. cerevisiae a-
1 ,2-mannosyltransferase was recently produced in sufficient amounts in P. pastoris 
for its crystal structure to be determined (Lobsanov et al., 2004). The P. pastoris 
expression system was also used to produce a putative Arabidopsis thaliana a-
xylosyltransferase that was identified by comparison of the molecular mechanism of 
a pea a-xylosyltransferase present in microsomes with that of a fenugreek CC-1,6- 
galactosyltransferase of known sequence (Faik et al., 2002). 
111-1-4-1 Requirements for secretion of glycosyltransferases 
One of the main interests of the P. pastoris expression system is the possibility to 
secrete the glycosyltransferases into the medium as this greatly simplifies the 
purification process. Since glycosyltransferases do not possess an endogenous 
secretion signal, secretion requires fusion to secretion signals, most commonly the S. 
cerevisiae a-factor or the P. pastoris acid phosphatase signal (Macauley-Patrick et 
al., 2005). Also, most glycosyltransferases are type II membrane proteins (Scheme 1-
11) and secreted production therefore requires truncation of the protein to eliminate 
the membrane targeting signal (Scheme 3-2). 
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This can be illustrated by the study carried out on the production of a human Gal 1-
1,3-glucuronosyltransferase in P. pastoris. The enzyme was produced in three 
different isoforms, i.e. the full-length enzyme as well as two truncated versions, one 
lacking only the cytoplasmic tail and another one lacking both the cytoplasmic tail 
and the transmembrane domain (Ouzzine et al., 2000). The full-length and 
cytoplasmic tail deleted forms were found to be targeted to the membrane while the 
cytoplasmic and trans-membrane deleted form was amenable to secretion through 
fusion to the a-factor secretion signal. Successful secretion was thus possible in the 
absence of the signal targeting the protein to the membrane. 
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Scheme 3-2: Different possible truncations of glycosyltransferases that might be required 
to allow for secretion of these enzymes to the culture medium. Secretion also requires 
fusion of the gene encoding the glycosyltransferase to a secretion signal sequence. TMD: 
trans-membrane domain. 
However, the extent of truncation required for secretion varies between 
glycosyltransferases and secretion of a ct-2,6-sialyltransferase was efficient only 
when the enzyme lacked its trans-membrane domain including the stem region. 
Similarly, the human fucosyltransferase Ill gene was expressed in the yeast Pichia 
pastoris to produce a trans-membrane deleted form of the enzyme, which was 
secreted into the medium thanks to the presence of the a-factor secretion signal at its 
N-terminus (Gallet et al., 1998). More generally, most of the literature found on the 
expression of glycosyltransferase genes in Pichia pastoris couples a truncation 
strategy with the fusion to a secretion signal (Thomson et al., 2000; Bencürová et al., 
2003; Chen et al., 2001). However, for D. melanogaster 0-1,4-galactosyltransferase 
05 
VII, the full-length enzyme was required for an active secreted form of the enzyme to 
be obtained (Bencflrová etal., 2003). 
111-1 -4-2 Advantages of the yeast expression system over other systems 
In some cases, expression in yeast has been found to be advantageous over bacterial 
expression to obtain an active glycosyltransferase. For example, the Candida 
albicans cz-1,2-mannosyltransferase encoded by the MNTJ gene was produced in a 
truncated, secreted and active form in yeast while expression in E. coli using the pET 
system had yielded an inactive enzyme (Thomson et al., 2000). Another case where 
the expression in P. pastoris of a glycosyltransferase gene proved beneficial over 
bacterial expression was for the production of New World monkey (marmoset) a-
1,3-galactosyltransferase (Chen et al., 2001). When the production of the 
galactosyltransferase was attempted in a bacterial expression system, most of the 
produced enzyme was found in an insoluble form within inclusion bodies and only 
low amounts of soluble, active cc- 1 ,3-galactosyltransferase were isolated from 
bacterial lysates (Chen et al., 2001). In contrast, the production and secretion of the 
a-1,3-galactosyltransferase as a N-terminal His6 tagged trans-membrane deleted 
form in a F. pastoris expression system yielded an active enzyme. 
111-1-4-3 Comparison between the methanol-induced and constitutive 
expressions for the production of a-1,3-gatactosyltransferase 
The study on the production of the a-1,3-galactosyltransferase was also interesting as 
the DNA sequence encoding the tagged truncated enzyme was cloned in both a 
vector for constitutive expression and a vector for methanol-induced expression 
(Chen et al., 2001). For this glycosyltransferase, only very low yields were obtained 
from the methanol-induced system (<20 pg.L') while expression was much more 
efficient under the GAP constitutive promoter (2 mg.L'). The low expression and 
partial inactivation of the enzyme under the methanol-inducible promoter were 
interpreted as being caused by the presence of methanol in the medium. However, 
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such a difference is not always observed and for the bovine P-1,4- 
galactosyltransferase I both systems yielded the same level of activity after 2-3 days 
of growth under induction of expression, if necessary (Bencürová et al., 2003). 
111-1-4-4 Importance of the culture conditions for the production of 
active glycosyltransferases 
Other factors must be considered when optimising the production of a 
glycosyltransferase in P. pastoris such as the temperature, cell density and medium 
formulation. For example, the production of a truncated version of A. thaliana core 
a-1,3-fucosyltransferase under the methanol inducible promoter was optimised and 
the composition of the medium was found to be critical to obtain maximal 
fucosyltransferase activity in the supernatant (Benci.irová et al., 2003). The addition 
of casamino acids, which act as substrates for the yeast proteases, was found 
beneficial for maintaining the integrity of the enzyme. The influence of the 
temperature was also demonstrated by the expression of the A. thaliana -1,2-
xylosyltransferase gene under a constitutive promoter at 16 °C that resulted in 30 
times more activity than expression under inducible promoter at 30 °C (Bencdrová et 
at, 2003). 
111-1 -4-5 Unsuccessful attempts to produce active human 
glycosyltransf erase in yeast 
In some other cases, P. pastoris failed to yield an active glycosyltransferase as for 
the expression of the gene encoding the human fetal liver Gal 3l,3-Ga1NAc-a2,3-
sialyltransferase (Shang et al., 1999). The DNA sequence encoding the putative 
catalytic domain was expressed in monkey kidney cells (COS-1), E. coli and P. 
pastoris cells. Although produced successfully in a truncated form in both E. coli and 
P. pastoris, activity was only detected when the enzyme was produced in COS-1 
cells. As only the mammalian expression system yielded an active enzyme, it was 
interpreted that the correct glycosylation, i.e. with complex type oligosaccharides 13 
(Scheme 1-6), was essential for proper folding and enzymatic activity (Shang et al., 
1999). 
111-1 -4-6 Summary 
As most Golgi glycosyltransferases possess a type II membrane topology (Scheme 1-
11), secreted expression generally requires deletion of the trans-membrane domain 
(Scheme 3-2) and the presence of a secretion signal to export the protein to the 
medium. The extent to which the N-terminal domain can be truncated is depending 
on each individual enzyme. In some cases, no truncations are tolerated while in some 
other truncations up to the stem region are possible without affecting the catalytic 
activity. But no general rules seem to emerge from the examples above even if, in 
most cases, truncation of the trans-membrane domain was found not to be deleterious 
to the glycosyltransferase activity. Also, the extent of deletion at the C- or N-
terminus of a glycosyltransferase and the addition of a tag at either ends need to be 
considered carefully before cloning can be undertaken. Some glycosyltransferases 
have indeed been found to be inactivated by C-terminal truncations or fusions. The 
successful secretion of glycosyltransferases requires fusion to a secretion signal 
sequence and both the (X-factor secretion signal and the acid phosphatase signal have 
been used with equal success. Concerning the choice between constitutive or 
inducible promoter, most researchers have used a methanol-inducible system but 
those who have employed a constitutive promoter have found it to yield at least 
similar levels of glycosyltransferase activity or even higher ones than the inducible 
promoter system. Moreover, it seems important to consider the growth conditions 
(temperature, culture medium) to enhance the activity of the produced enzyme but 
here again only trial and error seems to be the rule. 
111-1 -5 Yeast cells displaying glycosyltransferases 
Recently, glycosyltransferases have been displayed on the surface of yeast cells by 
fusion to either Pirl or Pir2, also known as Hspl50, proteins (Abe et al., 2003; Abe 
et al., 2004). The Pir proteins are encoded by 4 PIR genes and they form covalent 
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linkage to the -glycan of the cell surface through an unknown mechanism. They 
have been fused to a sialyltransferase, a mannosyltransferase, a glucosyltransferase 
and fucosyltransferase allowing the display of these glycosyltransferases on the 
surface of either Saccharomyces cerevisiae or Pichia pastoris cells (Salo et al., 
2005). Cell surface display of glycosyltiansferases had been difficult before, as the 
display strategy that was commonly used required the fusion of 
lycosylphosphatidylinositol (GPI) to the C-terminal of the protein to be displayed. 
Since glycosyltransferases are known to possess their catalytic domain at the C-
terminus, it was thought that display through such linkage might have adverse effect 
ui the glycosyltransferases catalytic activity (Abe et al., 2003; Abe et al., 2004). 
Therefore, the recent fusions of Pir proteins to the N-terminus of glycosyltransferases 
have paved the way for the use of whole cells catalysing glycosyl-transfer (Salo et 
(IL, 2005). In a directed evolution approach, selection of mutants with the desired 
binding, properties could he envisaged with .uch a display system. 
111-1-6 Aim of this chapter 









Figure 3-3: Solubility of GFPAlg1 ATM 1p produced by E. co/iBL21(DE3) cells harbouring 
pET16b-GFPALG1TM1. The protein content of the cell pellet was extracted 
progressively by addition of buffers of increasing urea concentrations, i.e. 2 M, 4 M, 6 M 
and 8 M urea (Lanes 2-5). Lane 1: BioRad Precision Plus protein Standards. The band at 
79 kDa, corresponding to the fusion protein, was getting stronger as the urea 
concentration increased. 
During the expression of the GFPALGMTM1 gene fusion in E. coli, it was found 
that the fusion protein was a target for the host proteases leading to some amino acid 
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sequences containing the whole GFP sequence to be cleaved off the rest of the 
enzyme, thereby interfering with the measurements of the fluorescence signal. This 
could prove problematic for application in the proposed assay as this fluorescent 
material will not behave in the same way as the fusion protein and might lead to 
erroneous interpretations. Also, most of the fusion protein was locked in inclusion 
bodies, as was demonstrated by extraction of the proteins by urea (Figure 3-3). 
To circumvent this problem and attempt to produce higher amounts of soluble 13-1,4-
mannosyltransferase, a yeast expression system was tried. The possibility to obtain 
an active enzyme was emphasised by the fact that the codon usage of Pichia pastoris 
is considered to be similar to that of Saccharoniyces cerevisiae and many S. 
cerevisiae genes have proven to be functional in P. pastoris. Initially, expression of 
the ALGILNTM gene was tried under both an inducible and a constitutive promoter. 
The GFPALGJATM1 gene fusion expression was tried to check whether a more 
stable chimera could be obtained from this expression system. Also, homologues of 
the ALGI gene were identified and cloned in vectors for Pichia pastoris expression 
in an attempt to obtain higher level of 13-1 ,4-mannosyltransferase production. Finally, 
a vector for the co-expression of S. cerevisiae Algip and Alg2p in P. pastoris was 
constructed as the two mannosyltransferases are known to interact in vivo and it was 
therefore hoped that co-expression will stabilise both enzymes and eventually lead to 
an active Alg2p (Gao et al., 2004). This enzyme has so far not been produced in an 
active form in a heterologous host and it has been suggested that the interaction with 
Algip might be required for dolichol recognition and therefore, activity (Davies, 
2004; Gao et al., 2004). 
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111-2 Materials 
111-2-1 Polymerase chain reactions 
Custom oligonucleotide primers were synthesised by either Thermo Electron GmbH 
(Ulm, Germany) or Invitrogen (Paisley, UK). 2'-deoxyribonucleoside 5'-
triphosphate (dNTP5) mixes were purchased either from Sigma-Aldrich (Poole, UK) 
or Roche (Lewes, UK), at a concentration of 10 mM of each dNTP. Turbo Pfu and 
YieldAce® polymerases were from Stratagene (Cambridge, UK) and Taq polymerase 
was from Promega (Southampton, UK). Alternatively, the KOD Hot Start DNA 
polymerase kit (Novagen, Madison, USA) was used. Reverse transcription was 
achieved using superscript III reverse transcriptase and RnaseOUT (Invitrogen, 
Paisley, UK). Polymerase chain reactions from the generated cDNAs were 
performed using the Expand High Fidelity PCR system (Roche, Lewes, UK). The 
GC rich buffer was obtained from the GC-RICH PCR system (Roche, Lewes, UK). 
Polymerase chain reactions were performed on either an Eppendorf Mastercycler® 
personal or Eppendorf Mastercycier®  gradient (Eppendorf, Hamburg, Germany). 
111-2-2 DNA gels 
The agarose for DNA gels was from Fisher Scientific (Fisher Biotech, molecular 
biology grade) and the gels were visualised using either a transilluminator 
(Anachem, Luton, UK) or an Image Master VDS-CL (Amersham Pharmacia 
Biotech, Little Chalfont, UK). The 1 kb ladder was from New England Biolabs 
(Hertfordshire, UK). The 100 bp ladder was from either New England Biolabs 
(Hertfordshire, UK) or Fermentas (St Leon-Rot, Germany). The 6xloading dye for 
the DNA samples was also from Fermentas (St Leon-Rot, Germany). 
111-2-3 Restriction digests and ligations 
Restriction endonucleases were from New England Biolabs (Hertfordshire, UK), 
Promega (Southampton, UK) or Fermentas (St Leon-Rot, Germany). T4 DNA ligase 
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was from New England Biolabs (Hertfordshire, UK). Alternatively, 14 DNA ligase 
was purchased from Promega (Southampton, UK) with a 2x rapid ligation buffer. 
The rapid ligation kit from Roche (Lewes, UK) was also used. Calf intestine 
phosphatase (Cifi) and Antarctic phophatase were purchased from New England 
Biolabs (Hertfordshire, UK) whereas Shrimp alkaline phosphatase was from 
Promega (Southampton, UK). 
111-2-4 Cloning and expression vectors 
The TOPO blunt end Cloning ® kit was from Invitrogen (Paisley, UK). The pPICZ 
vectors were from Invitrogen (Paisley, UK). pPICZcz-FLAG was a kind gift from 
Professor lain Wilson. 
111-2-5 DNA purification 
The QlAprep® miniprep kit for plasmid purification and the QlAquick ® spin gel 
extraction kit and PCR purification kit were from Qiagen(Crawley, UK). 
Alternatively, the NUCLEOSPIN plasmid kit from Macherey-Nagel (DUren, 
Germany) was used for the purification of plasmid DNA and the GFX PCR DNA 
and gel band purification kit (GE Healthcare, Life Sciences, Little Chalfont, UK) was 
used for cleaning of DNA fragment excised from agarose gels. 
111-2-6 Sequencing 
Sequencing reactions were carried out using the Bi gDye®Terminator  v3.1 Cycle 
sequencing kit (Applied Biosciences, Foster City, USA) and automated sequencing 
was performed as a service by the ICAPB sequencing service (University of 
Edinburgh) or by the sequencing service of the Universitat für Bodenkultur (Vienna, 
Austria). 
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111-2-7 Bacterial strains and yeast strains 
The chemically competent TOP 10 E. coli cells were purchased from Invitrogen 
(Paisley, UK). 05115 cells were a kind gift from Professor lain Wilson and KM71H 
cells were a kind gift from Doctor Nicholas Mullin. 
111-2-8 Culture media, antibiotics and electroporation 
Lysogeny broth low salt growth medium (or LB Lennox: 10 g.E' tryptone, 5 g.E' 
yeast extract, 5 g.E' NaCl) and LB low salt agar (10 g.L 1 tryptone, 5 g.L' yeast 
extract, 5 g.E' NaCl, 15 g.E' agar) were purchased either from Sigma-Aldrich or 
Fisher Scientific. Alternatively, the media were prepared by mixing their individual 
components which were brought from Sigma-Aldrich (Poole, UK). SOC medium 
was either prepared or obtained from Invitrogen (Paisley, UK). BACTO media 
components (Yeast nitrogen base, yeast extract and tryptone) were from Difco 
(Detroit, USA). YPP (1 % yeast extract, 2 % peptone, 1 % peptone from casein 
digest), MOYC (minimal glycerol yeast extract casamino acid; 7 partsYPP, I pat 
l0xyeast nitrogen base (YNB), 1 part 10 % glycerol, 1 part H20, 11500th volume of 
x500 biotin, 1110001h  volume of zeocin), MMYC (minimal methanol yeast extract 
casamino acid medium; 7 partsYPP, 1 part 1OxYNB, 0.1 part 100 % methanol, 1 part 
H20, 0.07 part of xSOO biotin), YPDS agar (yeast extract peptone dextrose sorbitol 
agar: 10 g.E' yeast extract, 20 gJJ 1 peptone, 20 g.E' agar and 100 niLE' of filter-
sterile 20 % dextrose added after autoclaving) were all prepared by mixing individual 
components, obtained from Sigma-Aldrich (Poole, UK). The antibiotic zeocin was 
purchased from InvivoGen (San Diego, USA). The electroporation cuvettes were the 
BioRad, Gene Pulser®  Cuvette, 0.2 cm electrode gap, 5 (BioRad, York, UK) and 
electroporation was achieved on a BioRad GenePulser II (York, UK). 
111-2-9 SDS PAGE and Western blot 
The electrophoresis tanks and power supplies, either 200 or 1000 and the short plates 
and the spacer plates were from BioRad (York, UK). The protein molecular weight 
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marker, Precision plus ProteinTM  Standards All Blue, was obtained from BioRad 
(York, UK). Alternatively, the PageRuler" Prestained Protein ladder from 
Fermentas (St Leon-Rot, Germany) was used. Semi-dry blots were performed using 
the BioRad trans-blot semi dry apparatus and PROTEAN XL blotting papers were 
also from BioRad (York, UK). 
Blotting was performed on BioTrace ® NT 30cmx3m pure nitrocellulose blotting 
membrane (Voigt Global Distribution, Kansas City, USA). The primary antibodies 
were either the anti-His monoclonal antibody clone 1 or the ANTIFLAG®  Ml 
Monoclonal Antibody mouse, both from Sigma-Aldrich (Poole, UK). The secondary 
antibody was an anti-mouse immunoglobulin G (IgG) (y-chain specific) alkaline 
phosphatase conjugated from Sigma-Aldrich. The primary anti-GFP antiserum was 
from Invitrogen (Paisley, UK) and the secondary antibody was an anti-rabbit IgG 
alkaline phosphatase conjugated from VECTOR (Burlingame, USA). The alkaline 
phosphatase substrate was Sigma FAST 5-bromo-4-chloro-3-indolylphosphate nitro 
blue tetrazolium. The Mouse Anti-FLAG Monoclonal Antibody, M2-peroxidase 
(HRP) conjugated antibody and the DAB peroxidase substrate (Sigma fast" 3, 3'-
diaminobenzidine tablet sets) were from Sigma-Aldrich (Poole,UK). 
111-2-10 General 
All other chemicals were laboratory grade reagents 
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111-3 Methods 
111-3-1 Agarose gel electrophoresis, DNA purification 
PCR products and restriction digest fragments were analysed on 1% Tris-acetate-
EDTA (TAE: 40 mlvi Tris, 20 mlvi acetic acid, 1 mlvi EDTA, pH = 8.0) agarose gels 
containing ethidium bromide (0.5 xg.mL'). The DNA fragments were visualised 
under a UV transilluminator at 312 nm. When required, the DNA fragment was 
excised from the gel using a sterile blade and the DNA was isolated using the 
QlAquick® spin gel extraction kit or GFX" PCR DNA kit following the provided 
protocols. DNA was precipitated by addition of 2.5 x V of 90 % ethanol, sodium 
acetate (0.2 M, pH = 5.2) to the samples (V). The sample was left at - 20 °C for at 
least 1 h and the DNA pellet was isolated by centrifugation at 13 000 x g, 4 °C, for 
30 mm. The DNA pellet was subsequently washed with 400 1sL of 70 % ethanol and 
isolated by centrifugation at 13 000 x g, 4 DC, for 10 mm. The pellet was air-dried for 
at least 30 min before being re-suspended in Tris-EDTA (TE) buffer or distilled 
water. 
111-3-2 Reverse transcription 
6.3 1.tL of DEPC-H20 (diethylpyrocarbonate treated water) was added to 1 jiL (1 pg) 
of RNA (Caenorhabditis elegans Bristol N2, Drosophila inelanogaster Canton S 
flies and Arabidopsis thaliana apical tissue) and the mixture was placed on ice. 1 RL 
of a dNTP mix (10 mlvi of each CINTP), 2.5 RL of 20 1.xM oligo-dTi8 and 2.2 tL of 
DEPC-H20 were added and the sample was heated at 65 °C for 5 mm. The sample 
was then placed back on ice and the following were added to it: 
- 4 jiL of Sx first strand buffer 
- 1Lof0.1MDTT 
- 1 iL of RNAseOUT (recombinant ribonuclease inhibitor; 400 U.1iL') 
- 1 FIL of superscript III reverse transcriptase (200 U.}iL') 
The sample was incubated at 50 °C for 1 h and at 70 °C for 15 mm. The generated 
cDNA was kept at -20 °C until required. 
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111-3-3 Amplification of the genes from the generated cDNA 
The PCR mixture was set as follows: 
- 0.2 RL of cDNA 
- 0.2 sL of sense oligonucleotide primer (100 jiM; Cf = 1 M) 
- 0.2 liL of antisense oligonucleotide primer (100 tM; Cf = 1 1iM) 
- 2 jiL of dNTP mix (2.5 mM each; C1 = 0.25 jiM) 
- 2 jiL of lOx Expand high fidelity buffer 2 (with M902) 
- 15.2uLofH20 
- 0.2 jiL of Expand high fidelity enzyme mix (3.5 U.PL' in 20 mM Tris-HCI, 
pH = 7.5; 100 mM KC1; 1 mM DTT; 0.1 mlvi EDTA; 0.5 % Nonidet P40 
(v/v); 0.5 % Tween 20 (v/v), 50 % glycerol (v/v)) 
The reaction was submitted to the following thermal cycle: 
> Thermal cycle 5 
- cycle l:95°C for 3 min, 50°C for 3Os,72°C for 2min 
- cycles 2: 95 °C for 30 s, 51 °C for 30 s, 72°C for 2 mm 
- cycle 3-13: 95 °C for 30 s, 58 ± 2 °C for 30 s, 72 °C for 2 mm 
- cycle 14-39: 95 °C for 30 s, 58 ± 2 °C for 30 s, 72 °C for 2 mm + 5 s per cycle 
- cycle 40: cycle 3-13: 95 °C for 30 s, 72 °C for S mm 
111-3-4 Standard PCR 
111-3-4-1 Standard PCR 3 
Genes were amplified from constructs using the following protocol: 
- 2 pL of 10 x PCR Buffer for KOD Hot Start DNA polymerase buffer 
- 0.4 1iL of DNA template 
- 1.2 jiL of sense oligonucleotide primer (5 pmol.RL'; Cf = 0.3 pmol.tL') 
- 0.6 j.xL of antisense oligonucleotide primer (10 pmol.jtL 1 ; C1 = 0.3 pmol.iLj 
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- 2 ML of dNTP mix (2 mM each; Cf = 0.2 mM each) 
- 0.8 j± of 25 MM  MgSO4 
- 12.6pLofH20 
- 0.4 psL of KOD Hot Start DNA polymerase (IU.pU' in 50 mM Tris-HCI, I 
mM Dfl, 0.1 mM EDTA, 50 % glycerol, 0.001 % Nonidet P-40, 0.001 % 
Tween-20, pH = 8.0) 
> Thermal cycle 6 
- cycle 1:95 °C for 3 mm 
- cycles 2-31: 95 °C for 30 s, 60 °C for 30 s, 72 °C for 2 mm 
- cycle 32; 72°C for 7min 
111-3-4-2 Standard PCR 4 
The PCR mixtures were set as follows in a 20 jtL volume with the addition of 
MgCl2: 
- 2 RL of 10 x Cloned Pfu DNA polymerase reaction buffer 
- 2 ilL of dNTP mix (2 mM; C1= 0.2mM each) 
- 0.4 iL of DNA template (10-50 fig; C1 = 0.2-1 ng.Ld) 
- 0.6 RL of sense primer (10 pmol.pL'; Cf = 0.3 pmol.p.tL') 
- 0.6 iJL  of antisense primer (10 prnol.sL 4 ; Cf = 0.3 pmoljxL') 
- 12.6 RL of sterile water 
- 0.8LofMgCl2(25mM;C1= 1mM) 
- 0.4 ilL of Turbo Pfü polymerase (2.5 U.pL') 
The samples were submitted to the following thermal cycle: 
> Thermal cycle 7 
- cycle]: 95 °C for 3 mm 
- cycles 2-31: 95 °C for 30s, 58 °C for 30 s, 72 °C for 2 mm 
- cycle 32: 72 °C for 7 mm 
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The PCR products were analysed on a 1% agarose 1xTAE electrophoresis gel. 
111-3-5 Inverse PCR 
Modified vectors were created using the following protocol: 
- 2 jiL of 10 x PCR Buffer for KOD Hot Start DNA polymerase 
- 0.4 1xL of DNA template 
- 1.2 jiL of sense oligonucleotide primer (5 pmol.RU'; C1= 0.3 pmol.tL') 
- 1.2 jiL of antisense oligonucleotide primer (5 pmol.itL 1 ; Cf = 0.3 pmol.j.tL') 
- 2pLofdNTP mix (2mM each; Cf=0.2niM) 
- 0.8JsLofMgSO4(25mM;Cf= 1 mM) 
- 12pLofH20 
- 0.2 RL of KOD Hot Start DNA polymerase (1U.pL 1 in 50 mlvi Tris-HC1, 1 
mM DTT, 0.1 mM EDTA, 50 % glycerol, 0.001 % Nonidet P-40, 0.001 % 
Tween-20, pH = 8.0) 
The inverse PCR was achieved using the following thermal conditions: 	- 
> Thermal cycle 8 
- cycle]: 94°C for 3min 
- cycles 2-26: 95 °C for 30 s, 60 °C for 30 s, 72 °C for 5 mm 
- cycle 27: 72 °C for 5 mm 
The PCR products were analysed on a 2 % agarose TAE electrophoresis gel. 
The obtained PCR product was circularised under the following conditions: 
- 2 RL of PCR product (60 ng.jtL') 
- 6 RL of H20 
- 1 [LL T4 DNA ligase xlO buffer (Promega: 300 mlvi Tris-HC1; pH = 7.8; 100 mM 
MgCl2; 100 mM DTT; 10 mlvi ATP) 
- 1JIL T4 DNA ligase (Promega: 1-3 U.isU1  in 10 mlvi Tris-HC1, pH = 7.4; 50 mM 
KCI; 1 mlvi DTT ; 0.1 mlvi EDTA; 50 % (v/v)glycerol) 
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The reaction was incubated at 14 °C, overnight and transformed into E. coli TOPIO 
as described in 111-3-7. 
111-3-6 Screening PCR 
Constructs were routinely analysed by screening PCR as follows: 
- 5 pL of PCR Master Mix (50 U.mL Taq DNA polymérase; 400 MM of each 
dNTP; 3 mM M902  in reaction buffer, pH = 8.5) 
- 41sLofH20 
- 0.5 ML of 5'-AOXI, 5'-T7 or gene specific oligonucleotide primer (Cf = 0.6 
pmol.ML') 
- 0.5 pL of 3'-AOXI, 3'-T7 or gene specific oligonucleotide primer (C1 = 0.6 
pmol.MU) 
- O.3sLofDNA 
5'-AOXJ 	Sense 	 5'-GACTGGflCCAAflGACAAGC-3' 
3'-AOXi 	Anüsense 	 5-GCAAATGGCAflCTGACATCC-3' 
5'-fl 	 Sense 	 5-TAATACGACTCACTATAGGG-3' 
3'-T7 	Antisense 	 5-TATGCTAGTFAflGCTCAG-3 
The reaction was submitted to the following thermal cycle: 
) Thermal cycle 9 
- cycle 1:95 °C for 3 mm 
- cycles 2-31: 95 °C for 30s, 57 °C for 30s, 72 °C for 2 min 30 s 
- cycle 32: 72 °C for 4 mm 
The PCR products were analysed on a TAE 1% agarose electrophoresis gel. 
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111-3-7 Transformation into E. coil TOP10 
Between 1 and 10 xL of DNA solution were transformed into 100 jtL of E. coli 
TOP1O cells. The cells were incubated on ice for 40 mm, heat-shocked at 42 °C for 1 
mm, cooled on ice for 2 min and added 300 jtL of room temperature SOC medium. 
The cells were subsequently grown at 37 °C, 225 rpm, for I h, prior to being plated 
onto selective LB agar medium or LB low salt agar medium and incubated at 37 °C, 
overnight. 
111-3-8 Restriction digest of the DNA samples 
The reactions were carried out as follows: 
NEB Buffer 	 2 jtL 
BSA 	 0.2j± 
PCR product or vector 	 9 JAL 
Restriction endonuclease 1 	0.3 ilL 
Restriction endonuclease 2 0.3 1iL 
H2O 	 8.5jiL 
The reaction buffer was chosen to maximise the efficiency of both endonucleases 
following the New England Biolabs recommendations. All reaction components 
were mixed and the reaction was carried out at 37 °C for 3 h. When the restriction 
digest was considered complete by agarose gel electrophoresis analysis (111-3-1), 4 
RL of lOx shrimp alkaline phosphatase (SAP) buffer (0.5 M Tris-HCI, pH = 9.0; 100 
mM M902) and 0.8 jit of SAP (1 U.pL 1 in 25 mM Tris-HCI, pH = 7.6; 1 mM 
MgCl2; 0.1 mlvi ZnCl2; 50 % (v/v) glycerol) were added and the reaction was 
incubated at 37 °C for 30 mm. Alternatively, 2 11L of lOx Antarctic phosphatase 
buffer (50mM Bis-Tris-propane-HO; 1 MM M902; 0.1 mM ZnCl2; pH = 6.0) and I 
.tL of Antarctic phosphatase (5,000 U.mL' in 10 mlvi Tris-HC1; 1 mlvi MgCl2;  1  MM 
•DTT; 50 % (v/v) glycerol; pH = 7.4) were added and the reaction was left at 37 °C 
120 
for 30 mm. The enzymes were deactivated following the Manufacturer's instructions. 
The DNA was finally ethanol-precipitated as described in 111-3-1. 
111-3-9 Partial restriction digest 
The optimal conditions for the partial restriction digest with the appropriate 
endonucleases were the following: 
Solution A (in ILL) 	Solution B (in jiL) 
NEB BamH I Buffer + BSA 	1.1 	 6.6 
Plasmid 	 5 	 18 
figIll 	 0.2 	 / 
BarnH I 	 0.2 	 / 
H20 	 3.5 	 35.4 
Solution B was split in 6 xIO RL and solution A was introduced in the first tube, 
from which 10 p.1. were subsequently taken and introduced in the following tube. 
This process was repeated until the last tube was reached to create solutions of 
decreasing concentrations of the two restriction endonucleases. The reactions were 
carried out for 30 mm, at 37 °C. The enzymes were finally deactivated at 80 °C for 
20 min and the restriction digest products were analysed by agarose gel 
electrophoresis (111-3-1). 
111-3-10 Restriction digest with BamH I and dephosphorylation 
The constructs were cut with BarnH I and dephosphorylated as follows 
NEB BamH I Buffer + BSA 2 p.L 
Construct 6 pL 
BamH I 0.8 p.L 
H20 11.6pL 
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All reaction components were mixed and the reaction was carried out at 37 °C. After 
3 h, 5 RL of NEBuffer 3 (50 mM Tris-HCI; 100 mM NaCl; 10 MM  MgCl2; 1 MM 
Dli'; pH =7.9) was added as well as 0.5 jiL of calf intestinal phosphatase (ClIP) 
(10,000 U.niLd  in 10 mM Tris-HCI; 50 mlvi KCI; 1 RIM M902; 0.1 mM ZnCl2; 50 
% (v/v) glycerol; pH = 8.2) and the volume was made up to 49.5 pL with sterile 
distilled water. After 30 mm, an extra 0.5 jiL of phosphatase was added and the 
reactions were pursued for an extra 1 h 30 mm. 
111-3-11 Ligation reactions 
111-3-11-1 Rapid ligation 
The rapid ligation reactions were carried out as follows: 
- 1 RL vector 
-3 .LL DNA insert 
- 5 gL 2x rapid ligation buffer (from LigaFast TM DNA ligation system, Promega) 
- lp.L T4 DNA ligase (Promega: 1-3 U.pL' in 10 mlvi Tris-HCI, pH = 1.4; 50 mM 
KCI; 1 mM Dli' ; 0.1 mM EDTA; 50 % (v/v)glycerol) 
The reaction was left at room temperature for 1 h and transformed into E. coli 
TOPIO as described in 111-3-7. 
111-3-11-2 Standard ligation 
The ligation reactions were carried out as follows: 
- I p1 vector 
- 3 p1 DNA insert 
-4 .iL of H20 
- 1 j.tL lOx T4 DNA ligase buffer 
- lp.L T4 DNA ligase (Fermentas: 5 U.pL' in 20 mlvi Tris-HCI, pH = 7.5; 1 mM 
Dli'; 50 mM KCI; 0.1 mM EDTA; 50% (v/v) glycerol) 
22 
The reaction was left overnight at 14 °C and transformed into E. coli TOP1O as 
described in 111-3-7. 
111-3-12 Linearisation of the vectors for transformation, phenol-
chloroform extraction and ethanol precipitation 
Constructs were cut prior to transformation using the following conditions: 
NEB Buffer + BSA 
	




Restriction endonuclease 	100 U 
H20 
	
up to 400 pL 
The reactions were left overnight, at 37 °C. A 0.5 11L aliquot was subsequently taken 
and analysed on a I % TAE electrophoresis gel. 500 pL of isoamyl alcohol phenol 
chloroform was added to the 400 1sL restriction digest solution and the sample was 
centrifuged at 13 200 x g, for 2 mm. The aqueous layer was washed by addition of 
500 iiL of isoamyl phenol chloroform and isolated by centrifugation at 13 200 x 
for 2 mm. This washing step was repeated and the aqueous layer was washed with 
500 piL of chloroform and isolated by centrifugation at 13 200 x g, for 2 mm. The 
DNA was then precipitated by addition of 30 pL of sodium acetate (3 M, pH = 5.3) 
and 750 jsL of 100 % ethanol. The sample was left at -20 °C for 1 h and the DNA 
pellet was isolated by centrifugation at 13 200 x g, 4 °C for 30 mm. The DNA pellet 
was subsequently washed with 400 RL of 70 % ethanol and isolated by centrifugation 
at 13 200 x g, 4 °C for 10 mm. The pellet was air-dried for at least 30 min before 
being re-suspended in TE buffer. 
111-3-13 Transformation into GS115 or KM71H 
A starting culture was prepared by inoculating 10 mL of YPD with a single colony. 
The culture was grown, overnight, at 29 °C, under continuous shaking. 250 tL of this 
starting culture was used to inoculate 250 mL of YPD medium. The cells were grown 
at 29 °C, under continuous shaking, until an absorbance at 600 nm of 1.3-1.5 was 
123 
reached. The cells were harvested by centrifugation at 3 000 rpm, 4 °C, for 5 mm. 
The medium was discarded and the cells were re-suspended in 250 mL of ice-cold 
sterile water by gentle manual shaking. The cells were isolated by centrifugation at 3 
000 rpm, 4 °C, for 5 mm. The cells were re-suspended in 125 mL of ice-cold water 
and harvested by centrifugation at 3 000 rpm, 4 °C, for 5 mm. 20 mL of ice-cold 1 M 
sorbitol was then added to wash the cells and the cell pellet was re-isolated by 
centrifugation at 3 000 rpm, 4 °C, for 5 mm. Finally, the cell pellet was re-suspended 
in 1 mL of I M ice-cold sorbitol and the cells were kept on ice until required. 80 jiL 
of cells was added to the DNA solution (20-100jig) and the mixture was transferred 
to a chilled electroporation cuvette (BioRad, Gene Pulser ® Cuvette, 0.2 cm electrode 
gap, 5). The cuvette was incubated on ice for 5 min and electroporation was carried 
out at 1.5 kV, 25 RF, 200 12. Immediately afterwards I mL of ice-cold I M sorbitol 
was added to the cells and introduced into a 15 mL tube. The cells were incubated at 
30 °C for 1-2 h and then plated on YPDS agar plates supplemented with 100 jig.mU l  
zeocin. The cells were grown at 30 °C for two days and then re-streaked on fresh 
YPDS-zeocin plates to eliminate false positives. 
111-3-14 Test expression in GS115 or KM71H 
One colony was typically used to inoculate 3 mL of MGYC and the cells were 
incubated at 29-30 °C, 200 rpm, for 24 Ii. The cells were harvested by centrifugation 
at 1 000 rcf for 1 mm. They were then washed with 1 nL of lx YNB and harvested 
by centrifugation at 1 000 rcf for 1 mm. Finally, the cell pellet was taken up in 500 
11L of MMYC, which were used to inoculate 9.5 mL of MMYC. The cultures were 
incubated at 29-30 °C or at 16 °C, for 4-5 days, under continuous shaking and 10 % 
of methanol was added every 24 h to promote expression. From the second day of 
expression onward, a I mL sample was taken every day for analysis. 
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111-3-15 SDS-PAGE 
To 100 RL or 200 1iL of culture supernatant was added 500 RL or 1 mL methanol. 
The samples were vigorously mixed under vortex and incubated at -20 °C for 30 mm. 
The pellet was isolated by centrifugation at 13 000 x g, at 4 °C, for 30 mm. The 
methanol was then removed, the pellet was dried and finally re-suspended in 20 1.tL 
of SDS-PAGE loading buffer. 100 jsL of lysis buffer (25 mM EDTA, 0.2 M MgCl2, 
0.2 M MnC12, 25 mM DTT,100 mM PMSF, 1/20111  of the volume of Sigma's protease 
inhibitor cocktail for His-tagged protein in 2-(N-morpholino)ethanesulfonic acid 
(MES) buffer, pH = 7.0) was added to the cell pellets. The cells were then re-
suspended in the buffer by mixing under vortex, 8 x 30 s. An equivalent volume of 
glass beads was added and the procedure was repeated. The supernatant was isolated 
by centrifugation at 4 °C, 13 000 x g, for 5 mm. Methanol precipitation was then 
carried out as described in 111-3-1. Separating gels (12 % w/v) and stacking gels (4 % 
w/v) were prepared using 30 % w/v acrylamide, 0.8 % w/v NN'-bis-methylene 
acrylamide and polymerisation was achieved by addition of 0.1 % v/v N,N,N',N'- 
[tetramethyijethylenediamine (TEMED) and 0.05 % ammonium persulphate (APS). 
Separating gels were made with 1.5 M Tris-HCI and 0.4 % w/v SDS, pH = 8.8 and 
stacking gels with 500 mM Tris-HC1, 0.4 % SDS, pH = 6.8. The running buffer was 
prepared using 192 mM glycine, 25 mM Tris-ECI, 0.1 % SDS, pH = 8.3. The gels 
were run for 40 min at 200 V. 
111-3-16 Western blot 
After SDS-PAGE, blotting to a nitrocellulose membrane was achieved by 
electrophoresis at 15 V for 15 mm. The transfer of proteins to the nitrocellulose 
membrane was verified by staining the membrane with Ponceau staining. The 
membrane was then extensively washed with distilled water and blocked by 
incubation in TBS, 0.05 % Tween 20, 0.5 % BSA, for 1 h. The membrane was then 
incubated in 2 mL TTBS supplemented with the primary antibody (0.7 1iL for the 
monoclonal anti-His antibody (dilution 1: 3 000), 0.2 j.tL for the monoclonal anti-
FLAG antibody (dilution 1: 10 000), 0. 4 isL  for the anti-GFP anti-serum (dilution I: 
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5 000)) on a horizontal shaker for at least 30 nun. The membrane was washed three 
times with TTBS and incubated with the secondary antibody in the conditions 
already described (0.2 p1. anti-mouse IgG, y-chain specific). The membrane was 
washed three times with TTBS and the alkaline phosphatase substrate was finally 
added to reveal the bands. 
For Western blots using the mouse anti-FLAG monoclonal antibody, M2-peroxidase 
(HRP) conjugated antibody, the protocol followed was identical to that described in 
11-3-14 (10 j.tL anti-FLAG HRP conjugated were used for the antibody reaction). 
111-3-17 Isolation of the genomic DNA 
I mL cell pellet was re-suspended in 250 pL of SET buffer (I M sorbitol, 10 mM 
Tris-HCI, pH = 8.0, 50 mM EDTA) and the sample was centrifuged at 13 000 x g, 
for 1 mm. The supernatant was removed and 250 1iL of SET buffer, 2.5 j.i of 3-
mercaptoethanol and 2.5 pL of lyticase solution (1 U.pL 1 in SET buffer) were 
added. The sample was mixed under vortex and incubated at 37 °C for 30 mm. The 
pellet was harvested by centrifugation, the supernatant was removed and 250 jiL of 
TE 50 (10 mM Tris-HCI, pH = 8.0, 50 mM EDTA, 5 M KAc, pH = 5.8) and 25 pL 
of 10 % wlv SDS were added. The sample was mixed by inverting the tube and 
incubated at 65 °C for 30 mm. Then, 100 pL of 5 M KAc, pH = 5.8 was added and 
the sample was kept on ice for 30 mm. The supernatant was isolated by 
centrifugation and transferred to a new tube. This was repeated a second time and the 
DNA was finally precipitated by addition of 0.7 x V of isopropanol. The DNA was 
isolated by centrifugation for 40 min and then ethanol-precipitated as described in 
111-3-1. The DNA was finally used as a template for a screening PCR. 
111-3-18 Construction of pPICZB-FLAG 
A FLAG tag was introduced into the pPJCZB to produce a vector for internal 
production of recombinant proteins bearing a FLAG tag. Oligonucleotide primers 








After the PCR, the product was isolated on a 1 % agarose TAE electrophoresis gel 
and the DNA was extracted from the gel and purified using two GFX columns (111-3-
1). The vector was re-circularised by ligation with T4 DNA ligase (111-3-11-2) and 
the ligation reaction was transformed into E. coli TOP1O (111-3-7). The colonies were 
screened by PCR using the AOX1 oligonucleotide primers (111-3-6). The resulting 
PCR products were analysed on a 2 % agarose TAE gel electrophoresis. The 
potential positive clones were sequenced (11-3-11) and constructs were selected for 
proper integration of the FLAG tag. 
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111-4 Results and discussion 
Due to the potential of the Pichia pastoris expression system to generate high 
quantities of soluble glycosyltransferases secreted into the medium (111-1-5), 
expression of the ALGITM1 gene and the HisGFP-link-ALGIaTMI gene fusion 
(11-4-6) was tried under both the constitutive promoter PGAP and the methanol-
inducible promoter PAOXI. For some genes, the level of expression seen with the GAP 
promoter can be slightly higher than that obtained with the AOXJ promoter and 
comparison of the two systems was therefore deemed necessary (Daly & Hearn, 
2005). 
111-4-1 Presentation of the expression system 
111-4-1-1 Constitutive expression in Pichia pastoris 
For constitutive expression, genes of interest were placed under the control of the 
GAP promoter (Goodi'ick et at, - 2001). In many organisms, including Pichia - 
pastoris, the glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) is 
constitutively expressed at high levels (Cereghino & Cregg, 2000). The Pichia 
pastoris GADPH gene was therefore isolated and introduced in the commercially 
available pGAPZ vectors series to allow for over-expression of heterologous genes 
by placing them under the control of this promoter (Goodrick et al., 2001). 
These vectors also contain a zeocin resistance protein gene, i.e. the 
Streptoalloteichus hindustanus bleomycin gene (Sh ble gene), for selection in both E. 
co/i and P. pastoris (Dally & Hearn, 2005). Thus, genetic manipulations can be 
carried out in E. ccli using low salt medium for the growth of E. coli cells harbouring 
the pGAPZ plasmid as zeocin is inhibited by high salt concentration. Expression of 
the Sh ble gene is under the control of the EM7 synthetic prokaryotic promoter for 
constitutive expression in E. co/i while it depends on the S. cerevisiae transcription 
elongation factor I gene promoter in P. pastoris. The S. cerevisiae CYCI 
transcription termination region is used for the Sh ble gene, allowing efficient mRNA 
processing, including polyadenylation for increased mRNA stability. 
Additionally, the pGAPZ vectors can bear the S. cerevisiae (X-factor signal sequence 
to target the fused protein to the secretory pathway and these vectors are referred to 
as the pGAPZa vectors (Houard et al., 2002). Due to the low quantities of proteins 
naturally secreted by P. pastoris, secretion of the recombinant 13-1,4-
mannosyltransferase and its GFP fusion was attempted in order to facilitate their 
subsequent purifications. 
111-4-1-2 Methanol-induced expression 
In parallel, expression of the genes of interest placed under the control of the 
methanol-inducible promoter PAQXJ was attempted. The PAOXJ promoter normally 
drives the expression of the AOXJ gene encoding the alcohol oxidase required by the 
yeast P. pastoris for metabolising methanol (Macauley-Patrick etal., 2005). 
When growth of P. pastoris cells is carried out in medium where methanol is the 
only source of carbon, expression of the AOX] gene is activated to generate the 
alcohol oxidase needed to initiate the metabolism of methanol (111-1-2). Expression 
of the AOXI gene is controlled at the transcription level by a complex repression / -. 
de-repression-induction mechanism (Yokoyama, 2003). Thus, when glucose is 
present, a different metabolic pathway is taken and the AOX] gene transcription is 
repressed while in the presence of glycerol, de-repression takes place but gene 
expression is very low. Hence, methanol is essential for the induction of transcription 
and the subsequent expression of the gene placed under the control of the PAOXJ 
promoter (Macauley-Patrick et al., 2005). This property makes the PAOXJ  promoter 
ideally suited for controlled over-expression of heterologous genes and any gene 
placed under the control of the PAQX/  promoter has the potential to yield a substantial 
amount of protein once methanol induction is started (ffl-1-3). 
The pPICZaA vector was therefore chosen for expression of the genes of interest 
under the PAOX) promoter and subsequent secretion of the produced proteins. This 
vector possesses the same backbone as the pGAPZa vector, i.e. the same multiple 
cloning sites, the same DNA sequences for the control of the Sit ble gene to confer 
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zeocin resistance and the same pUC origin to maintain and replicate the plasmid in E. 
coli (Daly & Hearn, 2005). 
111-4-1-3 Integration into the P. pastorisgenome 
As both the pGAPZa and pPICZcz vectors do not contain a yeast origin of 
replication, the integration of the gene of interest into the P. pastoris genome is an 
essential step for obtaining colonies that will grow on zeocin selective medium. 
Insertion generally takes place through a homologous recombination event between a 
DNA fragment of the vector and a region of homology within the genome (Daly & 
Hearn, 2005). Multiple insertion events occur spontaneously resulting, in the case of 
pGAPZ vectors, in the insertion of one or more copies of the vector upstream or 
downstream of the GAP locus (Gellissen, 2000). However, such events occur at a 
much lower frequency than the single insertion event (Daly & Hearn, 2005). Double 
crossovers, leading to gene replacement, are also possible but they are also much less 
likely to happen. Finally, by cutting the pGAPZaA-derived construct at a suitable 
restriction site, e.g. Avr II, recombination at the 5' end of the GAP promoter is 
favoured (Gellissen, 2000). The insertion of the plasmid at the intact GAP promoter 
locus induces the gain of PGAP, the gene of interest and the Sh ble gene. Similarly, 
using suitable restriction sites, three different position of the AOXJ loci can be 
targeted for integration: the AOXI promoter, the AOXI transcription termination 
region (TT) or sequences even further downstream of the AOXJ (3' AOXI). Hence, 
cutting pPICZczA-HisALGIATM1 at the Sac I restriction site should direct 
integration within the 5' AOX] region. 
111-4-1-4 Pichia pastoris strains 
111-4-1-4-1 0S115 
GS 115 strain has a mutation in the histidinol dehydrogenase gene (his4) that prevents 
it from synthesising histidine (Gellissen, 2000). This was initially developed as a 
kill 
mean to select successful integrants and the first expression plasmids carried the 
J-11S4 gene that complemented the his4 mutation in the host upon integration (Daly & 
Hearn, 2005). Only the colonies where integration had taken place could grow on 
histidine-deficient medium. However, when a medium such as YPD is used, the 
synthesis of histidine is not required and the mutation does not affect the growth of 
the cells. In the system used, the selection does not rely on gene complementation 
but uses the zeocin selection marker present on the commercial vector. 
111-4-1-4-2 KM71 
The parent strain of KM71H has a mutation in the argininosuccinate lyase gene 
(arg4) that prevents the strain from growing in the absence of arginine. However, in 
K1v17 1H, the wild-type AOX] gene is replaced by the aoxl:: ARG4 construct, where 
the wild-type ARG4 gene was used to disrupt AOXJ, replacing codon 16 through 227 
of A OX]. Due to the disruption of the AOXI gene, the yeast relies on the expression 
of the second gene encoding the alcohol oxidase, i.e. AOX2 for growth under 
methanolic conditions. Despite a 97 % homology between the two AOX genes, the 
AOX2 gene does not generate as much alcohol oxidase as AOX] leading to a much 
slower growth when cells solely rely on the expression of this gene to generate the 
alcohol oxidase and metabolise methanol. Yeast strains possessing such growth 
behaviour are referred to as IvIut 5 strains as opposed to the wild-type phenotype 
referred to as Mut. 
111-4-2 General cloning methods 
The cloning of the genes into the pGAPZctA and pPICZctA vectors used methods 
similar to those employed for the cloning into bacterial expression vectors (fl-4) and 
details of individual constructs will be given below. The pPJCZctA-ALG2ATM3 
construct (pJD12) used in the following work was a kind gift from Dr. James Davies 
(Davies, 2004). The pJD12 construct contains the 415-1305 bp region of the ALG2 
open-reading frame; terminated by a stop codon. The DNA fragment was ligated into 
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pPICZaA and this construct was designed to produce a fully trans-membrane deleted 
form, i.e. lacking residues 1 to 138 and 435 to 504, of the putative 
mannosyltransferase thought to be responsible for the transfer of a second mannose 
residue to Dol-PP-GIcNAc 2Man 7b (Scheme 1-17). 
111-4-3 pGAPZaA-HisALG1TM1 and pPICZaA-HisALG1ATM1 
To compare expression of the HisALG]ATM1 gene fusion under the methanol-
inducible promoter PAOXI  and the constitutive promoter PGAP,  both pPICZaA-
HisALGMTM 1 and pGAPZct-HisALGMTM I were constructed for secreted 
production of the mannosyltransferase. 
111-4-3-1 Expression of HisALG1ATM1 under the PGAP  promoter 
UII1IJIPP 	- 	YkIIII 	 Sh hie 
The pGAPZctA-HisALGIATMI was a kind gift from Dr. Nicholas Mullin. The 
construct possessed a 5 histidine tag coding sequence upstream and in frame of the 
ALGMTM1 gene and a stop codon at the 3' end of the ALGIATMI coding 
sequence. 
The pGAPZcA-HisALGMTM 1 construct was cut by restriction digest with Avr II 
(111-3-12) prior to transformation into GS1 15 (111-3-13). A first attempt to transform 
this construct into the yeast strain GS 115 proved unsuccessful as no colony was 
obtained on selective YPDS plate after 3 days of incubation at 30 °C. A second 
transformation yielded 6 colonies after 2 days of incubation of the plate at 30 °C, 
which grew when re-plated on fresh YPDS plate supplemented with 100 ig.mL' 
zeocin but then failed to grow in liquid medium. It was interpreted that expression of 
the HisALGMTM1 gene was probably toxic to the cells and thus successful 
integrants failed to grow while false positives did not survive re-streaking or liquid 
culture under selective conditions. 
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111-4-3-2 Construction of pPICZaA-HisALG1TM1 
In order to introduce the HisALGIATM1 gene into the pPICZctA vector, both 
pPICZctA-ALG2LVFM3 and pGAPZxA-HisALGIATM I were submitted to dual 
restriction digest with EcoR I and Not I (111-3-8). As pGAPZaA and pPICZctA have 
the same reading frame and multiple cloning site, the EcoR I / Not I HisALGMTM1 
DNA fragment was ligated into the corresponding sites of the pPICZctA vector, 
using the rapid ligation protocol (11-3-9-2). The proper introduction of the gene was 
verified by sequencing (11-3-11) and no mutation was found within the gene. 
111-4-3-3 Expression of HisALG1ATM1 under the PAQX1  promoter 
VJLJr 	3' 	411V1 	Ii 
The pPICZctA-HisALG]ATM1 construct was cut with Sac I (ffl-3-12) and 
transformed into GS 115 (111-3-13), leading to growth of colonies on YPDS selective 
plates after incubation at 30°C for 2 days. A test expression (111-3-14) of two 
different colonies was carried out for 5 days at both 16 °C and 30 °C. 
The culture supernatants were analysed by SDS-PAGE (111-3-15) and Western blot 
(111-3-16). A band at 57.8 kDa was not observed, even after 5 days of growth of the 
integrants under methanol-induction. The content of the cell pellets was also 
analysed to verify that the protein was not locked within the cells but no production 
of the protein over time could be detected on either a SDS-PAGE gel (111-3-15) or a 
Western blot (111-3-16). 
The genomic DNA was isolated (111-3-17) and integration of the gene of interest in 
the P. pastoris genome was confirmed by PCR amplification using the AOXJ 
oligonucleotide primers (111-3-6) (Figure 3-4). 
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Figure 3-4: Analysis of the genomic DNA of two different integrants (Lanes 2 and 3) 
obtained by transformation of GS115 with pP1CZaA-HisALG1iTM1 by PCR with the 
AOX1 oligonucleotide primers. Lane 1: Fermentas 100 bp ladder. The presence of two 
bands showed that the HisALG1TM1 (1.4 kb) and the AOX1 (1.6 kb) genes were 
present in the yeast genome. 
In conclusion, although integration of the HisALG1iTMl gene at the AOXI locus of 
GS 115 was successful, no His-tagged protein was detected in the culture medium or 
cell pellet of cells grown for 1 to 5 days at 16 or 30 °C, in the presence of methanol. 
Lowering the temperature after methanol-induction was tried as it had been found 
useful to produce more active glycosyltransferases or to limit their degradation by 
proteases (Bencürová et al., 2003). However, reducing the temperature after 
methanol-induction did not yield any difference and the protein was not detected by 
Western blot analysis. 
Problems of detection of N-terminally His tagged glycosyltransferases produced in P. 
pastoris have been observed by other workers (Professor lain Wilson, personal 
communication). Interestingly, when the His tag was replaced by a FLAG tag, the 
protein could be detected on Western blot using a primary anti-FLAG antibody, 
suggesting that the N-terminal His tag could be cleaved off the protein by P. pastoris 
specific proteases or at least proved problematic for the detection of the fusion 
partner. It was therefore decided to introduce the ALGIATM I gene into a pPICZaA 
vector, engineered to present an N-terminal FLAG tag coding sequence downstream 
and in frame with the a-factor secretion signal sequence and test whether production 
of a FLAG-tagged mannosyltransferase from this construct could be detected on a 
Western blot using an anti-FLAG antibody. 
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111-4-4 pPICZa-FLAG-ALG1ATM1 
111-4-4-1 Construction of pP1CZa-FLAG-ALG1TM1 
The pPICZa-FLAG-ALGJATM1 construct was made to introduce a FLAG tag, at 
the N-terminus of A1gIATM1p. The ALGJATM1 gene was amplified by PCR from 
the pGAPZaA-HisALGJATM 1 construct with oligonucleotide primers designed to 
introduce an EcoR I site at the 5' end and a Not I site as well as a stop codon at the 3' 
end. The gene was amplified using the Novagen KOD Hot Start DNA polymerase 
(111-3-4-1). 
	
ALG 1/FLAG! 	 5'-CCGGAArFCATTCG2\CCAAAAAAAGG2\TCAT -3' 
Sense 
I fEcoR! 	 EcoR I restriction site 
NAP-ALG 1- 	 5'-GTGGTGGTGGTGCGCGGCCGCTCAATGAAT7AGCTrCAA -3' 
Antisense 
Not-Rev 	 Not I retrIctioh1 stte mid ctop codon 
Following the isolation of the ALG 1AT\l 1 gene on a TAE 1 ',/ agarose eel 
electrophoresis (111-3-1), dual restriction digest (111-3-8) of this gene was necessary 
to generate the EcoR I and Not I cohesive termini required for the directive ligation 
into the corresponding sites of the pPICZa-FLAG vector, a kind gift of Professor 
lain Wilson. This vector was created from the pPICZaA vector by addition of a 
FLAG tag coding sequence downstream and in frame with the a-factor secretion 
signal sequence, using an inverse PCR strategy (identical to that described in 111-3- 
5). Insertion of the EcoR I I Not I DNA fragment into the corresponding sites of 
pPICZa-FLAG was achieved by standard ligation (111-3-11-2), leading to the 
pPICZa-FLAG-ALGI ATM 1 construct. The gene was fully sequenced (11-3-11) prior 
to being cut for transformation and correct introduction of the gene, in frame with the 
FLAG tag and the secretion signal coding sequences was verified. 
111-4-4-2 Expression of FLAG-ALGIATMI under the P,.10j promoter 
Sb hie 
After linearisation of pPICZcx-FLAG-ALGI ATM I with Sac I (111-3-12), 
transformation (IH-3-13) into GS115 was carried out yielding one colony on 
selective YPDS medium after 2 days of growth at 30 °C. The obtained colony was 
grown at either 16 °C or 30 °C for 5 days in the presence of methanol (111-3-14). A 
time course analysis by SDS-PAGE (ffl-3-15) and Western blot (111-3-16) of the 
culture supernatants did not reveal the appearance of a band of the correct size (49.5 
kDa). The content of the cell pellets was then analysed by Western blot using a 
primary anti-FLAG antibody and a secondary anti-mouse IgG antibody (111-3-16). A 
faint band at the expected size (49.5 kDa) was detected but the background binding 
of the antibodies was quite high and did not allow for clear conclusions. The 
construct was re-transformed in KrvI71H (111-3-13) and growth of the successful 
integrants was carried out at 30 °C for 5 days (111-3-14). The content of the 
supernatants and cell pellets was analysed and a faint band at 49.5 kDa could be 
detected on the Western blot using a single HRP-conjugated anti-FLAG antibody 
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Figure 3-5: Western blot of the protein content at the cell pellet Lanes 2, 4, 6, 8) and 
supernatant (Lanes 3, 5, 7, 9) of KM71H cells harbouring pPlCZct-FLAG-ALG1LTM1 
after 2 (Lanes 2 and 3), 3 (Lanes 4 and 5), 4 (Lanes 6 and 7) and 5 days (Lanes 8 and 9) 
of culture, in the presence of methanol. This blot was performed with a single, peroxidase 
conjugated anti-FLAG antibody. Lane 1: BioRad Precision Plus protein Standards. 
Both the supernatant (250 p.L) and the lysed cell pellet after 5 days of growth were 
assayed for mannosyltransferase activity (11-3-15) (Figure 3-6). No activity was 
detected in the supernatant while activity was detected in the cell pellet. The cell 
pellet of KM7IH cells transformed with the pPICZctB-VCP (vaccinia virus 
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complement control protein) construct and grown under methanol induction 
conditions for 5 days was used as a control for endogenous mannosyltransferase 
activity. The pPICZaB-VCP construct was a kind gift of Christoph Schmidt. No 
such activity was detected as the amount of radioactivity measured in the organic 
phase at the end of the reaction was 34 dpm, comparable to the value obtained in the 
absence of acceptor substrate 29a, i.e. 24 dpm. 
Figure 3-6: - Mannosyl-transfer catalysed by FLAGAIg1 ATM 1p from KM71H ceUs 
harbouring pPICZa-FLAG-ALGI&TM1 (1 and 2) or HisGFP-link-AIg1 ATM 1p from E. co/i 
BL21(0E3) cell extracts harbouring pET24a-HisGFP-link-ALGIaTM1 (3 and 4). The 
radioactivity levels of the organic and aqueous phases after mannosyltransferase reaction 
with radiolabelled GDP-Man 8 in the presence of PPGn 2 29a (1 and 3) or without (2 and 
4) were measured. The presence of radioactivity in the organic phase of the assayed 
sample indicated that mannosyl-transfer had occurred. 
In conclusion, production of the enzyme was detected from integrants of both the 
GS 115 and the KM71H strains. The replacement of the His tag by the FLAG tag did 
allow for the detection of the fusion protein by Western blot. The use of a single 
HRP-conjugated FLAG antibody enabled a better detection of the protein band than 
the use of a primary antibody followed by an alkaline phosphatase-conjugated 
secondary antibody, which gave a high background. Despite the presence of the cc-
factor secretion signal, the tagged protein could only be detected in the cell pellet 
even after 5 days of growth in the presence of methanol, suggesting that the protein 
had not been secreted. 
The study over 5 days ensured that the lack of secretion was not due to a slow 
secretion process as was observed for the cz-1,3/4-fucosyltransferase (Gallet et at., 
1998). This enzyme was indeed found to first accumulate in the cytosol, probably in 
exocytosis vesicles, and in the periplasmic space prior to being secreted. A delay of 
38 It was noted between the beginning of methanol induction and detection of 
fucosyltransferase activity in the culture medium. However, as the cell growth 
slowed down, more and more activity was detected in the supernatant and, at the end 
of the culture, whole cells enclosed fucosyltransferase represented only 0.1 % of the 
total enzyme activity (Gallet et at., 1998). However, in the present case, such 
behaviour was not observed and mannosyltransferase activity was only detected in 
the cell pellet. 
111-4-5 pPICZaA-HisGFP-Iink-ALG1ATM1 and pGAPZcA-HisGFP-link-
ALG1ATM1 
111-4-5-1 Construction of pPICZaA-HisGFP-link-ALGIATM1 and 
pGAPZaA-HsGFP-iink-ALGIATM1 
The pPICZaA-HisGFP-link-ALG]ATM 1 and pGAPZccA-HisGFP-link-ALGI ATMI 
constructs were made to attempt expression of the HisGFP-link-ALG]ATMI gene 
fusion in a yeast expression system under both inducible and constitutive promoters. 
The HisGFP-link-ALG]ATMI gene fusion was amplified by PCR from the pET24a-
HisGFP-link-ALG]ATMI construct (11-4-6) using oligonucleotide primers designed 
to introduce a EcoR I restriction site at the 5' end and a Not I restriction site and a 
stop codon at the 3' end (11-3-2: PCR1, thermal cycle 1). 
5'-AC1TFAAGAAGGAGAGAAnCATGGGCCATCATCATCAT-3' 
HisGFP-For 	Sense 
EcoR I restriction site 
5'- ATAG1TTAGCGGCCGCTCAATGAATTAGCnCAA -3 
3'ALG1NotJ Antisense 
Not I restriction site and stop codon 
The amplified PCR product was isolated on a TAE 1% agarose electrophoresis gel, 
purified (11I-3-1) and submitted to dual restriction digest using EcoR I and Not I 
endonucleases (111-3-8). The resulting DNA fragment was ligated directionally into 
the corresponding sites of either the pPICZaA or the pGAPZ(xA vector (11-3-9-2). 
Both constructs were verified by sequencing (11-3-11) and found not contain 
additional mutations as compared to the pET24a-Hi sGFP-1 ink-ALGI ATM I construct 
(11-4-6-1) (Appendix 1). 
111-4-5-2 Expression of HisGFP-Iink-ALG1ATM1 under the PGAP  promoter 
- 
	
Ht,, - 	c;i I' 	.tI(;/ VF1I • 	VJLP 
The pGAPZctA-HisGFP-link-ALGI ATM I construct was cut with Avr 11(111-3-12) 
prior to transformation into the GS 115 strain (111-3-13). Integration of the HisGFP-
link-ALGJATM1 expression cassette into the yeast GS115 genome gave 20-30 
colonies after 2 days of growth on selective YPDS plates, at 30 °C. A few of these 
colonies were re-streaked on zeocin selective YPDS plates but all failed to 
subsequently grow in liquid medium. From the lack of any colony that survived the 
selective growth conditions, the hypothesis that the expression of ALG]ATM1 was 
toxic to the cells was once again confirmed. Due to the high homology between the 
S. cerevisiae and the P. pasroris genes, it was hypothesised that the constitutive 
expression of ALG]ATMI might have interfered with the native 3-1,4-
mannosyltransferase. 
111-4-5-3 Expression of HisGFP-Iink-ALG1ATM1 under the PAOXI 
promoter 
U , 	• 	His,, 	(ill' 
4 
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The pPICZaA-HisGFP-link-ALGI ATM 1 construct was cut with Pme 1(111-3-12) and 
transformed into GS1 15 (111-3-13). Integration of HisGFP-link-ALGIATM1 
expression cassette into the GS115 genome proved successful as colonies were 
obtained that grew on both solid and liquid selective media. Test expression was 
therefore tried and cells were grown at 16 °C or 30 °C for 6 days (111-3-14). Cell 
fluorescence was observed under a confocal laser scanning microscope (Universität 
für Bodenkultur, Vienna) with the help of Dr. Renaud Leonard, after the fourth day 
of culture at both temperatures but only the cells were found to fluoresce suggesting 
that the protein was not secreted despite the presence of the a-factor secretion signal. 
However, the analysis of the supernatants by Western blot using a primary anti-GFP 
antibody (11I-3-16) led to the visualisation of a band between 24 kDa and 33 kDa for 
the 30 °C culture (Figure 3-7). Similar analysis of the supernatants of the 16 °C 
culture did not reveal any band. 











Figure 3-7: Western blot of the protein content of the culture supernatants of KM71 H cells 
harbouring pPlCZc-HisGFP-link-ALG1TM1 after 2, 3, 4, 5 and 6 days (Lanes 1-5) of 
growth at 30 CC, in the presence of methanol. Lane 6: PageRuler TM Prestained Protein 
ladder from Fermentas. 
In conclusion, integration of the HisGFP-link-ALGIATM1 expression cassette within 
the AOXJ promoter region proved more successful than within the GAP promoter 
region and fluorescence of the cells was observed by microscopy. The Western blot 
analysis of the supernatant also revealed the presence of a band at approximately 30 
kDa that could correspond to an N-terminal degradation product containing the entire 
GFP amino acid sequence. It was suggested that a degradation product roughly the 
size of GFP had been cleaved from the rest of the protein and secreted in an inactive 
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form. No fluorescence was indeed observed outside the cells suggesting that the GFP 
chromophore was not active. Finally, the fusion protein was found not to be more 
stable than when produced in a bacterial system and as a yeast expression system is 
less amenable to directed evolution studies, work on the HisGFP-link-ALGJATM1 
gene product was not continued further in P. pastoris. 
111-4-6 pPICZaA-ALG2TM3-HisALG1ATM1 constructs 
111-4-6-1 Construction of a pPICZaA-ALG2ATM3 construct with a 
HisALG1TM1 expression cassette from pPICZaA and attempted 
expression after integration in KM71 H 
- 
_____ ALG2ATM3 	YIwn 	S . 	_______ ALG/ATMI 	win, 	5•.ii)(! rr] 
The aim was to construct a pPICZaA-ALG2ATM3 vector with a HisALG/ATM1 
expression cassette from pPICZctA. This construct was made to co-express Alglp 
and Alg2p in Pichia pastoris, in the hope to stabilise both proteins, as they are meant 
to interact with one another in vivo (Gao et al., 2004). Recent research has indeed 
proved that in vivo, the two mannosyltransferases associate to form a heterodimer 
and it was proposed that the heterodimer formation may be essential for the optimal 
activity of both enzymes (Gao et al., 2004). 
Such co-expression construct has been reported for the co-production in P. pastoris 
of a bovine a-1,3-galactosyltransferase along with a mutated S  1E sucrose synthase 
from Vigna radiata and a truncated UDP-glucose C4 epimerase from Saccharoinyces 
cerevisiae (Shao et al., 2003). Three plasmids were created by cloning all three genes 
in the pA0815 plasmid and then expression cassettes of two of the constructs were 
generated by BamH I I Bgl II dual restriction digest and ligated into the BamH I site 
of the third construct. A single vector carrying the expression cassette of all three 
genes was thus generated and cut with Sal I prior to transformation of the yeast 
strains GS 115 and KM7 1. This yielded the insertion of all three expression cassettes 
into the GS 115 genome and thus an AOXJ promoter and a transcription terminator 
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was present for all three genes within the P. pastoris genomic DNA. The proteins 
were produced intracellularly and after cell permeabilisation the whole cells were 
used to synthesise the a-gal epitote with in situ regeneration of UDP-galactose (Shao 
et al., 2003). In the present case, however, the cloning was found not to be as 
straightforward as both ALGMTMI and ALG2ATM3 contained an internal Bgl H 
site and partial restriction digests step were necessary. 
The pPICZaA-HisALGMTM 1 construct was thus submitted to partial restriction 
digest with Bgl H and BarnH I (111-3-9) to isolate the expression cassette: PAOXI, 
HisALGMTM 1 and Sh ble. The next step was to cut the pPICZaA-ALG2LTM3 with 
BarnH I and then to dephosphorylate this vector to prevent its re-circularisation (III-
3-10). Finally, the expression cassette (BarnH IJBgl II) was ligated into the BamH I 
site of the cut pPICZctA-ALG2iTM3 construct, following the rapid ligation protocol 
(11-3-9-2). The construct was checked for introduction of the expression cassette in 
the right orientation by Eag I restriction digest (11-3-7) and successful constructs 
were further analysed by sequencing of both the HisALGMTM1 and ALG2L\TM3 
genes (11-3-11). Sufficient amounts of DNA (100 .tg) were generated to enable the 
triiisformation of the circular construct into Pichia pastoris KM71H (11I-3-13). One 
colony was obtained on selective YPDS plate after incubation at 30 °C for 2 days 
and it was grown at 30 °C for 5 days (HI-3-14). A time course analysis by SDS-
PAGE gel (111-3-15) and Western blot using an anti-His antibody (111-3-16) was 
carried out but in neither case was a band observed that could correspond to the 
association of both proteins or even the production of one of the two proteins 
HisAlgiATMip: 48.5 kDa and A1g2ATM3p: 33.9 kDa). 
111-4-6-2 Construction of a pPICZctA-ALG2ATM3 construct with a 
HisALG1ATM1 expression cassette from pGAPZaA and attempted 
integration in GS115 




A second construct was made to co-express the two ALG genes in Pichia pastoris, 
but this time, the expression of HisALGJATMI was placed under the control of the 
GAP promoter while the expression of ALG2ATM3 was placed under the control of 
the AOXI promoter. The pPICZaA-ALG2ATM3 construct was cut with BatnH I and 
dephosphorylated (111-3-10). Meanwhile, the Bgl II / BatnH I expression cassette was 
isolated from the pGAPZctA-HisALG]ATM1 by partial restriction digest with the 
two corresponding endonucleases (111-3-9). The rapid ligation protocol (11-3-9-2) was 
used to ligate the generated expression cassette into the BamH I site of the cut 
pPICZzA-ALG2ATM3 vector. After ligation, the obtained colonies were screened by 
single restriction digest with either BarnH I or Bgl II (11-3-7). The correct construct 
was further analysed by PCR amplification of the two genes HisALG]ATM1 and 
ALG2ATM3 using oligonucleotide primers specific for each gene sequence (11-3-3). 
Finally, the construct was sequenced (11-3-11) and a large amount of DNA was 
produced prior to transformation into the host strain GSI 15 (111-3-13). Attempted 
transformation into the yeast strain GS1 15 failed to yield colonies after incubation at 
30 °C for 2 days on an YPDS selective plate. 
111-4-6-3 Conclusion for the two co-expression constructs 
Transformation of the two co-expression constructs proved difficult, as the plasmids 
could not be cut prior to transformation without destruction of one of the expression 
cassettes and therefore a high quantity of circular DNA (100 .tg) was required to 
attempt integration into the P. pastoris genome. The transformation efficiency indeed 
drops of 10 to 100-fold when uncut plasmids are used for transformation. However, 
one colony was obtained after transformation of KM7IH cells with the pPICZct-
ALG2TM3 vector carrying the HisALGJaTM1 expression cassette isolated from 
pGAPZa. This colony grew in liquid medium and expression from the construct was 
tried by addition of methanol to the culture medium. However, when the protein 
content of the supernatants were analysed no bands were detected that could 
correspond to a single mannosyltransferase or to the association of the two 
mannosyltransferases. Further work was not carried out as the detection of His 
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tagged AIg1ATM1p had proved unsuccessful and no other tag is present in the 
system that would allow for the detection of the mannosyltransferases. Moreover, 
Algip was not likely to be produced to higher levels than when produced alone in the 
same system and thus SDS-PAGE analysis was unlikely to allow for the detection of 
the gene's products. 
111-4-7 Cloning of ALG1 homologues and attempted expression in P. 
pastoris 
Finally, attempts to express ALGI homologues from Caenorhabdizis elegans, 
Drosophila melanogaster and Arabidopsis thaliana in Pichia pastoris were made. 
Using the entire amino acid sequence deduced from the yeast S. cerevisiae gene 
ALGI, the database for the three organisms was searched and in all three cases an 
ALGI homolog was identified. Kyle-Doolittle hydrophobicity plots showed that none 
of the three proteins contained such N-terminal hydrophobic stretches (Figure 3-8). 
As no N-terminal trans-membrane domain could be identified, the full-length genes 
were generated from the corresponding RNA by reverse-transcription and cloned - 
into a pPICZB-FLAG vector designed for internal production of the proteins and 
modified to encode an N-terminal FLAG tag (111-3-18). Secretion was not attempted 
as export of AIgIATM1p to the medium had failed, irrespective of the construct from 
which it had been produced. The sequences of the three identified proteins were 
aligned and compared to that of the S. cerevisiae Algip protein sequence using 
CLUSTALW (http://www.ebi.ac.uklclutsalw ) (Appendix 2 for full alignment). From 
the alignment the absence of the N-terminal trans-membrane domain in all the amino 
acid sequences but the S. cerevisiae Algip sequence also appeared clearly (Figure 3-
8). 
The Algip homologues were therefore predicted not to possess the potential dolichol 
recognition sequence (1-6-2), similarly to the human Algip that was also found not to 
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Figure 3-8: Alignment of the N-terminal protein sequences of, from top to bottom, Drosophila melanogaster, Arabidopsis thaliana, 
Caenorhabditis elegans and Saccharomyces cerevisiae putative or known -1 ,4-mannosyltransferases. The S. cerevisiae Algip is the only 
sequence that presents an N-terminal hydrophobic domain. The Kyle-Doolittle hydrophobicity plots of the first 200 amino acids for each 
homolog also showed that S. cerevisiae Algi p is the only one to contain such a hydrophobic N-terminus. 
111-4-7-1 Construction of pPICZB-ara-ALG1 and pPICZB-FLAG-ara-ALG1 
and attempted expressions under the PAOX1  promoter 
ara-ALGI 	 JliL7r 	 AOXI7 11 Mi 
Lsiiie the entire amino acid sequence deduced fl urn the cast S. LC/e v/oat gene 
ALGI, the A. thaliana translated database was searched using the Basic Linear 
Alignment Search Tool (BLAST) from the National Center for Biotechnology 
Information (NCBI; hup://www.ncbi.nlm.nih.govIBLAST/) for the A. thaliana 
counterpart of ALGI. A homolog was detected in the non-redundant (nr) database 
(accession number NM_101521.2). Specific oligonucleotide primers were designed 
to amplify the gene from the corresponding cDNA, which was generated by reverse-
transcription of mRNA (111-3-2 and 1H--3) 
Sense 
KpnI 	 Kpn I restriction site 
\ra_A Ig 1/2/ 	 5- CTAGTCTAGATTCATGAATCTGCAATITGAGA-3 
Antisense 
XhaI/SC 	 Xbu I restriction site and snip ci don 
The amplification ot (lie gene was detected by the lresenee ol a single band at 1 397 
hp on agarose gel electrophoresis (Figure 3-9). 









Fgure 3-9: Agarose gel of the PGR product of the ara-ALGJ gene amplification from the 
corresponding cDNA, with an annealing temperature of 56 °C, 58.2 °C or 60 °C (Lanes 2-
4). Lane 1: Fermentas 100 bp ladder, 
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The Kpn I and Xba I restriction sites introduced in the 5' and 3' end oligonucleotide 
primers, respectively, were used to cut the PCR product and introduce it into the 
corresponding sites of the pPICZ-B vector (111-3-8 and 111-3-11-2). The correct 
introduction of the gene was detected by the presence of a band at 1.6 kb on agarose 
gel electrophoresis (111-3-1) after PCR screening of the transformants with the AOXJ 
oligonucleotide primers (ffl-3-6). The construct was sequenced (11-3-11) before 
being cut with Sac I (111-3-12) and no mutation was found in the ara-ALG] coding 
sequence. The pPICZB-ara-ALG] construct was initially transformed into GS1 15 
(111-3-13) and test expressions of two colonies were carried out at both 16 °C and 30 
°C (111-3-14) but no expression was detected as no band of the correct size (52.3 
kDa) could be observed on the SDS-PAGE gel (111-3-15). 
To facilitate the detection of the protein, the ara-ALGJ gene fragment was cloned 
into a pPICZB-FLAG vector (111-3-18). Sequencing (11-3-11) of the pPICZB-FLAG-
ara-ALG] construct confirmed the presence of the ara-ALG] gene in frame with the 
FLAG tag coding sequence. After restriction digest of the construct with Sac I (HI-3-
12) and transformation into GS1 15 (111-3-13), one colony was obtained on YPDS 
selective plate after growth at 30 °C for 2 days. The DNA content of the colony was 
checked confirming the correct insertion of the gene of interest into the genome (HI-
3-17). Due to time constraints a test expression was tried for only 2 days at 30 °C but 
no band of the correct size was detected on SDS-PAGE gel (111-3-15) or Western 
blot (111-3-16), when the intracellular protein content was analysed. 
Another transformation of the construct was carried out in P. pastoris KM71FI (111-3-
13). A culture was grown at 30 °C for 5 days (111-3-14) and the content of the cell 
pellet was analysed but a band of the correct size (53.3 kDa) was again not observed 
on SDS-PAGE gel (111-3-15) or Western blot (ffl-3-16). The content of the cell pellet 
was tested for mannosyltransferase activity but no transfer of radioactivity to the 
organic phase was detected (11-3-15) leading to the conclusion that mannosyl-transfer 
had not occurred. 
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111-4-7-2 Construction of pPICZB-FLAG-caeno-ALG1 and attempted 
expression under the PAOX1  promoter 
CJCfl4)-.%LG/ 
A protein query versus translated database (tblastn) search of the C. elegans nr 
database identified a homolog to the protein sequence encoded by ALGI (accession 
number T26A5.4). After reverse-transcription of C. elegans mRNA (111-3-2), the 
1463 bp gene was amplified from the obtained cDNA (111-3-3) with oligonucleotide 
primers designed to target the gene and containing the Kpn I and Xba I restriction 
sites and a stop codon at the 5' and 3' ends, respectively (Figure 3-10). 
Caeno_Alg 1/3/KpnI 	Sense 	
CGGGGTACCGCGTACAATGGCAAAGGAAG-3 
Kpn I restriction site 
Caeno_AIg I /4/XbaIJSC Antisense 	
5'-CTAGTCTAGAAATTA AAGCGATCTGAATGCC -3 
Xba I restriction site and stop codon 
The amplified DNA fragment was submitted to dual restriction digest with the 
endonucleases corresponding to the introduced restriction sites (111-3-8). The product 
of the restriction digest was inserted into the corresponding sites of the pPICZB-
FLAG vector thanks to the generated cohesive termini (111-3-11-2). Correct 
introduction of the gene was verified by PCR amplification using the AOXI 
oligonucleotide primers (111-3-6) enabling the detection of a band at 1.7 kb on a TAE 
1 % agarose electrophoresis gel (111-3-1). The construct was sequenced (11-3-11) and 
checked for the presence of the gene in frame with the FLAG tag coding sequence 
and no mutation was detected in the gene sequence. Finally, the construct was cut 
with Pme 1(111-3-12) and transformed into KM7IH (HI-3-13). A test expression (III-
3-14) was carried out at 30 °C for 5 days and the cell contents of the last two days of 
growth were analysed by SDS-PAGE gel (111-3-15) or Western blot (ffl-3-16) but no 
band of the correct size (56.4 kDa) was observed. 
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Figure 3-10: PCR products obtained after PCR amplification of caeno-ALG1 (Lanes 2-4) 
and droso-ALG1 (Lanes 5-7) from the corresponding cDNA using different annealing 
temperatures: 56 °C (Lanes 2 and 5), 58.2 °C (Lanes 3 and 6) and 60 °C (Lanes 4 and 7). 
Lane 1 Fermentas 100 bp ladder. 
111-4-7-3 Construction of pPICZB-FLAG-droso-ALG1 
	
p.to' 	 droso-ALG! 
The D. inelanogaster database was searched against the AIg 1 protein sequence and a 
homolog was found by tblastn search of the nr database (accession number BJ 
754534). The identified 1338 bp DNA fragment was amplified by PCR (111-3-3) 
from the corresponding cDNA, generated by reverse-transcription (HI-3-2) (Figure 
3-10). The oligonucleotide primers used were designed to introduce a Kpn I 
restriction site at the 5'end and an Xba I restriction site as well as a stop codon at the 
3' end. 
1)r..\I 1131 	 5- CGGU(SIACCTIXITIITC1IGCCCAUCG-3 
Sense 
kpnl 	 Kpn I restriction site 
Dro_AIg 1/2/ 	 5'- CTAGTCTAGACTATAGAAATGCCTCCAGTAC-3 
Antisense 
XhaI!SC' 	 .'k/i I reincnon !IC andoor C(dflfl 
\ only a small quanlity ol D\.-\ was obtained 1igure 3- 10), tue gene IragmUelil \\ as  
eInied into the pUBfBsd-TOPO vector (11-3-5-3). Positive clones were identified by 
PCR screening using the above gene specific oligonucleotide primers (111-3-6). The 
putative droso-ALGJ gene fragment was isolated from the TOPO vector by Kpn I 
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and Xba I dual restriction digest (111-3-8) and ligated into the corresponding sites of 
the pPICZB-FLAG vector (11-3-9-2). Transformants containing the correct construct 
were isolated by PCR screening with the AOXJ oligonucleotide primers (111-3-6) and 
sequencing (11-3-11) was performed to ensure that the gene had been introduced 
without mutations and in frame with the FLAG tag coding sequence. The construct 
was cut with Sac 1(111-3-12) and transformed into KM7IH (111-3-13). However, no 
colonies were obtained on selective plate after transformation and incubation at 30 
C br 2 days and no further work was carried out on this construct. 
111-4-7-4 Conclusion on the expression of ALG1 homologues in Pichia 
pastoris 
The transformation of pPICZB-FLAG-caeno-ALGJ and pPICZB-FLAG-ara-ALGI in 
KM7IH was found to yield integrants. However, after methanol-induced culture of 
the colonies, the obtained cell pellets failed to yield detectable amounts of 
mannosyltransferase activity and no protein band could be detected on Western blot. 
Due to the lack of success for these two homologues, the transformation of pPICZB-
FLAG-droso-ALG] was not re-tried after a first unsuccessful attempt. As, on overall, 
the E. co/i system was judged to be better for the expression of the ALGI gene, 
expression of the homologues was attempted in the bacterial host. Due to greater 
difficulties in the cloning, the expression of the D. nielanogaster putative ALGI 
homolog was not tried in E. co/i. The putative ara-ALGI and caeno-ALG] genes 
crc cloned Into) the pET.?a vector for attc I1)pICC! e\p1cdon in a hacteri a] host 
111-4-8 Attempted expression of the ALG1 homologues in the pET 
system 
111-4-8-1 Construction of pET28a-ara-ALG1 
I 	(t 
The ara-ALGJ gene was amplified by PCR from the pPICZB-FLAG-ara-ALG] 
construct (111-4-7-1) using the following oligonucleotide primers (11-3-2: PCR2, 
thermal cycle 2): 
Ara- 	 5'-CTAGCTAGCATGGGGAAAAGAGGAAGGG -3' 
Sense 
ALG1/pET28a/NheJJl 	 Nhe I restriction site 
Ma- 	 5'-CCCGCTCGAGTCATGAATCTGcAAITFGAGAC -3' 
Antisense 
ALG1/pET28aJNheIJ1 	 Xho I restriction site and stop codon 
The amplified DNA fragment was ligated into pUBIBsd-TOPO (11-3-5-3) and 
positive clones were identified by screening PCR using the above gene specific 
oligonucleotide primers (111-3-6). The pUBIBsd-TOPO-ara-ALG] construct was 
subsequently submitted to dual restriction digest with N/ic I and Xho I (111-3-8), 
producing the sticking ends required for directional cloning into the pET28a vector 
(11-3-9-2). The correct pET28a-ara-ALGJ constructs were identified by screening 
PCR with the T7 oligonucleotide primers (111-3-6). The presence of the intact coding 
DNA sequence in frame with the S'end His tag coding sequence of the vector was 
verified by sequencing (11-3-11). 
111-4-8-2 Expression of ara-ALGI from pET28a-ara-ALG1 in E. coil 
BL21 (DE3)pLysS 
Transformation of the pET28a-ara-ALGI construct into E. coli BL21(DE3)pLysS 
cells and the subsequent culture of the obtained colonies were carried out as 
described in 11-3-12. 
Production of the ara-Algl protein (55.1 kDa) was not detected by SDS-PAGE 
analysis (11-3-13), when the protein content of the cell extract was analysed. 
However, a band was detected at around 12 kDa on the Western blot (11-3-14), 
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Figure 3-11: Western blot of the whole cell content of two cultures of E. co/i BL21(DE3) 
cells harbouring pET28a-ara-ALG1 grown at 37 °C (Lanes 2 and 5), 30°C (Lanes 3 and 6) 
and room temperature (Lanes 4 and 7).Lane 1: His tagged protein as a positive control. 
Lane 8: BioRad Precision Plus protein Standards. 
The cell extract was tested for mannosyltransferase activity (11-3-15) and transfer of 
radioactive mannose to PPGn 2 29a was detected (Figure 3-12). The protein was 
therefore produced in an active form, despite the fact that it could not be detected in 
its full-length on the Western blot or the SIDS-PAGE gel. 
Figure 3-12: Mannosyl-transfer catalysed by ara-Algip from E. co/iBL21(DE3)pLysS cell 
extracts harbouring pET28a-ara-ALG1 (1 and 2) or HIsGFP-link-Algli\TM1p from E. co/i 
BL21 (DE3) cell extracts harbouring pET24a-HisGFP-link-ALG1ATM1 (3 and 4). The 
radioactivity levels of the organic and aqueous phases after man nosyltransferase reaction 
with radiolabelled GDP-Man 8 in the presence of PPGn 2 29a (1 and 3) or without (2 and 
4) were measured. The presence of radioactivity in the organic phase of the assayed 
sample indicated that mannosyl-transfer had occurred. 
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111-4-8-3 Construction of pET28a-caeno-ALG1 
LAA 	caeno-1tL(;1 	I 
The ALGJ homolog from C. elegans was amplified by PCR (111-3-4-2) from the 
pPICZB-FLAG-caeno-ALGI (ffi-4-7-2) construct using 5' end and 3' end 
oligonucleotide primers containing, respectively, a Nhe I and an Xho I restriction site 
as well as a stop codon. 
Caeno- 	 5'-CTAGCTAGCGCAAAGGAAGACGACGAATC -3 
Sense 
ALG1/pET28afNheI/1 	 Nhe I restriction site 
Caeno- 	 5'-CCCGCTCGAGTTAAAGCGATCTGAATGCCC -3 
Antisense 
ALG1/pET28aINheIJl 	 Xho I restriction site and stop codon 
The obtained DNA fragment was ligated into pUB/Bsd-TOPO (11-3-5-3) and positive 
clones were identified by PCR screening (111-3-6) using the above oligonucleotide 
primers. The obtained construct was submitted to dual restriction digest using Nhe I 
and Xho I (111-3-8). The produced cohesive termini were used to ligate the gene into 
the unique corresponding sites of the pET28a vector (11-3-9-2). The positive clones 
were identified by PCR screening using the T7 primers (ffl-3-6). Sequencing (11-3-
11) of the pET28a-caeno-ALGI construct confirmed the introduction of the gene in 
frame of the N-terminal His tag coding sequence of the vector. 
111-4-8-4 Expression of caeno-ALG1 from pET28a-caeno-ALG1 in E. coil 
BL21(DE3) 
Transformation of the pET28a-caeno-ALGI construct into E. coli BL21(DE3)pLysS 
cells and the subsequent culture of the obtained colonies were carried out as 
described in 11-3-12. Production of the caeno-Alglp (58.2 kDa) was not detected on 
SDS-PAGE gel (11-3-13), when the protein content of the cell extract was analysed. 
However, as for ara-AIg Ip, a band was detected at around 12 kDa on the Western 
blot using an anti-His tag antibody (11-3-14), suggesting that expression from the 
construct did occur (Figure 3-13). The cell pellet was tested for mannosyltransferase 
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activity but this time no transfer of radioactivity took place, leading to the conclusion 










Figure 3-13 Western blot of the whole cell content of E. co/i BL21(DE3) cells harbouring 
pET28a-caeno-ALG1, grown at room temperature (Lanes 1 and 4), 30 °C (Lanes 2 and 
5) or 37 °C (Lanes 3 and 6). Lane 7: His tagged protein as a positive control. Lane 8: 
BioRad Precision Plus protein Standards. 
In both cases, detection of a band at around 12 kDa on Western blot suggested that 
the N-terminal fragment of the fusion protein had been cleaved from the rest of the 
protein, thus displaying the N-terminal His tag. However, when a 
mannosyltransferase activity assay was carried out, activity was detected for the A. 
thaliana homolog but not for the C. elegans homolog. The level of transfer was not 
better than that of the HisGFP-link-AIg1ATMIp and further work was therefore 
continued with the S. cereiisiae Alg I ATM I p. 
111-4-9 Conclusion 
Despite the promises of the yeast expression system, the production of the 
mannosyltransferase in this system did not yield improvements compared to the 
existing bacterial system. Even if the mannosyltransferase was found to be produced 
in an active form in this system, the lack of secretion did not allow for facilitated use 
and characterisation of the -1,4-mannosyltransferase. As export of the protein 
seemed to be a problem it was difficult to imagine that the display of the 
mannosyltransferase on the surface of yeast cells could work. Also, expression of the 
ALGI homologues in a bacterial system yielded much lower activity than expression 
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of ALGI itself and were also not advantageous over the existing system. Work was 
therefore continued with the HisGFP-link-ALG]aTM1 gene fusion as it was the 
most amenable to further manipulations and studies. 
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IV Development of a new assay and directed evolution of the yeast P-
1 ,4-mannosyltransferase 
IV-1 Introduction to directed evolution and assay development 
IV-1-1 Modifying glycosidases by rational design: glycosynthases 
Further understanding of the functions of oligosaccharides has generated the need to 
synthesise oligosaccharides of defined composition by enzymatic approaches (Feng 
et al., 2005). For such strategies to be applied, modifications of the natural 
glycosidases and glycosyltransferases are needed to improve or modify either their 
stereoselectivity or substrate specificities (Feng et al., 2005). With this aim, 
glycosynthases have been designed from different retaining glycosidases by 
converting the catalytic nucleophile of these enzymes into a non-nucleophile residue 
(Scheme 4-1) (Kim et al., 2004). 
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Scheme 4-1: Mechanism of action of a retaining glycosidase (top) and of a glycosynthase 
(bottom). Retaining glycosidases use two acidic residues, one acting as a general 
base/acid and the other one as a nucleophile. In glycosynthases, the nucleophile has 
been mutated to a small hydrophobic residue and the enzyme catalyses trans-
glycosylation reactions by using glycosyl fluoride 56 that mimics the transition state (From 
Lin et al., 2004). Only the functional groups essential for the reactions are represented. 
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The resulting enzymes are then capable of synthesising a glycosidic bond between a 
glycosyl fluoride 56 and aryl glycosides 57 (Scheme 4-1). Glycosyl fluorides 56 of 
opposite anomeric configuration compared to the original substrate 54 of the 
glycosidase simulate the glycosyl enzyme intermediates and explain the new 
specificities of the glycosynthases (Kim et al., 2004). The yields of reactions are high 
but limitations include the slow activity compared to the wild-type, although 
improvements have been made (Kim et al., 2004). Moreover, the acceptor specificity 
is often limited to aryl-glycosides 57 and no transfer to natural disaccharides has 
been reported (Feng et al., 2005). Due to these limitations, alternatives are sought 
and directed evolution bears the potential to tailor glycosidases and 
glycosyltransferases towards new specificities for the synthesis of natural and 
unnatural oligosaccharides of specific composition (Feng et al., 2005). 
IV-1-2 Modifying carbohydrate-active enzymes by directed evolution 
IV-1-2-1 Generalities on directed evolution 
Directed evolution aims at altering the function of known proteins by random 
nucleotide-sequence mutagenesis, functional screening and amplification (Scheme 4-
2) (Farinas et al., 2001). This method has proved particularly useful for proteins of 
unknown structure for which rational design can not be applied (Zhang et al., 1997). 
Even for proteins of known function, rational design has failed to provide general 
rules for engineering activity and stability (Sriprapundh et al., 2003). Moreover, 
random mutagenesis enables the potential alteration of all possible amino acids of a 
protein sequence, allowing the discovery of beneficial mutations that would not have 
been thought of by rational design (Leemhuis et al., 2003). 
Directed evolution involves the generation of a library of randomly mutagenised 
DNA sequences and the efficient isolation of mutants displaying the desired function 
from the pool of altered proteins (McCarthy et al., 2004). Random mutagenesis can 
be achieved through a panel of methods including DNA shuffling (Crameri et al., 
1996), error-prone PCR (epPCR) (Ldnn et al., 2002), oligonucleotide cassette 
mutagenesis and mutator strain (Greener et al., 1997). Introduction of random 
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mutations along the entire length of a gene is most commonly achieved by error-
prone PCR (epPCR), where the gene to be mutated is amplified under conditions that 
favour the introduction of mismatches (Sriprapundh et al., 2003). The success of the 
directed evolution approach depends on the proper balancing between the mutation 
rate, the library size and the selection pressure (Zhang et al., 1997). Also, different 
rounds of mutagenesis / screening are applied to enhance the proportion of mutant 
clones possessing the desired property against the background of null clones 
(McCarthy et al., 2004). Therefore when a mutant with slightly better characteristics 
than the wild-type is obtained in the first round of mutagenesis, its DNA is used as 
the template for a second run and so on until no more improvement towards the 
desired property can be obtained. 
library of 	 library of mutated enzymes best 
random 
mutated genes Eilll 	n positive mutants gene 	mutagenesis -: 	expression screening E 
1YPe1fl wild 
L_J enzyme 
Multiple rounds positive 
mutant 
gene 
Scheme 4-2: General representation of a directed evolution approach. First, a library of 
mutated genes is generated by random mutagenesis, mutated genes are then 
expressed, and produced enzymes are screened for the desired activity. The DNA of 
the best mutant is finally isolated and used as a template in a new cycle of 
mutagenesis and screening. Adapted from Reetz, 2001. 
IV-1-2-2 Applications to carbohydrate-active enzymes 
Directed evolution has been applied to carbohydrate-active enzymes, most of the 
work focusing on glycosidases. Examples include the evolution of E. coli lacZ f3- 
galactosidase into a 3-fucosidase (Zhang et al., 1997), the improvement of the 
activity of a glycosynthase (Kim et al., 2004) and the conversion of a f3-glycosidase 
into a f3-transglycosidase (Feng et al., 2005). In all those cases, the pressure was 
directed at improving a minor activity of the enzyme at the expense of its natural 
activity. For example, the f3-glycosidase from Thermus ther.'nophilus is essentially 
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catalysing the hydrolysis of glycosyl bonds but it is also known to catalyse self-
condensation reactions (50 %) and transglycosylations (8 %) (Feng et al., 2005). 
Thereby, by first selecting mutants displaying a reduced hydrolytic activity and, 
among those, by isolating those having an increased transglycosylation activity, a 
mutant mostly active towards transglycosylation was identified (Feng et al., 2005). 
Similarly, the E. ccli lacZ 3-galactosidase was known to be highly selective for the 
hydrolysis of galactosyl rather than fucosyl substrates and the iterative rounds of 
DNA shuffling and screening applied to this enzyme enabled to reverse this 
selectivity (Zhang et al., 1997). 
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Scheme 4-3: Schematic representation of the three possible reactions catalysed by 
cyclodextrin glycosyltransferase. Reproduced from Leemhuis et a'., 2003. The hydroxyl 








More generally, random mutagenesis has been applied to glycosidases in order to 
improve their regioselectivity, substrate specificity or transferase activity (Feng et 
al., 2005). The only report of mutagenesis on a glycosyltransferase concerns a 
cyclodextrin glycosyltransferase (Leemhuis et al., 2003). This glycosyltransferase is 
an atypical member of the ct-amylase family since it preferably catalyses 
transglycosylation reaction while other members of the family have a preference for 
hydrolysis (Scheme 4-3). Directed evolution was therefore applied to increase the 
hydrolase activity relatively to the transglycosylation reaction so as to understand the 
reasons for the singularity of the cyclodextrin glycosyltransferase (Leemhuis et al., 
2003). 
Although directed evolution has been reported for glycosidases, glycosyltransferases 
have not been the study of such approach. This might be explained by the difficulty 
of producing these enzymes and the fact that their substrates are not readily 
available. By contrast, glycosidases are soluble and robust enzymes with much 
simpler and cheaper substrates (Feng et al., 2005). Also, there is no generally 
applicable screening method for assaying glycosyltransferase. Efforts are nonetheless 
focusing on developing high-throughput assays for the study of glycosyitransferases. 
IV-1-3 Existing assays for glycosyltransferases 
IV-1-3-1 Radiochemical assay 
The most general assay for measuring glycosyltransferase activity remains the 
radiochemical assay upon which a radiolabelled sugar is transferred from a NDP-
sugar donor 25a to an acceptor molecule 26 (Schemes 1-9 & 1-17). The sensitivity of 
this assay has been particularly useful for the quantification of the low amounts of 
glycosyltransferases present in natural sources (Palcic & Sujino, 2001). Once the 
transfer of radioactivity from the donor 25a to the acceptor 26 has taken place, the 
product 27 is isolated from the starting materials by a variety of methods, mostly 
chromatographic. Despite the effectiveness of this assay, the degradation of the 
NDP-sugar donors 25a by the action of hydrolases in crude extracts can generate 
high background values. Moreover, this assay method is costly and creates problems 
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of radiochemical waste disposal (Oubihi et at, 1998). Adapting this assay to a 96-
well format would prove both expensive and hazardous. Radiochemical methods 
have thus not been automated and their use for high-throughput applications has not 
been considered (Palcic & Sujino, 2001). 
IV-1-3-2 Immunological assay 
Alternatively, immunological assays have been developed and offer the possibility to 
be adapted to the microtiter plate format (Palcic & Sujino, 2001). Usually the 
glycoprotein or glycolipid acceptor 26 is immobilised in the well of a microtiter plate 
and the reaction is carried out by addition of the glycosyltransferase and the NDP-
sugar donor 25a (Oubihi et at., 1998). The reaction mixture is then removed, the 
wells are washed and an antibody or a lectin specific for the formed product 27 is 
added to each well. Reaction with a conjugated-secondary antibody allows for the 
detection of the product 27 in a specific and sensitive manner (Scheme 4-4) (Oubihi 
et al., 1998). 
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Scheme 4-4: Schematic representation of an immunological assay. 1: to the immobilised 
acceptor substrate 26 are added the donor substrate 25 and the glycosyltransferase. 2: 
the wells are washed to remove the reaction mixture. 3: an antibody or a lectin specific to 
the formed product 27 is added and detected by reaction of a conjugated-secondary 
antibody. 
However, with this method, only a low concentration of acceptors 26 can be 
displayed in the wells of the microtiter plate (Palcic & Sujino, 2001). The glycolipid 
or glycoprotein acceptor 26 is not always stably immobilised despite the addition of 
stabilising reagents such as polyisobutylmethacrylate, creating problems of 
reproducibility (Oubihi et at, 1998). Such reproducibility problems would also arise 
from the availability of large quantities of homogenous neoglycoprotein or 
neoglycolipid, limiting the extension of such system to the analysis of a large number 
of samples (Oubihi et al., 1998). The synthesis of a polyacrylamide derivative having 
a P-linked N-acetylglucosamine 67 moiety on each monomeric unit was shown to 
overcome the immobilisation problem for the assay of a 3-1,4-galactosyltransferase 
as this polymer had a strong adhesiveness to the polystyrene of the microtiter plate 
withstanding up to 1 % of detergent without any loss of the immobilised acceptor 67 
(Oubihi et al., 1998). Moreover, the high concentration or clustering of 
carbohydrates along the polymer chain leads to the efficient display of the acceptor 
67. However, two other such polymers were synthesised and tested but were found to 
display the acceptor 67 in such a way that it was not accepted by the -1,4-
galactosyltransferase (Oubihi et al., 1998). This probably limits the applicability of 
this method as, for each acceptor 26, a series of polymers would have to be 
synthesised in order to find the ones that will enable the binding of the enzyme. 
Finally, a monoclonal antibody or a lectin specific for the product 27 or acceptor 
substrate 26 needs to be available and this can be the major obstacle to the use of this 
assay for certain glycosyltransferases. Recently, this problem was tackled by the 
development of an enzyme-linked immunosorbent assay (ELISA) derived assay for 
polypeptide N-ct-acetylgalactosaminyltransferases through immobilisation of 
biotinylated substrates on NeutrAvidin coated plates and use of an azido-sugar 
nucleotide 68 (Hang et al., 2004). The azide of the sugar nucleotide 68 was reacted 
with a phosphine bearing a FLAG tag and detected by conventional conjugated 
antibodies reaction (Kiick et al., 2002). This method nonetheless required the 
synthesis of the sugar with the azido group at all five possible positions on the 
hexose in order to find the one that would be best tolerated by the transferase. Also, a 
biotin tag needs to be added to the acceptor substrate 26 without modifying the 
binding properties of the glycosyltransferase (Hang et al., 2004). 
IV-1-3-3 UV/visible assay 
Generally, assays involving UV/visible or fluorescence changes are of high interest 
as the reaction can then be followed in a continuous way, facilitating kinetic studies. 
However, no direct UV/visible or fluorescence changes are associated with glycosyl-
transfers. To circumvent this problem, a spectrophotometric assay has been 
developed that couples the glycosyl-transfer with other enzymatic reactions that can 
be followed by measurement of absorbance values. The method was initially used for 
0- 1 ,4-galactosyltransferases (Scheme 4-5). 
UDP-Gal + acceptor 	
GlT 	
Gal-acceptor + UDP 
PK 
UDP + phosphoenolpyruvate 	 pyruvate + UTP 
pyruvate + NADH 	
LDH 
	lactate + NAD 
Scheme 4-5: Coupled reactions of galactosyltransferase (GaIT), phosphate kinase (PR) 
and lactate dehydrogenase (LDH) for the UV/visible detection of glycosyl-transfer. UDP: 
uridine 5'-diphosphate; UTP: uridine 5-triphosphate; NAD: nicotinamide adenine 
dinucleotide. Reproduced from Palcic & Sujino, 2001. 
The decrease in absorbance at 340 nm, corresponding to the oxidation of NADH, 
reflects the glycosyl-transfer and is proportional to the amount of 
gal actosyltransferase present. This coupled assay is not limited to UDP-sugar donors 
as GDP, CDP and ADP can also be accepted by pyruvate kinase. This method is 
however limited when the Km for the substrate is lower than 5 jiM as the extinction 
coefficient for NADH oxidation is not great enough to measure small absorbance 
changes accurately (Palcic & Sujino, 2001) but measurement of the NADH 
fluorescence signal could circumvent this problem. High-throughput assays using 
this enzymatic coupled method are thus precluded since small absorbance changes at 
low concentration are generally barely detectable. Moreover for microtiter plate 
assays, a minimum of 0.2 mU of enzyme is required in each well. 
IV-1-3-4 Chromatographic assay 
Chromatographic methods, such as thin-layer chromatography (TLC), ion-exchange 
chromatography, paper chromatography, high-voltage paper electrophoresis, lectin 
affinity chromatography and high performance liquid chromatography (HPLC) have 
also been widely employed (Palcic & Sujino, 2001). Fluorescently labelled acceptors 
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are commonly used in combination with HPLC and capillary electrophoresis where 
the fluorescence is used to detect and quantify the product. The advantages of 
coupling capillary electrophoresis and fluorescence detection are the high resolution, 
the sensitivity and the product 27 identification. The method is nonetheless limited 
by the requirement for a fluorescently labelled acceptor substrate 26 and is not 
readily applicable to the screening of a large number of samples (Palcic & Sujino, 
2001). 
IV-1-3-5 Mass spectrometry 
Common methods to analyse the product 27 of a glycosyl-transfer include mass 
spectrometry methods, electrospray ionisation and matrix-assisted laser desorption 
ionisation. These methods offer the advantage of identifying the product 27 without 
the requirement for purification from the reaction mixture (Palcic & Sujino, 2001) 
and also offer the possibility to work in volumes as small as a few microlitres. 
!V-135 Solid-phase assay 	 - 
IV-1-3-6-1 Immobilisation of sugars on nitrocellulose 
More recently, solid-phase assays using cellulose membranes have been developed to 
facilitate isolation of the product 27 (Jobron et al., 2003). The method was tested on 
four glycosyltransferases, whose N-actelylactosamine acceptor had been immobilised 
on a cellulose membrane, either through an amine-cleavable linker or a photolinker. 
The product 27 was detected either by autoradiography, fluorescence or, after 
cleavage from the membrane, by mass spectrometry, depending on the nature of the 
NDP-sugar donor 25a (Jobron et al., 2003). The reaction can be performed in 
volumes as small as 200 p1. with between 3 jiU and 400 iW of enzyme depending on 
the detection method used potentially requiring less enzyme than immunological 
assays (Jobron et at, 2003). Currently, this assay is nonetheless limited by the 
amount of acceptor substrate 26 accessible to the enzymes on the membrane but, if a 
better way to immobilise the substrate 26 onto the membrane could be found, it could 
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be applied to the high-throughput assays of any glycosyltransferase that accepts 
immobilised acceptors 26 (Jobron et al., 2003). 
IV-1-3-6-2 Applications of neoglycolipids 
The display of neoglycolipids 69 on microtiter plate or nitrocellulose has been 
considered for the development of oligosaccharide microarrays for the isolation of 
carbohydrate proteins (Scheme 4-6) (Fazio et al., 2002; Fukui et al., 2002). These 
microarrays do not constitute a means to identify a glycosyl- transfer product 27 but 
offer alternative methods for the immobilisation of the acceptor substrates 26. 
Detection of the glycosyl-transfer would still require one of the methods presented 
above. Neoglycolipids 69 are synthesised by reaction of the reducing sugar of an 
oligosaccharide chain 25 with an amino lipid and the product 69 is then immobilised 
on the nitrocellulose membrane (Fukui et al., 2002). Neoglycolipids 69 
immobilisation on nitrocellulose offer multivalent display of the oligosaccharide 25, 
a property of interest as the affinities of oligosaccharide ligands 25 in the monovalent 
state are generally low (Fukui et at., 2002). This reaction is applicable to any sugar 
chains 25 and thus the source of oligosaccharides 25 is unlimited, ranging from 
glycoproteins, glycolipids, whole organs and chemically synthesised 
oligosaccharides (Fukui et al., 2002). By this method, the terminal residue is present 
in its open-chain, which might be problematic if this sugar is part of the recognition 
unit of the carbohydrate-binding enzyme as the ring structure is likely to be essential 
for binding, as was shown for core fucosyltransferases (Fukui et al., 2002). 
Similar glycoarrays using neoglycolipids 69 have been prepared but the 
neoglycolipids 69 were immobilised in the polystyrene wells of a microtiter plate 
(Fazio et al., 2002). The neoglycolipids 69 were synthesised directly in the wells of 
microtiter plates, by reaction of saccharides 25 with saturated hydrocarbon chains, 13 
to 15 carbons in length, through formation of Cu(I)-catalysed triazole (Scheme 4-6) 
(Fazio et al., 2002). After evaporation of the methanol, the neoglycolipids 69 
adhered sufficiently to the polystyrene of the microtiter plates to withstand aqueous 
washings and biological assay conditions (Fazio et al., 2002). The method was used 
to immobilise the substrate for a fucosyltransferase and fucose was indeed transfer to 
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the immobilised substrate 69a as detected by a product specific lectin, allowing 
subsequent inhibitors studies (Scheme 4-6). 
Scheme 4-6: Immobilisation of galactose as a neoglycolipid 69a onto the wells of 
microtiter plates (left). The immobilised trisaccharide (right) was used as a substrate for 
the fucosyltransferase reaction (1) and the detection of the product was achieved with a 
product specific lectin (2). 
Alternatively, oligosaccharides microarrays have been developed by immobilising 
microbial polysaccharides, namely dextrans, on surface-modified glass slide without 
chemical conjugation (Wang et at., 2002). Nitrocellulose-coated glass slides were 
found to be able to immobilise microspots of these bacterial polymers of glucoses 
without covalent conjugation. However, the efficiency of the immobilisation was 
depending on the molecular weight of the dextran preparation and a minimal of 20 
kDa was needed for immobilisation. The exposed dextrans were found to retain their 
antigenic determinants and epitotes and the system was proposed to be generalised to 
the study of carbohydrate-receptor interaction (Wang et al., 2002). Maybe due to the 
specific requirement for carbohydrate polymers in this method, there is no report on 
its use in association with glycosyltransferases. 
IIVITI 
IV-1-3-7 Summary 
In conclusion, the development of methods for assaying glycosyltransferases has 
been driven by the special needs of researchers and apart from the radiochemical 
method (IV-1-3-1) no assay method has been generalised to all glycosyltransferases 
(Palcic & Sujino, 2001). Ideally, assays should be carried out in real time under 
saturating substrates concentrations. However, substrate saturation is often difficult 
to achieve, especially for routine applications due to the high cost and low 
availability of most of the glycosyltransferases substrates. Moreover, there is no 
direct UV/visible or fluorescence changes associated with glycosyl-transfers, 
therefore some other method must be derived to continually monitor the substrate 26 
conversion (Palcic & Sujino, 2001). 
A generally applicable high-throughput screening method is currently not available 
as using radiolabelled NDP-sugars 25a in this format would prove both too costly 
and hazardous to be envisaged. High-throughput screenings have therefore been 
developed according to the particular specificity of each considered 
__1_._!1,_.._.__c_._,_ 	 c-.- iytuyitiaiitciase to iueiiuiy inmuavia ornovel1y¼aioy1trans1...4ass 
this particular enzyme. 
IV-1-4 Aim of this chapter 
Due to limitations in substrates availability for the -1,4-mannosyltransferase, a 
screening method that would limit their use was considered. A binding assay was 
therefore envisaged relying on the fluorescent labelling of the 13-1,4-
mannosyltransferase and on the binding of the fusion enzyme to immobilised GDP 
31 (Scheme 1-20). The work presented in this chapter therefore aimed at testing the 
possibility to immobilise the fluorescently labelled mannosyltransferase on GDP 31 
displayed on solid support. Moreover, given the difficulties in developing an assay 
for the mannosyltransferase activity due to the poor solubility of the enzyme, it was 
decided to first evolve the enzyme towards either higher solubility or expression 
levels using a screening method independent of the function of the enzyme. The 
GFP-folding reporter assay (Waldo et al., 1999). 	was considered ideal to improve the 
robustness of the fusion protein as all it required was a fusion to the 6FF that had 
already been made (11-4-6). The GFP fusion to the mannosyltransferase was thus 
used to evaluate both the potential of the proposed binding assay and the possibility 
to evolve the mannosyltransferase. Moreover, with the long-term goal of screening 
mutants for activity towards a new substrate, the GFP fusion to the 13-1,4-
mannosyltransferase (11-4-4 to 11-4-7) was thought to enable the elimination of the 
non-fluorescent mutants and thus limit the number of mutants to be screened for 
activity for a protein-linked substrate 30a. 
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IV-2 Materials 
IV-2-1 Polynierase chain reactions 
Custom oligonucleotide primers were synthesised by either Thermo Electron GmbH 
(Ulm, Germany) or Invitrogen (Paisley, UK). 2'deoxyribonucleoside 5'-triphosphate 
(dNTPs) mixes were purchased from Sigma-Aldrich (Poole, UK), at a concentration 
of 10 niM of each dNTP. The individual 2'deoxyribonucleosides 5'-triphosphate 
were from Qbiogen (Cambridge, UK) and were provided at a concentration of 100 
mM. The Turbo Pfu polymerase was purchased from Stratagene (Cambridge, UK) 
and the Taq polymerase was from Promega (Southampton, UK). Polymerase chain 
reactions were performed on an Eppendorf Mastercycler®  personal or Eppendorf 
Mastercycler® gradient (Eppendorf, Hamburg, Germany). 
IV-2-2 DNA gels 
The agarose for DNA gels was from Fisher Scientific (Fisher Biotech, molecular 
biology grade) and the gels were visualised using an Anachem transilluminator 
(Anachem, Luton, UK). The 1 kb DNA ladder was from New England Biolabs 
(Hertfordshire, UK). 
IV-2-3 DNA purification 
The QlAprep®miniprep kit for plasmid purification and the QlAquick ® spin gel 
extraction kit and PCR purification kit were from Qiagen (Crawley, UK). 
IV-2-4 Sequencing 
Sequencing reactions were carried out using the BigDye®Terminator  v3.1 Cycle 
sequencing kit (Applied Biosciences, Foster City, USA) and automated sequencing 
was performed as a service by the ICAPB sequencing service (University of 
Edinburgh). 
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IV-2-5 Bacterial strains 
E. coli BL21(DE3) and BL21(DE3)pLysS strains and the chemically competent TOP 
10 E. coli cells were purchased from Invitrogen (Paisley, UK). Chemically 
competent XL1-blue E. coli cells were from Stratagene (Cambridge, UK). 
IV-2-6 Culture media, antibiotics and induction of expression 
Lysogeny broth growth medium (Miller) was purchased either from Sigma-Aldrich 
(Poole, UK) or Fisher Scientific (Pittsburgh, USA). SOC medium was either 
prepared by mixing individual components or obtained from Invitrogen (Paisley, 
UK). The antibiotics ampicillin, kanamycin and chloramphenicol were obtained from 
Sigma-Aldrich (Poole, UK). Incubations were performed either in orbital incubators 
SI50 (Stuart Scientific, Surrey, UK) or in New Brunswick Scientific incubator 
shakers (models G25 or innova Tm 4300 or 4330, New Brunswick Scientific, 
Ayrshire, Scotland). Isopropyl-l-thio--u-ga1actoside (IPTG) was purchased from 
Promega (Southampton, UK). Absorbance measurements of cell -cultures were 
carried out on a Biophotometer Eppendorf (Hamburg, Germany), at 600 nm. The 
BugBuster (primary amine-free) Protein extraction reagent was from Novagen 
(CN Biosciences, UK) and it was supplemented with Complete Mini, Protease 
inhibitor cocktail tablets (Roche, Lewes, UK). 
IV-2-7 SDS PAGE and Western blot 
Pre-cast gels for polyacrylamide electrophoresis (4-20 % or 10-20 % Tris-HCI) and 
10 x TGS running buffer were from BioRad (York, UK). The protein molecular 
weight marker, Precision plus Protein Standards All Blue, was obtained from 
BioRad (York, UK) as well as the electrophoresis tanks and power supplies, either 
200 or 1000. SDS-PAGE gels were routinely stained with EZ BlueTh  gel staining 
reagent from Sigma-Aldrich (Poole, UK). Western blotting was performed on 
Hybond m ECLTM nitrocellulose membrane (Amersham Pharmacia Biotech, Little 
Chalfont, UK) using a monoclonal poly anti-His peroxidase conjugate serum (Sigma- 
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Aldrich) and revealed with DAB peroxidase substrate (Sigma fast 	3, 3'- 
diaminobenzidine tablet sets). Alternatively Western blot was performed on PVDF 
Western blotting membranes from Roche (Lewes, UK). Blotting papers PROTEAN 
XL and thick blotting papers were from BioRad. Liquid blots were performed using 
the BioRad Mini Trans-Blot® cell. Semi-dry blots were performed using the BioRad 
trans-blot semi dry apparatus. 
IV-2-8 Fluorescent measurements 
Fluorescence measurements were performed on a spectra MAX gemini XS 
spectrofluorimeter (Molecular Devices, Sunnyvale, USA) and the results were 
analysed using the software SoftMaxPro. The microtiter plates used were either the 
black well microplates, 96 well, FluoroNunc' from Nunc (Roskilde, Denmark) or 
the Sero-Wel, polystyrene microtiter microplates, 96-well from Sterilin (Barloworld 
Scientific, Staffordshire, UK). Fluorescence was observed under an Anachem 
transilluminator (Anachem, Luton, UK). 
IV-2-9 Quantification of protein 
Total protein contents were estimated using either a Bradford assay or the BCA 
assay. For the Bradford assay, the solution was made from individual components 
and for the BCA assay, the BCA Protein Assay kit from Pierce was used (Perbio 
Science UK Ltd, Northumberland, UK). The assay was carried out in the microtiter 
plate format using Sero-Wel, polystyrene microtiter microplates, 96-well from 
Sterilin (Barloworld Scientific, Staffordshire, UK). The absorbance was measured on 
the microtiter plate reader VersaMax from Molecular Devices (Sunnyvale, USA) and 
the data were collected with the SoftMaxPro software. 
IV-2-10 Immobilisation on GDP matrices 
Immobilisation on GDP 31 was carried out using either GDP-agarose matrix (Sigma- 
Aldrich, Poole, UK) or GDP-hexanolamine sepharose commercially known as 
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affinity-gel glycosyltransferases GDP (Calbiochem, San Diego, USA). Bovine serum 
albumine (BSA) 73, periodate-oxidized GDP 78, glutaraldehyde 74, adipic acid 
dihydrazide 76 and adipic acid dihydrazide agarose were bought from Sigma-Aldrich 
(Poole, UK). The dialysis tubing was the SnakeSkin dialysis tubing from Pierce 
(Perbio Science UK Ltd, Northumberland, UK) The GDP-hexanolamine sepharose 
(Calbiochem, San Diego, USA) was loaded onto a Unifilter 800-filter-well plate 
(GFID glass fiber filter, Polyfiltronics, Whatman, Middlesex, UK) and vacuum was 
applied using the Plate Prep Vacuum Manifold (Supelco, Bellefonte, USA). 
IV-2-11 Radioactive assay 
Ultima Gold scintillation fluid was from Packard Bioscience (Groningen, The 
Netherlands). The ammonium salt of guanosine diphospho-D-[U-' 4C] mannose was 
from Amersham Pharmacia Biotech (Little Chalfont, UK). Scintillation counting was 
performed on a liquid scintillation analyzer TRJ-CARB 2100TR (Packard, The 
Netherlands). 
IV-2-12 Microtiter plates 
Immobilisation of proteins or BSA-GDP conjugate 79 was carried on Nunc 
MaxiSorpTM  flat-bottom 96 well plates (Nunc, Roskilde, Denmark). 1.7 mL cultures 
were carried out in 2.2 mL, 96 square well storage plates from AB Gene (Epsom, 
UK) and the plates were sealed with gas permeable adhesive seals from AB Gene 
(Epsom, UK). 
IV-2-13 General 
All other chemicals were laboratory grade reagents. 
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IV-3 Methods 
IV-3-1 	Immobilisation 	of 	the 	fluorescently 	labelled 	13-1,4-  
man nosyltransferase on GDP-affinity matrices 
IV-3-1-1 Immobilisation on 1 mL of GDP-affinity matrices 
To approximately 0.3 g of bacterial cell pellet was added 1 mL of GDP-agarose 
buffer A (10 mM Tris-HC1, 20 % v/v glycerol, 5 MM M902, 0.1 % v/v Triton-X-
100, 0.5 mM DTT, pH = 7.0) and lysis was promoted by sonication over a period of 
three minutes. The cell-free extract was isolated by centrifugation at 4 °C, 13 000 x 
g, for 5 min and subsequently loaded onto 1 mL of GDP-affinity matrix, which had 
been washed with water and equilibrated with GDP-agarose buffer A, at 4 °C. The 
flow-through was re-loaded, left to run under gravity flow and the column was 
washed with 6 x 1 mL and 1 x 3 mL of GDP-agarose buffer A. Elution was achieved 
with a gradient of sodium chloride (NaCl), as follows: 
1 ml. of 70 mlvi NaCl in GDP-agarose buffer A 
1 mL of 140 mM NaCl in GDP-agarose buffer A 
1 mL of 210 mlvi NaCl in GDP-agarose buffer A 
1 ml. of 280 mM NaCl in GDP-agarose buffer A 
2 x 2 mL of 350 mM NaCl in GDP-agarose buffer A 
50 ltL of each fraction was added 50 ltL of 2 x SDS-PAGE loading buffer. The 
different fractions of the purification process were analysed by SDS-PAGE (11-3-13) 
or Western blot using the monoclonal poly anti-His peroxidase conjugate serum (II-
3-14). 200 jit of each elution fractions were introduced in the wells of a microtiter 
plate and the GFP fluorescence emission spectrum was measured using the 
spectrofluorimeter MAX gemini XS, with a fixed excitation wavelength of 395 nm 
and measurements were taken between 480 nm and 530 mm The data were collected 
with the SoftMaxpro software. 
The gel was routinely regenerated by washing with 20 niL H20, 6 M urea in GDP-
agarose buffer A, 20 mL H20 and kept at 4 °C in GDP-agarose buffer A 
supplemented with 0.02 % sodium azide (NaN3) until required. 
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IV-3-1-2 Immobilisation on 100 / 300 iiL of GDP-hexanolamine 
sepharose 
The mini-columns were developed in a similar way as was described for the 
immobilisation of a trans-sialidase on Q-Sepharose mini columns (Schrader et al., 
2003). Columns were prepared with only 300 jiL of GDP-hexanolamine sepharose 
(Calbiochem) as preparation for final adaptation to a 100 RL volume for application 
to the 96-well format. To approximately 0.1 g of bacterial cell pellet from a culture 
of E. coli BL21(DE3) harbouring pET24a-HisGFP-link-ALG]ATM1 (11-4-6) was 
added 600 RL of GDP-agarose buffer A. The cells were lysed by sonication over a 
period of 2 min and the cell debris were harvested by centrifugation at 13 200 x g, 4 
°C, for 5 mm. Alternatively 600 jsL of BugBuster (primary amine free) supplemented 
with a protease inhibitor cocktail (Complete mini, Roche) was added to the bacterial 
cell pellet. To promote lysis, the cell pellet was re-suspended in the solution and the 
mixture was incubated at room temperature, on a shaker, for 10 mm. The insoluble 
fraction was isolated by centrifugation at 13 200 x g, 4 °C, for 20 mm. 
In both cases, the supernatant was loaded on 100 tiL or 300 j.1 of GDP- 	- 
hexanolamine sepharose equilibrated with GDP-agarose buffer A and re-loaded a 
second time. The column was washed with 3 x 300 jtL, 2 x 600 1iL and 1 x 900 RL 
of GDP-agarose buffer A and elution was achieved with a gradient of sodium 
chloride (NaC1), as follows: 
300 [LL of 70 mM NaC1 in GDP-agarose buffer A 
300 RL of 140 mlvi NaC1 in GDP-agarose buffer A 
300 RL of 210 m NaC1 in GDP-agarose buffer A 
300 t.tL of 280 mlvi NaCl in GDP-agarose buffer A 
2 x 300 RL of 350 niM NaCl in GDP-agarose buffer A 
2 x 300 j.tL of 1.5 M NaC1 in GDP-agarose buffer A 
The columns were routinely followed by measurement of the GEP fluorescence 
emission spectrum recorded at a fixed excitation wavelength of 395 nm on the 
fluorescence plate reader. The spectrum was taken between 480 nm and 540 nm, 
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with a cut off at 475 nm. The data were collected and analysed with the SoftMaxPro 
software. 
The gel was regenerated as described in P1-3-1-I and kept at 4 °C in GDP-agarose 
buffer A supplemented with 0.02 % sodium azide (NaN3) until required. 
IV-3-2 Error-prone PCR 
Random mutagenesis of ALGIATM1 was achieved by amplification of the gene 
from the pET24a-HisGFP-link-ALG1 ATM I construct (11-4-6) under the following 
error-prone PCR conditions: 
- 25 pL DNA polymerase lOx buffer, magnesium free (10 mlvi Tris-HCI, pH = 
9.0; 50 m KCI; 0.1 % Triton-X- 100) 
- 2 j.iL DNA template (pET24a-HisGFP-link-ALG1 ATM 1, 22 ng.pL') 
- I jiL Forward primer (100 pmol.pL4 ; C1 = 0.4 pmol.pL 1 ) 
- I tL Reverse primer (100 pmol.pL'; C1= 0.4 pmol.jsL') 
- 2.5sLdflP(100mM;Cf=IniM) 
- 2.5pLdCTP(100m.M;Cç=i 111M)
- 0.5 1.tL dATP (100 mlvi; Cf= 0.2 mM) 
- 0.5JILdGTP(100mM;Cf=0.2mIvI) 
- 70pLM902(25mM;Cr=7mM) 
- 2.5 11L MnCl2 (5 mM; Cf = 0.05 mM) 
- 2.5 pL Taq polymerase (5 U.pLj 
- 130uLH2O 
The reaction mixture was split in 5 x 50 pL and submitted to the following thermal 
cycle: 
> Thermal cycle 10 
- cycle 1: 95 °C for 3 mm 
- cycles 2-28: 95 °C for I mm, 58 °C for 1 mm, 72 °C for 2 mm 
- cycle 29: 72 °C for 10 mm 
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IV-3-3 Whole plasmid PCR 
The procedure for the amplification of the construct was adapted from the Stratagene 
Quickchange site-directed mutagenesis protocol but the single point mutation 
oligonucleotide primers were replaced by the product of the above epPCR, therefore 
introducing mutated genes in place of the wild-type sequence without the 
requirement for restriction digest and ligation into the expression vector, (Scheme 4-
11). 
The reaction mixture was set as follows: 
- 0.5 j.tL of 10 x Cloned Pfu DNA polymerase reaction buffer 
- 6 jiL DNA template (pET24a-H1sGFP-link-ALGI ATM 1, 13 ng.sU') 
- 5, 10 or 15 1iL 1.2kb DNA fragment from epPCR 
- 5pLDMSO 
- 0.5 pL dNTP mix (Sigma) 
- 2.5 jL Pfu Turbo polymerase (2.5 U.jiL') 
- 28,23ori8 [CL H20 
The PCR mixtures were submitted to the following thermal cycle: 
> Thermal cycle 11 
- cycle l:95°C for 3min 
- cycles 2-29: 95 °C for 30 s, 55 °C for 1 mm, 68 °C for 8 mm (iminlkb) 
IV-3-4 Dpn I restriction digest 
0.6 jiL of Dpn I (Roche, 10 U.jsL 1 ) was added directly to the PCR sample in order to 
cut the methylated wild-type DNA produced by the E. coli XL1-blue cells while 
leaving the non-methylated PCR-generated DNA intact (Scheme 4-11). The 
restriction digest was left at 37 °C for 1 h. 
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IV-3-5 Transformation into XL1 -Blue competent E. coil cells 
I iL of the Dpn I-treated PCR product was directly added to 50 liL of XL1-Blue E. 
coli cells. The cells were incubated on ice for 30 min and heat-shocked at 42 °C for 
45 s. They were cooled on ice for 2 min before the addition of 500 tiL Soc medium, 
previously warmed to 42 °c. The cells were grown at 37 °C, 250 rpm, for 1 h. The 
resulting 550 jL transformation volume was split into two: 
- a 150 p1 aliquot was spread on LB agar plates supplemented with 50 j.tg.mL 1 
kanamycin. The aim was to obtain the DNA of 10 individual colonies in order to 
evaluate the success of the random mutagenesis and the Dpn I restriction digest. 10 
colonies were thus randomly selected, grown in 3 mL LB supplemented with 
kanamycin, overnight, at 37 °c, 250 rpm and their DNA was isolated from the 
overnight culture using the Qiagen mini prep kit (P1-3-6). The DNA isolated from 
each of the 10 colonies was used as a template for a sequencing PR (IV-3-6) 
The colonies remaining on the LB agar plate after the overnight incubation of the 
plate at 37 °c were re-suspended in 2 x 1 ml. of LB medium supplemented with 
kanamycin at the usual concentration. The DNA mixture was isolated using the 
Qiagen mini prep kit and is now referred to as the DNA library. 
- the remaining 350 xL of the transformation volume were used to inoculate 10 mL 
of LB medium supplemented with 12.5 jxg.mL' kanamycin, which were grown 
overnight, at 37 °c, 250 rpm. The DNA was finally isolated using 2 Qiagen mini 
prep columns, one per cell pellet of 5 mL of overnight culture. The isolated DNA 
mixture was added to the library. 
IV-3-6 Sequencing PCR 
- 200-300 ng DNA template 
- 1 !.IL primer (3.2 pmol.jiU'; cf = 0.16 pmol.pL') 
- 4pL Big Dye v3.l 
- H20 to a final volume of 20 1iL 
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The sequencing cycle was run: 
> Thermal cycle 4 
- cycle l:95°C for lmin 
- cycles 2-29: 96 °C for 30s, 50 °C for 30 s, 60 °C for 4 mm 
The results of the sequencing PCR was analysed as a service by the ICAPB 
sequencing service (University of Edinburgh). 
IV-3-7 Transformation of the mutant library into E. coil expression 
strains 
1 pL of the DNA library (IV-3-5) was transformed into 50 L of E. coli BL2 I (DE3) or 
E. coli BL2I(DE3)pLyss. The cells were incubated with the DNA on ice for 30 mm 
and heat-shocked at 42 °C for 30 s. After a 2 min on ice incubation, 250 jit of room 
temperature Soc medium were added to the cells. The cells were subsequently 
grown at 37 °c, 250 rpm, for I h. The transformation volume was split in 7 x 100 [IL 
and each aliquot was spread unto a nitrocellulose membrane laid on top of a LB agar 
plate supplemented with 50 g.mL' kanamycin and 34 ig.mL' chloramphenicol, 
for the pLysS strain. 
IV-3-8 First step of the screening procedure 
The colonies were grown, overnight, at 37 °C and the membrane was then lifted and 
laid on top of a LB agar plate supplemented with the appropriate antibiotic(s) and I 
mM IPTG. The plates were incubated at 37 °c for 3 h and then observed under the 
trans-illuminator. Bright colonies were picked and re-streaked on fresh LB agar 
plates supplemented with the appropriate antibiotic(s). Bright colonies on these 
plates were either directly grown for further characterisation or submitted to the 
second step of the screening process. 
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IV-3-9 Second step of the screening procedure 
After the development of the mini columns (P1-3-1-2), the GDP-hexanolamine 
sepharose was introduced in the wells of a 96-well plate. 
96 colonies were picked from the LB agar plates obtained in P1-3-8 and grown in 1.7 
mL of LB medium supplemented with 50 kanamycin and 1mM IPTU, in a 
deep-well 96-well plate (2 niL), overnight, at 37 °C. 300 1L of each culture was 
added to 60 p1. of 100 % glycerol and the glycerol stocks were kept at -80 °C. The 
cell pellets were harvested by centrifugation at 4 000 rpm, 4 °C, for 20 mm. The 
supernatants were discarded and 280 p1. of BugBuster (primary amine free) was 
added to each well and the cells were re-suspended. The lysis was carried out at 
room temperature, on a shaker, for 10 mm. The cell debris were isolated by 
centrifugation at 4 000 rpm, 4 °C, for 20 mm. The fluorescence of the supernatants 
was measured and afterwards, the whole 280 1iL was loaded onto 100 pL of GDP-
hexanolamine sepharose loaded into the wells of a 96-well plate and pre-equilibrated 
with GDP-column buffer A (10 mM Tris-HC1, 5 MM M902, 10  MM  3-
mercaptoethanol, 0.01 % v / v Triton-X- 100, 10 % glycerol, pH = 7.5). Elution was 
achieved under vacuum using the Plate Prep Vacuum Manifold (Supelco). The 
columns were washed with 6 x 300 j.tL of GDP-column buffer A and 4 x 300 pL of 
GDP-column buffer A supplemented with 70 mM NaCl. The protein was then eluted 
with 2 x 300 sL of GDP-column buffer B (10 mM Tris-HCI, 5 mlvi M902, 10  MM 
fi-mercaptoethanol, 0.01 % v / v Triton-X-100, 10 % glycerol, 0.35 M NaCl, pH = 
7.5) and 2 x 300 jsL of GDP-column buffer C (10 mM Tris-HCI, 5 MM M902, 10 
mM 13-mercaptoethanol, 0.01 % v/v Triton-X-100, 10 % v/v glycerol, pH = 7.5). All 
the steps were followed by measurement of the GFP fluorescence signal of 200 j.xL of 
each fraction at a fixed excitation wavelength of 395 nm and a fixed emission 
wavelength of 507 nm, on the spectra MAX gemini XS. The data were collected with 
the SoftMaxPro software. 
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IV-3-10 Culture of the selected mutants 
Once mutants of interest were identified (IV-3-9), the corresponding glycerol stock 
was used to inoculate a culture in order to isolate the plasmid DNA. The plasmids 
were purified following the Qiagen mini prep protocol. 0.3 RL of the obtained 
plasmid was transformed into 10 RL of E. coli BL21(DE3) or E. coli 
BL21(DE3)pLysS. The cells were incubated with the DNA on ice for 30 min, then 
heat-shocked at 42 °C for 30 s, cooled on ice for 2 min and finally added 250 RL of 
room temperature Soc medium. The cells were grown at 37 °C for 1 h and 
afterwards spread onto LB agar plates supplemented with 50 ig.niL' kanamycin and 
34 j.tg.mL chloramphenicol for the pLysS strain. Individual colonies were 
subsequently used to inoculate 10 mL of LB medium supplemented with the 
appropriate antibiotic(s) and cells were grown, overnight, at 37 °C, under shaking at 
225 rpm. Typically, 100 niL of LB medium supplemented with the antibiotic(s) were 
inoculated with 5 mL of these starting cultures and cells were grown at 37 °C, until 
an absorbance at 600 nm of 0.6. Expression was then induced by addition of 100 .tL 
of 1 M IPTG to a final concentration of 1 mM. Cells were grown at varying 
temperatures for an additional three hours and the cell pellet was harvested by 
centrifugation at 4 °C, 4 000 rpm, for 20 mm. The cell pellets were routinely stored at 
-20 °c until required. 
IV-3-11 Reaction of BSA (73) with glutaraldehyde (74) 
BSA-NH3+ + 	 BSA-N O 
73 	 74 	 75 
To 12.5 mg of BSA 73 (approximately 1.88 x 10 -7 mol) in 1.714 mL of 0.1 M 
sodium phosphate, pH = 7.0 was added 286 RL of a 70 % solution of glutaraldehyde 
74, to obtain a final concentration of approximately 10 %. The reaction to yield 75 
was carried out at room temperature for 1 h and the excess reagent was subsequently 
removed by dialysis. The 2 mL reaction volume was introduced into a dialysis bag 
Ell 
BSA_N N N 2 
9 	77 	0 
sodium cyanoborohydride 
BSA—N " N 
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(Pierce, Snakeskin, 7 kDa cut off, 34 mm wide flat dry) and dialysed for 24 h against 
500 mL of 0.1 M sodium phosphate, which was repeated twice during the process. 
IV-3-12 Reaction of BSA-glutaraldehyde (75) with adipic acid 
dihydrazide (76) 
BSA —N o + H2N_N _NH2 
75 	 o 	76 
BSA _N N_N N_NH2 
77 0 
To the previously obtained sample 75 were added 0.192 g of adipic acid dihydrazide 
76(1.11 xl0 3  mol) and an extra 2 mL of 0.1 M sodium phosphate. The reaction was 
carried out at room temperature for 1 h and excess reagent was removed by dialysis 
as described in IV-3-1 1. 
!V-3-13 Reaction of BSA-glutaraldehyde-adipic acid. dihydrazide -(77) 
with guanosine-5'-diphosphate-2', 3'-dialdehyde (periodate-oxidised 
GDP 78) 
To the dialysed sample obtained in the previous step 77 was added 5 mg of 
periodate-oxidised GDP 78 (1.13 x 10-5 mol). The reaction was carried out at room 
temperature for 1 h 30 min and 10 mg of sodium cyanoborohydride was added and 
the reaction was continued for an additional 17 h. The excess reagents were removed 
by dialysis against the phosphate buffer. The modified protein 79 concentration was 
determined using the BCA protein detection kit. 
IV-3-14 Coating of the plates with the obtained BSA-GDP conjugate (79) 
The coating of the plates was achieved as described in the literature (Palcic et al., 
1990). The wells of a maxisorp microtiter plate were coated with 100 RL of a 20 
j.tg.niL' of BSA-GDP conjugate 79 in 0.1 M sodium phosphate, pH = 7.0, 
supplemented with 5 mM MgC12 and a point spatula of sodium azide (Palcic et al., 
1990). The plate was incubated at room temperature for 16 h. The solution was 
removed from the plate by aspiration and the wells were blocked by incubation with 
5 % BSA in PBS for 4 h, at 4 °C. The wells were washed four times with PBS, three 
times with distilled water and finally air-dried for a few minutes. 
IV-3-15 Incubation of the coated plate with the cell lysates 
A 33.5 niL cell pellet from the culture of K colt BL21(DE3)pLysS cells harbouring 
pET24a-HisGFP-link-ALG1 ATM1 was added 3 mL of GDP-agarose buffer A 
supplemented with 30 jiL PMSF. The cells were opened by sonication over a period 
of 2 min and the supernatant was isolated by centrifugation at 4 °C for 5 mm. 200 jtL 
of this preparation was added to the first well of the plate and 100 [IL of PBS was 
added to all the other wells of the lane. The sample was diluted across the plate by 
adding 100 11L of the cell extract to the second well, mixing the solutions and taking 
100 j.tL of this diluted solution and adding it to the next well. This operation was 
repeated until the last well was reached. The plate was then incubated at 4 °C for 45 
min and washed two times with 200 1jL PBS. The fluorescence was finally measured 
on the fluorescent microtiter plate reader. 
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IV-3-16 Reaction of adipic acid dihydrazide (76) agarose with 
guanosine-5'-diphosphate-2', 3'-dialdehyde (78) 
To 2 .mL of adipic acid dihydrazide agarose slurry (Sigma, 8-15 j.tmol.mL') 
equilibrated with PBS was added 10 mg (2.26 x 10 -5 mol) of periodate-oxidised GDP 
78. The reaction was left overnight at 4 °C and the column was finally extensively 
washed with GDP-agarose buffer A before being used as described in IV-3-1-1. 
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IV-4 Results and discussion 
IV-4-1 Immobilisation of the fusion proteins on GDP-sepharose 
With the aim of isolating mutants of the 13-I ,4-mannosyltransferase with modified 
substrate specificity, an assay relying on GDP 31 binding and subsequent elution 
with modified substrates 30a was considered (Scheme 1-20). It was thus necessary to 
check whether the HisGFP-link-Algl ATM ip could be immobilised on GDP 31 and 
if the binding of the fluorescent chimera could be monitored by measurements of its 
fluorescent signal. 
IV-4-1-1 Development of ribonucleotide affinity chromatography 
The use of resin-linked ribonucleoside for the isolation of ribonucleoside binding 
proteins is a well-established method (Seela & Waldek, 1975). The principle of 
affinity chromatography lies in the ability of a protein that recognises its immobilised 
ligand or inhibitor to be retarded on the matrix to an extent related to the affinity 
constant under the experimental conditions while any other protein will pass through 
the column, un-retarded (Cuatrecasas, 1970). Beaded agarose, i.e. sepharose, is 
considered an ideal matrix as it has good flow properties that are retained throughout 
the purification process and it shows minimal non-specific interactions with proteins 
(Cuatrecasas, 1970). Nucleotide-agarose conjugates have been developed for the 
purification of glycosyltransferases from natural sources as early as the 1970s. 













Scheme 4-7: Three hexanolamine derivatives used for the immobilisation of the 
galactosyltransferase: N-acetylglucosamine-hexanolamine 70, UDP-hexanolamine 71 
and galactosyl pyrophosphoryt-hexanolamine 72. 
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An initial study reported on the synthesis of agarose derivatives of uridine 5'-
diphosphate and N-acetylglucosamine (Scheme 4-7) and compared the relative 
effectiveness of each column for the purification of a galactosyltransferase (Barker et 
al., 1972). UDP-hexanolamine 71 agarose and N-acetylglucosamine-hexanolamine 
70 agarose retained the enzyme while galactosyl pyrophosphoryl-hexanolamine 72 
agarose was found to have a low capacity and specificity of binding for the 
galactosyltransferase. Moreover, when the ligand was directly attached to the agarose 
matrix, it was completely ineffective in retaining the enzyme. It was necessary to 
allow the ligand to extend from the matrix through a linear side chain to enhance the 
affinity of the enzyme (Barker et al., 1972). Especially low Km or K1 values were not 
necessary for effective binding to UDP-hexanolamine 71 agarose and it was 
concluded that enzymes having K. or K1 values for uridine derivatives in the same 
range as those of the galactosyltransferase (UDP: K1 = 7 x 10-5M;  UDP-glucose: K1 
= 104 M; UDP-galactose: Km = 6 x 10-5M)  could be immobilised on similar 
matrices (Barker et al., 1972). 
IV-4-1-2 Examples of glycosyltransf erases purified on ribonucleotide-
sepharose 
The success of UDP-hexanolamine 71 agarose made it the matrix of choice for the 
immobilisation of the gal actosyl transferase (Barker et al., 1972) and other 
glycosyltransferases including a galactosyltransferase from bovine milk, a fucosyl a-
1 ,2-galactoside a-N-acetylglucosan -iinyltransferase from rat liver and a a-mannoside-
fl-N-acetylglucosaminyltransferase from rabbit liver (Sadler et al., 1979). 
The method was then extended to other ribonucleotides and exploited to purify 
glycosyltransferases from natural sources. Hence, both a a-2,3-sialyltransferase and 
a a-2,6-sialyltransferase isolated from porcine sub-maxillary glands were purified on 
CDP-hexanolamine agarose (Sadler et al., 1979). Similarly, a GDP-hexanolamine 
sepharose matrix was used to purify an H blood group-specific fucosyltransferase 
from porcine sub-maxillary glands (Beyer et al., 1980) and a 
acetylglucosaminide a-1,3-fucosyltransferase from human milk (Sadler et al., 1979). 
More recently, GDP-hexanolamine-agarose has been reported for the purification of 
a pea a-i ,2-fucosyltransferase (Faik et al., 2000). Finally purification through 
immobilisation on nucleotide-hexanolamine-sepharose conjugates was applied to a 
great variety of glycosyltransferases illustrating the versatility and power of such 
adsorbents, even in the separation of enzymes that catalyse quite similar reactions 
using related substrates (Beyer et at, 1980; Sadler et at, 1982). On this basis, 
immobilisation of HisGFP-link-A181ATMIp was attempted on a GDP-hexanolamine 
sepharose. 
IV-4-1-3 Immobilisation of AIg1ATM1 fusion proteins on GOP-
hexanolamine sepharose 
The soluble fraction of a 50 mL cell pellet of E. coli BL21(DE3) cells harbouring 
pET24a-HisGFP-link-ALGJ ATM I was loaded onto I mL of GDP-hexanolamine 
sepharose. The column was washed with the loading buffer until no fluorescence 
signal was detected in the washing fraction and the immobilised fusion protein was 










Figure 4-8: Western blot of the soluble fraction from E. co/i 8L21(DE3) cells harbouring 
pET24a-HisGFP-link-.4LGIaTM1 in GDP-agarose buffer at different steps of the 
purification process on GDP-hexanolamine sepharose. Lane 1: BioRad Precision Plus 
protein Standards; Lane 2: loaded sample; Lane 3: flow-through ; Lanes 4 to 6: washing 
steps; Lanes 7-10: elution with GDP-agarose buffer A + 70 mM, 140 mM, 210 mM and 
280 mM NaCl. 
The eluted fractions were found to be fluorescent when the GFP fluorescence 
spectrum was recorded, although the fluorescence level was rather low (Figure 4-9). 
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Figure 4-9: Emission spectrum of the GFP chromophore recorded at a fixed excitation 
wavelength of 395 nm. W and E corresponded, respectively, to the washing fractions 
concentrated to a volume of 400 jiL and the elution fractions that were found to contain 
the fusion protein (Figure 4-8), concentrated to a volume of 400 ixL. 
Attempts were also made to immobilise SNAPAIg1ATM1p reacted with BG-
fluorescein 37 (11-3-22 and IV-3-1-1) (Figure 4-10). 
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Figure 4-10: Emission spectrum of H15 6SNAPAIg1ATM1p reacted with BG-fluorescein 37 
recorded at a fixed excitation wavelength of 488 nm. A decrease of fluorescence during 
the washings and an increase during the elution steps were observed but the 
fluorescence value remained quite high throughout the purification process. 
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It was thought that the excess of BG-fluorescein 37 would be removed during the 
washings of the column. However, even after extensive washings, the fluorescence 
background was still high compared to the signal (Figure 4-10). 
Further work was thus carried out with HisGFP-Iink-AIg1 ATM 1p, despite the 
presence of the Fl 15C substitution (11-4-6). The enzyme was found not only to have 
bound to the resin but also to have been separated from the main degradation 
products (Figure 4-8). It was therefore considered that the degradation products 
displaying GFP fluorescence might not be a major obstacle to the screening of 
mutants with increased affinity for a protein linked substrate 30a as they were likely 
not to be retained on a GDP 31 affinity matrix. However, only very small quantities 
of chimeric protein were eluted from the column and when immobilisation was 
repeated, the protein could only be detected by measurement of the GFP fluorescence 
signal as even a Western blot did not prove sensitive enough for the detection of the 
fusion protein. The low quantity of immobilised protein was considered to result 
from the low solubility of the GFP-fused mannosyltransferase (Chapter 2). 
Moreover, the amount of soluble fusion protein was variable from one experiment to 
the other, creating problems of reproducibility. - - - - 
Given these results, it was decided to focus initially on obtaining better production of 
the fusion protein. Directed evolution of the chimeric protein, together with the GFP-
folding reporter assay (Waldo et at, 1999), was used in an attempt to isolate GFP-
fused mannosyltransferase mutants with improved fluorescence levels and solubility. 
IV-4-2 GFP-folding reporter assay 
IV-4-2-1 GFP4olding reporter assay: generalities 
The GFP-folding reporter assay was developed to isolate mutants of aggregation-
prone proteins possessing improved solubility compared to the wild-type by creating 
mutants bearing a C-terminal GFP fusion and screening them for improved whole 
cell fluorescence (Waldo et al., 1999). Using a panel of 20 proteins of variable 
solubility, it was indeed established that the GFP folding trajectory is dependent on 
the correct folding of the protein fused upstream. Hence, GFP fluorescence was only 
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observed in E. coli cells when the upstream protein was properly folded and 
increased GFP fluorescence signal of the cell, when observed under UV light, was 
correlated to increased solubility of the fused enzyme (Waldo et at., 1999). Directed 
evolution using the GFP-folding reporter assay was subsequently applied to four 
enzymes of different nature and function and the method was judged able to produce 
mutants of improved stability and solubility while maintaining the native catalytic 
activity (Waldo et al., 1999; Pédelacq et al., 2002). It was therefore concluded that 
the structure of proteins with one or a few mutations is generally very close to that of 
the wild-type and therefore likely to retain activity (Pédelacq et al., 2002). 
Finally, the advantage of the system lies in the simple colony-plating technique used 
for screening that avoids the need to develop a specific assay for each enzyme 
(Pédelacq et at., 2002; Omoya et al., 2004). 
IV-4-2-2 GFP-folding reporter assay: application to the 	-1,4- 
man nosyltransferase 
Directed evolution using the GFP-folding reporter assay was applied to the GFP-
labelled 3-1,4-mannosyltransferase to identify mutants with improved stability 
compared to the wild-type fusion protein. The aim was not only to obtain GFP-fused 
mannosyltransferase mutants of increased robustness but also to test the possibility to 
evolve the mannosyltransferase without the requirement to first develop an assay. 
In this study, however, a C-terminal fusion to the mannosyltransferase was not 
envisaged as a loss of activity was observed for the His5AIg1ATM1SNAPp (11-4-8-3) 
and the His6GFPA1g1ATM1His 6p proteins (11-4-7-3). It was therefore decided to 
work with the already produced N-terminal GFP fusion to A1g1ATMIp (11-4-6). 
Despite the fact that the mannosyltransferase was not fused upstream but 
downstream of the GFP, it was considered that cells producing higher amounts of 
fusion protein could still be detected as they ought to display higher fluorescence 
levels than cells producing the wild-type or non-functional variants. It was thought 
that a higher background might result from an N-terminal GFP fusion to the 
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mannosyltransferase but it was deemed essential to retain the mannosyltransferase 
activity and therefore to avoid C-terminal fusions (11-4-7-3 and 11-4-8-3). 
Finally, for the more global aim of screening for modified activity, it was thought 
that the fluorescence of the colonies could be used to distinguish the colonies 
harbouring functional fusion proteins from those harbouring non-functional variants. 
In other words, colonies not displaying fluorescence when observed under UV light 
could be left out of the screening process as they are likely not to harbour functional 
enzymes. This would be of interest to reduce the number of mutants to be screened in 
the search for a new activity, the availability of substrates being limited. 
IV-4-3 Directed evolution strategy 
To obtain a library of N-terminally GFP-labelled 13-I ,4-mannosyltransferase mutants, 
random mutagenesis on the ALG]ATMI coding sequence was first required. A 
library of mutated ALGJEsTM1 gene was generated using a method developed in our 
laboratories by Dr. Franck Escalettes based on an error-prone PCR (epPCR) step 
followed by a whole plasmid PCR (wpPCR) step (Scheme 4-11). 
The first step of this method consists of an error-prone PCR (epPCR) that is a PCR 
run under non-optimal conditions for the polymerase so as to yield higher 
mismatches during the extension and thus introduce mutations in the gene of interest. 
A variety of factors can be varied to affect the Taq polymerase activity and in the 
developed method, the addition of Mn 2 ions and the use of unbalanced dNTPs 
concentrations (dflP: C1 =1 mM; dCTP: C1 = 1 mlvi; dATP: Cf = 0.2 mM; dGTP: Cf 
= 0.2 mM) have been chosen for this purpose. 
The epPCR product corresponding to the gene of interest is then isolated by DNA 
agarose gel electrophoresis and used as a primer for the amplification of the construct 
that served as the template for the epPCR. This step is therefore a PCR, i.e. wpPCR, 
but instead of using conventional oligonucleotide primers, the mutated DNA 
fragments are used to anneal the construct and prime amplification of the rest of the 
construct (Miyazaki & Takenouchi, 2002) (Scheme 4-11). 
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Scheme 4-11: Schematic representation of the random mutagenesis technique. The DNA 
fr9ment is first amplified under unbalanced dNTP concentrations and in the presence of 
Mn . The amplified DNA is used as the primer for the amplification of the remaining of the 
construct. The PCR template is then eliminated by restriction digest with Dpn I. The nicked 
mutated plasmids are finally repaired by transformation into XLI-Blue competent cells. 
As the PCR synthesised constructs are not methylated, the PCR template can be 
easily eliminated by restriction digest with Dpn I. This restriction endonuclease only 
acts on methylated DNA therefore cutting the template but not the PCR-synthesised 
mutated plasmids. The Dpn I-treated wpPCR product is then directly transformed 
into XL1-Blue cells, which will repair the nick in the mutated plasmids (Scheme 4-
II). 
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This strategy avoids the restriction digest and ligation steps that usually result in a 
decrease in the diversity of the library and in low transformation efficiency 
(Miyazaki & Takenouchi, 2002). After isolation of the repaired DNA, the final step 
consists in transforming an expression strain with the mutated plasmids and after the 
growth of the colonies, to screen for the property of interest. The method was applied 
to the mannosyltransferase gene fused to the GFP gene and the resulting library of 
mutants was screened using the GFP folding reporter assay (Waldo et al., 1999). 
IV-4-4 Random mutagenesis on ALG1TM1 
IV-4-4-1 Error—prone PCR 
The ALGJATM1 gene was amplified by PCR from the pET24a-HisGFP-link-
ALGJATMI construct (11-4-6), in the presence of 0.05 mM MnCl 2 and unbalanced 
dNTPs concentrations (IV-3-2) with the following oligonucleotide primers: 
mutpET24a- 	
Sense 	 5'-CAAAAGCGGTGGTGGTACA-3 
ALO I/For/i 
mutpET24a- 	
Antisense 	 5'-CTCGAGTGCGGCCGCAA-3' 
ALG 1 /Rev/2 
The resulting 1.2 kb epPCR product was isolated on a TAE 1 % agarose 
electrophoresis gel (111-3-1) (Figure 4-12) and purified from this gel. 
	





Figure 4-12: Analysis of the epPCR products of 5 identical reactions on a 1 % TAE 
agarose electrophoresis gel. Lane 1: New England Biolabs 1 kb DNA ladder; Lanes 2-6: 
epPCR products; Lane 7: empty lane; Lane 8: cut template; for all the reactions the 1.2 kb 
band corresponding to the ALG1LiTM1 gene was observed. 
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IV-4-4-2 Whole plasmid PCR and Dpn I restriction digest 
Either 5, 10 or 15 tL of the purified 1.2 kb DNA fragment from the epPCR were 
then introduced in a PCR mixture where it acted as primers for the amplification of 
the remaining of the pET24a-GFP-link-ALG]ATM 1 construct, yielding nicked 
complete plasmids bearing different mutations in their ALGIATMI gene (IV-3-3). 
After completion of the wpPCR, the presence of an amplified plasmid was checked 
by DNA agarose gel electrophoresis (ffl-3-1) (Figure 4-13). The Dpn I restriction 
endonuclease was then directly added to the 5 and 10 p.L mixtures for the elimination 
of the PCR template (IV-3-4). The 15 pL mixture was not taken further due to the 
low quantity of PCR product obtained in this sample and the high quantity of epPCR 
product left unreacted (Figure 4-13). 
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Figure 4-13: Analysis of wpPCR products on a 1 % TAE agarose electrophoresis gel. 
Lane 1: New England Biolabs 1 kb DNA ladder; Lanes 2-4: wpPCR run in the presence of 
5, 10 or 15 .tL of 1.2 kb epPCR product. As the quantity of 1.2 kb epPCR increased, the 
yield of the wpPCR decreased and more epPCR product was left non-reacted. 
IV-4-4-3 XL1 -Blue transformation and evaluation of the library 
.\ltci t1c ictrictioii digct. both I.)pil 1-octtcd PCR pioduck \\CFC iiutiIoiiiic1 iiiN 
() tL of XLI-blue cells (IV-3-5). 150 jiL of each transformation mixture was spread 
nto a selective plate and for the Dpn I-treated wpPCR product obtained from the 5 
jiL of epPCR product, 160 colonies were obtained after overnight growth at 37 °C 
vhi1e for the other transformation 100 colonies were counted after identical growth 
iiditions. Although the transformation efficiencies were quite low, it was 
1)ncthc1c Uccided to cvaluatc the produced library. 
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As the wpPCR using 5 iL of epPCR product proved more successful than the other 
wpPCRs, further work focused on this wpPCR product. 10 colonies from the 
corresponding plate were selected for isolation of their DNA and their subsequent 
sequencing (IV-3-6) enabled assessment of both the library (Table 4-14) and the 
success of the Dpn I restriction digest. Out of the 10 plasmids sequenced, only one 
was found not to contain a mutation in the sequenced region. The Dpn I restriction 
digest of the PCR template had therefore been efficient and the library was judged to 
mostly contain mutated plasmids. For the other sequences, the number of mutations 
in the analysed region was between 1 and 4 base pair mutations, corresponding to 
between 1 and 3 amino acid substitutions. A table summarising the sequencing 


































1 593 4 6.7x10 3 8.4 3 6.3 
2 602 1 1.7x10 3 2.1 1 2.1 
3 604 2 3.3x10 3 4.1 1 2.1 
4 652 2 3.1x1(13 3.8 2 3.8 
5 505 0 0 0 0 0 
6 630 2 3.2x10 3 3.9 2 3.9 
7 588 2 3.4x10 3 4.2 2 4.2 
8 652 1 1.5x10 3 1.9 1 1.9 
9 630 1 1.6x10 3 1.9 1 1.9 
10 650 3 4.6x10 3 5.8 2 3.8 
average 3.6 3 
Table 4-14: Evaluation of the library by the analysis of 10 randomly selected clones. 
The extent to which each plasmid had been sequenced varied from one clone to the 
other but the variation was taken into account in the calculations of the average 
number of mutated base pairs and of amino acid substitutions. The mutated region 
covers the 1245 bp of the ALG1TM 1 sequence. 
Types of mutations 1 2 
Bias indicator 
Ts/Tv 1.25 0.9 0.8 
AT-*GC/GC--AT 17 2.8 1.9 
Transitions (Ts) 
A--)G 11% 
50% 33.3% 27.6% _ 
39% 
5.5% 




22.2% 35.7% 40.9% 
T-*A 5.6% 
A-IC 5.6% 
 22.2% 6.3% 7.3% 
T-*G 16.6% 
G--)C 0% 
0% 0% 1.4% 
0% 
0% 
0% 7.9% 4.5% 
0% 
Summary 
A-+N, T--)N 94.4% 75.4% 75.9 % 
G-tNC->N 5.6% 19.8% 19.6% 
Table 4-15: Mutational spectrum of the first library (column 1). The results were compared 
with those obtained for the generation of galactose oxidase mutants using the same 
method (column 2) and with those obtained in the literature using similar epPCR 
conditions (column 31 (Shafikhani etal.. 1997). 
The estimated number of base pair mutations in the ALGJATMI gene ranged from 0 
to 8 bp and mutants displaying a large difference in the number of amino acid 
substitutions were therefore expected. From the 10 sequencing results, the error rate 
per position was calculated to be 0.0029 and the mutation frequency was 344, results 
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in good agreement with those obtained for mutation of the galactose oxidase gene 
where an error rate of 0.0030 and a mutation frequency of 337 was reported for the 
same concentration of Mn 2 (Franck Escalettes, personal communication). The 
average number of base pair mutations in the ALGIATM1 gene was 3.6 
corresponding to an average number of amino acid substitution of 3. Bias in the 
mutational spectrum (Table 4-15) was observed but was explained by the natural bias 
of the Taq DNA polymerase. Under unbalanced dNTP concentrations and in the 
presence of Mn2 ions, the Taq DNA polymerase is indeed known to replace A or T 
with G or C. Moreover, the enzyme is two to six times more likely to generate A-->N 
and T--->N mutations than G---)N and C---)N mutations (Shafikhani et al., 1997). The 
bias was however particularly strong in the case of the ALGJLTM1 gene mutations 
as compared to results reported in the literature or in the galactose oxidase gene 
experiment. The library was thus considered to be sufficiently diverse for further 
applications but higher transformation efficiency was sought to facilitate the creation 
of the library. 
IV-4-4-4 Attempts to improve transformation efficiencies 	- 
To optimise the transformation efficiency into XL 1-Blue cells (IV-3-5), 1 pit, 5 jiL 
and 10 RL of the Dpn I-treated wpPCR product were transformed into 50 lit of XL1-
Blue cells, yielding respectively, 634 colonies, 7 colonies and 143 colonies on 
selective medium, after overnight growth at 37 °C. The number of colonies was 
estimated by spreading 150 jit of the transformation on selective LB agar, counting 
the number of colonies after overnight growth at 37 °C and calculating the 
corresponding number of colonies in the whole 550 j.tL transformation volume. As 
the transformation with I jil. was found to yield the highest number of colonies, 
attempts to lower the amount of Dpn I-treated wpPCR used for transformation 
further were made but 0.5 piL yielded 286 colonies while 1 RL  yielded 495 colonies, 
after overnight growth at 37 °C on selective medium. 
At this point, the library size was estimated to be 2 519 colonies while a minimum of 
10 000 was required to represent the diversity of the generated library (Waldo et al., 
1999). The low transformation efficiency was thought to be due to low amounts of 
wpPCR product and it was decided to try and optimise the whole plasmid PCR step 
(IV-3-3). 
New wpPCRs were thus run using 10, 5 or 2.5 RL of epPCR product with 10 jiL of 
DMSO or 5 j.iL of MgCl2 (IV-3-3). The use of 2.5 tL of 1:2  kb epPCR product 
seemed to yield more wpPCR product. Hence, the wpPCR was repeated with M902 
and 2.5 isL of 1.2 kb epPCR product and the obtained product was submitted to 
restriction digest with Dpn I (IV-3-4). Transformation of the resulting plasmids into 
XL1-blue cells yielded 5 500 colonies after overnight growth at 37 °C on selective 
medium (IV-3-5). However, when the DNA of 10 randomly selected colonies were 
sequenced, all were found to have the wild-type sequence over the analysed region. 
This result suggested that the Dpn I restriction digest did not work. An attempt was 
made to re-cut the wpPCR product but very few colonies were finally obtained (IV-
3-4 and IV-3-5). Work was therefore continued with the initially prepared wpPCR 
mixture for which 5 iiL of epPCR product had been used (IV-4-4-2), as it had proved 
to contain mostly mutated constructs. 
IV-4-4-5 Library generation and screening 
Due to the low transformation efficiency of the Dpn I-treated wpPCR product (IV-4-
4-3), twelve transformations were carried out in parallel to obtain a library of 
reasonable size (P1-3-5). All together, 8 330 colonies were obtained after overnight 
growth at 37 °C on selective medium. With the already obtained 2 520 colonies, the 
library size was estimated to be around 10 850. 
I .tL of the library was transformed into the expression strain E. coli BL21(DE3) and 
the transformation volume was spread onto nitrocellulose membranes laid on top of a 
LB agar plates, which were subsequently incubated overnight at 37 °C (IV-3-7). An 
estimated 51 840 colonies were obtained and subsequently screened (IV-3-8). The 
membranes were placed onto LB agar supplemented with IPTU and left at 37 °C for 
3 h (IV-3-8). The fluorescence of the colonies was observed by direct exposure of the 
membranes to UV light (P1-3-8) and differences in the fluorescence level of 
individual colonies were found. This result was in agreement with variable levels of 
expression from one colony to the other. 
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Figure 4-16: Western blot of the whole cell content of E. co/i BL21 (DE3) cells harbouring 
pET24a-HisGFP-link-ALG1TM1 bearing mutations in the ALG1LTM1 gene: 1,2,3,4,5, 
6, 7 and 8 (Lanes 2-9). Lane 1: BioRad Precision Plus protein Standards. Most mutants 
appeared to be degraded as the main band observed was between 25 and 37 kDa. 
The DNA of 30 of the brightest colonies was isolated and the plasmids were 
transformed into either E. co/i BL21(DE3) (clones 1 to 10 and 23) or E. coli 
BL21(DE3)pLysS (clones 11 to 22 and 24 to 30) (IV-3-10). For all mutants, 
fluorescence of the colonies was observed after overnight growth on LB agar. 
Mutants were found to fluoresce to variable levels after growth in liquid medium. 
The protein content of the cell pellets were analysed by SDS-PAGE gel (11-3-13) and 
Western blot (11-3-14) but no band corresponding to the fusion protein (77.7 kDa) 
was detected (Figures 4-16 & 4-17). 
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Figure 4-17: Western blot of the whole cell content of E. co/i BL21 (DE3)pLysS cells 
harbouring pET24a-HisGFP-link-ALG1TM1 (Lane 2) or bearing plasmids with different 
mutations in the ALG1LTM1 gene: 16, 17, 18, 19, 20, 21, 22, 24 and 25 (Lanes 3-11). 
Lane 1: BioRad Precision Plus protein Standards. 
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Only a strong degradation band was observed between 25 and 37.5 kDa on the 
Western blot (11-3-14) (Figure 4-16). Similarly, mutants transformed into E. coli 
BL21(DE3)pLysS only gave a faint degradation band on Western blot (11-3-14) 
(Figure 4-17). 
Finally, the 1245 bp DNA fragment corresponding to the ALG]ATM1 gene of clones 
I to 6 were sequenced (IV-3-6) and the sequencing result revealed that one mutant 
had lost the ALGJATM1 gene while among the 5 remaining sequences, 4 were found 
to have the ALGIATMI stop codon mutated to a cysteine residue. The removal of 
the stop codon and hence the addition of 33 extra amino acids at the C-terminal end 
of the mannosyltransferase had a drastic effect on the fusion protein stability. It was 
also hypothesised that the introduction of a cysteine in place of the stop codon might 
have favoured improper disulfide bond formation, which could partially explain the 
high level of degradation observed. The formation of an extra disulfide bond might 
have occured with the extra cysteine resulting from the Fl 15C substitution 
introduced during the cloning (11-4-6-1) and this could explain the complete lack of 
stability of the mutants. 
Given these results, the generation of a new library using - an aitisense 
oligonucleotide primer encoding the stop codon to ensure that the stop codon would 
be present in the mutated sequences was deemed necessary. Furthermore, direct 
screening for improved fluorescence only yielded mutants that were more easily 
degraded than the wild-type fusion enzyme. 
The difference in fluorescence level of the E. coli cells containing different GFP-
fused mannosyltransferase mutants when observed under UV light was nonetheless 
an encouraging result in itself. It implied that a C-terminal fusion was not essential to 
observe variable levels of GFP fluorescence in colonies producing GFP fused 
mannosyltransferase mutants. However, in order to isolate N-terminally GFP labelled 
mannosyltransferase mutants of higher stability than the wild-type from the 
degradation products that also displayed high fluorescence values it was considered 
necessary to develop an additional, mannosyltransferase-specific, screening step. 
IV-4-5 Display of GDP in the wells of microtiter plates 
As direct screening using increased fluorescence of the cells was deemed unable to 
isolate mutants with the desired property, another step in the screening process was 
introduced. After screening for fluorescence, mutants were tested for their ability to 
bind GDP 31. By ensuring that the mutants bind to GDP 31, all cells displaying 
increased fluorescence only because they contain an N-terminal degradation product 
or a protein possessing a premature stop codon in its amino acid sequence should be 
eliminated without the requirement for further characterisations, as their protein 
content should not be able to bind GDP 31. 
The immobilisation of the HisGFP-link-A1g1 ATM 1p on GDP-hexanolamine 
sepharose was found to have separated the full-length fusion protein from the 
fluorescent degradation product (IV-4-1-3). Immobilisation on GDP 31 was thus 
considered ideal to isolate mutants that would not only display higher fluorescence 
levels than the wild-type but also retained the ability to bind to GDP 31, thus 
increasing the chance to identify active mutants. As the screening of a library was 
planned, development of a GDP-binding assay in a 96-well plate format was sought. 
IV-4-5-1 Conjugation of GDP 31 to BSA 73 
Methods to immobilise GDP 31 on a solid support were found in the literature, most 
of them concerning the binding of GDP 31 to agarose. However, instead of 
immobilising GDP 31 on agarose, it would be of higher interest to link GDP 31 to a 
molecule that adheres to the wells of 96-well plates. For this purpose, bovine serum 
albumin (BSA) 73 has traditionally been used (Stowell et al., 2004; Gan et al., 2004). 
To achieve proper display, it is necessary to introduce a spacer region between BSA 
73 and GDP 31 so as to minimise steric hindrance around the binding site of the 
enzyme. Moreover, to couple a molecule to a protein, a two step process should be 
favoured as it enables to control polymerisation and achieve maximal display of 
active ligand (Nygren & Hansson, 1981). 
BSA 73 was therefore reacted with glutaraldehyde 74, a five carbon chain carrying 
two aldehyde functions at both ends. The formed conjugate 75 was then reacted with 
adipic acid dihydrazide 76 and the product of this reaction 77 was finally coupled to 
periodate-activated GDP 78 (Scheme 4-18). 
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Scheme 4-16: Preparation of the GDP-BSA conjugate 79. The amino groups of BSA 73 
were first reacted with one of the carboxyl group of glutaraldehyde 74. Then, the 
remaining carboxyl group of glutaraldehyde was reacted with one of the azido groups of 
adipic acid dihydrazide 76. Finally the remaining free azido group was reacted with the 
aldehyde functions of guanosine-5'-diphosphate-2', 3'-dialdehyde 78 in the presence of 
sodium cyanoborohydride. 
IV-4-5-2 Preparation of the BSA-GDP conjugate 79 
Glutaraldeyde 74 is known to react primarily with the free amino groups of proteins 
(Molin et al., 1978). When proteins like BSA 73 are used glutaraldehyde 74 reacts 
predominantly with the c-amino groups of lysine but reactions also occur with 
tyrosine, histidine and sulfhydryl residues (Habeeb & Hiramoto, 1968). The reaction 
of glutaraldehyde 74 with proteins was reported to yield two species: monomers 
containing intramolecular cross-linkages and soluble aggregates formed through 
intermolecular cross-linking (Habeeb & Hiramoto, 1968). To avoid intermolecular 
cross-linking a large excess of glutaraldehyde 74 to protein is often used (Molin et 
al., 1978). This method is effective as glutaraldehyde 74 was reported to conjugate 
1 
ovalbumin to BSA 73 and the product was found to contain only minor contaminants 
of aggregated ovalbumin and BSA 73 (Habeeb & Hiramoto, 1968). Excess 
glutaraldehyde 74 was then removed using either extensive dialysis or Sephadex G-
25 columns (Habeeb & Hiramoto, 1968; Nygren & Hansson, 1981). 
In the present study, one molecule of BSA 73 was estimated to bear around 60 amino 
groups, all of which should ideally bear a GDP molecule 31 at the end of the 
reactions. The reaction was thus carried out at pH 7.0 and with a final concentration 
of glutaraldehyde 74 of 10 % (IV-3-1 1). A high concentration of glutaraldehyde 74 
was used to drive the reaction quickly and avoid cross-linking. After reaction with 
glutaraldehyde 74, the conjugate 75 was reacted with adipic acid dihydrazide 76 in 
order to produce a long linker between BSA 73 and GDP 31 and to re-introduce an 
tmino group on the BSA-conjugate 77 for the final reaction with periodate-oxidised 
GDP 78. For this reaction, as well, a large excess of adipic acid dihydrazide 76 was 
used to drive the reaction quickly and avoid the formation of cross-linkages (IV-3-
I 2). The excess reagent was removed by extensive dialysis against the reaction 
buffer. Finally, the BSA-conjugate 77 was reacted with periodate-oxidised GDP 78 
uid sodium cyanoborohydride was added to enable ring closure (IV-3-13). This 
periodate activation method has been widely used to couple oligosaccharides to 
cdlTier molecules such as BSA 73 (Gan et al., 2004). The different reactions were 
ftillowed by SDS-PAGE (Figure 4-19) and a slight increase in the size of the band 
)bSCi\Cd t' ilie ieactioii were earned oUt. 
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Figure 4-19: SOS-PAGE gel of the different reaction steps, before (3, 5, 7 and 9) and 
after dialysis (4, 6, 8 and 10), leading to the BSA-GDP conjugate. Lane 1: BioRad 
Precision Plus protein Standards; Lane 2: BSA 73; Lanes 3-4: BSA-glutaraldehyde 75; 
Lanes 5-7: BSA-glutaraldehyde reacted with adipic acid dihydrazide 77: Lanes 8-10: final 
reaction with neriodate-activated GOP 78 to form 79. 
IV-4-5-3 Coating of the plates with the BSA-GDP conjugate 79 and 
attempts to immobilise the fusion proteins 
The estimated quantity of produced conjugate 79 was determined to be 1.5 mg.mL' 
using the BCA protein quantification kit. The solution was diluted with PBS to 
obtain a final concentration of 20 j.tg.mL' and this solution was used to coat the 
wells of a microtiter plate ([V-3-14) (Palcic et al., 1990). After addition of 
HisSNAPAIg1ATM1p to the wells (IV-3-15), reaction with BG-fluorescein 37 and 
washing to remove the excess of reagent 37 (11-3-22), no fluorescence was detected 
by measurement of the BG-Fluorescein 37 emission spectrum using a fluorescence 
plate reader. Similarly, Hi5GFP-link-A1g1 ATM 1p was probably not immobilised 
(P1-3-I5) as no GFP fluorescence signal was detected after the final washing steps, 
irrespectively of the amount of fusion protein introduced in the well. The absence of 
fluorescence signals was possibly due to improper binding of GDP 31 to BSA 73 due 
to cross-linking reactions (Habeeb & Hiramoto, 1968), improper display of GDP 31 
on BSA 73 caused by conformational constraints introduced by the coupling reaction 
(Gan et al., 2004), destruction of the ribose ring or degradation of the protein during 
the incubation time. 
IV-4-5-4 Immobilisation of periodate-activated GDP 78 on agarose and 
comparison with GDP-hexanolamine sepharose 
To test whether binding of the GFP-fused mannosyltransferase to guanosine-5'-
diphosphate-2',3'-dialdehyde conjugated through its ribose ring was possible, 
periodate-activated GDP 78 was reacted with adipic acid dihydrazide 76 immobilised 
on agarose (IV-3-16) (Seela & Waldek, 1975). Such a column was successfully 
applied to the purification of a 32 kDa polypeptide from natural sources and elution 
was achieved by addition of 8 m1v1 of GDP 31 to the buffer (Ricquier et al., 1979). 
Similarly, an m7GDP-agarose resin was prepared for the purification of a eukaryotic 
initiation factor-4E (Edery et al., 1988). 
Periodate-activated GDP 78 was thus coupled to adipic acid dihyclrazide 76 agarose 
to generate a GDP-agarose matrix (IV-3-16). Comparative immobilisation was 
carried out with the commercially available GDP-hexanolaniine sepharose 
(Calbiochem) by loading the same sample on both columns and running the columns 
in parallel. The prepared GDP-agarose was found not to retain the HisGFP-link-
A1g1ATM1 protein while the GDP-hexanolamine sepharose (Calbiochem) 
successfully immobilised the enzyme as determined by GFP emission spectrum of 
the various fractions measured by a fluorescence plate reader (Figure 4-20). 
•fl •W1 .W2 •11113 •W4 •E1 '62 '63 .64 eES 
flax.... 612 511 406 491 406 506 BOB 107 508 BOB 
(fafim) 
Ft .W1 ,W2 .W3 .W4 •E1 .62 .62 .E4 .65 
"laX BOB 509 503• 495 492 401 BOB 496 491 494 
(is, on,) 
Figure 4-20: Immobilisation of Hi5GFP-link-AlgthTMlp on GDP-hexanolamine sepharose 
(left) and on prepared GDP-agarose (right) followed by measurement of the GFP 
emission spectrum at a fixed excitation wavelength of 395 nm. On the GDP-
hexanolamine sepharose, GFP fluorescence was measured in the flow-through and the 
first washing, then fluorescence was absent from the following washing steps and finally 
(3FP fluorescence was detected in the elution steps. When the prepared GDP-agarose 
column fractions were analysed by measurement of GFP fluorescence, only the flow-
through and the first washing were found to fluoresce. 
To rule out the possibility that the reaction between adipic acid dihydrazide 76 and 
guanosine-5'-diphosphate-2',3'-dialdehyde 78 did not work and was the reason for 
the lack of binding observed, a GDP-agarose column was purchased from Sigma, as 
this company was found to use the same coupling strategy to immobilise periodate-
activated GDP 78 on agarose adipic acid dihydrazide. Immobilisation on this matrix 
was compared to that on the GDP-hexanolamine sepharose but the result was 
identical to the one obtained above, i.e. only GDP-hexanolamine sepharose retained 
the fluorescent fusion protein (IV-3-1-1). 
In the synthesis of the GDP-hexanolaniine matrix, 31 was immobilised through its 
pyrophosphate, thus leaving the ribose ring unaltered. The integrity of the ribose ring 
is probably essential for the binding of the mannosyltransferase and this would 
explain the lack of binding observed when immobilised periodate-activated GDP 78 
was used. This hypothesis was supporthd by the fact that residues involved in 
binding the ribose ring have been identified in the solved crystal structures of 
glycosyltransferases (Ha et al., 2000). Additionally, purification of 
glycosyltransferases was carried out exclusively on nucleotide-hexanolamine agarose 
suggesting that the other way to prepare the matrix, although successful for other 
proteins is not suitable for glycosyltransferases (IV-4-1-2). Another drawback of the 
employed synthesis was the absence of control of the amount of GDP 31 displayed 
per mL bed volume and this parameter was found essential for the success of 
nucleotide-agarose columns. For example both a a-2,3-sialyltransferase and a ct-2,6-
sialyltransferase isolated from porcine submaxillary glands were found to have a 
rather low affinity for the adsorbent and a high ligand concentration (14 pimoles per 
mL of gel) was deemed crucial to the success of the purification (Sadler et al., 1979). 
IV-4-6 Development of the GDP-binding screening step 
Due to the lack of success of the BSA-GDP conjugate 79, the GDP-hexanolamine 
sepharose column (IV-4-1-3) was adapted to the 96-well format using an approach 
similar to the adaptation of Q-sepharose column to a 96-well plate formal for the 
study of a trans-sialidase (IV-3-1-2) (Schrader et al., 2003). The volume GDP-
hexanolamine sepharose (10 Rmoles per mL of gel) was lowered to 300 jiL and 
subsequently to 100 jtL and immobilisation was obtained according to the 
measurements of the GFP fluorescence signal, even when cells were lysed with the 
BugBuster Protein extraction reagent (IV-3-1-2). A 96-well plate filter plate was 
finally loaded with 100 jtL of GDP-hexanolamine sepharose and used as an 
additional screening step for the mutants (Figure 4-21). 
As the new screening step was being developed, the random mutagenesis on 
ALGIATM1 was repeated and a new library was generated by repeating the wpPCR, 
the Dpn I restriction digest and the transformation into XL1-Blue cells, in the same 
way as described for the first library generated (1V-4-4). The mutants were 
subsequently screened for improved fluorescence of the colonies when screened 
under UV light. The selected fluorescent colonies were grown in small volumes and 
then subject to the GDP-binding assay. 
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Figure 4-21: Schematic representation of the screening method. After transformation of 
the library in the expression strain, fluorescent colonies under UV light were selected, re-
streaked and cultured in 1.7 mL of LB medium, overnight, at 37 IC. After lysis of the cells 
with a protein extraction reagent and centrifugation, the supernatants were loaded onto 
100 jiL of GDP-hexanolamine sepharose. The columns were washed and the bound GFP-
labelled mannosyltransferase mutants were eluted using a salt gradient. The fluorescence 
of the different steps of the purification was followed by measurements of the GFP signal 
at a fixed excitation wavelength of 395 nm and emission wavelength of 507 nm. 
IV-4-7 Production of a new library 
IV-4-7-1 Random mutagenesis on ALG1ATMI 
The method for generating the library, including an epPCR followed by a wpPCR, a 
Dpn I restriction digest and a transformation into XL1-Blue cells, was identical to 
that described in (IV-4-4) as it had proved relatively successful for the production of 
a diverse library. However, the 3' end oligonucleotide primer, i.e. mutpET24a-
ALG lIRevI4 contained the ALGJATM 1 stop codon to ensure that no extra sequence 
would be added at the end of the AIg1ATM1p. The 5' end oligonucleotide primer, 
i.e. mutpET24a-ALG1/For/l was kept (IV-4-4-1) as it allowed for mutations to start 
at the first amino acid of the ALGItVFM I coding sequence present in the HisGFP-
link-ALGMTM1 gene fusion. The ALGJATMI gene was thus amplified from the 
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pET24a-HisGFP-link-ALGJ ATM 1 construct (11-4-6) under epPCR conditions (IV-3-
2), using the following oligonucleotide primers: 
mutpEl24a- 
Sense 	 5'-CAAAAGCGGTGGTGGTACA-3' 
ALG 1/For/i 
mutpET24a- 	 5'-CTCGAGTGCGGCCGTCA-3' 
Antisense 
ALGIIRev/4 	 Stop codon 
The band at 1.2 kb corresponding to the ALG1ATM1 gene was isolated on DNA 
agarose electrophoresis gel (111-3-I) (Figure 4-22), purified from this gel and used as 
a primer for the whole plasmid PCR (IV-3-3). 
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Figure 4-22: Analysis of the epPCR products of 5 identical reactions on a 1 % TAE 
agarose electrophoresis gel. Lane 1: New England Biolabs 1 kb DNA ladder. Lanes 2-6: 
PCR products obtained after the epPCRs. For all the reactions the 1.2 kb band 
corresponding to the ALG1LTM1 gene was the strongest. 
IV-4-7-2 Whole plasmid PCR, Dpn I restriction digest and transformation 
into XU-Blue cells 
3 parallel wpPCRs were run, using 10 p.L of 1.2 kb epPCR product each (IV-3-3). 
The reaction mixtures were submitted to PCR cycles that differ in the annealing 
temperatures: 50 °C, 55 °C or 60 °C. The wpPCR run with an annealing temperature 
of 50 °C gave a much higher quantity of DNA and the resulting wpPCR product was 
used in the following steps (Figure 4-23). 
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The wpPCR product was submitted to restriction digest with Dpn I and 1 p.L of Dpn 
I-treated wpPCR was transformed into 50 .tL of XL1-blue cells (IV-3-4 and IV-3-5). 
Of the 550 .tL transformation volume, a 150 pL aliquot was spread on selective LB 
agar and 517 colonies were obtained after overnight growth enabling to estimate the 
total number of colonies obtained from 50 .tL of XLI-blue cells to 1 895 colonies. 









Figure 4-23: Analysis of the wpPCR products produced by wpPCR with an annealing 
temperature of 50, 55 or 60 °C (Lanes 2-4) on a 1 % TAE agarose electrophoresis gel. 
Lane 1: New England Biolabs 1 kb DNA ladder. An annealing temperature of 50 °C 
clearly yielded more wpPCR product. 
IV-4-7-3 Estimation of the generated library 
To estimate the library, the DNA of 9 colonies was isolated and analysed by 
sequencing (P1-3-6). 4 out 9 clones were found to have the wild-type sequence over 
the analysed DNA fragment. 3 clones had 1 mutation and 2 clones had 2 mutations. 
The Dpn I restriction digest of the methylated template was obviously not complete 
and the wpPCR product was re-submitted to restriction digest with Dpn I (IV-3-4). A 
new transformation of 1 tL of the Dpn 1-treated wpPCR product into 50 jiL of XL!-
blue cells was carried out (IV-3-5). From the spreading of 150 pL of the 
transformation, 7 223 colonies were obtained after overnight growth at 37 °C, thus 
giving potentially 7 223 colonies per 50 pL of XL I-Blue cells. This time, of the 10 
isolated clones, only one was found to be the wild-type after sequencing (IV-3-6) 

































I I 456 2.2x10 3 2.7 1 2.7 
2 I 627 1.6x1c13 1.9 0 0 
3 1 622 1.6x10 3 2 1 2.0 
4 0 645 0 0 0 0 
5 3 589 5.1x10 3 6.3 3 6.3 
6 2 488 4.1x10 3 5.1 2 5.1 
7 2 498 4.0x10 3 4.2 2 4.2 
8 2 523 3.8x10 3 4.7 0 0 
9 1 514 1.9x10 3 2.4 0 0 
10 1 585 1.7x10 3 2.1 1 2.1 
3.2 2.1 
Table 4-24: Evaluation of the library by the analysis of 10 randomly selected clones. 
A mutation frequency of 386 was calculated. Transversions represented 28.5 % while 
transitions represented 71.5 % (Table 4-25). The bias due to the use of the Taq 
polymerase was observed but it was found not to be as high as in the first attempt and 
closer to the reported values (IV-4-4-3). 
The transformation efficiency was found to be much higher than that of the first 
library (P1-4-4-4) and 6 x I tiL of Dpn I-treated wpPCR product were transformed 
into 6 x 50 gL of XL1-blue cells (TV-3-5). For each transformation, a 150 iL aliquot 
of the transformation was spread on selective LB agar plate to evaluate the number 
of clones that was obtained for each transformation and the library size was 
estimated to be 42 940. 
Types of mutations 1 	2 3 
Bias indicator 
Ts/Tv 2.5 0.9 0.8 
AT-GC/GC--,AT 3.6 2.8 1.9 
Transitions (Ts) 
A-*G 42.9% 
57.1 % 33.3% 27.6% 
14.2% 
7.1% 
14.2% 11.9% 13.6% 
C-if 7.1 % 
Transversjons (Tv) 
A--if 7.1% 





14.2% 6.3% 7.3% 
14.2% 
0% 
0% 0% 1.4% 
C--)G 0% 
7.1% 





A--)N, T-*N 78% 75.4% 75.9% 
G-4N, C--iN 22% 19.8% 1 19.6% 
Table 4-25: Mutational spectrum of the second library (column 1). The library was 
compared with a library of galactose oxidase mutants prepared in the same fashion 
(column 2) and results reported in the literature (Shafikhani et al., 1997, column 3). 
IV-4-7-4 Screening of the library 
1 RL of the library was transformed into E. coli BL21(DE3) (P1-3-7) and the 
transformation volume was spread onto 5 membranes laid on top of selective agar 
plates, which displayed an estimated number of colonies of 3 600 each after 
overnight growth at 37 °C. The membranes were lifted and directly placed on top of 
LB agar supplemented with antibiotics and IPTO and cells were grown at 37 °C for 3 
h. The fluorescent colonies as detected by exposure to UV light were picked and re-
streaked on fresh LB agar plates supplemented with antibiotics, to eliminate false- 
10 
positives (IV-3-8). 22 colonies were selected from the plates, grown on a small scale 
and their protein contents were submitted to screening on 96-well filter plate loaded 
with 300 .tL of GDP-hexanolamine sepharose (IV-3-9). The bound mutants were 
eluted with 0.35 M NaCl and the brightest eluted fractions were immediately 
analysed by SDS-PAGE gel (11-3-13) and Western blot (11-3-14) (Figure 4-26). 
However, only degradation bands were observed implying that high degradation led 
to non-specific binding of the degradation products to the column and more thorough 
washing was required prior to elution. 
Ia 	1 2 3 4 5 6 7 8 9 




Figure 4-26: Western blot of the eluted fractions containing the different mutants isolated 
after screening on GDP microtiter plate. Lane 1: BioRad Precision Plus protein 
Standards. Lanes 2-9: eluted fraction of different mutants. For most mutants, a band 
between 37 and 50 kDa was observed, corresponding to a degradation product. 
The conditions necessary for the removal of the non-specific binding were studied by 
passing through either 300 j.tL or 100 RL of GDP-hexanolamine sepharose the cell 
extract of a 10 mL culture of E. co/i BL21(DE3) harbouring pET 16b-GFP in a way 
similar to that described in IV-3-1-2. The 100 tL of GDP-hexanolamine sepharose 
needed to be washed with a minimum of 3 mL of GDP-column buffer A followed by 
3 ml of GDP-column buffer A supplemented with 70 mM NaCl. 
A new screening of 94 colonies was carried out with these optimised conditions (IV-
3-9). 14 colonies were identified which gave a variation of fluorescence possibly 
corresponding to immobilisation followed by elution of the fusion protein. The DNA 
of these colonies was isolated and re-transformed into E. co/i BL2I(DE3) (IV-3-10) 
and the protein content of the cells was analysed by SDS-PAGE gel (11-3-13) and 
Western blot (11-3-14). 7 out of the 14 whole protein cell contents analysed gave a 
band corresponding to the full-length enzyme (77.7 kDa), namely 1H1, 1F3, 1A4, 
1D5, 1E6, 1F6 and 1B8 and further studies were concentrated on these mutants 
(Figure 4-27). 
Figure 4-27: Western blot of the whole cell content of E. co/i BL21(DE3) cells producing 
the different mutants: 1H1, 1E3, 1F3, 1A4, 1D4, 105, 1D5, 106, 1D6, 1E6, 1F6, 1A7, 1B8 
and 1 E8 (lanes 2 to 15). Lane 1: BioRad Precision Plus protein Standards. 
IV-4-8 Further characterisation of the mutants 
Cells transformed with the different mutated plasniids 1H1, 1F3, 1A4, 1D5, 1E6, 1F6 
and 1B8, were grown in parallel to cells transformed with the wild-type construct 
(IV-3-10) and the expression levels of the corresponding genes were compared by 
analysis of the whole cell protein content on SDS-PAGE gel (11-3-13) (Figure 4-28). 
Figure 4-28: SDS-PAGE gel of E. co/i BL21 (DE3) cells harbouring different mutants. Lane 1: 
BioRad Precision Plus protein Standards; Lane 2: wild-type construct; Lanes 3-9: 1 Hi, 1 F3, 
1A4, 1D5, 1E6, iF6and 1B8. 
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The amount of proteins present in cell pellets of the same size was quantified using 
the BCA reaction kit and the GFP fluorescence level of the soluble factions were also 
measured using the fluorescence plate reader (Table 4-29). All mutants were found to 
display higher GFP fluorescence level than the wild-type (Table 4-29). 
WT 11-11 1F3 1A4 1D5 lEG 1F6 1138 
Protein 
concentration 356 323 516 601 386 791 641 663 
(ig.mL 1 ) 
C EP 
fluorescence 300 440 1 520 715 695 310 545 305 
(RFU) 
Yield PPGn 2 21 
10 16 17 11 
17 12 1 13 
Specific 
0.291 
activity 0.159 0.152 0.145 0.142 
(mU.mg) 
0.237 0.074 0.008 0.099 
Number of bp 
0 1 6 5 5 9 3 1 
mutations 
Table 4-29: Comparison of the different mutants obtained after screening of the second 
library. The protein content of a 1 mL bacterial cell pellet was determined using the BCA 
protein assay. The GFP fluorescence of the soluble fraction of a 1 mL cell pellet was 
recorded at a fixed excitation wavelength of 395 nm. The mannosyltransferase assay was 
carried out in two batches (first series second series in bold) and the yield of formed 
PPGn 2  and the specific activity were calculated in each case. 
Moreover, the protein content of the 1 nil, cell pellets was higher than that of the 
wild-type, with the exception of 1H1, suggesting that overall protein production had 
been higher for the mutants (Table 4-29). However, none of the mutants were more 
active than the wild-type when a mannosyltransferase assay was carried out (Table 4-
29). Also, some mutants gave a strong degradation band in addition to the band for 
the full-length protein. This could explain the higher fluorescence observed despite 
the lower transferase activity compared to the wild-type. 
ii 
When the mutants were sequenced, they were found to contain mixtures of different 
clones. This was unexpected as colonies selected from the first screening step were 
re-streaked on fresh LB agar plates supplemented with antibiotics prior to the second 
screening step (IV-3-8). The presence of mixtures was probably due to the picking of 
more than one colony at a time from the LB agar plate. As the selection of colonies 
was carried out under UV lamp, non-fluorescent colonies were not visualised and it 
is therefore hypothesised that neighbouring non-fluorescent colonies were picked 
together with the fluorescent colonies. Further experiments were carried out with a 
much lower density of colonies per plate to circumvent this problem. 
Due to the presence of mixtures, it was decided to re-transform the different mixtures 
and to re-screen the obtained individual colonies using the assay developed (IV-3-9) 
(Scheme 4-21). Therefore, the DNA plasmids isolated from the colonies harbouring 
the most promising mutants, i.e. 1F3, 1A4, 1E6 and 1B8, were transformed into E. 
coli BL21(DE3). 6 fluorescent colonies from each transformation were grown and 
the produced proteins were submitted to the GDP-binding screening step (Scheme 4-
21). The different steps were followed by measuring the GFP fluorescence signal 
using the fluorescence plate reader (11-3-18). The variations of the GFP fluorescence 
signal during GDP-immobilisation was found to be promising as some fluorescent 
proteins were detected as being washed away from the columns while others seemed 
to be retained by the column, as the washing fraction was found not to contain 
fluorescent material while the elution fraction displayed fluorescence. However, 
analysis by SDS-PAGE (11-3-13) revealed strong degradation bands in the protein 
contents of the brightest fractions, leading to the conclusion that the removal of the 
degradation material proved difficult and highly variable from one well to the other. 
The mutants that corresponded to the full-length protein, i.e. lA4-1, 1A4-4, 1E6-2 
and 1E6-5 were assayed for transfer of mannose from radiolabelled GDP-Man 8 to 
PPQn2  29a. Two of the mutants, i.e. 1E6-2 and 1E6-5, were found to be active, with 
a yield of formation of PPGn2 29a of 11.2 % and 5 % respectively, although less than 
the wild-type that gave a yield of formation of PPGn2 29a of 25.3 %. The two other 
mutants, 1A4-1 and 1A4-4 were non-active with a yield of formation of PPGn2 29a 
of 0.9 % and 0.7 %, respectively. 
El 
Upon sequencing, both lE6-2 and lE6-5 mutants were found to be identical and to 
contain the following amino acid substitutions: L96S, A244T, F297S, Y326F and 
F335L (Appendix 3) (11-4-6). The non-active mutants, 1A4-1 and 1A44, were found 
to contain the following amino acid substitutions: D226V, F308Y, S375A, Y384F 
and R404G (Appendix 3). 
The assay for mannosyltransferase activity was carried out again and this time the 
1E6-2 mutant was found to be more active than the wild-type with a yield of 
formation of PPGn 2 29a of 13.9 % compared to 7 % for the wild-type. The 1A4-1 
mutant inactivity was confirmed as it gave a yield of 0.8 % for the formation of 
PPGn 2 29a. To obtain more comparable results the DNA from both the wild-type and 
the promising mutant were isolated and new E. co/i BL21(DE3) cells were 
transformed (IV-3-10). Parallel growth of 6 colonies was carried out and the whole 
cell contents were analysed (Figure 4-30). 
Figure 4-30: Analysis of the whole cell content from parallel cultures of five colonies of E. 
co/i BL21 (DE3) cells harbouring either the WT plasmid or the mutated 1 A4-1 or 1 E6-2 
plasmids. Lane 1: BioRad Precision Plus protein Standards. Lanes 2 a to e: WT. Lanes 3 
a toe: 1A4-1. Lanes 4 a toe: 1E6-2. 
3 of the cultures were also assayed for mannosyl-transfer. The transfer of radioactive 
mannose from GDP-Man 8 to PPGn 2 29a of the wild-type was found to be highly 
variable from one batch to the other as the radioactivity of the organic phase varied 
between 401 dpni and 165 dpm (Figure 4-3 1). 
The 1E6 -2 mutant showed very little activity, with a radioactivity level of the 
organic phase between 56 dpm, that is equivalent to the background (58 dpm) and 
144 dpm, which is not far from the lowest value detected for the wild-type, i.e. 165 
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background, that is a measured level of radioactivity of 56 dpm compared to 55 dpm 
for the background, at the end of the reaction. 
Figure 4-31: Mannosyl-transfer catalysed by H1sGFP-link-AIg1ATM1 p mutants from E. 
co/i BL21(DE3) cell extracts harbouring either the wild-type construct (1-4) or the best 
mutant, 1E6-2 (5-8). The radioactivity levels of the organic and aqueous phases after 
mannosyltransferase reaction with radiolabelled GOP-Man 8 in the presence of PPGn 2 
29a (1-3 & 5-7) or without (4 & 8) were measured. 
IV-4-9 Conclusion 
The possibility of immobilisation of the fluorescently labelled 131,4-
mannosyltransferase on GDP-hexanolamine sepharose was demonstrated. However, 
only a small quantity of fusion protein could be immobilised probably owing to the 
small quantities of soluble full-length fusion protein that could be produced. The 
GFP-folding reporter assay was thus tried to improve the stability of the GFP-
labelled mannosyltransferase but the whole cell fluorescence screening assay was 
found unable to isolate mutants of interest, as only variants that were more easily 
degraded were isolated. An additional screening step was therefore added to select 
mutants that retained the ability to bind to GDP 31. Initially, attempts were made to 
immobilise the GFP-mannosyltransferase fusion on immobilised periodate-oxidised 
GDP 78. However, this derivative of GDP was found not to retain the enzyme. It was 
then decided to use a filter plate loaded with GDP-hexanolamine sepharose, which 
had proved efficient in retaining the chimeric protein. A new library of mutants was 
generated and screened in a hierarchical method: firstly, folded proteins were 
identified by the good fluorescence level of the colonies in which they were 
produced. Secondly, fluorescent mutants binding to GDP 31 were isolated. However, 
the low stability of the fusion proteins made it difficult to isolate mutants displaying 
higher robustness as results seemed to vary quite significantly from one culture of 
cells harbouring the same construct to the next. In conclusion, none of the mutants 
showed substantially higher production level than the wild-type or transferase 
activity and they did not display much higher fluorescence. Attempts were however 
made to explain the influence of the mutations based on the structural prediction for 
Algip. 
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V Structural predictions for the S. cerevisiae '3-1,4-mannosyltransterase 
Following previous work (Davies, 2004), in which a prediction of the secondary 
structure of Algip was determined by homology search using FFAS 
(http://ffas.ljcrf.edulffas-cgi/cgilffas.pl)  with the aid of Biolnfo Meta server 
(http://bioinfo.pllMeta/),  a model of A1g1ATM1p was constructed based on the best 
hit, i.e. 1FOK. The 1FOK structure corresponds to domain A of E. coli MurG, an N-
acetyiglucosaminyltransferase that catalyses the transfer of N-acetylglucosamine 
from UDP-G1cNAc to N-acetyl muramyl pentapeptide 80, which has been solved 
(Ha et al., 2000; Hu et al., 2003) (Figure 5-1). 
cell wall 
cytoplasm 	 ) ( MurG 
'o UDP-GIcNAc 	UDP '0 
L-Ala 
'y-O-Glu 
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Figure 5-1: Reaction catalysed by E. cob MurG. Reproduced from Ha et al, 2000. 
To build the model, the two sequences of the glycosyltransferases were aligned using 
CLUSTALW (http://www.ebi.ac.ukJclutsalw ) (Figure 5-2). The alignment was then 
submitted to the alignment interface of the http://swissmodel.expasy.org//  website 
along with the PDB file 1FOK-A and a model was produced. Further modelling was 
carried out by Dr. Kevin Bailey at the University of Manchester. 
[:1 
CLUSTAL M (1.82) multiple sequence alignment 
snP16661 IALG1_YEAST TMB. .LFYGNKSTKKRIIIE'V:GDVGHSPRIC"I 60 
IfOkA 	 MMSGQG --- KRLYvMP 	HVFPGLAVAI-I 28 
* 
sn IPI 6661 AG 	YEAS: SFSKLGWQVECGYVEDTLPKIISSDPNITVHHMSNIKRKGGGTSVIFMVKKVLFQVLSI 120 
If 0k_A 11LMAQGWQVRWLGTADRMEADLVPKHG-IEIDFIRISGLRGALAP•I 	87 
SpIP16661IALG1_YEAST [KLLWELRGSDYZLVQNPPSIPILPIAVL1KLTGCK:::DWHNLAYSTLQLKFKGNY..P 180 
0k_A AAIMKAYKPDVVL ------ -----i-VSGPGGLAAS-LGTPVVLG----- 129 
spFP16661 ALG1_YEAST LVLISYMVEMIFSKF -ADYNLTVTEANPKYLIQSE'•-NPKRCAVLYI_RPASQE'QPLAGDIS 240 
if 0k_A --- IAGLTN ---- KWLIIATKVMQAF'EGAFPNAEVVGNPITDVLAL_PLPQOR_LAGREG 182 
splP16661 	ALG1_YEASI' RQKILT:KAFIKIYIRDD [. JTEKGDKIIVTSTSFTPDFD_GTLLGALK I YENSYVKUSS 300 
if 0k_A PVRVLVVQGARILNQTMPQVAAKLGDSVTIWHQSG ----- KGSQQSVEQAYAEAGQP 237 
sp I P 16661 IALG1_YEAST LPEILC ITGKGPLKEKYMKQVEEUWKRCQ:EIVWLSAEDYPKLLQLCDYGVSLHTSSS 360 
if 0k_A QHKVT 	D---1AAAY-AWADVVVCRSGALVSEIAAAGLPALFVPFQH---------284 
sp1P1666i IALG1_YEAST GLDLPNKILDMEGGLPVTAMNPVLDELVQFNVNJGLKVDELHESLIFAMKDADLYQ 420 
if 0k_A KDRQQYWMALPLEKAGAAKIIEQPQLSVDAVANTLAGWSRETLLT ------ MAE 332 
spIP666l IALG1_YEAST KLKKNVTQEAENRWQSNWERTMLKLI5--.- 449 
ifOkA RARAASIPDATERVANEVSRVARALEHEU-U-IHH 364 
WF' re ure 5-2: ClustaIW alignment of the truncated Algip and E co/i MurG. The numbering of the Algip sequence corresponds to the full-length Algip. G loops; : invariant loop in GT-B superfamily; GAL: AA located in the a/131a  motif; U: residues involved in UDP binding; U: hydrophobic 
atch surrounded by basic residues proposed to be involved in the membrane association of MurG; I: mutations found in the active mutant, 1 E6-2; 
mutations found in the inactive mutant, 1A4; I: mutations found in the pET16b-GFPALG1TM1 construct. 
Figure 5-3: Crude model structure of Alg1TM1p based on the E. co/i MurG structure 
obtained with sw!ssmode!. The general mode!!ed strictIre of A1g1ATM1p ws 
represented as a ribbon diagram, the green domains corresponding to regions that could 
be modelled from the 1 FOK-A structure and the red regions to domains that could not be 
modelled due to low homology. 
The first observation was that, despite the low similarities in the sequence (15 % 
identity and 30 % similarity), the model retained the overall structure and in 
particular the two aJ[3/a motifs separated by a deep cleft. This structure of parallel 13 
sheets connected by a helices is referred to as the Rossmann fold and is characteristic 
of dinucleotide binding proteins (Mulichak et al., 2001). The presence of two 
Rossmann folds connected by a deep cleft is typical of the glycosyltransferase B 
superfamily, to which E. coli MurG belongs (1-4-4). 
Closer analysis of the MurG structure and the AIgIATMIp model enabled the 
proposal of some hypotheses concerning the functions of certain regions of 
A1g1ATM1p. It has to be clear that all of the interpretations made below are purely 
speculative and were made on a model, not a solved crystal structure of the enzyme 
and therefore can only he trusted as far as the model can be trusted. 
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In order to clarify the hypotheses, structural elements of E. co/i MurG were taken 
one by one, following the amino acid sequence, and their presence or absence in the 
AIg1ATMIp model was interpreted. 
V-i G loop I (GGTGGH) 
The first G loop of the N domain of E. co/i MurG has been shown to be structurally 
well conserved and proposed to bind the phosphate groups of the acceptor substrate, 
lipid 180 (Ha et aL, 2000; Hu et al., 2003). In the model, the aligned residues of 
Aigip, i.e. residues 46 to 50, i.e. LGDVG, were also modelled into a loop (Figure 5-
4). It was therefore hypothesised that this loop could play an identical role in binding 
the phosphate groups of the Do]-PP-GlcNAc 2 7a. 
, 
 
Figure 5-4: Model of the G loop -1 in the predicted Algip structure. The Algip residues 
modelled as a loop are represented. The model structure, i.e. the E. coil MurG structure, 
is represented in green and the important residues, i.e. GGTGG, have been indicated. 
Model realised by Doctor Kevin Bailey. 
V-2 Hydrophobic patch 
The sequence of E. co/i MurG then presents a hydrophobic patch consisting of 
residues 175, L79, F82, W85 and WI 16, surrounded by basic residues: K72, K140, 
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K69, R80, R86 and R89. This patch has been proposed to associate with the 
membrane. Similar patches have been found in the Algip sequence, between 
residues 105 and 121 and residues 143 and 159 (Davies, 2004). From the alignment 
(Figure 5-2), the core of the hydrophobic patch of E. cciii MurG, from residue 72 to 
89, was found to align well with the first hydrophobic patch of Algip, from residue 
105 to 121. It was therefore hypothesised that the two hydrophobic patches of Algip 
might interact with the membrane in a way similar to the hydrophobic patch of E. 
cciii MurO. 
V-3 G loop 2 (GMGG) 
The second G loop of the N domain (GMGG) was also found to be a structurally 
conserved element and it was proposed to be involved in binding the phosphates of 
lipid 180 (Hu et al., 2003). A similar loop could not be produced in the AIg1ATM1p 
model suggesting that this structural element is not present in A1g1ATM1p. 
However, from the alignment (Figure 5-2), it was observed that the G loop was in 
front of a non-aligned region corresponding  to the second hydrophobic patch of - - - 
Alglp, i.e. residues 143 to 159. It could also be observed that this sequence of Alglp 
is proline-rich and proline-rich sequences are motifs often found in GT-B 
superfamily members (Hu et al., 2003). However, due to the lack of modelling of 
this region the structural importance of this sequence could not be evaluated. 
V-4 HEQN loop 
The HEQN loop of E. coli MurG was found to be invariant among MurG 
homologues (Ha et at., 2000). The loop, located between N5 and NctS, has been 
proposed to be the acceptor substrate 80 binding site. 
Additionally, by comparison with the solved crystal structure of another member of 
the glycosyltransferase B superfamily, namely UDP-glycosyltransferase GtfB 
(Mulichak et at., 2001) and other glycosyltransferases, this loop was found to be 
located at a position similar to the variable loops of these other glycosyltransferases 
(Hu et at., 2003). It was interpreted that this loop varies in length and composition 
between the different glycosyltransferases in order to accommodate the various 
structures of acceptor substrates for these enzymes (Hu et al., 2003). 
On this basis, it was considered not surprising that modelling of this region had failed 
and this fact could be interpreted as reflecting the difference of structures between 
the acceptor substrates of Algip and E. coli MurU. To further support the hypothesis 
that a loop with similar function is present in Alglp at a similar position, the 
alignment of Algip and its two homologues from H. sapiens and A. thaliana (Figure 
5-5), showed that this sequence is well-conserved between the three homologues and 
notably the DWHN sequence (residues 161 to 164 of the S. cerevisiae Algl.p 
sequence). 
V-5 Linker region between the N- and C-domain 
The linker region between the N- and C-domain of the structure of E. coli MurO, 
corresponding to residues 171 to 178 in this sequence, was found to be highly 
variable even among homologues of the same enzyme (Ha et al., 2000). It could 
therefore be expected that modelling of this region would fail as actually observed. 
V-6 G Ioop3 (GGS) 
The G loop of the C domain of E. coli MurO, OGS, was found to play a role in the 
conformational adjustment required for the binding of the acceptor substrate 80 and 
to interact directly with UDP-GlcNAc. Despite the modelling of this region, the 
sequence of Algip does not present any glycine-rich or proline-rich sequences in this 
region, the constituents of the sequence motif found in most of the GT-B 
superfamily. 
A. thaliana -MG--KRGR 	 - ACVVVt 	 4QYHAL 26 
H. sapiens  ---- MAASCLVLLALCLLI PLLTLGGWKRWRRGR- -AARHVVAVVI 4QYHAL 54 
S. cerevisjae MFLEIPRWLLALIILYLSIPLWYYVIPYLFYGNKSTKKRIIIFVT 	ICYHAI 60 
A. thaliana SLARQASFQVDIVAYGGSIPFIEAVLNHPSTHTF1T IQYYPKILYPVTLLLKAEIQ 
H. Sapiens SLANHG-FSVTLLGFCNSKPHDELLQNNRIQIVGLT -. QSLAVGPRV1Q-YG--VVVLQ 
S. cerevisiae SFSKLG-WQVELCGYVEDTLPKIISSDPNITVHHMS KRKGGGTSVIFFIVKKVLFQVLS 119 
:. 	 ... . .... * 	: 	:  :C 
A. thai i ana FTr4LLWFLFV}cVPAPJ) IFLVQNPPSVPTL LAVKWASSWRRAAFVVDNTHNFGYTLLALSLG 
H. sapiens Ar*IYLLWKLMWREPGAYIFLQ_NPPGLPSIAVCWFVGCLCGLLVIDWFJNYGYSIMGLVHG 
S. cerevisjae IFKLLxELRGSD --- YILVQ -NPPSTPILPIAVLY-KLTGCKLIrDWHNLAYSILQLKFK 175 
A. thaijana RN--NLLVSLYRWSENHYGKMJTGSLCVTKN.'QHF,DQ ---- NWGVpAKVL 	PPEFFRP 
H. sapiens PN-- UPLVLLAKWYEKFI?GRLSHLNLCVTNAMRED[,AD---I'JWH I RAVTV PASFFKE 
S. cerevisiae GNFYRPLVLISYMVEM1FSKFADYNLTVTEMRKYLrQSFHLNPKRCAVL ASQFQP 235 
A. thaliana ALLEERHELF'CRvRKDLCHP IGVYDFIS ENQELNETLFTTKFNADI LK---QNRPA 
H. sapi ens TPLDLQHRLFMIILGSMHS-p ----- SPA PEDPVTEIAFTERDAGS LVTRLRERPA 
S. cerevisiae ------------  LAGDIS -------- RQK LTTKAFIKNYTRDDFDTE; 	UK-------- 267 
A.t:haiiana S TN N 	I 	MYDRRVA. SKGSETAEISEEQHHYP 	I 	PS 
H.sapi ens 5 	II I EKITEQI,TL1) HNLPS PS 
Kill' s S. cerevis.iae 
------------- 
* 
	P 	I 	KTYENSYVK- ------------ SSLP 	
* 	
PS 
­ :..- 	 ~
::. 
315 
A.thaliana KEMYKEKIKI NfRRVAF IAAEDYPLLLGSADLGVC 	.SSSGI 
H.sapiens REYYSRLIII HFQIIIOVC PWIEI\EDYPLLLGSADLGVC 	SSSGL M 
 T  S.cerevjsiae KEKYMKQVEF DWKRCQ1E W]SJ\EDYPKLLQLCDYGVSL 	SSSGI F 
.**** 
375 





rd 	LVTrd-IEENGLVFEI)S 	II 	L-SS3NrPA5iTiT55L55 
VLDELVQHNVNGLKFVD 	LEE5LIFAMK----DJ\DTYQh'JKKNVTOE- 430 
A. thaliana SSGRWATEI4EDCAkcPLITQVVSQIApS 
H. sapiens QQLRWDFISKVQTVLPLVMDT -------  
S. cerevj.sjae 	APNRWQSNHERTMIH)I.KTIF{ ------- 449 
Figure 5-5: CLUSTALW Alignment of A. thaliana, H. sapiens and S. cerevisiae -1,4-
mannosyltransferases. 
Important domains/residues: 
1MB: trans-membrane domain 
PDRS: potential dolichol recognition sequence of S. cerevisiae Algl p. 
Hydrophobic N-terminal domain essential for functional expression 
iiwshi et at., 2000). 
residues also showing similarities with residues of the Glycosyl Transferase 1 
famaily whenalignment of this family was carried out (Davies, 2004). 
motif: motif conserved among glycosyltransferases. 
residues found essential for catalytic activity as their replacement by K, D or 0, 
respectively, yielded an inactive mutant (Gao et al., 2004). 
W: mutated to a stop codon in the algi-1 mutant, growth sensitive mutant identified at the 
beginning of work on ALG1. The absence of this C-terminal 16 AA was shown to be 
detrimental to Algi p-Algl p homo-oligomerisation in vivo (Gao et al., 2004). 
I: mutations S150R and S258L of the human ALG1 found to be responsible for a loss of 
activity leading to CDG type 1k (Grubenmann et al., 2004). 
Found mutations: 
K: wild type mutation Fl 15C. 
WERT: 1 E6-4 mutations: L96S, A244T, F297S, Y326F and F335L. 
WERT: 1A4-1 mutations: D226V, F308Y, S375A, Y384F and R404G. 
- - 	 - 	
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V-7 F244 
The residue F244 together with 1245 and R164 are involved in binding the base of 
the UDP-GIcNAc donor substrate (Hu et al., 2003). The F244 residue has been found 
to stack over the uracil ring and also similar aromatic residues have been identified in 
approximately the same position as F244 in other glycosyltransferases, suggesting 
that this capping mechanism is conserved among glycosyltransferases (Hu et al., 
2003). It was therefore interesting to realise that the Algip possessed this group at 
the same position, P308 (Figure 5-2). The following region, residues 310 to 321 of 
the Algip sequence, was not modelled and it could be hypothesised that it might 
correspond to residues involved in the binding of the larger GDP-Man 8. 
V-8 End of C-domain 
In the putative C-domain of Algip, the Algip amino acids sequence presents a large 
conserved region, from residue 336 to residue 379, containing a histidine residue, 
11356 that has been shown to be essential for catalysis as its replacement with a 
glutamine residue has been shown to abolish catalytic activity (Gao et al., 2004). 
Histidine residues are thought to be important for catalysis of glycosyltransferases in 
general (Breton & Imberty, 1999). The region also contains a DX61) motif (363-370). 
The shorter DXD motif is considered to be involved in the coordination of a divalent 
cation in the binding of the NDP-sugar 25a (Breton & Imberty, 1999). However, the 
replacement of the two aspartates by alanine was found to have no effect on catalysis 
suggesting that the DX61) motif is not essential for the mannosyltransferase activity 
and does not act in a similar way as the DXD motif (Gao et al., 2004). The H356, the 
DX61) motif and the surrounding sequence were however not modelled as E. cob 
MurG does not possess similar elements. However, similar 0-S sequences regions 
have been identified in the C-domain of GtfB and T4 phage -GT (Mulichak et al., 
2001) and in the T4 phage f3-GT complex. One of the serine residue was found to 
form a hydrogen bound with the pyrophosphate of UDP and this residue was located 
in a flexible loop that became ordered upon substrate binding. Finally, the 16 C- 
terminal end residues of Algip have been shown to be important for homo-
oligomerisation of S. cerevisiae Algip in vivo and the structural organisation of this 
region is therefore likely to be specific to this enzyme. 
V-9 Interpretation of the obtained mutations 
V-9-1 Mutations of the pET1 6b construct 
When the pET16b-GFPALG1ATM1 construct was made it was found to contain the 
following mutations within the Algip sequence: H216Y, N254D and D444G. These 
mutations were found not to be detrimental to the activity as the GFPA1g1ATM1p 
was found to be active (11-4-4-2). The mutations were located in regions that were 
not proposed to be involved in substrate binding in the above study. This mutant 
therefore supports the idea that the structure of proteins with one or a few mutations 
is generally very close to that of the wild-type and likely to retain activity (Pédelacq 
et al., 2002). 
V-9-2 Mutations of the 1 E64 mutant 
The 1E64 mutant, which contains the following amino acid substitutions: L96S, 
A244T, F297S, Y326F and F335L, was found to retain activity, although to a much 
lower level than the wild-type. This mutant was modelled in a similar way as the 
wild-type, i.e. the mutated sequence was aligned with that of E. coli MurG using 
CLUSTAL and the alignment was submitted to the alignment interface of the 
http://swissmodel.expasy.org//  website along with the PDB file 1FOK-A. Further 
modelling was carried out by Dr. Kevin Bailey at the University of Manchester. In 
the model (Figure 5-6), the mutations were all found to be distant from the substrate 
binding site and did not appear to be located in positions that would explain the 
reduced activity compared to the wild-type. 
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Figure 5-6: Model structure for the active mutant 1E6-4. The mutations are shown in 
purple, from left to right, 297S, 244T, 325F, 334L and 98S. The model structure, i.e. E. 
co/i MurG, structure is shown in green. 
V-9-3 Mutations of the 1 A4-1 mutant 
The 1A4-1 mutant contains the following amino acid substitutions: D226V, F308Y, 
S375A, Y384F and R404G and was found to be inactive despite the fact that it had 
bound GDP 31. 
From the alignment (Figure 5-5), the D226 corresponds to a residue found in a 
conserved region of the Algip homologues. The second mutation F308Y 
corresponds to the F214 of the E. co/i MurG sequence and it was proposed to play a 
similar role in the base stacking mechanism. Its replacement by another aromatic 
residue would not be expected to affect catalysis as it has been reported that other 
glycosyltransferases have different aromatic residues at this position (Hu et al., 
2003). The following mutation S375A was found in the highly conserved region of 
Alglp that also contains the DX6D motif, the G-S sequence and the catalytically 
important residue, i.e. H356. The Y384F and R404G mutations were not identified as 
being part of a conserved region. 
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The mutated sequence was subsequently aligned to that of E. co/i MurG using 
CLUSTALW and the alignment was submitted to the alignment interface of the 
http://swissmodel.expasy.org//  website along with the PDB file 1FOK-A. Further 
modelling was carried out by Dr. Kevin Bailey at the University of Manchester. 





Figure 5-7: Model structure for the active mutant 1A4-1. The mutations are shown in 
purple, from left to right: 403G, 307Y, 383F, 226V and 374A. The model structure, i.e. E. 
co/iMurG structure, is shown in green. 
Mutations were found in regions far from the binding site of the substrate and the 
cleft and it was considered impossible to interpret the loss of activity observed for 
the 1A4-1 mutant. 
In conclusion, the model of Algip based on the E. coli MurG structure as well as 
alignments with Algip homologues have enabled some speculations concerning 
regions of the S. cerevisiae -1,-4-man nosy] transferase that might he important to the 
functioning of the enzyme. The modelling study has however failed to explain the 
activities of the two mutants, 1E6-4 and I A4-1, obtained after screening using the 
GFP-folding reporter assay followed by the GDP-binding assay (Figure 4-21). 
- 	 - 	228 
VI General discussion 
VI-1 Summary of the findings of the project 
The aims of the project have been to study the possibility of introducing a fluorescent 
label on the yeast 0-1,4-mannosyltransferase and applying this fusion enzyme to the 
development of a binding assay for the isolation of 13-1,4-mannosyltransferase 
fusions of improved stability. 
Chapter 2 described the production of N-terminal GFP fusion and SNAP tag fusions 
to 13-1 ,4-mannosyltransferase, as fluorescent, catalytically active fusion proteins. A 
number of different fusions have been made to identify the fusion that retained the 
highest activity and this fusion was subsequently applied in a directed evolution 
approach to try and improve its stability 
In chapter 3, the S. cerevisiae 13-1,4-mannosyltransferase was produced in the Pichia 
pasroris expression system as an active catalyst. The cloning of putative 13-1,4-
mannosyltransferase genes enabled the production of the f3-1,4-mannosyltransferase 
from Arabidopsis thaliana as a bioactive enzyme when produced from the pET 
expression system. 
In chapter 4, the immobilisation of both the N-terminally GFP or SNAP tag labelled 
13-1,4-mannosyltransferase on GDP-hexanolamine-sepharose matrix was monitored 
by measurements of the fluorescent signal of the label, setting the ground for the 
development of an affinity binding assay for 13-1,4-mannosyltransferase mutants. 
Additionally, the possibility to evolve the fluorescently labelled 13-1,4-
mannosyltransferase was evaluated by generating a library by random mutagenesis. 
The mutants were screened using the GFP-folding reporter assay (Waldo et al., 
1999) followed by the GDP-binding assay. The method has so far failed to yield OFF 
labelled -I ,4-mannosyltransferase mutants of real significance, owing to the low 
stability of both the wild-type and the obtained mutants. 
Finally, using a model of the S. cerevisiae 3-1,4-mannosyltransferase structure based 
on the structure of E. coli MurO and a series of alignments, some speculations have 
been made regarding the amino acids of the Algip sequence that might be important 
for substrates binding and catalysis. 
VI-2 Future directions 
Chemo-enzymatic approaches have found applications in the synthesis of complex 
oligosaccharides of defined structure. Recombinant glycosyltransferase as well as 
one pot strategies for sequential monosaccharide additions and nucleotide-sugar 
regeneration have been essential to this development (Koeller & Wong, 2000; Shao 
et al., 2003). Future directions could aim at diversifying the applicability of chemo-
enzymatic syntheses by altering the substrate specificities of carbohydrate-active 
enzymes to widen the scope of catalysed reactions (Thorson et al., 2004). 
The use of engineered glycosidases for the biocatalytic synthesis of oligosaccharides 
of specific composition has become a reality, notably with the rational design of 
glycosynthases (Kim et al., 2004). With the solving of more and more 
glycosyltransferases crystal structures and the accumulation of structural studies on 
glycosyltransferases, insights into how the glycosyltransferases specificities can be 
modulated are arising, paving the way for the rational design of this class of enzymes 
(Mulichak et al., 2001). In parallel, directed evolution of glycosyltransferases bear 
the potential to isolate new biocatalysts by selection of mutants displaying novel 
properties without prior knowledge of the structure and of the sites influencing the 
activity of the enzyme. 
The work in this thesis lays the ground for the development of a GDP binding assay 
for fluorescently labelled 3-1,4-mannosyltransferase for the future isolation of f3-1,4- 
mannosyltransferase mutants displaying activity towards protein-linked substrates. A 
N-terminal GFP fusion to the -1 ,4-mannosyltransferase was produced and 
immobilised on GDP-hexanolan -i.jne matrix. From this result, a GDP binding assay 
for fluorescently labelled I-1 ,4-mannosyltransferase was developed and applied to 
the selection of mutants generated by random mutagenesis. The method failed to 
isolate a mutant displaying improved stability pointing to the need to screen a larger 
number of mutants and to include further improvements in the screening procedure. 
Limiting the random mutagenesis to regions of the enzyme more likely to be 
involved in the acceptor-substrate binding or part of the active site would be of 
interest, especially when the screening of mutants for activity towards protein-linked 
substrates will be considered. For this reason, some speculations were made 
regarding the amino acid regions of Alglp that might be important in this enzyme's 
function and these represent ideal targets for evolution studies. 
Direct synthesis of the oligosaccharide chains on proteins will greatly facilitate 
access to glycoproteins bearing N-linked glycans by eliminating the need to 
synthesise lipid-linked intermediates and the need to subsequently transfer the sugar 
ChaIIiS to proteins. This not only requires the evolution of the 13-1,4-
mannosyltransferase towards new activity but also the cloning of the subsequent 
mannosyltransferases of the N-glycan biosynthetic pathway. 
More generally, the synthesis of oligoaccharides of ever increasing complexity will 
bring new insights into their biological functions allowing further control of the 
biological processes in which they are involved. This knowledge can then be directly 
applied to drug targeting and carbohydrate-based therapeutics, expanding the 
applications of carbohydrates as medicinal biomolecules. 
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VIII Appendices 
Appendix 1: Saccharomyces cerevisiae 3-1 ,4-mannosyltransferase 
protein sequence. 
S. cerevisiae.....MFLEIPRWLLALI ILYLSIPLVVYYVIPYLFYGNKSTKKRI IIFVLGDVGHSPRICYHAI 	60 
S. cerevisiae ..... SFSKLc3WQVELCGYVEDTLPKIJSSDPNITVHHMSNLKRKGGGTSVIFMVKKV 	115 
S. cerevisiae ..... QVLSI FKLLWELRGSDYILVQNPPSIPILPIAVLYKLTGCKLIIDWHNLAYSILQLKFK 	174 
S. cerevisiae.....GNFYHPLVLISYMVEMIFSKFADYNLTVTEAMRKVLIQS ILNPKRCAVLYDRPAS 230 
S. cerevisiae ..... QFQPLAGDISRQKALTTKAFI IYIRDDFDTEKGDKIIVTSTSFTPOEDIGILLGALK 	288 
S. cerevisiae ..... IYENSYVKFDSSLPKILCFITGKGPLKEKYMKQVEEYDWKRCQIEFVWLSAEDYP 	343 
. 	 1(1 i ('SI (flV(.V't UTQQ(I fli OVAwtI 	IQ(I DtIIAIMIVO/I nI 1rUItuMlI V 	100 
S. cerevisiae ..... FVDRRELI-IESLIFAMKDADLYQKLKKNVTQEAENRWQSNWERTM ILKLIH 	449 
Regions highly conserved between mannosyltransferases from different species, S. 
cerevisiae, H. sapiens and C. elegans (Takahashi et at., 2000) are highlighted in 
grey. 
The 11216Y, N254D and D444G amino acid substitutions present in the proteins 
produced from the pET16b-GFPALG/ATM1, pET20b-GFPALGJATM1 and 
pET28a-GFPALG]ATM1 constructs are highlighted in green. 
The F1I5C amino acid substitution present in the proteins produced from the 
pET24a-HisGFP-link-ALG/ATM 1, pGAPZcA-HisGFP-link-ALG1ATM 1 and 
pPICZaA-HisGFP-link-ALG1 ATM 1 constructs is highlighted in red. 
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Appendix 2: CLUSTALW alignment of the protein sequences of A. 
thaliana, H. sapiens and S. cerevisiae -1 ,4-mannosyltransferases. 
CLUSTAL W (1.7) multiple sequence alignment 
A. 	thaiina ----------------------- MG--KRGR --------- ACVVVLGDLGRSPRNQYHAL 26 
H. 	sapiens MAASCLVLLALCLLLPLLLLGGWKRWPRGR—AARHVVAVVLGDVGRSPRMQYHAL 54 
S. 	cerevisiae MFLE1PRWLLALIILYLSIPLVVYVIPYLFYGNKSTKKRIIIFVLGDVGHSPRICYHAI 60 
A. 	thaliana SLARQASFQVDIVAYGGSIPHEAVLNFJPSIHIHfl4AQPRFIQYFPKILYPVTLLLKAFIQ 76 
H. 	sapiens SLAMHG-FSVTLLGECNSKPHDELLQNNRIQIVGLTELQsLAVGPRVFQ-yg--vKVVLQ 110 
S. 	cerevisiae SFSKLG-WQVELCGYVEDTLPKIISSDPNITVHHMSNLKRKGGGTSvIFMvKKvLFQVLS 
* 	. . 	. 	* 	..... 	 . 
119 
A. 	thaliana FTMLLWFLFVKVPAPDIFLVQNPPSvpTLIAvKWAsSWRRAAFvvDWHNFGYTLLALsLG 136 
H. 	sapiens AMYLLWKLMVREPGAYIFLQ-NPpGLpSIAVCWFVGCLCGSKLvIDWHNYGYS1MGLVHG 169 
S. 	cerevisiae IFKLLWELRGSD --- YILVQ-NPPSIPILPIAvLY-KLTGCKLIIDWHNLAYSILQLKFK 175 
A. 	thaliana RN--NLLVSLYRWSENHyGKMATGSLCVTK7d1QUEDQ ---- 4WGVRAKVLYDQPPEFFRP 190 
H. 	sapiens PN--HPLVLLAKWYEKFFGRLSHLNLCVTNAMREDLAD --- NWHIRAVTVYDKPASFFKE 224 
S. 	cerevisiae 6NFYHPLVLISYMVEMIFSKFADYNLTVTEAMRKYLIQSFULNPKRCAVLYDRPASQFQP 235 
A. 	thaliana ALLEERHELFCRVRKDLCHPIGVYDFISRELENQELNETLFTTKFNADISLK --- QNRPA 247 
H. 	sapiens TPLDLQFIRLITMKLGSMHS-P ----- FRARSEPEDPVTERSAFTERDAGSGLVTRLRERPA 278 
S. 	cerevisiae ------------ LAGDIS -------- RQKALTTKAEUKNYIRDDFDTEKGDK -------- 267 
A. 	thaliana LVVSSTSWTPDENFGILLEAAVMYDRRVAARSKGSETAEISEEQHHYPNLLFIITGKGPE 307 
H. 	sapiens LLVSSTSWTEDEDESILLAALEKE'EQLTLDG ------------- HNLPSLVCVITGKGPL 325 
S. 	cerevisiae I IVTSTSFTPDEOIGILLGALKIYENSYVKFD------------SSLPIcILCFITGKGPL 315 
A. 	thsliana KEMYEEKIKRLNLRHVAFRTMWLPAEDYPLLLGSADLGVCLHTSSSGLDLP4KVVDMEGC 367 
H. 	sapiens REYYSRLIHQKHEQK1QVCTPWLEAEDYPLLLGSADLGVCLHTSSSGLDLPMKVVDMFGC 385 
S. 	cerevisiae KEKYMKQVEEYDWKRCQIEE'VWLSAEDYPKLLQLCDYGVSLHTSSSGLDLPMKILDMFGS 375 
thaliana GLPVCSVSYSCIQELVKDGKNGLLFSSSSELADQLLILFKGFPGNCDALMSLKAGAMETG 427 
sapiens CLPVCAVNEKCLHELVKHEENGLVFEDSEELAAQLQMLFSNFPDPAGKLNQERKNLRES - 444 
S. 	cerevisiae GLPVIAMNYPVLDELVQHNVNGLKFVDRRELHESLIFAMK -- 	DADLYQKLKKNVTQE 
* 	- **.... . 
430 
A. 	thaliana SSGRATEWEDCAKPLITQVVSQ1ADS 454 
H. 	sapiens QQLRWDESWVQTVLPLVMDT-------464 
S. 	cerevisiae AENRWQSNWERTNDLRLIH ------- 449 
** 	* 	* 
247 
Appendix 3: Protein sequence of S. cerevisiae 	-1,4- 
mannosyltransferase showing the amino acids substitutions resulting 
from the random mutagenesis. 
S. cerevisiae.....MFLEIPRWLLALII LYLSIPLVVYYVIPYLFYGNKSTKKRI I IFVLGDVGHSPRICYHAI 	60 
S. cerevisiae..... SFSKLGWQVELCGYVEDTLPKIISSDPNITVHHMS1KRKGGGTSVIFMvKKv1 	115 
S. cerevisiae ..... QVLSI FKLLWELRGSOYILVQNPPSIPILPIAVLYKLTGCKLIIDWHNLAYSILQLKFK 	174 
S. cerevisiae..... GNFYHPLVLISYMVEMIFSKFADYNLTVTEAMRKYLIQSFHLNPKRCAVL IRPAS 230 
S. cerevisia8 ..... QFQPLAGDISRQ ILTTKAFIKNYIRDDFDTEKGDKIIVTSTSFrPDEDIGILLGALK 	288 
S. cerevisiae ..... IYENSYV DSSLPKILCF1TGKGPLKEKYMKQVE DWKRCQI WLSAEDYP 	343 
I 
S. cerovisiae..... KLLQLCDYGVSLHTSSSGLDLPMKILDMFGSGLPVIAMPVLDELVQHNVNGLK 	398 
I 
S. cerevisiae..... FVD IELHESLIFAMKDADLYQKLKKNVTQEAENRWQSNWERTMRDLKLIH 	449 
Regions highly conserved between mannosyltransferases from different species, S. 
cerevisiae, H. sapiens and C. elegans (Takahashi et aL, 2000) are highlighted in 
grey. 
The Fl 15C amino acid substitution present in the protein produced from the 
construct used as the template for the random mutagenesis, pET24a-HisGFP-link-
ALGIATM1, is highlighted in red. 
The L96S, A244T, F297S, Y326F and F335L amino acid substitutions present in the 
protein produced from the 1E6-4 construct are highlighted in green. 
The D226V, F308Y, S375A, Y384F and R404G amino acid substitutions present in 
the protein produced from the 1A4-1 construct are highlighted in pink. 
